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ABSTRACT 
The gibberellin (GA) phytohormones are integral to many aspects of plant growth and 
development.  Perhaps due to the importance of GA signaling, many plant-associated 
microbes, both fungal and bacterial, are also capable of producing GAs, presumably to 
manipulate their plant host.  The plant and fungal GA biosynthetic pathways have been well 
studied and fully characterized, revealing that these organisms have convergently evolved the 
ability to produce GA.  However, GA biosynthesis in bacteria has remained elusive.  Many 
rhizobia, the bacterial, nitrogen-fixing symbionts associated with legumes, have been found 
to contain a putative GA biosynthetic gene cluster/operon (GA operon).  Through 
characterization of the genes from this operon, GA biosynthesis in rhizobia has now been 
fully elucidated, thereby providing the first GA biosynthetic pathway for bacteria.  Analysis 
of this pathway revealed not only that bacteria have convergently evolved GA biosynthesis 
independently of plants and fungi, but also that some of the key biochemical transformations 
are conserved, including mechanisms of the ring contraction reaction that represents a 
committed step in GA biosynthesis.  It has further been found that some rhizobia contain an 
additional gene that is responsible for converting the non-bioactive product of the GA operon 
into a common bioactive form, and phylogenetic analyses suggest that this gene has been 
obtained independently of the GA operon itself.  Ultimately, it appears that rhizobia produce 
GA in order to manipulate their host during symbiosis, specifically by increasing the size of 
the nodules in which they reside, thereby increasing the number of bacteria within the nodule 
that can be released into the soil.  Thus, bacteria seem to have acquired GA biosynthesis in 
order to gain a selective advantage in their symbiosis with legumes. 
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CHAPTER 1 
GENERAL INTRODUCTION AND BACKGROUND 
 
 It has been firmly established that many plant-associated microbes are capable of 
producing plant hormones, or structural mimics of these compounds.1  One of the earliest 
examples of this phenomenon was the discovery of gibberellic acid (GA) production by the 
fungus Gibberella fujikuroi (anamorph Fusarium fujikuroi), which causes “bakanae” or 
“foolish seedling” disease in rice.2 This disease is characterized by infected plants being 
greatly elongated and chlorotic, and it was recognized that fungal GA was responsible for 
this phenotype.  This effect on plant height led to the correct assumption and subsequent 
discovery that GAs were endogenously produced by plants as growth promoting hormones.3  
Collectively, research of both plant and fungal GA biosynthesis has led to the discovery and 
characterization of a large number of GAs, all of which are structurally and biosynthetically 
related, with that number currently at 136 confirmed GAs.2  It was recognized early on that a 
universal naming system would need to be applied in order to logically keep track of new GA 
compounds.  It was decided upon that instead of gibberellic acid, these compounds would be 
termed “gibberellins” and would be numbered sequentially in order of discovery, using the 
nomenclature gibberellin A1–An, and thus the abbreviation would remain as GA.4  This 
included allocation of the name GA3 to “gibberellic acid”, the bioactive compound originally 
isolated from G. fujikuroi.5  Although gibberellic acid is often used interchangeably with 
gibberellin within the literature, it should be noted that gibberellic acid, though not correct in 
terms of nomenclature, is commonly used to specifically refer to the compound GA3. 
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 Chemically, GAs are diterpenoid-derived compounds containing a fused, tetracyclic 
6-5-6-5 ring structure, referred to as the ent-gibberellane backbone.6  As diterpenoids, they 
are derived from the general 20-carbon precursor (E,E,E)-geranylgeranyl diphosphate 
(GGPP).  However, GAs can be classified into two major categories: the diterpenoid C20 GAs 
and the norditerpenoid C19 GAs.  While both contain a C-7 carboxylate moiety, the C19 GAs 
have a 19,10 γ-lactone ring and have lost C-20 as CO2, at least within both plant and fungal 
biosynthesis.  The biosynthesis of these compounds from GGPP is complex and requires over 
10 distinct enzymatic steps in order for biologically active GAs to be produced, and overall, 
GA biosynthesis in both plants and fungi has been essentially fully elucidated (see Figure 1 
for summarized biosynthetic pathways).  Although there are examples of some species-
specific GAs that seem to have a distinct biological effect (e.g. the induction of flowering by 
GA5 and GA6 in Lolium species7), there are only four recognized common bioactive GAs: 
GA1, GA3, GA4, and GA7.  All four of these are C19 GAs, and each further contains a 3β-
hydroxyl group, which is necessary for bioactivity via binding to the requisite receptor.8  A 
1,2 double bond (GA3 and GA7) and/or 13-hydroxyl group (GA1 and GA3) can also be 
present, and these alter bioactivity to a certain degree.9   
 
GA Biosynthesis 
Plants 
 In plants, the isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl 
diphosphate  (DMAPP) can be synthesized either through the cytosolic mevalonate (MVA) 
pathway or the plastid-localized methylerythritol phosphate (MEP) pathway.  The GGPP 
pool utilized within plant GA biosynthesis is predominantly derived from MEP pathway-
3 
 
 
derived precursors within the plastid.10  Plant GA biosynthesis is then initiated within the 
plastid via cyclization of GGPP to ent-copalyl diphosphate (CPP) by ent-copalyl diphosphate 
synthase (CPS), a class II diterpene cyclase.11  CPP is then further cyclized to the tetracyclic 
ent-kaurene via the action of a class I diterpene synthase, ent-kaurene synthase (KS),12 
resulting in formation of the fused, tetracyclic 6-6-6-5 ent-kaurane backbone (see Figure 2 
for ring structure and carbon numbering), and this reaction is also performed within the 
plastid.13   Following formation of this diterpene olefin, a series of oxygenations are carried 
out by a combination of cytochrome P450 monooxygenases (CYPs) and 2-oxoglutarate 
dependent dioxygenases (2ODDs).  For the most part, the CYP-catalyzed oxidations occur 
within the endoplasmic reticulum (ER), as plant CYPs are membrane-bound here, while the 
2ODD oxidations occur within the cytosol, as 2ODD are soluble enzymes.7  Oxidation of 
ent-kaurene is carried out by an ent-kaurene oxidase (KO), a CYP belonging to the 
CYP701A subfamily,14 which sequentially oxidizes C-19 to first form ent-kaurenol, then ent-
kaurenal, and ultimately ent-kaurenoic acid.15  This particular CYP seems to be localized 
within the outer plastid envelope, thus providing biosynthetic proximity to the downstream 
CYPs located within the ER.16  A committed step into GA biosynthesis is then carried out by 
an ent-kaurenoic acid oxidase (KAO), a member of the CYP88A subfamily, which catalyzes 
the contraction of the B ring to form the 6-5-6-5 ent-gibberellane backbone (Figure 2).  This 
occurs first through oxidation of C-7 to form ent-7α-hydroxykaurenoic acid, after which this 
compound is further transformed via ring contraction and oxidative extrusion of C-7 to form 
GA12-aldehyde.17  Typically, the plant KAO will also further oxidize the C-7 aldehyde to the 
acid to form GA12, though there are cases in specific plant lineages (e.g. Cucurbits) where a 
2ODD GA 7-oxidase (GA7ox) is required for this final C-7 oxidation.18 
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 Following formation of GA12, GA biosynthesis in plants proceeds through two major 
routes: the 13-hydroxylation or non-13-hydroxylation pathways.  In the 13-hydroxylation 
pathway, CYPs from the CYP714B subfamily act as 13-oxidases to hydroxylate C-13 and 
produce GA53.19  C-20 of  this intermediate is then oxidized by a GA 20-oxidase (GA20ox), 
which is a 2ODD enzyme,20 to form GA44 (C-20 alcohol), GA19 (C-20 aldehyde), and 
ultimately GA20 in which C-20 has been further oxidized and lost as CO2,21 with a resulting 
19,10 γ-lactone ring.  In the non-13-hydroxylation pathway, oxidations by GA20ox are 
analogous to the reactions found in the non-13-hydroxylation pathway, whereby GA12 is first 
oxidized to GA15 (C-20 alcohol), then to GA24 (C-20 aldehyde), and finally to GA9, where 
again, C-20 has been lost and a 19,10 γ-lactone ring has been formed.20  The final enzyme to 
act in the formation of bioactive GAs is a GA 3-oxidase (GA3ox), a 2ODD that adds a C-3β 
hydroxyl group and/or desaturates the bond between C-2 and C-3.22–24  In most plants, simple 
3β-hydroxylation occurs on GA9 to form GA4 and on GA20 to form GA1. Alternatively, in 
certain plant systems, 2,3-desaturation can occur on GA9 to produce 2,3-dehydro-GA9, and 
this is then followed by 3β-hydroxylation to ultimately produce GA7, which contains a 1,2 
double bond.  This same sequence of reactions can be performed on GA20 to first form GA5, 
then GA3.6  Overall, GA1 and GA4 appear to be the major bioactive compounds produced 
endogenously by plants, as they have been found within all plants that have been studied, 
while GA3 and GA7 only seems to be an endogenous hormone in certain plant lineages.7 
 GAs are commonly inactivated through the addition of a C-2β hydroxyl group 
catalyzed by GA 2-oxidases (GA2ox), which are 2ODD enzymes.7  Specific GA2ox enzymes 
can act on either the C20 GAs or the C19 GAs, with both resulting in inactivation of the 
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relevant GA.25,26  Additionally, GAs may be inactivated through 16α,17 epoxidation, which 
is catalyzed by a CYP (CYP714D).27 
Fungi 
 In fungi, a biosynthetic gene cluster encodes for the necessary GA biosynthetic 
enzymes, and these were predominantly characterized for G. fujikuroi, though some of the 
initial characterization was performed in another fungal species, Phaeosphaeria sp. L487.28  
This gene cluster contains all of the enzymes needed for fungal GA biosynthesis, in 
particular, a GGPP synthase (ggs2), a fused CPS/KS synthase (cps/ks), four CYPs (P450-1, 
P450-2, P450-3, and P450-4) and a desaturase (des).  In contrast to plants, the isoprenoid 
precursors for fungal GA biosynthesis seem to be derived from the MVA pathway.29  The 
initial steps of fungal GA biosynthesis proceed in a similar fashion to that of plants, but with 
some notable exceptions.  First, while biosynthesis is also initiated via cyclization of GGPP 
to ent-CPP then ent-kaurene, these reactions are carried out by a single fused protein that 
contains both CPS and KS domains.30  The KO-catalyzed oxidation of ent-kaurene to ent-
kaurenoic acid is then carried out by a CYP (P450-4),31 but this enzyme falls within the 
CYP503 family and has distinct evolutionary origins from the plant CYP.32  The fungal KAO 
is similarly distinct, as while it is a CYP (P450-1) that catalyzes the formation of GA12-
aldehyde from ent-kaurenoic acid, it belongs to the CYP68A subfamily, which is distinct 
from the analogous plant CYP.33  Additionally, the biochemistry performed by the fungal 
KAO also differs from that in plants, as it further hydroxylates GA12-aldehyde at the C-3β 
position to form GA14-aldehyde before performing the final oxidation on C-7 to form GA14. 
 The nature of the GA20ox in fungi is completely distinct from plants, as fungi make 
use of a CYP (P450-2; CYP68B) as opposed to the 2ODD utilized by plants.  However, the 
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general chemical transformation catalyzed by this enzyme is the same, as the fungal GA20ox 
oxidizes C-20 of GA14, resulting in loss of C-20 as CO2,34 and formation of a 19,10 γ-lactone 
ring to form bioactive GA4.35  The final GA produced is species-dependent in fungi, and GA4 
can be further converted into GA7 via 1,2 double bond formation performed by the fungal 
desaturase, which was found to be a 2ODD type enzyme.36,37  Finally, GA7 can be 13-
hydroxylated by another CYP (P450-3; CYP69A1), resulting in GA3.33,36  Again, this is 
distinct from plant 13-hydroxylation, as this occurs as the ultimate step in fugal GA 
biosynthesis, as compared to it being an intermediate step in plant biosynthesis.  
Additionally, while both plants and fungi make use of CYPs for this reaction, they too fall 
into distinct CYP families. 
 Collectively, the plant and fungal GA biosynthetic pathways differ in both enzymes 
utilized and biosynthetic intermediates.  However, because both pathways end on bioactive 
GAs (with specific convergence on bioactive GA4), this represents an extreme example of 
biosynthetic convergent evolution.32  While the early cyclization steps are suggested to share 
an evolutionary origin,30,38 it is widely held that the downstream oxidative steps have been 
independently evolved in plants and fungi. 
GA biosynthesis in bacteria 
 The first evidence of GA production by bacteria using modern methods such as gas 
chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography 
(HPLC) was presented for the rhizobial strain Rhizobium etli bv. phaseoli 8002 (previously 
known as R. leguminosarum bv. phaseoli 8002), which was reported to produce GA9, GA20, 
GA4, and GA1 in aerobic culture, although only GA1 and GA4 were verified with GC-MS.39  
Subsequent studies reported the production of GAs in a number of different species of 
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rhizobacteria,40,41 which are soil bacteria that typically inhabit the rhizosphere surrounding 
plant roots.  Additionally, many of the reported species were rhizobia, the nitrogen-fixing 
symbionts associated with legumes, and this included Bradyrhizobium japonicum, the 
symbiont of soybean (Glycine max).42  
 Prior to sequencing of the B. japonicum genome, a cytochrome P450 monooxygenase 
(CYP)-rich locus was identified within this species (Figure 3).43  The CYPs within this locus 
(CYP112 and CYP114) were found to be expressed at a low level anaerobically with much 
higher expression within the nodule during symbiosis.  Mutants of this locus did not seem to 
be impaired in their ability to nodulate, and thus this locus was deemed to be non-essential 
for symbiotic interactions between B. japonicum and soybean.  Follow-up studies revealed 
that these CYPs were part of a larger gene cluster that contained in total three full length 
CYPs (CYP112, CYP114, CYP117), a CYP pseudogene (pCYP115), a ferredoxin (Fdx), a 
predicted short-chain alcohol dehydrogenase/reductase (Adh), an isoprenoid diphosphate 
synthase (IDS) sharing homology with the dimethylallyltranstranserase from E. coli 
(DMATT), and two putative diterpene cyclases (ORF7 and ORF8).44  This gene cluster was 
predicted to act transcriptionally as an operon, and was subsequently found to be distributed 
more widely in rhizobia, with examples of this gene cluster found within the 
Bradyrhizobium, Mesorhizobium, Rhizobium, and Sinorhizobium genera.45  Due to the 
presence of genes putatively involved in diterpene synthesis in conjunction with oxidative 
enzymes, this operon was predicted to be involved in GA biosynthesis within rhizobia.44,45 
 The first genes to be characterized from this operon were the putative diterpene 
synthases from B. japonicum, which were shown to act as CPS and KS enzymes, as they 
were able to act consecutively to produce ent-kaurene from a GGPP precursor (Figure 4).  In 
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particular, the gene originally annotated as ORF7 was shown to act as a CPS, and the gene 
annotated as ORF8 was shown to act as a KS.38  As such, these genes will be referred to as 
CPS and KS throughout the remainder of this dissertation.  The CPS and KS homologs from 
M. loti MAFF303099, R. etli CFN 42, and S. fredii NGR234 were similarly characterized, 
showing that the function of these enzymes is conserved throughout the rhizobia containing 
this operon.46  Furthermore, the proposed IDS homolog (DMATT) from S. fredii was further 
shown to be necessary for CPS and KS activity, indirectly demonstrating that this gene is 
responsible for producing the GGPP substrate pool.46  Thus, the gene originally annotated as 
DMATT is acting as a GGPS, and as such will be referred to by this name for the remainder 
of this dissertation.  This operon was further identified within the bacterial rice pathogen 
Xanthomonas oryzae pv. oryzicola BLS256 (Xoc), and the functions of the CPS and KS from 
this distantly homologous operon were shown to be conserved here as well.47  Furthermore, 
mutagenesis of this operon revealed that the product of this operon acted as a virulence factor 
for this pathogen through suppression of the JA-mediated defense response.47 
 Subsequent studies with B. japonicum cells isolated from soybean nodules (termed 
“bacteroids”) revealed distinct GA oxidase activity that appears to be directly from the 
bacteria and not the plant host.48  In particular, within this study, radioisotope-labeled GA 
precursors were incubated within isolated and purified bacteroids, and this led to the 
extraction and detection of various labeled GA products.  Specifically, labeled ent-kaurenoic 
acid that was incubated in bacteroid fractions was converted into GA24 and GA9, labeled 
GA12-aldehyde was converted into GA9, and labeled GA12 was converted into GA15, GA24, 
and GA9.  Surprisingly, labeled GA9 was not converted by bacteroids into any bioactive GAs 
(such as GA4) through 3β-hydroxylation, suggesting that B. japonicum bacteroids may not be 
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capable of GA biosynthesis beyond GA9 as a final product.  Indeed, GA9 was one of the 
major GAs found endogenously within the bacteroid extract (i.e. without labeled substrates 
being incubated), further implicating GA9 as the ultimate GA produced by B. japonicum.  It 
was also determined within this same manuscript that cps and ks transcripts from the operon 
are not expressed at a high level early on during the symbiosis between B. japonicum and 
soybean, but are noticeably increased later in soybean development, particularly during the 
flowering and early pod stages.  Correspondingly, the aforementioned GA oxidase activities 
associated with B. japonicum were only detected from bacteroids isolated from nodules after 
the flowering stage.  This suggests that GA biosynthetic enzymes from this organism are not 
highly expressed early in symbiosis, and may not then have a physiological impact until at or 
after the flowering stage of the plant. 
 
Enzymes of the Putative GA Operon 
Isoprenoid diphosphate synthases 
 The isoprenoid diphosphate synthase (IDS) enzymes catalyze head to tail 
condensation of 5-carbon isoprenoid building blocks to form the linear precursors of 
terpenoid-derived compounds.49  This is initiated through the initial condensation of IPP with 
DMAPP to form the monoterpenoid (C10) precursor geranyl diphosphate (GPP), with an 
additional condensation of IPP and GPP producing the sesquiterpenoid (C15) precursor 
farnesyl diphosphate (FPP), and a third condensation of IPP with FPP resulting in the 
diterpenoid (C20) precursor GGPP.  The specific enzymes that form each of these as a final, 
major product are named accordingly as a geranyl diphosphate synthase (GPS), farnesyl 
diphosphate synthase (FPS), and GGPP synthase (GGPS). These enzymes typically form one 
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linear terpenoid as a major product with minimal amounts of the precursors being formed.  
For example, though the GGPS enzyme necessarily forms GPP and FPP, the predominantly 
observed final product is GGPP.  The majority of diterpenoid compounds are derived from 
all-trans GGPP (i.e. [E,E,E]-GGPP), though there are enzymes that can produce the all-cis 
compound (Z,Z,Z)-nerylneryl diphosphate (NNPP).50 
Diterpene cyclases 
 Within diterpenoid natural product biosynthesis, the linear diterpenoid precursor 
GGPP is generally transformed initially by diterpene cyclases, which often results in 
substrate cyclization.  One major class of diterpenoid natural products is the labdane-related 
diterpenoids, which are characterized as having a labdane/decalin ring fused ring structure 
(see ent-CPP in Figure 1 for example).51  The initial core labdane structure is formed by 
class II diterpene cyclases that carry out protonation-initiated cyclization of GGPP.  This 
cyclization by class II enzymes can produce multiple stereoisomers, depending on the 
enzyme, including normal, ent-, and syn- conformations.  In GA biosynthesis, this activity is 
performed by the CPS enzyme that produces ent-CPP from GGPP.   
Class II diterpene cyclase products are further transformed via the action of class I 
diterpene synthases, which carry out catalysis through the lysis/ionization of the diphosphate 
moiety, often resulting in further cyclization of the compound, though this is not always the 
case.  The corresponding enzyme in GA biosynthesis is the KS, which acts to convert 
bicyclic ent-CPP into tetracyclic ent-kaurene, thus producing the eponymous 6-6-6-5 fused 
ent-kaurane backbone.  Within plant GA biosynthesis, both the class II and class I diterpene 
synthase enzymes are localized within the plastid as a result of an N-terminal signaling 
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peptide, and are anchored within the membrane,7 while in bacteria, diterpene synthases seem 
to be soluble. 
Cytochrome P450 monooxygenases 
 Cytochrome P450 monooxygenases (CYPs) are heme-containing enzymes that 
commonly catalyze the addition of a hydroxyl group onto a non-activated carbon.  The 
“P450” nomenclature was given to these enzymes due to the characteristic spectral 
absorbance peak observed at 450 nm following reduction of the heme-bound iron and carbon 
monoxide (CO) binding.52  The CYP catalytic cycle has been well defined, and is initiated 
through the binding of the appropriate substrate to the enzyme active site, which displaces 
water from interacting with the ferric (Fe3+) heme-bound iron, thus resulting in a spin shift 
change of that iron from low spin to high spin.  This change in spin state results in a higher 
redox potential for the heme-bound iron, which is crucial for the subsequent reductions of 
this iron to the ferrous (Fe2+) state catalyzed by CYP redox partners.  The initial reduction to 
the ferrous state allows for molecular oxygen (O2) to be coordinated to this iron atom.  
Subsequent reduction and protonation results in the release of one oxygen atom as water, and 
the formation of the highly reactive ferryl-oxo intermediate referred to as “Compound I”, 
which then prototypically carries out monooxygenase activity on an unactivated carbon.  
This is typically achieved through the stereospecific abstraction of a hydrogen from a carbon, 
resulting in the formation of a radical intermediate in which the radical is localized to this 
reactive carbon center.  Through an “oxygen rebound” mechanism, a hydroxyl group derived 
from the reactive ferryl-oxo species is added to the carbon (Figure 5).  Though this is the 
basic scenario for a CYP-catalyzed reaction, CYPs are capable of much more complex 
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chemical transformations such as ring contraction/expansion, decarboxylation or 
decarbonylation, and carbon-carbon bond cleavage.52 
 As stated previously, in order to be catalytically active, CYPs require electrons to 
reduce the heme-bound iron.  In eukaryotes, these are typically supplied by a cytochrome 
P450 reductase (CPR) that obtains electrons from NAD(P)H.53  Eukaryotic CYPs, along with 
their requisite CPRs, are typically associated with a membrane, usually the endoplasmic 
reticulum, via a transmembrane, anchoring domain. In bacteria, the electrons supplied to 
CYPs are often provided by a soluble ferredoxin (Fd) that is reduced through the action of a 
ferredoxin reductase (FdR) that acquires electrons from NAD(P)H (Figure 6).53   
 CYPs are normally annotated within numerical families, which is indicative of amino 
acid sequence identity ≥40%.  Subfamilies, which are representative of CYPs with amino 
acid identity ≥55%,  are annotated further through the addition of a unique letter to the end of 
the family number.54  However, this nomenclature is relatively non-descript, as enzymes are 
numbered and named based upon order of discovery, and thus the family number itself is not 
indicative of relative similarity to other CYP families.  
Ferredoxins 
 Ferredoxin (Fd) proteins act as electron carriers to reduce and activate CYPs for 
enzymatic activity.  These proteins are typically soluble within bacteria and contain varying 
iron-sulfur clusters such as [2Fe-2S], [3Fe-4S], and [4Fe-4S].53  Within CYP redox chemistry 
in bacteria, a Fd protein usually carries electrons from an FAD-containing ferredoxin 
reductase (FdR), which is reduced via NAD(P)H, to a corresponding CYP, which the Fd 
reduces twice as part of the CYP catalytic cycle (Figure 6).52  
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Short chain dehydrogenases/reductases 
 The short-chain dehydrogenase/reductase (SDR) family are unified by their Rossman-
fold motif that allows for binding to NAD(P)(H).  These enzymes often perform 
oxidoreductase chemistries, such as the alcohol-ketone and aldehyde-carboxylate redox 
reactions, though they are capable of more complex chemistries such as epimerization, 
isomerization, and decarboxylation.55 
 
GA Signaling in Plants 
 Although produced by plant-associated microbes, GAs are only recognized to exert a 
physiological effect in plants.  More generally, bioactive GAs control multiple endogenous 
processes within plants such as cell expansion, stem elongation, flowering, and seed 
germination.56  GA phytohormones are perceived by GIBBERELLIN INSENSITIVE 
DWARF1 (GID1) proteins, which are nuclear localized receptors.57–59  This signaling 
mechanism appears to be conserved throughout plants that utilize GA signaling, as the 
lycophyte Selaginella moellendorffii, which produces GAs, also relies on GID1 to perceive 
GA, whereas the bryophyte Physcomitrella patens, which does not produce GAs, does not.60  
Indeed, it appears that GA signaling evolved in land plants following the divergence of the 
bryophytes, and GAs seem to be a major component associated with vascular plants.61,62 
 The binding of bioactive GA to GID1 results in an interaction between GID1 and 
DELLA growth repressor proteins such as GIBBERELLIN INSENSITIVE (GAI).63  Under 
conditions where bioactive GA is low or absent, DELLA proteins act as negative 
transcriptional regulators of GA signaling.  The binding of GA to GID1 causes an allosteric 
change in GID1 that creates a binding region for DELLA proteins,8 and upon interaction with 
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GID1, the DELLA proteins undergo a conformational change that exposes them for 
ubiquitin-mediated degradation.64  Degradation of the DELLA proteins relieves their 
repression of GA-related transcription factors, thus allowing for expression of genes that 
control the aforementioned GA-induced physiological effects. 
 In addition to physiological effects on growth and development, there are also 
implications for GA-mediated effects on plant defense.  In particular, it has been established 
that at least in some plant species, increases in GA-mediated signaling can cause changes in 
resistance and susceptibility to certain pathogens,65 and this has been shown to be caused, at 
least in part, through decreases in jasmonic acid (JA)-induced plant defenses.66  This 
phenomenon is enacted through the interaction of DELLA proteins with JA ZIM-domain 
(JAZ) proteins, which act as negative transcriptional regulators of JA-induced gene 
expression.67   Accordingly, it was discovered that GA and JA act antagonistically to one 
another, presumably as a means for the plant to balance growth and defense, respectively.68  
Indeed, increased GA signaling or application of exogenous GA3 to rice plants leads to 
increased susceptibility to the bacterial pathogen Xanthomonas oryzae pv. oryzae.65,69  These 
observations provided the rationale that G. fujikuroi likely produces bioactive GA in order to 
create an imbalance in the defense signaling of the infected host, thus allowing for increased 
virulence of the pathogen.  This idea is strengthened by the decreased virulence observed in 
the infection of rice by GA-deficient knockouts of G. fujikuroi.70 
 
The Rhizobia-Legume Symbiosis 
 Rhizobia are gram negative, soil-dwelling proteobacteria that are able to reduce 
atmospheric nitrogen (N2) into ammonium via the activity of the nitrogenase enzyme.71  
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These bacteria have evolved with legumes to form a symbiotic interaction in which rhizobia 
fix nitrogen and supply it to the host plant in exchange for a carbon supply and relatively 
competition-free niche.  Nitrogen fixation by rhizobia in symbiosis with legumes accounts 
for approximately 200 million tons of reduced N2 per year,72 and is thus a major means by 
which nitrogen is incorporated into the biological environment. 
 Within this symbiosis, rhizobia reside within root organs referred to as nodules.  In 
general, nodules are classified into two distinct groups: indeterminate and determinate 
nodules.73  Indeterminate nodules are characterized as having a persistent meristem, and thus 
continuously grow via cell division.  This growth mechanism results in an elongated and 
sometimes branched structure.  In contrast, determinate nodules do not have persistent 
meristems and typically grow via cell expansion after cell division ceases.  When inside the 
nodule, rhizobia cells are referred to as bacteroids, and reside within membrane-bound 
structures called symbiosomes.74  In general, bacteroids that inhabit indeterminate nodules 
are elongated and differentiated such that they cannot continue free living in the soil after 
escape from the nodule following nodule senescence.75  Conversely, bacteroids that inhabit 
determinate nodules are usually non-differentiated and can continue living within the soil 
following nodule senescence. 
A role for the putative GA operon in symbiosis 
 As a part of the initial discovery and analysis of the putative GA operon, it was noted 
that CYP112 and CYP114 proteins from B. japonicum seem to be specifically expressed in 
symbiosis with soybean, with a lower level of expression during anaerobic culture growth.43  
Follow up experiments confirmed that the promoter of the entire operon was active within 
symbiosis and, to a lesser degree, in anaerobic growth,44  and multiple transcriptomic and 
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proteomic studies have further verified this symbiotic expression in B. japonicum.76–81  
Specific upregulation of operon gene expression during symbiosis has also been confirmed in 
M. loti, R. etli, and S. fredii, suggesting that expression of the operon in symbiosis is likely 
true in all rhizobia with this gene cluster.82–87  Also, this further indicates that this operon, 
and the effect imparted by this operon, is probably involved in the interaction of rhizobial 
species with their host plant during symbiosis. 
 Indeed, analysis of the genomic location of the GA operon revealed that it is 
invariably located within the symbiotic island or plasmid of a rhizobial species, at least 
within organisms with fully sequenced and annotated genomes such as B. japonicum 
USDA110, M. loti MAFF303099, M. loti R7A, S. fredii NGR234, and R. etli CFN 42.83,88–92  
Interestingly, the GC content of these operons is significantly higher than the surrounding 
DNA content of the symbiotic module (~10% higher) and the operons are often flanked by 
various insertion sequence (IS) elements such as transposases, suggesting that this gene 
cluster has been mobilized through horizontal gene transfer.90–92   Additionally, these operons 
seem to be under control of NifA-RpoN promoters,46,85,93,94 which are typically associated 
with genes involved in nitrogen fixation.  The association with nitrogen fixation gene 
expression is further implicated by their expression seemingly being affected by the RegSR 
transcription factor that activates NifA,95 along with the FixLJ-FixK2 signaling cascade that 
is involved in promoting microanaerobic respiration utilized in the microoxic conditions of 
the nodule.96   Collectively, the location on the symbiotic module, coexpression with nitrogen 
fixation-related genes, and specific expression during symbiosis would strongly suggest that 
this putative GA operon is playing a role in a rhizobial species’ symbiotic interaction with its 
host legume.  However, initial knockout studies with the putative GA operon from B. 
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japonicum revealed that the genes from this operon are not essential for this species’ 
symbiosis with soybean, and that no noticeable differences in physical phenotypes (i.e. 
height, mass, nodulation) were observed between plants nodulated by wild-type and operon 
knockout strains of B. japonicum.43  Thus, although expressed by bacteroids within the 
nodule, a role for this operon in symbiosis has remained elusive. 
GA in nodulation and symbiosis 
 It has been demonstrated that plant-derived GA likely plays a role in the nodulation 
process, both in the initiation of nodulation and in nodule development.97  For example, a 
lack GA signaling impairs nodule formation, with a reduction in overall nodulation and 
aberrantly formed nodules,98 and GA biosynthesis-related genes are upregulated early during 
the nodulation process,97 both of which suggest that GAs are essential for the initial 
development of nodules.  However, the addition of bioactive GA to various legumes of both 
nodule types (i.e. indeterminate and determinate) also results in a delay and overall reduction 
in the formation of nodules.98–106  In general, the application of higher concentrations of 
bioactive GA (>10-6 M) to root systems results in a decrease in nodule number, as does 
constitutive, or significantly up-regulated endogenous GA signaling.107  Thus, the effect of 
GAs in nodulation can either be positive or negative depending on the concentration of GA, 
though this amount varies with the legume species being tested.  However, the collective 
findings on GA in nodulation would suggest that concentrations that are either too high or 
too low (i.e. below what the plant would normally produce) are inhibitory to nodulation. 
 Interestingly, it has been found in some indeterminate nodule-forming species (Pisum 
sativum and Medicago truncatula) that GA may play a negative role in nodule senescence.  
In particular, transcriptomic studies of aging nodules revealed an upregulation of GA2ox 
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genes, which would be involved in deactivating GA signaling.108,109  This suggests that 
bioactive GA may inhibit the onset of nodule senescence and that this activity must be turned 
off in order for senescence to occur normally. 
 The numerous reports of rhizobia being capable of GA production39,41,42 would then 
suggest that rhizobial GA may also be playing a role in nodulation.  However, a function for 
this putative GA production has not been established, and the actual GA production itself by 
bacteria has not been defined, making the physiological mechanism of rhizobial GA a major 
question.  
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Figure 1. GA biosynthesis in plants and fungi.  Shown are the biosynthetic schemes for 
GA production in plants (green) and fungi (brown). 
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Figure 2. Ring structure, nomenclature, and numbering for ent-kaurane and ent-
gibberellane diterpenoids.  The GA precursor ent-kaurene is representative of the 6-6-6-5 
ent-kaurane carbon backbone, while GA12-aldehyde is representative of the 6-5-6-5 ent-
gibberellane backbone.  Note that in the C19 GAs, carbon 20 has been lost. 
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Figure 3. Putative GA biosynthetic operon in rhizobia.  This gene cluster/operon is 
representative of that initially identified in Bradyrhizobium japonicum USDA110.  Although 
additional genes such as a full length CYP115 and isopententyl diphosphate δ-isomerase 
(IDI) are found in this operon within some bacterial strains, the genes spanning from 
CYP112 to KS are essentially always found, and are thus referred to as the “core operon”.  
kb = kilobase. 
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Figure 4.  Confirmed enzyme functions from putative GA biosynthetic operon.  It has 
previously been shown that the putative GGPS, CPS, and KS do indeed possess the predicted 
enzymatic activity, acting sequentially to produce ent-kaurene from isoprenoid precursors.  
This was shown for genes from several rhizobial species38,46 and one Xanthomonas species.47 
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Figure 5. Prototypical CYP-catalyzed hydroxylation reaction. Although CYPs are 
capable of catalyzing much more complex chemistry, hydroxylation through the “oxygen 
rebound” mechanism is well defined and representative of many CYPs.  In this scenario, the 
R groups usually represent bonds to either hydrogen or carbon. 
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Figure 6. Three-component CYP redox system in bacteria. In this system, an electron (e-) 
is supplied to an FAD-containing ferredoxin reductase through oxidation of NAD(P)H. This 
reductase then reduces a ferredoxin, which in turn shuttles the electron to the CYP as part of 
the CYP catalytic cycle.  This electron transfer must be performed twice (thereby supplying 
two electrons in total) for completion of the CYP catalytic cycle, and thus activation of 
molecular oxygen (O2) for addition onto a substrate. 
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Abstract 
Gibberellins (GAs) are crucial phytohormones involved in many aspects of plant 
growth and development, including plant-microbe interactions, which has led to GA 
production by plant-associated fungi and bacteria as well.  While the GA biosynthetic 
pathways in plants and fungi have been elucidated and found to have independently arisen 
through convergent evolution, little has been uncovered about GA biosynthesis in bacteria.  
Some nitrogen-fixing/symbiotic, legume-associated rhizobia, including Bradyrhizobium 
japonicum, the symbiont of soybean, and Sinorhizobium fredii, a broad-host-nodulating 
species, contain a putative GA biosynthetic operon/gene cluster.  Through functional 
characterization of five unknown genes, we demonstrate that this operon encodes the 
enzymes necessary to produce GA9, thereby elucidating bacterial GA biosynthesis.  The 
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distinct nature of these enzymes indicates that bacteria have independently evolved a third 
biosynthetic pathway for GA production.  Furthermore, our results also reveal a central 
biochemical logic that is followed in all three convergently evolved GA biosynthetic 
pathway. 
 
Introduction 
Gibberellins (GAs) are complex diterpenoid phytohormones characterized by their 6-
5-6-5 tetracyclic ent-gibberellane backbone (See Supplementary Results, Supplementary 
Fig. 1 for structure annotation).  The common bioactive GAs (GA1, GA3, GA4, and GA7) are 
crucial to plant growth and development1,2, as well as plant-microbe interactions3,4, and other 
GAs have been implicated in species-specific bioactivity (e.g. GA5 and GA6 in Lolium sp. 
flower-induction2).  Notably, the semi-dwarf crop varieties at the center of the “Green 
Revolution”, which led to significant increases in worldwide crop yields, were found to result 
from altered GA signaling5,6.   Although endogenous to plants, GAs were initially discovered 
in the fungal plant pathogen Gibberella fujikuroi7 (also known as Fusarium fujikuroi), and 
subsequently, many plant-associated fungi and bacteria have been found to produce GAs8.  
Biosynthesis of GAs is elucidated in plants and fungi1,9 (Supplementary Fig. 2a), and 
differences between the pathways and relevant enzymes indicate the independent evolution 
of GA production in each of these two biological kingdoms7.   
As diterpenoids, GAs are derived from the 20-carbon isoprenyl precursor (E,E,E)-
geranylgeranyl diphosphate (GGPP).  In both plants and fungi, GA biosynthesis is initiated 
by two cyclization reactions, first through production of ent-copalyl diphosphate (CPP) from 
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GGPP by ent-CPP synthase (CPS), then via formation of ent-kaurene by ent-kaurene 
synthase (KS)1.  While these cyclizations are performed by two separate enzymes in plants2 
and a bifunctional enzyme in fungi9, it is possible that these diterpene cyclases share a 
common evolutionary origin7,10.  However, following ent-kaurene formation, GA 
biosynthesis between plants and fungi clearly diverges.  In plants, ent-kaurene is 
oxygenated/oxidized by both cytochrome P450 monooxygenases (CYPs) and 2-oxoglutarate-
dependent dioxygenases (2ODDs)2,11, while fungi make use of several CYPs and a 
desaturase9,12.  Notably, the CYPs utilized by plants, as compared to those of fungi, do not 
share significant amino acid sequence identity and belong to separate CYP families13.  
Furthermore, the chronology of the peripheral hydroxylation reactions at C-3 and C-13 
differs between plants and fungi.  In particular, 3β-hydroxylation, which is essential for GA 
bioactivity2, occurs earlier in fungal biosynthesis, while occurring late in the plant pathway7. 
Therefore, the intervening biosynthetic intermediates are distinct in each pathway. Because 
of these differences it is clear that plants and fungi have convergently evolved the ability to 
produce bioactive GAs7.   
 GA biosynthesis in bacteria has remained uncharacterized, though it has been 
accepted for decades that bacteria can produce GAs8,14.  The soybean symbiont, 
Bradyrhizobium japonicum USDA110 (now classified as Bradyrhizobium diazoefficiens 
USDA11015), contains an operon/gene cluster comprised of an isoprenoid synthase (IDS), 
two putative diterpene cyclases, three CYPs (CYP112, CYP114, and CYP117), a ferredoxin 
(FdGA), and a short-chain dehydrogenase/reductase (SDRGA)16,17 (Supplementary Fig. 2b).  
The presence of the IDS and putative diterpene cyclases in conjunction with oxidative 
enzymes, particularly CYPs, led to speculation that this operon is involved in GA 
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biosynthesis17,18, although it was only recently that B. japonicum was convincingly shown to 
produce GAs19.  This operon was subsequently found to be distributed in many other 
symbiotic rhizobia such as Sinorhizobium fredii NGR234, Mesorhizobium loti 
MAFF303099, and Rhizobium etli CFN4218,20.  Although there are additional genes present 
in the operons found in some of these other species, these appear to encode accessory 
enzymes that would not be directly involved in GA biosynthesis per se (e.g., an oft-found 
isopentenyl diphosphate δ-isomerase presumably balances the upstream supply of isoprenoid 
precursors).  Accordingly, the collection of the aforementioned genes in B. japonicum 
appears to represent a “core operon”, as they are found in nearly all cases of this operon 
within rhizobia. 
Previously, we have shown that the IDS produces GGPP, and is thus a GGPP 
synthase (GGPS), and that the two putative diterpene cyclases further act as a CPS and KS, 
whose sequential activity produces ent-kaurene10,20.  Moreover, the function of these 
enzymes is conserved across four major genera of rhizobia10,20.  In addition, recent isotope-
labeled feeding studies with B. japonicum isolated from soybean nodules (termed 
“bacteroids”) demonstrated GA oxidase activity, and found that the major metabolites are 
ent-kaurenoic acid, GA12, GA15, GA24, and ultimately GA9, suggesting a pathway similar to 
that found in plants19.  However, these bacteroids do not appear to be capable of producing 
3β- or 13-hydroxylated GAs, despite 3β-hydroxylation being essential for classical 
bioactivity2.  Here, through a combination of heterologous expression and knockout 
bacteroid incubations, we were able to unambiguously assign function to the remaining 
uncharacterized genes of the putative GA operon, elucidating their roles in bacterial 
biosynthesis of GA9 (Fig. 1). 
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Results 
General approach 
To determine the function of the five remaining proteins potentially involved in 
rhizobial GA biosynthesis (CYP112, CYP114, CYP117, SDRGA, and FdGA) we expressed the 
corresponding genes from the putative GA core operon of S. fredii NGR234 in the relatively 
closely related S. meliloti 1021 (Sm1021), which does not contain the operon21.  In order to 
evaluate if FdGA is required to supply the electrons needed to activate one or more of the 
CYPs22, each CYP was expressed alone and in coexpression with FdGA.  We incubated 
putative GA precursors/intermediates19 in these heterologous cultures and analyzed the 
extracts with gas chromatography-mass spectrometry (GC-MS), which allowed us to 
designate a function for each gene in GA biosynthesis (Fig. 1). 
Additionally, we validated our results in vivo via a genetic (knock-out) approach23,24, 
in which we deleted each uncharacterized gene (in-frame) within the operons of both B. 
japonicum and S. fredii to create the following strains in each species: Δcyp112, Δcyp114, 
Δcyp117, ΔfdGA, and ΔsdrGA.  These deletion strains were used to nodulate compatible 
legume hosts, B. japonicum with soybean (Glycine max) and S. fredii with cowpea (Vigna 
unguiculata), as functional expression of this operon and GA oxidase activity has only been 
detected in bacteroids19 (i.e. bacteria isolated from nodules).  Isolated bacteroids were 
incubated with isotope-labeled GA intermediates, after which metabolites were extracted and 
analyzed using high performance liquid chromatography (HPLC) and GC-MS to determine 
any obstruction in GA metabolism corresponding to the deleted gene (summarized for B. 
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japonicum in Fig. 2; see Supplementary Fig. 3 for full summary of both B. japonicum and 
S. fredii bacteroid incubation studies).   
CYP117 is an ent-kaurene oxidase (KO) 
The olefin precursor ent-kaurene (1) is converted to ent-kaurenoic acid (4) by cultures 
expressing CYP117 (Fig. 3 & Supplementary Fig. 4), with trace amounts of the 
intermediates ent-kaurenol (2) and ent-kaurenal (3) also found (Supplementary Figs. 4 & 5), 
demonstrating that CYP117 acts as an ent-kaurene oxidase (KO).  Furthermore, cells 
expressing CYP117 could efficiently convert either 2 or 3 to 4 (Fig. 3), confirming that 
CYP117 sequentially oxidizes 1 to the C-19 alcohol (2), aldehyde (3) and carboxylic acid (4).  
This activity did not depend on co-expression with FdGA, indicating that an endogenous 
redox system in the S. meliloti host could supply electrons to CYP117.  Wild-
type/untransformed S. meliloti 1021 did not metabolize any of these substrates, nor any of the 
subsequently tested GA intermediates, confirming that the chemical transformations were 
due to the expressed genes.   In accordance with the heterologous expression, Δcyp117 
bacteroids were unable to metabolize 2 but could react with 4 and other downstream 
intermediates (Fig. 2; see Supplementary Tables 1 & 2 for raw data).  
CYP114 (+FdGA) is an ent-kaurenoic acid oxidase (KAO)  
Incubation of 4 in cells expressing CYP114 resulted in production of ent-7α-
hydroxykaurenoic acid (5; also referred to as 7β-hydroxy-ent-kaurenoic acid or ent-7α-OH-
kaurenoic acid) (Fig. 4a & Supplementary Fig. 6).  Interestingly, further chemical 
transformation was observed when CYP114 was co-expressed with FdGA (CYP114-FdGA), 
with these cultures converting 4 to both 5 and GA12-aldehyde (6), implicating FdGA as 
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necessary for full CYP114 functionality (Fig. 4a & Supplementary Fig. 6).  Trace amounts 
of GA12 (7) could be detected from these incubations (Supplementary Fig. 7), indicating that 
CYP114 is capable of full oxidation of C-7, albeit with low efficiency.  Incubation of 6 in 
cells expressing CYP114-FdGA resulted in a detectable, but very low level of turnover to 7, 
demonstrating that while CYP114-FdGA can catalyze this reaction, it is quite inefficient.  
Δcyp114 bacteroids were blocked at the corresponding step as there was no transformation of 
4 or 5 to 6 or other downstream compounds (Fig. 2 & Supplementary Tables 1 & 2). ΔfdGA 
bacteroids showed decreased activity, with upstream substrate feeding leading to 
accumulation of 5, but with no obstruction of downstream metabolism (Fig. 2 & 
Supplementary Tables 3 & 4), confirming the necessity of FdGA for full CYP114 
functionality.    
To our surprise, feeding 5 to cells expressing either CYP114 or CYP114-FdGA did not 
result in any significant transformation to 6 (Fig. 4b).  This did not appear to be due to lack 
of transportation of 5 into our heterologous cells, as this compound could be found in both 
the cell pellet and in the aqueous supernatant in substantial quantities (Supplementary Fig. 
8).  However, this substrate was metabolized by bacteroids into 6 and further downstream 
metabolites (Fig. 2 & Supplementary Tables 3 & 4), suggesting that 5 may indeed be an 
intermediate in the bacterial GA biosynthesis pathway, just as in plants and fungi7.  If 5 is a 
true chemical intermediate between 4 and 6, it is possible that suboptimal conditions in our 
heterologous expression system may prevent turnover to a sufficient level for detection, as 
the natively-expressed CYP114 in B. japonicum and S. fredii appear capable of catalyzing 
this reaction (Fig. 2 & Supplementary Tables 3 & 4).  
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Molecular modeling indicates that the C-19 carboxylate of 4 is in close proximity to 
C-6 (Supplementary Figure 9), which we suggest may enable formation of a C-6 
carbocation intermediate, thus allowing for the ring contraction to occur via a semipinacol 
rearrangement mechanism25–27. In support of this, neither 3 (which in the diol form sterically 
resembles 4) nor the methyl ester of 4, both of which lack a free C-19 carboxylate, were 
chemically transformed by cells expressing CYP114-FdGA (Supplementary Table 5), 
suggesting a need for the free carboxylate in this reaction.  
Regardless of such speculation, it is clear that CYP114 acts as an ent-kaurenoic acid 
oxidase (KAO) and produces 6 as the major product from ent-kaurenoic acid.  While it 
appears that CYP114 is capable of full oxidation of C-7 to form 7, the conversion of 6 to 7 
does not seem to be efficiently catalyzed by CYP114.  This is distinct from the KAOs of 
plants or fungi, which convert 4 to 7 or GA14, respectively (both of which contain the fully 
oxidized C-7 carboxylate) without much production of the corresponding C-7 aldehyde28,29.  
In addition, CYP114 requires FdGA in order to catalyze the ring contraction reaction 
necessary for formation of 6 and 7 from 4, though it appears that endogenous Fd(s) from S. 
meliloti can supply electrons to CYP114 and elicit partial activity (i.e. oxidation of 4 to 5).   
SDRGA is a GA 7-oxidase 
When incubated with cultures expressing SDRGA, 6 is efficiently converted to 7 via 
C-7 oxidation (Fig. 5 & Supplementary Fig. 10), and thus SDRGA functions as an aldehyde 
dehydrogenase, and can be designated as a GA 7-oxidase.  This was demonstrated by 
heterologous expression of SDRGA from both S. fredii and B. japonicum, with the latter 
expressed in E. coli (Supplementary Figs. 10 & 11).  Consistent with these results, 6 
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accumulated in incubations of BjΔsdrGA bacteroids with 2 or 5 (Fig. 2 & Supplementary 
Tables 3 & 4).  Transformation from 6 to 7 in BjΔsdrGA and SfΔsdrGA bacteroids was not 
entirely blocked (Fig. 2 & Supplementary Tables 3 & 4), and this is likely due to the low 
level conversion of 4 to 7 catalyzed by CYP114.  Thus it seems that while CYP114 is 
catalytically capable of the full transformation of 4 to 7, SDRGA is necessary for the efficient 
oxidation of 6 to 7 to occur.  The use of a dehydrogenase for this type of chemical 
transformation is not uncommon, as it has been shown in biosynthetic pathways for other 
metabolites that the relevant CYPs do not efficiently catalyze full oxidation to the 
carboxylate, leading to a requirement for alcohol and/or aldehyde dehydrogenases for 
complete conversion30–32.  However, neither plant nor fungal GA biosynthesis rely on a 
dedicated dehydrogenase1, and therefore this enzyme is unique to the bacterial pathway.  
CYP112 is a GA 20-oxidase 
Cultures expressing CYP112 convert 7 to GA15 (8), GA24 (9) and, ultimately, GA9 
(10), and this does not require FdGA coexpression (Fig. 6 & Supplementary Fig. 12).  
Separate incubations with 8 and 9 demonstrated that CYP112-expressing cells can convert 
both of these intermediates to the final product, 10 (Fig. 6).  This demonstrates that 7 is 
oxidized by CYP112 first to the C-20 alcohol (8), then to the aldehyde (9) before loss of C-
20 and formation of the lactone ring in 10.  In correspondence with our heterologous 
expression results, Δcyp112 bacteroids were blocked in the conversion of 7 to 10, but could 
transform all upstream intermediates (Fig. 2 & Supplementary Tables 1 & 2).  These 
results show that CYP112 acts as a GA 20-oxidase (GA20ox), catalyzing sequential 
oxygenation/oxidation of the C-20 methyl, culminating in demethylation and formation of 
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the C-19,10-γ-lactone ring.  Additionally, these results are consistent with a previous report 
indicating that 10 is the final product in these rhizobia19. 
The bacterial GA biosynthetic pathway is linear 
Our initial results indicated that rhizobial GA biosynthesis likely proceeds via a direct 
pathway.  However, GA metabolism in fungi and, especially, plants forms a more complex 
network2.  To investigate this possibility within bacterial GA biosynthesis, all identified 
intermediates were incubated with each heterologously expressed enzyme to evaluate the 
possibility of promiscuous activity (e.g., could CYP112 form the C-19,10-γ-lactone ring with 
4 or 6).  Detectable activity was only observed with each previously described substrate, 
strongly suggesting linearity of GA biosynthesis in rhizobia (Supplementary Table 5).  
Thus, we were able to unequivocally assign the biosynthetic function of each gene found in 
the core GA operon along with demonstrating that these specific functions are relevant in 
vivo/planta, as shown through the knockout bacteroid experiments.  Moreover, our results 
validate the functional equivalence of this operon in two distinct rhizobia from separate 
genera, and therefore conservation of the assigned catalytic activity of these enzymes in GA 
biosynthesis. 
 
Discussion 
Elucidation of this pathway indicates that bacteria have independently evolved a third 
route for GA production that is distinct from either plant or fungal biosynthesis 
(Supplementary Fig. 2a).  Although the intermediates in bacterial GA biosynthesis are 
identical to those in the non-13-hydroxylation pathway found in plants, bacteria utilize a 
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distinct set of enzymes to catalyze the relevant transformations.  Other than the two diterpene 
cyclases (CPS and KS), which share some (albeit distant) sequence and structural homology 
with the plant and fungal cyclases10,33,34, the enzymes involved in rhizobial GA biosynthesis 
share little or no homology with their functionally analogous counterparts in plants and fungi.   
CYP112, CYP114, and CYP117 seem to clearly be of bacterial ancestry35, and the 
CYPs utilized by each kingdom are more similar to each other than to their functional 
analogs from the other kingdoms (Supplementary Table 6).  Specifically, CYP117, the 
bacterial KO, is distinct from that of plants and fungi, as they belong to the CYP701 and 
CYP503 families, respectively2,9, and CYP114, the bacterial KAO, is also distinct, as the 
KAO from plants falls within the CYP88 family, and that of fungi in the CYP68A sub-
family2,9.  Furthermore, bacteria use an SDR to efficiently convert 6 to 7.  This is unique to 
bacterial GA biosynthesis, as the full oxidation of C-7 appears to be accomplished by the 
KAO of plants and fungi without the assistance of a separate dehydrogenase.  However, in 
some plants (e.g., within the Cucurbitaceae family), a 2ODD has been shown to act as a GA 
7-oxidase2,36, converting 6 to 7 and perhaps suggesting that oxidation of C-7 to the 
carboxylate by KAOs is also inefficient in those species.  For GA20ox activity, rhizobia 
nominally resemble fungi in that they use a CYP, but again, CYP112 is distinct from the 
fungal enzyme, which is from the CYP68B sub-family2,9, and this is completely dissimilar 
from plants, which use a 2ODD to carry out this reaction2.  This appears to provide an 
extreme example for convergent evolution of such complex metabolism in three kingdoms, 
as over ten chemical transformations are necessary to reach 10 from the general diterpene 
precursor GGPP (Fig. 1).  Furthermore, there appear to be few examples of organisms having 
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independently converged on identical biosynthetic pathways37, as is the case with the 
bacterial and plant pathways, which share common intermediates but not enzymes. 
With three examples of independently evolved GA biosynthetic pathways now 
known, it can be appreciated that these all follow a common order of central chemical 
transformations, perhaps reflecting biochemical constraints that may have shaped GA 
production.  In particular, within all three pathways, 4 is formed prior to the neighboring B-
ring contraction.  We suggest that the C-19 carboxylate of this molecule may provide 
anchimeric assistance via stabilization of a non-classical C-6 carbocation intermediate that 
has been invoked in these CYP (KO) catalyzed ring contraction reactions38.  Specifically, it 
has been proposed that B-ring contraction may proceed via a pinacol-type rearrangement (as 
has been utilized in chemical synthesis of GAs)25–27, and the presence of the nearby C-19 
carboxylate could presumably promote selective formation of the carbocation at C-639, 
although a radical mechanism is also plausible27.  Notably, the inability of CYP114 to 
catalyze this ring contraction with 3 or the methyl ester of 4, both of which lack a free C-19 
carboxylate, is consistent with this hypothesis (Supplementary Table 5).   
Furthermore, this ring contraction always precedes incorporation of the C-19 
carboxylate into the γ-lactone ring.  3D structural modeling shows that B-ring contraction 
brings the C-19 carboxylate closer to C-20 (Supplementary Fig. 9), perhaps assisting the 
coupled demethylation (i.e., loss of C-20) and C-19,10-γ-lactone ring formation catalyzed by 
the GA20ox.  However, such incorporation of the carboxylate into the lactone also eliminates 
the negative charge that may guide the ring contraction reaction.  Thus, these transformations 
potentially revolve around the early formation and availability of the C-19 carboxylate.  We 
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propose that γ-lactone formation cannot precede ring contraction because this results in loss 
of the free C-19 carboxylate.  Indeed, the ancient origin of the C-19 carboxylate in pathway 
evolution is supported by evidence that 4 was an ancient plant metabolite, as indicated by its 
use as a precursor to non-GA signaling molecules in early diverging land plants40.  
Accordingly, the early presence of the C-19 carboxylate may have shaped the complex 
metabolic evolutionary process leading to contemporary GA biosynthesis. 
While the role for GA production in symbiotic rhizobia is still unclear, as operon 
knockouts of B. japonicum have been shown to be unhindered in nodule formation and 
symbiosis16, it is known that phytopathogens use GA as a virulence factor, likely through 
suppression of the jasmonic acid (JA) induced defense responses41,42.  This has been shown 
for two rice pathogens, specifically the fungus G. fujikuroi43 and the bacterial species 
Xanthomonas oryzae pv. oryzicola (which possesses a homologous operon to that studied 
here)44.  It is tempting to speculate that production of ancient GA precursor hormones by 
plant-associated microbes, presumably to manipulate the plant, may have driven the 
elaboration of plant GA biosynthesis to the extant bioactive molecules in an “arms race”-like 
scenario45.  However, we cannot rule out the possibility that bacteria and/or fungi only 
developed their GA biosynthetic pathways following full evolution of GA biosynthesis and 
signaling by plants, with the observed independent evolution simply a reflection of the value 
that production of GA offers these microbes in interaction with their plant hosts.  
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Methods 
Culture and growth conditions 
 All chemicals were purchased from Thermo Fisher Scientific and Sigma-Aldrich.  
Where indicated and unless noted otherwise, antibiotics were used at the following 
concentrations: kanamycin (Km) 50 μg/mL, chloramphenicol (Cm) 25 μg/mL, streptomycin 
(Sm) 500 μg/mL, spectinomycin (Sp) 50 μg/mL, tetracycline (Tc) 20 μg/mL, rifampicin (Rf) 
25 μg/mL.  E. coli was grown at 37˚ C in NZY media (5 g/L yeast extract, 10 g/L casein 
hydrolysate, 5 g/L NaCl, and 1 g/L MgSO4·7H2O).  S. meliloti 102146 was grown at 30˚ C in 
LB/MC media (Luria-Bertani media supplemented with 2.5 mM MgSO4·7H2O and 2.5 mM 
CaCl2·2H2O) using Sm as the selecting antibiotic.  S. fredii NGR23447 was grown at 30˚C in 
TY media (5 g/L tryptone, 5 g/L yeast extract, and 2.5 mM CaCl2·2H2O) using Rf as the 
selecting antibiotic.  B. japonicum USDA110 was grown in AG media (1 g/L arabinose, 1 
g/L gluconate, and 1 g/L yeast extract) with Cm (34 ug/mL) as the selecting antibiotic.  See 
Supplementary Table 7 for all strains used in this study. 
GA operon in B. japonicum USDA110 and S. fredii NGR234 
 The core GA operon is found in both B. japonicum USDA110 and S. fredii NGR234.  
Each operon contains CYP112, CYP114, FdGA, SDRGA, CYP117, GGPS, CPS, and KS.  The 
locus tags for the genes characterized in this manuscript in B. japonicum are as follows: 
cyp112, blr2144; cyp114, blr2145, fdGA (not annotated in NCBI); sdrGA, blr2146; cyp117, 
blr2147.  The locus tags for these genes in S. fredii are as follows: cyp112, 
cpxP/NGR_a02700; cyp114, cpxR/NGR_a02710; fdGA, NGR_a02720; sdrGA, NGR_a02730; 
cyp117, cpxU/NGR_a02740.  
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 CYP117 falls into class II/class E (subgroup IV) within the CYP superfamily, which 
archetypically have a two-component electron transfer system in which an NADPH-
cytochrome P450 reductase (CPR) directly supplies electrons to the CYP22, although in 
several cases it has been demonstrated that such CYPs can be reduced by the more typical 
bacterial 3-component system48,49.  CYP114 and CYP112 belong to class B of the CYP 
superfamily.  CYPs in this group typically utilize a 3-component electron transfer system 
consisting of a Fd reductase (FdR), ferredoxins (Fd), and a CYP22.  Even given co-expression 
of the FdGA, this requires reduction by an endogenous FdR (e.g., from the S. meliloti host in 
the exogenous expression system used here), and it appears that an endogenous Fd or 
flavodoxin also can reduce these CYPs (i.e., even CYP114 exhibits some, albeit not full, 
activity in the absence of FdGA).  
Cloning of operon genes 
 Unless noted otherwise, all molecular biology reagents were purchased from Thermo 
Fisher Scientific.  CYP114 (cpxR; NGR_a02710) and FdGA (NGR_a02720) were amplified 
directly from S. fredii NGR234 gDNA as a single construct using primers that anneal to the 
5’ end of CYP114 and the 3’ end of FdGA (See Supplementary Table 8 for all primers used 
here).  Synthetic clones of CYP112 (cpxP; NGR_a02700) and CYP117 (cpxU; 
NGR_a02740) were created with GeneArtTM gene synthesis via Thermo Fisher Scientific, in 
which each CYP was followed directly by the non-coding region following CYP114, along 
with FdGA.  These synthetic constructs were made to contain silent point mutations to remove 
EcoRI and BamHI from the coding sequences to allow for use of these restriction sites for 
downstream cloning (G606A and A738G in CYP112; G202A in CYP117).  S. fredii 
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NGR234 SDRGA (NGR_a02730) was cloned directly from gDNA. Constructs were initially 
amplified through PCR with AccuPrime Pfx and cloned into pCRTM-Blunt II-TOPO® (KmR) 
for subsequent propagation.  For S. meliloti expression, constructs were amplified with 
forward primers that annealed to the 5’ end of the gene and also contained a “linker” 
sequence containing stop codons and a ribosome binding site along with a 5’ BamHI 
restriction site, and a reverse primer that added a 3’ EcoRI site to the end of the gene 
(Supplementary Table 8).  For individual CYP expression, the reverse primer was specific 
to the 3’ end of the CYP, whereas for CYP coexpression with FdGA, the reverse primer was 
specific to the 3’ end of FdGA.  The S. fredii NGR234 CYP constructs with and without FdGA 
were digested and subsequently ligated into the pstb-LAFR5 vector (TcR, mob+), while the S. 
fredii SDRGA was cloned into this plasmid without FdGA.  The pstb-LAFR5 vector contains a 
promoter sequence that has been shown to be highly and constitutively expressed in S. 
meliloti 102150, and was thus deemed appropriate for heterologous expression of the operon 
genes.   
E. coli codon-optimized synthetic B. japonicum USDA110 gene constructs for 
CYP114 (blr2145), FdGA, SDRGA (blr2146), and five putative ferredoxin reductases (FdR1, 
mvrA/blr3831; FdR2, blr3195; FdR3, bll0100; FdR4, blr7998; and FdR5, paaE/blr2895) 
were ordered from Thermo Fisher scientific (via GeneArtTM gene synthesis).  The synthetic 
CYP114 was cloned into pET101/D-TOPO (SpR) as per the manufacturer’s instructions, but 
with the stop codon included to prevent fusion with the C-terminal tag.  The B. japonicum 
USDA110 SDRGA and FdGA were cloned separately into the pCDF-duet expression vector 
(SpR) with FdGA coexpressed with each of the putative FdR’s (Supplementary Table 7). Of 
these synthetic genes only BjSDRGA was found to be functionally expressed in E. coli. 
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Triparental mating for movement of constructs into S. meliloti 1021 
 For expression in S. meliloti 1021, the pstb-LAFR5 constructs (Supplementary 
Table 7) were moved into the host cells through triparental mating.  First, pstb-LAFR5 
constructs were transformed into chemically competent E. coli MM294A cells51 using LB 
plates with Tc to select for positive colonies.  Liquid cultures of the transformed MM294A 
cells along with the helper E. coli strain MT61652 (CmR) and the host, S. meliloti 1021 (SmR) 
were grown to mid-log phase, at which point 1 mL of each culture was centrifuged at 4000 x 
g to pellet the cells.  Cell pellets were resuspended in 1 mL of sterile 0.85% NaCl to wash 
away media and antibiotics, after which the cells were again pelleted by centrifugation at 
4000 x g.  These cell pellets were then resuspended in 50 μL of sterile 0.85% NaCl and each 
culture was mixed in equal proportion.   The mixtures were spotted in 10-30 μL aliquots onto 
non-selective LB/MC plates and allowed to incubate at 30˚ C for 1-2 days.  The spots were 
then resuspended in 1 mL of sterile 0.85% NaCl, serially diluted, and plated on LB/MC 
plates containing Sm and Tc to select for S. meliloti 1021 (SmR) colonies that contain the 
pstb-LAFR5 construct (TcR).  Positives were confirmed through colony PCR for the gene(s) 
of interest. 
Substrates for heterologous expression 
The ent-kaurene (1), ent-kaurenol (2), and ent-kaurenoic acid (4) substrates/standards 
were made through our metabolic engineering system in E. coli, as previously described53.  
Authentic ent-7α-hydroxykaurenoic acid (5), GA15 (8), and GA24 (9)-methyl ester were 
provided by Dr. Peter Hedden.  GA12-aldehyde (6), GA12 (7), and GA9 (10) were purchased 
from OlChemIm Ltd.   
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 Production of ent-kaurenal (3) was achieved through the oxidation of 2 with MnO2.  
Approximately 1 mg of 2 was dissolved in MeOH, and an excess (>1000-fold molar ratio) of 
activated MnO2 was added and stirred overnight with a magnetic stir bar and plate.  The 
mixture of catalyst and compound(s) was filtered through Whatman filter paper (GE 
Healthcare Life Sciences) to remove MnO2, dried down under a gentle nitrogen stream, and 
resuspended in n-hexane for GC analysis.  This process yielded nearly 100% conversion and 
recovery of 3 from 2. 
 GA12-aldehyde (6) substrate was purchased from OlChemIm Ltd. for use as a 
substrate.  However, this preparation contained a small amount of GA12 (7), which would 
potentially confound results, as 7 is the product expected from enzymatic activity with 6 
substrate19.  Therefore, 2 mg of this substrate was further purified with an Agilent 1200 series 
HPLC equipped with a reverse-phase C-8 column (Kromasil® C8, 50 x 4.6 mm, 5 µm 
particle size), autosampler, diode array UV detector, and fraction collector.  The mobile 
phases utilized were acetonitrile and water, both with 0.1% formic acid to lower the pH to 
~3, which leads to predominant protonation of carboxylic acids and better peak resolution. 6 
was dissolved in MeOH, and this sample was injected in 50 μL aliquots at a flow rate of 0.5 
mL/min (300 bar, 25˚C) with an initial mobile phase of 50% acetonitrile in water which was 
held for 2 minutes.  For the next 5 minutes, the mobile phase was increased to 100% 
acetonitrile.   This was held for 16 minutes, at which point the mobile phase was switched 
back to 50% acetonitrile in water over a time of 1 minute, and this was held for 3 minutes.  
With this method, a single peak of 6 eluted at 14.3 minutes, and a fraction was collected from 
14.0 to 14.5 minutes to recover purified product.  With this purification, most of the 
contaminating 7 was removed, enabling use of this preparation of 6 as a substrate. 
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GA24 (9) was produced from 9-methyl ester for substrate feeding studies through base 
hydrolysis.  Briefly, 9-methyl ester (~1 mg) was resuspended in 0.5 M KOH in methanol (3 
mL) and incubated at 40˚ C for 16 hours.  Water (10 mL) was used to quench the reaction, 
and this aqueous fraction was acidified to pH 3.  The acidified aqueous fraction was extracted 
five times with ethyl acetate (10 mL), and this organic fraction was dried down under a 
gentle nitrogen stream and resuspended in MeOH.  Hydrolysis was confirmed through GC-
MS, both of the hydrolyzed product (i.e. disappearance of a peak on GC-MS due to loss of 
methyl ester derivatization) and re-methylated product to confirm the presence of 9. 
Before incubation, GA15 (8) was hydrolyzed to preferentially form the free C-20 
alcohol in contrast to the 20,19 δ-lactone, as the free alcohol form has been implicated as the 
major substrate of GA 20-oxidases in plant GA biosynthesis54.  This was done by dissolving 
8 in 0.5 M KOH with subsequent heating at 100˚C for 2 hours, as previously described55.  As 
with the plant system, we found more efficient turnover with hydrolyzed 8 in our cells 
expressing CYP112. 
Substrates were dissolved in ethanol (1, 2, and 3) or methanol (4, 5, 6, 7, 8, 9, and 10) 
and stored at a concentration of 2 or 3 mg/mL. 
Heterologous expression and substrate feeding studies 
 For S. meliloti 1021 heterologous expression and feeding with potential substrates, 5 
mL culture tubes of liquid LB/MC with appropriate antibiotics (Sm for wild-type controls, 
Sm and Tc for expression constructs) were inoculated with individual colonies and allowed 
to grow to confluence, with shaking at 225 RPM for 1-2 days at 30 ˚C.  The presence of the 
construct in the cells of the culture was confirmed with colony PCR using gene specific 
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primers.  0.5 mL of the starter culture and 5 mL of phosphate buffer was then added to 50 
mL LB/MC containing the appropriate antibiotics.  These larger cultures were grown to log 
phase (OD600 0.5-09), and substrate (in EtOH or MeOH) mixed with DMSO in a 1:1 
mixture was added into the culture to a final concentration of 10 µM.  Additionally, 
riboflavin (1 mM) was added for enhanced metabolism, 5-aminolevulinic acid (1 mM) for 
enhanced heme synthesis, and FeCl3 (0.25 mM) for increased CYP and Fd functionality (i.e. 
supplying iron for the CYP heme and Fd)56.  Substrates were incubated for three days in the 
cultures while shaken at 30 ˚C and 225 RPM.  Once the GA operon enzymes were found to 
be functionally expressed, culture size was reduced to 10 mL and substrate concentration was 
reduced to 5 µM for subsequent experiments.  Each substrate incubation which resulted in 
chemical transformation was repeated at least twice to ensure reproducibility.  See 
Supplementary Table 9 for a list of all of the functionally characterized genes, along with 
their NCBI/GenBank and UniProtKB identifiers. 
 To determine if substrates were able to enter the CYP114-FdGA-expressing cells, 
cultures were incubated with substrate as described above, and following incubation, were 
centrifuged at 4000 x g to pellet cells away from aqueous media.  The cell pellet was washed 
twice with an original culture volume of 0.85% NaCl, these aqueous washes were combined 
with the original media supernatant, and the cell pellet was resuspended in an original culture 
volume of 0.85% NaCl.  Both the cell pellet fraction and the aqueous fraction were extracted 
and analyzed as described below (see Metabolite extraction, purification, and GC/MS 
analysis for heterologous expression studies). 
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 In order to assess whether GA12-aldehyde (6) oxidation to GA12 (7) can be catalyzed 
by non-specific oxidoreductases in rhizobia or by CYP114 (+/-FdGA), 6 was incubated in 
non-inoculated media (supplied with antibiotics and expression supplements), wild-
type/untransformed S. meliloti 1021, and S. meliloti cells expressing either CYP114 or 
CYP114-FdGA.  Because trace amounts of 7 were still present in 6 substrate following HPLC 
purification, each incubation was run in triplicate, and potential increases in the amount of 7 
as an enzymatic product were determined by dividing the ion extracted peak area (m/z = 300) 
of 7 by the ion extracted peak area (m/z = 300) of 6 in each sample and averaging this value 
between treatments (Supplementary Figure 7).  Statistical analysis (Student’s t-test: Two-
Sample Assuming Equal Variance) was performed in Microsoft Excel.  The corresponding p-
values are listed in Supplementary Figure 7, and the variances between the cultures 
incubations were reasonably similar (Sm1021=6.37x10-5; CYP114=3.09x10-4; CYP114-
FdGA=1.11x10-4).   
 For E. coli expression and substrate feeding, 5 mL culture tubes of Terrific Broth 
(TB) media (12 g/L casein, 24 g/L extract, 0.4% glycerol) with Sp for selection were 
inoculated with individual colonies of E. coli C41 cells transformed with the construct of 
interest.  These small cultures were allowed to grow to late log phase overnight at 37 ˚C and 
with 225 RPM shaking.  1 mL of this starter culture and 5 mL phosphate buffer was then 
added to 50 mL TB containing appropriate antibiotics.  50 mL cultures were grown to log 
phase at 37 ˚C with 225 RPM shaking, then moved to 16 ˚C with 225 shaking for one hour, 
after which expression was induced with 1 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG), and riboflavin (1 mM) and substrate (10 μM) were added.  Cultures were incubated 
with substrate for 3 days at 16 ˚C and 225 RPM shaking. 
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Metabolite extraction, purification, and GC/MS analysis for heterologous expression 
studies 
 After three days of incubation with substrate, the cultures were acidified to pH 3 with 
5.0 M HCl to neutralize the carboxylate groups on the targeted compounds, and these were 
then and extracted three times with an equivalent volume of hexanes (for 1, 2, and 3 
substrates) or ethyl acetate (for 4, 4-methyl ester, 5, 6, 7, 8, 9, and 10 substrates).  The three 
extractions from each culture were combined in a round bottom flask and dried on a rotary 
evaporator.  The residue was resuspended in 1 mL of ethyl acetate and loaded onto a ~1 mL 
silica gel column and purified with elution of hexane:ethyl acetate solutions.  Briefly, this 
was done by adding 1 mL aliquots of elution solvent, starting with 100% hexane, and 
incrementally increasing the ethyl acetate concentration (by 5-10%) until reaching a final 
elution of 100% ethyl acetate.  Distinct fractions were collected for each elution solvent, and 
these were dried down under a gentle nitrogen stream, dissolved in ethyl acetate, and 
derivatized with diazomethane in order to esterify any free acids.  Derivatized samples were 
dried down under a stream of nitrogen, re-dissolved in n-hexane and analyzed with gas 
chromatography coupled to a mass spectrometer detector (GC-MS), using a 3900 Saturn GC 
with Saturn 2100T ion trap MS (Varian) equipped with an HP-5MS column (Agilent).  For 
analysis of each sample, 1 μL was injected in splitless mode with a column flow of 1.2 
mL/minute at an initial injector temperature of 250 ˚C and a column temperature of 50˚C, 
which was held for 3 minutes.  The column temperature was then increased to 300˚C at a rate 
of 15˚C/minute, and this temperature (300˚C) was further held for 3 minutes.  Mass spectra 
acquisition using electron ionization with a low mass ion limit of 90 m/z and a high mass ion 
limit of 650 m/z began at 13 minutes and continued until the end of the run.  For optimal peak 
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resolution, publication quality GC-MS runs were performed as described, but with a column 
temperature increase of 10˚C/min and a mass range of 90-450 m/z.    Potential products were 
compared to authentic standards and published chromatograms/mass spectra57 
(www.planthormones.info/gibberellins.htm).  Fractions from each individual sample that 
contained the GA substrate and products were combined for the final published 
chromatograms. 
Development of B. japonicum and S. fredii knockout mutants 
 To delete the GA operon genes of interest in B. japonicum (cyp112/blr2144, 
cyp114/blr2145, fdGA, sdrGA/blr2146, and cyp117/blr2147) and S. fredii (cyp112, cyp114, 
fdGA, sdrGA, and cyp117) we utilized the well-established double-homologous recombination 
approach, which has been shown to be effective in a number of different bacterial 
species23,24.  To begin, we cloned regions that were 500-1000 bp upstream and downstream 
of the gene of interest, including a 3’ linker on the upstream fragment that is complementary 
to the 5’ fragment, and a 5’ linker on the downstream fragment that is complementary to the 
3’ fragment (Supplementary Table 8).  These two fragments were fused using crossover-
PCR, and appropriate restriction sites were added to the ends of this construct using unique 
primers.  This construct was then ligated into the suicide vector pK19mobsacB 
(Supplementary Table 7), which is mobilizable and contains the Km resistance cassette for 
positive selection of colonies, along with the sacB gene, which results a restricted growth 
phenotype on sucrose for bacteria carrying the plasmid, and thus negative selection of 
colonies. 
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 These plasmid constructs were transformed into chemically competent MM294A E. 
coli cells and moved into the rhizobia of interest through triparental mating (see Triparental 
mating for movement of constructs into S. meliloti 1021 for general outline of this 
procedure).  Briefly, cultures of the “donor” MM294A cells, “helper” MT616 E. coli cells, 
and the “recipient” strain (either B. japonicum USDA110 or S. fredii NGR234) 
(Supplementary Table 7) were grown to late log phase, mixed in equal proportion, and 
spotted on non-selective agar media (AG for B. japonicum and TY for S. fredii) for 3-5 days 
(B. japonicum) or 1-2 days (S. fredii).  These mixtures were suspended in sterile 0.85% NaCl, 
and serial dilutions were plated on the appropriate agar containing an antibiotic to select for 
the recipient (Tc at 10 ug/mL for B. japonicum and Rf for S. fredii) and Km to select for the 
first crossover integration of the suicide vector into the genome.  Potential first crossover 
colonies were streaked out on Km-containing plates at least once in order to confirm their 
resistance, and these colonies were further confirmed with colony PCR using primers 
designed to amplify a region of the sacB gene.  Positive strains were grown to late log phase 
in non-selective liquid media (thus allowing for the 2nd crossover event to occur), and serial 
dilutions were plated on the appropriate media containing 10% (w/v) sucrose.  Possible 
double recombinants were streaked on Km along with on sucrose plates to ensure loss of the 
vector, resulting in restricted growth on Km and the ability to grow on sucrose.  Colony PCR 
with primers designed upstream and downstream of the gene of interest was used to 
determine whether the 2nd recombination resulted in restoration to the wild-type or the 
deletion of the gene of interest (i.e. a reduction in amplicon size equal to the length of the 
gene indicated a successful deletion). 
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Isolation of B. japonicum or S. fredii knockout bacteroids 
Soybean (Glycine max cv. Jack) plants inoculated with liquid cultures of B. 
japonicum knockout mutants, or alternatively cowpea (Vigna unguiculata cv. Blackeye) 
plants inoculated with liquid cultures of S. fredii knockout mutants, were grown in Leonard 
jars as described19. Symbiotic root nodules were obtained from plants around flowering and 
stored at -20 C.  Bacteroids were isolated from nodule homogenates by differential 
centrifugation as described19 and the bacteroid pellet, resuspended in 50 mM TES pH 7.5, 2.5 
mM MgCl2, 1 mM KHPO4, was utilized for enzymatic assays. 
Labeled substrates for bacteroid enzymatic assays 
14C4GA12-aldehyde and ent-14C47α-hydroxykaurenoic acid were synthesized from 
R-[2-14Cmevalonic acid (Amersham) by incubation with an endosperm preparation from 
Cucurbita maxima58,59.  ent-17-14C1kaurenoic acid, 17-14C1GA12, 17-14C1GA15, 17-
14C1GA24, and 17-14C1GA9 were obtained from Professor L. Mander (Australian National 
University, Canberra). ent-kaurenol (2) was prepared as described above.  
Knockout bacteroid incubations with labeled GA precursors 
14C-GA precursors (830-5000 Bq, 0.1-0.6 nmoles) were added as methanolic 
solutions to 2 mL of a bacteroid suspension prepared from 0.5 g of root nodules.  After 
incubation for 3 days at 28 C with shaking at 200 rpm, products were extracted and isolated 
from the reaction media.  The suspension was centrifuged at 12,000 x g for 5 min and the 
supernatant extracted with ethyl acetate after acidification to pH 3.0.  Products were further 
separated by HPLC on a C18 Symmetry column (5µm; 250x4 mm; Waters) in a Waters 600 
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HPLC instrument, after purification by solid phase extraction in C18 cartridges. A linear 
gradient of MeOH:H2O pH 3.0 (60:40 100:0; v/v) over 30 min was used for elution at a 
flow rate of 1 mL/min. Fractions (1 mL) were collected and the radioactivity measured by 
liquid scintillation counting.  
Purified fractions containing 14C-labeled products were derivatized with ethereal 
diazomethane and N-methyl-N-trimethylsilyltrifluoroacetamide and identified by GC-MS as 
described60.  Compounds were identified by comparison of their mass spectra with published 
spectra57.  For GA9 17-nor-16-one and GA12 17-nor-16-one the spectra of the methyl esters 
of ketone and enol-TMS derivative were compared to those of authentic standards. 
In these knockout-bacteroid feeding experiments, various oxidized kaurenoid or GA-
derived compounds were identified that are unlikely to belong to the GA biosynthesis 
pathway. These would presumably correspond to reactions potentially catalyzed by non-
pathway-related oxidoreductases due to blocked biosynthesis and/or intermediate 
accumulation.  In correspondence with this, previous experimentation has found non-
pathway related GAs such as GA9-norketone and 13-OH-kaurenoic acid, which do not seem 
to be relevant GA intermediates, in incubations with wild-type B. japonicum19.  Also, as 
summarized in Supplementary Figure 3, greater substrate turnover was detected in B. 
japonicum bacteroid incubations than for those in S. fredii. 
Molecular modeling 
 ent-kaurenoic acid (4) and GA12-aldehyde (6) were modeled using Jmol 13.0.  
Briefly, the simplified molecular-input line-entry system (SMILES) for each molecule were 
used to create a 3D structure in Jmol.  Each molecule was computationally energy-optimized 
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within Jmol and the distance from C-19 to C-20 and C-19 to C-6 was measured.  The same 
measurements were made using 3D structures generated from the International Chemical 
Identifier (InChl) and Chemical Abstracts Service (CAS) number of each compound to 
confirm the measured distances. 
CYP sequence analysis 
 CYPs involved in GA biosynthesis in plants (Arabidopsis thaliana KO/CYP701A3, 
KAO1/CYP88A3, and KAO2/CYP88A4), fungi (Gibberella fujikuroi KO/CYP503, 
KAO/CYP68A, and GA20ox/CYP68B) , and bacteria (Bradyrhizobium japonicum 
USDA110 CYP117, CYP114, and CYP112) were compared using the Needle EMBOSS 
(Needleman-Munsch algorithm) pairwise alignment tool available on the European 
Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) website 
(www.ebi.ac.uk/Tools/psa/emboss_needle) to determine the amino acid percent identity 
shared between each enzyme.  The default parameters were used for this analysis, and are as 
follows: matrix=BLOSUM62, gap open=10, gap extend=0.5, end gap penalty=false, end gap 
open=10, end gap extend=0.5. 
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Figure 1. GA biosynthesis in rhizobia. Elucidated GA biosynthetic pathway in core operon-
containing rhizobia. 
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Figure 2. Summary of GA biosynthetic pathway reactions detected in incubations of B. 
japonicum gene-deletion bacteroids with GA precursors.  Arrows indicate observed 
reactions, with arrow thickness representing relative efficiency of the detected reactions.  (–), 
reaction not detected. BjΔ, B. japonicum gene deletion.  The source data are available in 
Supplementary Tables 1-4. 
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Figure 3. CYP117 is an ent-kaurene oxidase (KO).  CYP117 converts ent-kaurene (1) into 
ent-kaurenoic acid (4), as shown here by GC-MS chromatograms with comparison to an 
authentic standard (std.) of 4 (the relevant mass spectra can be found in Supplementary Fig. 
4).  Additionally, individual incubations with ent-kaurenol (2) and ent-kaurenal (3) result in 
efficient conversion to 4, demonstrating the sequential oxidation of C-19 to the alcohol (2), 
aldehyde (3), and acid (4) by CYP117. 
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Figure 4. CYP114 is an ent-kaurenoic acid oxidase (KAO) and requires FdGA for full 
functionality. a) CYP114 converts ent-kaurenoic acid (4) into ent-7α-hydroxykaurenoic acid 
(5) and ultimately GA12-aldehyde (6) as the major product, as shown here by GC-MS 
chromatograms with comparison to an authentic standard (std.) of 5 and 6 (the relevant mass 
spectra can be found in Supplementary Fig. 6), but production of 6 is only observed when 
FdGA is coexpressed. b) Incubation with 5 does not result in detectable conversion to 6. 
77 
 
 
Io
n 
Ab
un
da
nc
e 
(m
/z
 =
 2
41
)
 
201918171615
Retention Time (min.)
Sm1021 + 6
SDRGA + 6
7 std.
6
 
Figure 5. SDRGA oxidizes GA12-aldehyde (6) to produce GA12 (7).  SDRGA is able to 
efficiently oxidize the extruded C-7 aldehyde of 6 to an acid, thus producing 7, as shown in 
this GC-MS chromatogram with comparison to an authentic standard (std.) of 7 (the relevant 
mass spectra can be found in Supplementary Fig. 10).  SDRGA can therefore be referred to 
as a GA 7-oxidase. 
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Figure 6. CYP112 is a GA 20-oxidase.  CYP112 converts GA12 (7) into GA9 (10) via GA15 
(8) and GA24 (9) as shown here by GC-MS chromatograms with comparison to authentic 
standards (stds.) of 8, 9, and 10 (the relevant mass spectra can be found in Supplementary 
Fig. 12).  8 and 9 also both act as substrates for CYP112, showing sequential oxidation of C-
20 to the alcohol (8) and aldehyde (9) before being lost to form 10.  The selected ions for 
each chromatogram are as follows: +7 m/z = 226, 300; +8 m/z = 270, 284; +9 m/z = 226. 
*Contaminating substance found in 8 standard used for incubations. 
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Supplementary Figure 1. Numbering system and ring identification for 
diterpenoids/gibberellins. Shown is the carbon numbering system for a representative 
diterpene/diterpenoid, ent-kaurene (1; ent-kaurane backbone, 6-6-6-5), and a representative 
gibberellin, GA12-aldehyde (6; ent-gibberellane backbone, 6-5-6-5).  Also shown is the 
nomenclature of the characteristic ring systems (A, B, C, and D).  Note the changes in 6 that 
result from B-ring contraction and extrusion of C-7‡. (‡this is the presumed carbon that is 
extruded, but has not been shown for bacterial GA biosynthesis). 
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Supplementary Figure 2. GA biosynthesis in plants, fungi, and bacteria. a) Convergent 
biosynthetic pathways have evolved for GA production in plants (green), fungi (brown), and 
core-operon containing rhizobia (blue).  Shown here are abbreviated pathways, with plants 
and fungi converging on GA4.  Note that the 13-hydroxylation pathway for plants is not 
represented here.  Also, while GA3 is the major final product for the fungus Gibberella 
fujikuroi, other fungal species produce different bioactive GAs as their major product. GGPP 
= (E,E,E)-geranylgeranyl diphosphate; GGPS = (E,E,E)-geranylgeranyl diphosphate 
synthase; ent-CPP = ent-copalyl diphosphate; CPS =  ent-copalyl diphosphate synthase; KS = 
ent-kaurene synthase; KO = ent-kaurene oxidase; KAO = ent-kaurenoic acid oxidase; CYP = 
cytochrome P450 monooxygenase; 2ODD = 2-oxoglutarate dependent dioxygenase. b) GA 
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biosynthetic operon found in B. japonicum and S. fredii.  1 kb = 1 kilobase; Fd = ferredoxin; 
SDR = short chain dehydrogenase/reductase. 
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Supplementary Figure 3. Summary of GA biosynthesis reactions detected in 
Bradyrhizobium japonicum and Sinorhizobium fredii knockout bacteroid incubations.  
Arrows indicate observed reactions, with arrow thickness representing relative efficiency of 
the detected reactions.  (-): reaction not detected.  Note that overall substrate turnover was 
higher in B. japonicum. 
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Supplementary Figure 4.  Mass spectra of putative ent-kaurenol (2), ent-kaurenal (3), 
and ent-kaurenoic acid (4) from CYP117 incubations.  To confirm production of 2, 3, and 
4 from incubations of CYP117 with ent-kaurene (1), 2, or 3, the mass spectrum for each 
compound was compared to that of an authentic standard (std.).  These mass spectra 
correspond to the peaks identified in Figure 3 and Supplementary Figure 5. 
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Supplementary Figure 5. Trace amounts of ent-kaurenol (2) and ent-kaurenal (3) are 
produced from incubation of ent-kaurene (1) with CYP117.  In addition to the C-19 acid, 
ent-kaurenoic acid (4), the C-19 alcohol (2) and aldehyde (3) are produced from incubations 
of 1 with CYP117, as shown here in gas chromatograms with comparison to authentic 
standards (stds.) of 2, 3, and 4, confirming the sequential oxidation of C-19 catalyzed by 
CYP117. To obtain sufficient peak resolution for detection of 2 and 3, the sample shown here 
was run using a decreased rate of temperature increase, resulting in retention time change 
from those seen in Figure 3. 
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Supplementary Figure 6. Mass spectra of putative ent-7α-hydroxykaurenoic acid (5) 
and GA12-aldehyde (6) detected in CYP114 (+/- FdGA) incubations.  To confirm 
production of 5 and 6 from incubations of CYP114 (+/-FdGA) with ent-kaurenoic acid (4), the 
mass spectrum for each compound was compared to that of an authentic standard (std.). 
These mass spectra correspond to the peaks identified in Figure 4. 
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Supplementary Figure 7. CYP114-FdGA can oxidize GA12-aldehyde (6) to GA12 (7) at 
low efficiency.  a) Incubation of ent-kaurenoic acid (4) in cells expressing CYP114-FdGA 
results in trace amounts of a putative GA12 (7) peak being produced in addition to the much 
more substantial amounts of GA12-aldehyde (6).  In particular, 7 is only detectable with 
compound specific ion extraction (m/z=300) and is of low abundance (note the scale changes 
on the y-axis for each chromatogram; TIC, total ion chromatogram; EIC, extracted ion 
chromatogram). b) The mass spectrum obtained from the putative 7 peak (*) matches that of 
c) the mass spectrum from an authentic 7 standard (std.). d) Incubating 6 in cells expressing 
CYP114-FdGA results in a small increase in the amount of 7 extracted (6 substrate contains 
trace amounts of 7).  e) Quantification of the peak area ratio of 7 to 6 shows that turnover 
from 6 to 7 is significantly (Student’s t-test; p<0.05), but only slightly higher in cells 
expressing CYP114-FdGA; n=3 for each culture, data represent mean values ± standard 
deviation.  f) Thus, while CYP114-FdGA converts 4 mainly to 6, 7 is also produced in 
miniscule amounts.  This reduced catalytic efficiency is indicated in this scheme by arrow 
size.  
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Supplementary Figure 8.  ent-7α-hydroxykaurenoic acid (5) is sufficiently transported 
into S. meliloti cells heterologously expressing CYP114-FdGA.  a) ent-kaurenoic acid (4), 
which is converted to ent-7α-hydroxykaurenoic acid (5) and GA12-aldehyde (6) by CYP114-
FdGA, is found in both the cell pellet and supernatant b) Similarly, 5 is found in both the cell 
pellet and supernatant, but is unable to be further transformed. 
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Supplementary Figure 9. Molecular modeling supports the role of a C-19 carboxylate in 
ring contraction and γ-lactone formation.  A three-dimensional rendering of ent-kaurenoic 
acid (4) shows that the C-19 is in close proximity (3.12 Å) to C-6, allowing for potential 
stabilization of a C-6 carbocation by the C-19 carboxylate.  Furthermore, B-ring contraction 
from the conversion of 4 to GA12-aldehyde (6) brings the C-19 carboxylate 0.32 Å closer to 
C-20 (from 3.23 Å in 4 to 2.91 Å in 6) potentially aiding subsequent C-20 loss and lactone 
formation in the reaction catalyzed by the GA 20-oxidase. 
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Supplementary Figure 10. Mass spectra of putative GA12 (7) from SfSDRGA and 
BjSDRGA incubations. To confirm production of 7 from incubations of SfSDRGA or 
BjSDRGA with GA12-aldehyde (6), the mass spectrum from each was compared to that of an 
authentic standard (std.).  These mass spectra correspond to the peaks identified in Figure 5 
and Supplementary Figure 11. 
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Supplementary Figure 11. SDRGA from Bradyrhizobium japonicum oxidizes GA12-
aldehyde (6) to GA12 (7).  When expressed and induced in E. coli, BjSDRGA elicits the same 
function as SDRGA from S. fredii, as shown here through gas chromatograms with 
comparison to an authentic standard (std.) of 7.  IPTG=isopropyl β-D-1-
thiogalactopyranoside; used to induce SDRGA expression. 
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Supplementary Figure 12. Mass spectra of putative GA15 (8), GA24 (9), and GA9 (10) 
from CYP112 incubations. To confirm production of 8, 9, and 10 from incubations of 
CYP112 with GA12 (7), 8, or 9, the mass spectrum for each compound was compared to that 
of an authentic standard (std.).  These mass spectra correspond to the peaks identified in 
Figure 6. 
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Supplementary Table 1. Products (methyl esters and TMS-ethers) identified by GC-MS 
from incubations of 14C-labeled and unlabeled GA precursors with bacteroids of B. 
japonicum CYP knock-out mutants. 
Mutant Substrate Product(s) (% recovered products) 
Mass spectrum of Me ester 
TMSi ether 
m/z (% relative abundance) 
Bjcyp117  ent-kaurenol 
 
ent-kaurenol (100) 
 
M+ 360(7), 345(8), 270(68), 
257(100), 255(27), 241(14), 
227(18), 201(17), 187(14), 
175(22), 161(24), 147(21), 
131(20), 123(68) 
 
Bjcyp117 
 
ent-14C1]kaurenoic acid   ent-6β,7β-diOH-
14C1]kaurenoic acid (31) 
M+ 594(0.2), 479(85), 404(26), 
389(7), 329(7), 269(100), 
255(14), 209(36) 
  14C1]GA15 (<1) 
 
 
M+ 346(12), 314(10), 286(55), 
241(100), 195(28) 
 
  14C1]GA12 (2) 
 
330(13), 302(100), 300(28), 
287(19), 271(13), 243(34), 
242(24), 227(26), 187(14) 
 
  GA12 norketone (47) M+ 362(14), 334(21), 330(100), 
302(69), 287(27), 274(21), 
271(27), 270(37), 259(48), 
255(33), 243(76), 242(39), 
227(36), 215(30), 201(36), 
199(37), 173(16), 159(24), 
145(26) 
 
  GA12 norketone standard M+ 362(15), 334(18), 330(100), 
302(59), 287(24), 274(16), 
271(20), 270(27), 259(36), 
255(25), 243(62), 242(28), 
227(25), 215(21), 201(27), 
199(25), 173(10), 159(16), 
145(16) 
 
Bjcyp117 14C1]GA12   14C1]GA15 (8) M+ 346(13), 314(21), 286(46), 
241(100), 195(21) 
  Putative GA15 norketone 
enolTMS (10) 
 
M+418(100), 403(17), 387(8), 
360(21), 359(24), 345(16), 
301(11), 270(10), 243(13), 
241(17), 237(11), 223(13), 
197(10), 157(9), 143(42), 
117(34) 
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Supplementary Table 1 continued 
  [14C1]GA24 (6) 
 
M+ 376(3), 344(26), 316(67), 
312(28), 288(61), 287(51), 
284(36), 256(33), 229(62), 
228(100), 227(87) 
 
  Putative GA24  norketone 
enolTMS (21) 
 
M+448(18), 433(5), 419(4), 
387(10), 360(10), 359(10), 
327(5), 298(11), 271(10), 
270(12), 238(23), 223(8), 
221(10), 179(7), 168(100), 
143(27), 117(10) 
 
  14C1]GA9 (trace) 
 
M+ 332(4), 300(100), 288(8), 
272(93), 243(80), 229(60), 
228(53) 
 
 
  GA9 norketone enolTMS 
(2) 
 
M+ 404(100), 389(16), 361(24), 
360(16), 345(37), 301(27), 
287(10), 270(6), 243(9), 211(13), 
195(6), 183(9), 159(14), 143(52) 
 
  14C1]GA12 (5) 
 
 
M+ 362(1), 330(14), 302(100), 
287(22), 271(6), 243(31), 
242(26), 227(16), 187(11) 
 
  GA12 norketone (48) M+ 362(14), 334(20), 330(100), 
302(58), 287(27), 274(20), 
271(22), 270(33), 259(43), 
255(29), 243(68), 242(33), 
227(30), 215(24), 201(31), 
199(32), 173(12), 159(20), 
145(21) 
 
Bjcyp114 ent-kaurenol 
 
ent-kaurenol (44) 
 
M+ 360(9), 345(8), 270(70), 
257(100), 255(24), 241(12), 
227(16), 201(14), 187(15), 
175(18), 161(20), 147(29), 
131(21) 
 
  ent-kaurenal (41) 
 
M+ 286(51), 271(20), 257(46), 
253(13), 243(100), 225(22), 
215(22), 199(25) 
 
  ent-kaurenoic acid (14) M+ 316(50), 301(39), 273(70), 
257(100), 256(41), 241(70), 
201(13), 187(22), 131(37), 
121(57) 
 
Bjcyp114 ent-14C1]kaurenoic acid   ent-7-oxo-14C1]kaurenoic 
acid (0.3) 
(13-OHKA 10%) 
M+ 332(55), 300(11), 272(79), 
257(33), 175(26), 149(100), 
121(31) 
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Supplementary Table 1 continued 
Bjcyp114 ent-7α-OH-
14C4]kaurenoic acid   
ent-7-oxo-14C4]kaurenoic 
acid (66) 
 
 
M+ 338(51), 336(29), 330(7), 
306(7), 278(67), 276(38), 270(9), 
263(25), 261(24), 205(10), 
181(11), 177(12), 151(100), 
149(38), 147(16), 121(27) 
 
Bjcyp114 14C4]GA12-aldehyde 14C4]GA12 (25) M+ 368(1), 336(16), 334(13), 
328(7), 308(100), 306(69), 
300(48), 293(11), 291(16), 
285(11), 247(37), 246(37), 
241(15), 231(17), 229(17) 
  14C4]GA15 (5) 
 
M+ 352(12), 350(8), 344(5), 
320(15), 318(11), 306(17), 
304(11), 290(44), 288(21), 
245(100), 243(39), 239(39), 
201(31)199(18) 
 
  14C4]GA24 (35) 
 
M+ 382(3), 380(2), 350(27), 
348(15), 322(66), 320(49), 
318(45), 314(34), 294(35), 
293(47), 292(53), 290(47), 
286(30), 262(26), 261(30), 
260(26), 233(46), 232(80), 
231(100), 229(43), 227(25), 
226(28), 225(29) 
 
  14C4]GA9 (25) M+ 338(5), 336(4), 306(100), 
304(54), 298(33), 294(15), 
292(13), 276(90), 274(43), 
270(27), 251(47), 249(33), 
243(18), 233(60), 232(63), 
231(48), 230(40), 227(18), 
226(18) 
 
Bjcyp114 14C1]GA12   14C1]GA15 (13) M+ 346(16), 314(25), 286(53), 
241(100), 195(24) 
  14C1]GA24 (56) 
 
M+ 376(5), 344(35), 316(100), 
312(42), 288(76), 287(58), 
284(41), 256(45), 229(63), 
228(91), 227(93) 
 
 
  14C1]GA9 (31) M+ 332(6), 300(100), 288(14), 
272(99), 243(50), 229(52), 
228(55), 217(28) 
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Supplementary Table 1 continued 
Bjcyp112 ent-kaurenol 
 
ent-kaurenol (88) 
 
M+ 360(8), 345(8), 270(73), 
257(100), 255(25), 241(14), 
227(17), 201(15), 187(14), 
175(21), 161(23), 147(21), 
131(16), 123(65) 
  ent-kaurenal (9) 
 
 
M+ 286(54), 271(17), 257(53), 
253(9), 243(100), 225(39), 
215(17), 199(33) 
 
  ent-kaurenoic acid (3) M+ 316(56), 301(38), 273(80), 
257(100), 256(34), 241(59), 
201(11), 187(21), 131(44), 
121(57) 
 
Bjcyp112 ent-14C1]kaurenoic acid   ent-7α-
OH14C1]kaurenoic acid 
(<1) 
M+ 406(38), 391(12), 316(100), 
301(29), 257(57), 256(46), 
241(26) 
  14C1]GA12 (37) 
 
M+ 362((1), 330(20), 302(100), 
300(29), 287(18), 271(7), 
243(29), 242(24), 227(15), 
187(8) 
 
Bjcyp112 14C1]GA12   14C1]GA12 (93) M+ 362(1), 330(19), 302(100), 
300(14), 287(16), 271(7), 
243(27), 242(22), 227(15), 
187(8) 
 
  14C1]GA12 norketone (7) M+ 362(21), 334(16), 330(100), 
302(72), 287(17), 271(33), 
270(22), 259(21), 255(23), 
243(44), 242(37), 227(15), 
215(37), 201(27), 199(22), 
173(17), 159(10), 145(11) 
 
Bjcyp112 14C1]GA15   14C1]GA15 (96) M+ 346(14), 314(15), 300(10), 
286(43), 241(100), 195(19) 
  Putative GA15 norketone 
enolTMS (3) 
 
 
M+418(100), 403(19), 387(7), 
360(15), 359(23), 345(14), 
301(8), 270(10), 243(17), 
241(13), 237(9), 223(11), 
197(10), 143(42) 
 
  14C1]GA24 (1) 
 
M+ 376(6), 344(32), 316(93), 
312(29), 288(76), 287(65), 
285(33), 284(34), 256(35), 
229(64), 228(95), 227(100) 
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Bjcyp112 14C1]GA24 14C1]GA24 (>99) M+ 376(3), 344(31), 316(85), 
312(28), 288(76), 287(57), 
285(37), 284(33), 256(36), 
229(64), 228(92), 227(100) 
  Putative GA24 norketone 
(<1) 
348(24), 330(17), 320(95), 
316(100), 298(27), 288(81), 
285(26), 284(27), 273(23), 
270(21), 260(27), 256(79), 
246(46), 245(40), 229(67), 
228(54), 227(64), 213(26), 
194(22), 185(51), 168(72) 
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Supplementary Table 2. Products (methyl esters and TMS-ethers) identified by GC-MS 
from incubations of 14C-labeled GA precursors with bacteroids of S. fredii CYP knock-out 
mutants. 
Mutant Substrate Product(s) (% recovered products) 
Mass spectrum of Me 
ester TMSi ether 
m/z (% relative 
abundance) 
Sfcyp117 
 
ent-14C1]kaurenoic acid   ent-7α-OH14C1]kaurenoic 
acid (5) 
M+ 406(44), 391(14), 
316(100), 301(28), 257(50), 
256(45), 241(41) 
 
  14C1]GA12 (9) 
 
330(15), 302(100), 300(14), 
287(18), 271(9), 243(30), 
242(18), 227(17), 187(10) 
 
  ent-3-OH14C1]kaurenoic acid 
(6) 
 
M+ 406(5), 391(15), 
346(11), 346(11), 316(45), 
301(13), 277(89), 257(36), 
241(19), 217(8), 189(100) 
 
  ent-15β-OH14C1]kaurenoic 
acid (12) 
 
 
M+ 406(7), 391(2), 316(11), 
301(14), 274(10), 257(26), 
241(11), 199(13), 197(11), 
158(100) 
 
  ent-14C1]kaurenoic acid (46) 
 
M+ 318(55), 303(46), 
273(100), 259(93), 258(59), 
257(54), 243(83), 213(48), 
189(27), 121(97) 
 
  ent-kaurenoic acid 
norketone (5) 
M+ 318(21), 300(5), 
286(19), 259(100), 245(12), 
241(12), 218(9), 189(8) 
 
Sfcyp117 
 
14C1]GA12   14C1]GA12 (65) M+ 362(1), 330(17), 
302(100), 300(7), 287(17), 
271(6), 243(28), 242(22), 
227(15), 187(8) 
 
  GA12 norketone (6) 
 
M+ 362(15), 334(18), 
330(100), 302(59), 287(24), 
274(16), 271(23), 270(35), 
259(41), 255(26), 243(59), 
242(30), 227(27), 215(23), 
201(27), 199(28), 173(11), 
159(15), 145(15) 
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  14C1]GA15 (29) 
 
M+ 346(15), 314(19), 
300(12), 286(47), 241(100), 
213(8), 195(21) 
 
  14C1]GA24 (<1) 
 
 
344(24), 316(81), 312(43), 
288(94), 287(61), 285(38), 
284(41), 256(54), 229(60), 
228(95), 227(100) 
 
Sfcyp114 
  
ent-14C1]kaurenoic acid   ent-14C1]kaurenoic acid (100) M+ 318(55), 303(40), 
273(100), 259(95), 258(57), 
257(47), 243(81), 213(48), 
189(24), 121(93) 
 
Sfcyp114 
 
ent-7α-OH-
14C4]kaurenoic acid   
ent-7α-OH-14C4]kaurenoic 
acid (58) 
M+ 412(39), 410(47), 
408(22), 404(3), 397(14), 
395(17), 322(86), 320(100), 
318(50), 307(40), 305(44), 
263(51), 262(51), 261(70), 
260(54), 259(37), 247(38), 
245(43), 240(30), 227(29), 
225(31) 
 
  7-oxo-14C4]kaurenoic acid 
(42) 
M+ 338(36), 336(39), 
334(20), 330(3), 306(6), 
304(7), 278(48), 276(60), 
274(31), 263(19), 261(29), 
259(17), 205(8), 203(11), 
181(14), 179(17), 177(15), 
151(100), 149(68), 123(21), 
121(32) 
 
Sfcyp114 
 
14C4]GA12-aldehyde 14C4]GA12 (60) M+ 368(1), 336(18), 
334(10), 328(7), 308(100), 
306(61), 300(36), 293(16), 
291(14), 285(7), 277(8), 
247(32), 246(28), 241(11), 
231(16), 229(11) 
 
  14C4]GA15 (38) 
 
M+ 352(15), 350(9), 344(4), 
320(18), 318(9), 306(12), 
304(8), 290(50), 288(18), 
284(15), 245(100), 243(48), 
239(31), 201(32), 199(15) 
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  14C4]GA24 (2) 
 
350(18), 348(17), 322(40), 
320(36), 318(47), 314(28), 
294(26), 293(48), 292(55), 
290(52), 262(39), 261(19), 
260(26), 233(60), 232(100), 
231(73), 229(36), 226(23) 
 
Sfcyp114 
 
14C1]GA12   14C1]GA12 (45) 
 
M+ 362(0.6), 330(17), 
302(100), 300(8), 287(17), 
271(6), 243(27), 242(21), 
227(15), 187(8) 
  GA12 norketone (2) 
 
M+ 362(17), 334(23), 
330(100), 302(58), 287(23), 
274(12), 271(15), 270(28), 
259(36), 255(18), 243(58), 
242(28), 227(23), 215(15), 
201(22), 199(18), 173(12), 
159(19), 148(23) 
  14C1]GA15 (50) M+ 346(16), 314(18), 
300(12), 286(47), 241(100), 
213(8), 195(19) 
  14C1]GA24 (3) 
 
344(40), 316(95), 312(44), 
288(83), 287(62), 285(29), 
284(53), 256(40), 229(49), 
228(100), 227(91) 
Sfcyp112 
 
ent-14C1]kaurenoic acid   ent-7α-OH-14C1]kaurenoic 
acid (10) 
M+ 406(46), 391(15), 
316(100), 301(32), 257(68), 
256(55), 241(32) 
  14C1]GA12 (10) 
 
330(16), 302(100), 287(17), 
271(6), 243(27), 242(26), 
227(18), 187(10) 
 
  ent-15-OH14C1]kaurenoic 
acid (9) 
 
M+ 406(6), 391(8), 316(8), 
301(21), 274(15), 257(37), 
241(18), 199(15), 197(15), 
158(100) 
 
  7-oxo-14C1]kaurenoic acid (9) 
 
M+ 332(32), 300(8), 
272(66), 257(38), 175(31), 
149(100) 
  ent-14C1]kaurenoic acid (35) M+ 318(56), 303(43), 
273(100), 259(92), 258(59), 
257(54), 243(87), 213(47), 
189(26), 121(99) 
Sfcyp112 
 
14C1]GA12   14C1]GA12 (100) M+ 362(0.5), 330(15), 
302(100), 300(7), 287(17), 
271(6), 243(28), 242(22), 
227(16), 187(8) 
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Supplementary Table 2 continued 
Sfcyp112 
 
14C1]GA15   14C1]GA15 (100) M+ 346(12), 314(15), 
300(12), 286(47), 241(100), 
213(9), 195(25) 
Sfcyp112 
 
14C1]GA24 14C1]GA24 (100) M+ 376(3), 344(27), 
316(76), 312(22), 288(67), 
287(51), 285(36), 284(33), 
256(35), 229(61), 228(85), 
227(100) 
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Supplementary Table 3. Products (methyl esters and TMS-ethers) identified by GC-MS 
from incubations of 14C-labeled and unlabeled GA precursors with bacteroids of B. 
japonicum SDRGA or FdGA knock-out mutants. 
 
Mutant 
 
Substrate Product(s) 
(% recovered products) 
Mass spectrum of Me 
ester TMSi ether 
m/z (% relative 
abundance) 
BjsdrGA  ent-kaurenol 
 
ent-kaurenoic acid (22) M+ 316(58), 301(43), 
273(75), 257(100), 256(40), 
241(73), 201(12), 187(29), 
131(46), 121(49) 
 
  ent-7-OH-kaurenoic acid (6) M+ 404(39), 389(20), 
314(100), 299(31), 285(23), 
255(60), 254(40), 239(27) 
 
  GA12-aldehyde (2) M+ 330(12), 287(11), 
270(48), 253(29), 241(100), 
227(8), 199(21) 
 
  GA12 (18) M+ 360(0.6), 328(21), 
300(100), 285(20), 269(7), 
241(27), 240(22), 225(16), 
185(10) 
 
  GA15 (3) M+ 344(12), 312(19), 
298(13), 284(49), 239(100), 
211(8), 195(22) 
 
BjsdrGA  ent-14C1]kaurenoic acid 
(KA) 
ent-7-OH14C1]kaurenoic acid 
(trace) 
 
M+ 406(37), 391(34), 
316(100), 257(73), 256(45), 
241(35) 
  ent-6,7-diOH-
14C1]kaurenoic acid (5) 
 
479(91), 404(26), 389(7), 
329(8), 301(5), 269(100), 
255(10), 209(41) 
 
  putative ent-6,7-di-OH-
kaurenoic acid norketone (39) 
 
479(100), 419((5), 404(19), 
389(5), 361(10), 329(27), 
269(85), 255(14), 209(45) 
 
  Unknown 14C1 product 1 (11) 318(52), 314(100), 312(27), 
299(17), 290(17), 286(43), 
269(24), 268(25), 258(50), 
257(89), 241(41), 239(56), 
229(75), 227(52), 231(30), 
197(24), 195(25), 191(28), 
187(31), 185(31), 172(40), 
150(61), 138(70) 
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  Unknown 14C1 product 2 (31) 316(20), 287(28), 285(13), 
270(28), 253(13), 241(100), 
239(31), 227(14), 213(17), 
207(15), 197(19), 185(22), 
159(24), 157(24) 
 
BjsdrGA  ent-7-OH 
14C4]kaurenoic acid 
ent-6,7-diOH-
14C4]kaurenoic acid (34) 
485(79), 483(70), 481(34), 
477(17), 410(20), 408(25), 
395(17), 393(9), 273(100), 
271(59), 269(22), 257(13), 
213(41), 207(21)  
 
  14C4]GA12-aldehyde (10) M+ 338(11), 336(13), 330(5), 
293(18), 291(15), 287(9), 
278(38), 276(38), 274(22), 
270(10), 261(24), 259(11), 
247(69), 245(100), 243(45), 
241(44), 231(14), 203(12), 
199(23) 
 
  14C4]GA12 (3) 336(20), 334(29), 308(100), 
306(93), 304(81), 302(40), 
300(33), 291(20), 289(22), 
287(20), 248(30), 247(14), 
246(37), 245(26), 244(27), 
243(20), 231(33), 227(25) 
 
  14C4]GA15 (13) M+ 352(16), 350(12), 
344(3), 320(13), 318(19), 
306(14), 304(11), 290(47), 
288(43), 245(100), 243(97), 
239(21), 201(36), 199(27) 
 
  14C4]GA24 (3) 350(23), 348(20), 322(63), 
320(55), 318(56), 314(47), 
294(26), 293(49), 292(69), 
290(74), 288(51), 285(33), 
262(30), 233(88), 232(60), 
231(100), 229(60), 228(58), 
227(51), 226(21), 225(19) 
 
  Unknown 14C4] product 1(15) 
 
 
 
 
 
 
 
 
 
 
324(33), 322(44), 320(100), 
318(72), 316(50), 314(15), 
312(19), 303(17), 301(14), 
292(26), 290(40), 274(18), 
272(17), 271(25), 263(53), 
261(81), 259(39), 245(39), 
243(49), 233(64), 231(85), 
229(55), 201(42), 187(44) 
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  Unknown 14C4] product 2(15) 322(23), 320(32), 314(8), 
291(26), 289(27), 276(16), 
274(19), 259(14), 257(18), 
245(100), 243(87), 241(33), 
239(24), 231(20), 229(18), 
203(20), 201(28), 189(22), 
187(24) 
 
BjsdrGA  14C4]GA12-aldehyde 14C4]GA12 (4) 336(24), 334(8), 328(10), 
308(100), 306(63), 304(14), 
302(37), 300(45), 293(14), 
291(17), 247(38), 246(35), 
245(21), 244(16), 231(23), 
229(15) 
 
  14C4]GA15 (7) M+ 352(12), 350(7), 344(8), 
320(13), 318(7), 306(8), 
304(6), 290(37), 288(17), 
284(17), 245(100), 243(39), 
239(30), 201(25), 199(14) 
 
  14C4]GA24 (15) 350(25), 348(15), 342(9), 
322(61), 320(39), 318(27), 
316(15), 314(29), 294(30), 
293(41), 292(43), 291(51), 
290(40), 286(27), 262(22), 
261(19), 260(24), 233(50), 
232(82), 231(100), 230(38), 
229(35), 227(29), 226(22), 
225(28) 
 
  14C4]GA9 (15) M+ 338(9), 336(4), 330(2), 
306(100), 304(60), 298(40), 
294(23), 292(18), 276(86), 
274(48), 270(40), 251(54), 
249(30), 243(32), 233(86), 
232(68), 231(63), 230(43), 
227(50), 226(46) 
 
  Unknown 14C4] product 1 (29) M+? 352(6), 348(2), 344(2),  
324(45), 322(31), 320(100), 
318(57), 316(28), 312(35), 
303(20), 301(10), 292(45), 
290(28), 274(22), 263(72), 
261(53), 259(22), 255(34), 
245(41), 243(35), 233(69), 
231(57), 229(24), 201(27), 
187(30), 152(79), 140(79), 
123(81) 
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  Unknown 14C4] product 2 (11) 
 
 
322(32), 320(16), 314(13), 
291(32), 289(14), 285(16), 
276(19), 274(11), 259(13), 
245(100), 243(42), 241(17), 
239(39), 233(14), 231(13), 
229(11), 203(20), 201(17), 
199(11), 189(16), 187(18) 
 
BjsdrGA  14C1]GA12 14C1]GA24 (6) 344(20), 316(81), 312(28), 
288(78), 287(50), 285(36), 
284(36), 256(36), 229(68), 
228(77), 227(100) 
 
 
putative GA24 norketone 
(enolTMS) (29) 
 
M+ 448(10), 348(19), 
330(19), 320(85), 316(100), 
305(10), 298(19), 288(70), 
285(27), 284(28), 273(22), 
271(19), 270(20), 260(27), 
257(33), 256(76), 246(47), 
245(40), 229(84), 228(63), 
227(49), 213(22), 201(24), 
187(41), 185(48), 168(54) 
  GA9 norketone (44) 304(100), 301(14), 286(9), 
272(32), 260(47), 258(21), 
245(42), 244(34), 229(74), 
228(98), 218(12), 217(14), 
213(15), 201(44), 200(25), 
199(27), 187(19), 185(86), 
183(20), 159(33), 145(41) 
 
  GA12 norketone (21) M+ 362(16), 334(20), 
330(100), 315(8), 302(64), 
287(29), 274(20), 271(25), 
270(36), 259(46), 255(31), 
243(69), 242(36), 227(33), 
215(27), 201(35), 199(34), 
173(15), 159(23), 145(22) 
 
BjfdGA ent-kaurenol 
 
ent-kaurenoic acid (11) 
 
M+ 316(47), 301(43), 
273(75), 257(100), 256(43), 
241(72), 201(13), 187(22), 
131(47), 121(85) 
 
  ent-7-OH-kaurenoic acid (2) 
 
M+ 404(40), 314(100), 
299(31), 255(58), 254(43), 
239(20) 
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  7-oxo-kaurenoic acid (72) M+ 330(53), 315(2), 298(6), 
270(75), 255(29), 242(9), 
227(6), 201(6), 199(6), 
187(13), 175(15), 147(100) 
  13-OH-kaurenoic acid (7) M+ 404(27), 389(5), 345(4), 
207(5), 193(100), 180(6), 
165(9) 
 
BjfdGA ent-14C1]kaurenoic acid  ent-7-OH-14C1]kaurenoic acid 
(10) 
M+ 406(40), 391(12), 
316(100), 301(30), 257(59), 
256(46), 241(29) 
 
  14C1]GA15 (5) 
 
M+ 346(13), 314(18), 
300(8), 286(39), 241(100), 
195(20) 
 
  15-OH-14C1-kaurenoic acid 
(3) 
 
M+ 406(9), 391(5), 316(5), 
301(13), 274(12), 257(23), 
241(10), 199(9), 197(10), 
158(100) 
  7-oxo-14C1 kaurenoic acid 
(60) 
M+ 332(54), 300(6), 
272(77), 257(28), 255(14), 
244(8), 229(7), 203(6), 
201(6), 189(5), 175(21), 
149(100) 
  Putative 7-oxo-kaurenoic acid 
norketone (13) 
M+ 332(53), 300(12), 
272(67), 257(13), 244(10), 
217(9), 209(9), 203(9), 
126(34), 121(21), 109(100) 
 
  13-OH-14C1- kaurenoic acid 
(1) 
Diluted with endogenous 
compound 
M+ 406(30), 404(26), 
391(6), 389(4), 348(9), 
347(5), 277(2), 195(100), 
193(82), 180(2) 
 
BjfdGA ent-7-OH-
14C4]kaurenoic acid 
7-oxo-14C4 kaurenoic acid 
(39) 
M+ 338(34), 336(41), 
334(21), 330(8), 306(5), 
304(6), 278(47), 276(60), 
272(16), 270(13), 263(18), 
261(29),  259(17), 233(9), 
219(9), 205(11), 203(12),  
181(13), 180(11), 179(16), 
177(18), 175(18), 165(11), 
163(14), 151(100), 149(82), 
147(34) 
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  Putative 7-oxo-14C4]kaurenoic 
acid norketone (4) 
M+ [340(36), 338(37), 
336(23), 332(28)], 280(41), 
278(63), 276(25), 272(37), 
265(12), 263(13), 261(14), 
221(16), 215(10), 213(14), 
209(16), 169(31), 165(24), 
140(35), 125(38), 121(26), 
113(94), 111(90), 109(100) 
  Putative dehydro-ent-7-OH-
14C4]kaurenoic acid (20) 
 
M+ 410(79), 408(100), 
406(50), 404(25), 402(25), 
395(20), 393(26), 391(14), 
379(6), 377(5), 367(7), 
365(8), 351(17), 349(23), 
335(33), 333(43), 331(23), 
320(16), 318(14), 307(15), 
305(14), 293(24), 291(26), 
280(25), 278(54), 277(61), 
276(27), 275(46), 265(20), 
263(21), 247(27), 235(33), 
233(25) 
 
  Plus other unidentified 
products – possibly norketones 
of the major products as the 
enol-TMS derivatives 
 
 
BjfdGA 14C4]GA12-aldehyde 14C4]GA12 (4) 
 
336(15), 334(8), 328(8), 
308(100), 306(74), 304(13), 
300(45), 293(14), 291(20), 
247(29), 246(32), 245(21), 
244(20), 231(14), 229(10) 
 
  14C4]GA15 (3) 
 
M+ [352(11), 350(7), 
344(2)], 320(16), 318(7), 
306(6), 304(10), 290(40), 
288(14), 245(100), 243(40), 
239(32), 201(22), 199(10) 
 
  14C4]GA24 (8) 
 
350(21), 348(18), 342(8), 
322(69), 320(38), 318(27), 
316(12), 314(19), 294(32), 
293(55), 292(51), 291(37), 
290(45), 286(17), 262(15), 
261(18), 260(26), 233(58), 
232(70), 231(100), 230(39), 
229(41), 227(20), 226(23), 
225(41) 
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Supplementary Table 3 continued 
  14C4]GA9 (4) 
 
M+ 338(7), 306(83), 
304(66), 298(35), 294(14), 
292(18), 276(100), 274(44), 
270(37), 251(62), 249(27), 
243(26), 233(70), 232(79), 
231(60), 230(53), 227(27), 
226(37) 
 
  14C4]GA9 norketone (enolTMS) 
(6) 
M+ 412(100), 410(60), 
404(31)], 397(13), 381(5), 
368(17), 367(26), 365(11), 
351(37), 349(14), 345(18), 
307(20), 305(14), 293(12), 
257(13), 217(12), 215(17), 
195(14), 161(12), 159(13), 
147(25), 145(68), 143(38) 
 
  Putative 14C4]GA15 norketone 
(enolTMS) (2) 
 
M+ [426(100), 424(62), 
418(27)], 409(12), 403(15), 
366(21), 365(32), 351(17), 
349(18), 345(14), 305(16), 
249(19), 247(14), 145(62), 
143(53) 
 
  Putative 14C4]GA24 norketone 
(enolTMS) (16) 
 
M+ [456(15), 454(9), 448(3)], 
441(5), 396(8), 366(9), 
356(9), 338(8), 336(10), 
328(36), 326(24), 324(42), 
322(22), 320(19), 296(25), 
294(30), 292(19), 262(27), 
239(25), 235(33), 233(36), 
225(19), 191(29), 170(100), 
168(39), 145(38) 
 
  14C4]GA12 norketone (29) M+ 370(19), 368(11), 
362(5), 342(22), 340(14), 
338(100), 336(57), 330(29), 
310(58), 308(39), 302(17), 
295(21), 292(21), 279(26), 
278(37), 276(24), 267(36), 
265(31), 262(34), 261(26), 
249(80), 248(43), 247(39), 
243(21), 233(32), 221(28), 
207(30), 205(46) 
 
BjfdGA 14C1]GA12 14C1]GA12 (33) M+ 362(0.5), 330(15), 
302(100), 287(17), 271(6), 
243(26), 242(20), 227(14), 
187(7) 
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  GA12 norketone (23) M+ 362(14), 334(20) 
330(100), 302(58), 287(25), 
274(16), 271(23), 270(29), 
259(38), 255(27), 243(62), 
242(29), 227(25), 215(23), 
201(29), 199(26), 173(11), 
159(17), 145(17) 
 
  14C1]GA15 (10) 
 
 
Putative GA15 norketone 
enolTMS (3) 
 
M+ 346(16), 314(16), 
300(12), 286(44), 241(100), 
195(20) 
M+418(100), 403(20), 
387(6), 360(20), 359(25), 
345(17), 301(10), 270(10), 
243(19), 241(13), 238(8), 
223(13), 197(10), 157(7), 
143(44), 117(38) 
 
  14C1]GA24 (7) M+ 376(3), 348(11), 
344(34), 316(86), 312(32), 
288(81), 287(60), 285(32), 
284(38), 256(40), 229(76), 
228(98), 227(100) 
  Putative GA24 norketone 
enolTMS (4) 
 
M+448(15), 433(4), 419(4), 
387(7), 360(10), 359(8), 
327(4), 298(9), 271(8), 
270(7), 238(23), 223(7), 
221(10), 179(7), 168(100), 
143(27), 117(10) 
 
  14C1]GA9 (3) M+ 332(6), 300(100), 
288(18), 272(95), 244(24), 
243(57), 229(64), 228(74), 
227(30), 218(22), 217(33), 
213(18), 185(21), 183(23), 
159(39) 
 
  GA9  norketone (enolTMS) (1) M+ 404(100), 389(15), 
373(7), 361(26), 360(14), 
345(38), 301(18), 287(5), 
270(7), 257(10), 243(10), 
211(7), 183(4), 159(5), 
143(46) 
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Supplementary Table 4. Products (methyl esters and TMS-ethers) identified by GC-MS 
from incubations of 14C-labeled and unlabeled GA precursors with bacteroids of S. fredii 
SDRGA or FdGA knock-out mutants. 
Mutant Substrate Product (% recovered products) 
Mass spectrum of Me 
ester TMSi ether 
m/z (% relative 
abundance) 
SfsdrGA  ent-kaurenol 
 
ent-kaurenol (95) 
 
M+ 360(9), 345(9), 270(88), 
257(100), 255(30), 241(16), 
227(19), 201(17), 187(15), 
175(24), 161(27), 147(27), 
131(16), 123(77) 
 
  ent-kaurenal (3) 
 
M+ 286(62), 271(19), 
257(57), 252(17), 243(100), 
225(36), 215(23), 199(38), 
161(43) 
 
  ent-kaurenoic acid (2) M+ 316(50), 301(38), 
273(67), 257(100), 256(45), 
241(74), 201(15), 187(24), 
131(41), 121(64) 
 
  ent-7-OH-kaurenoic acid (<1) M+ 404(40), 314(100), 
299(21), 255(64), 254(33), 
239(25) 
 
SfsdrGA  ent-14C1]kaurenoic acid 
(KA) 
ent-7-OH-14C1]kaurenoic acid 
(18) 
M+ 406(39), 391(14), 
316(100), 301(32), 257(56), 
256(44), 241(29) 
 
  14C1]GA12 (<1) 
 
330(28), 302(100), 287(49), 
271(25), 243(65), 242(37), 
227(4), 187(21) 
 
  15-OH-14C1KA (7) 
 
M+ 406(8), 391(7), 316(7), 
301(21), 274(11), 257(36), 
241(18), 199(7), 197(7), 
158(100) 
 
  ent-14C1]kaurenoic acid (56) M+ 318(60), 303(45), 
273(100), 259(99), 258(56), 
257(52), 243(83), 213(39), 
189(26), 121(93) 
 
SfsdrGA  14C4]GA12-aldehyde 14C4]GA12 (17) 
 
 
 
 
 
 
336(16), 334(6), 328(11), 
308(100), 306(62), 304(11), 
302(9), 300(41), 293(5), 
291(8), 246(26), 231(10), 
229(15) 
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Supplementary Table 4 continued 
  14C4]GA12-aldehyde (60) M+ 338(12), 336(6), 293(15), 
291(7), 287(6), 278(47), 
276(28), 270(14), 261(15), 
259(6), 247(100), 245(65), 
243(20), 241(31), 233(12), 
231(9), 203(11) 
 
SfsdrGA  14C1]GA12 14C1]GA15 (33) 
 
M+ 346(17), 314(16), 
300(13), 286(48), 241(100), 
195(22) 
 
  14C1]GA24 (4) 
 
344(33), 316(82), 312(31), 
288(83), 287(60), 285(51), 
284(35), 256(39), 229(68), 
228(84), 227(100) 
 
  14C1]GA12 (60) 
 
 
M+ 362(0.6), 330(17), 
302(100), 287(18), 271(7), 
243(29), 242(22), 227(16), 
187(8)  
 
  GA12 norketone (2) M+ 362(22), 334(22), 
330(100), 302(70), 287(30), 
274(24), 271(20), 270(45), 
259(45), 255(22), 243(76), 
242(37), 227(28), 215(24), 
201(32), 199(32), 173(11), 
159(20), 145(22) 
 
SffdGA ent-kaurenol 
 
ent-kaurenol (98) M+ 360(10), 345(9), 
270(100), 257(83), 255(31), 
241(17), 227(20), 201(18), 
187(16), 175(26), 161(27), 
147(27), 131(18), 123(81) 
  ent-kaurenal (<1) M+ 286(59), 271(46), 
257(45), 243(100), 225(38), 
199(9), 161(21) 
  ent-kaurenoic acid (1) M+ 316(48), 301(38), 
273(63), 257(100), 256(38), 
241(68), 213(27), 201(12), 
187(21), 131(31), 121(55) 
SffdGA ent-14C1]kaurenoic acid  ent-7-OH-14C1]kaurenoic acid 
(2) 
M+ 406(68), 316(100), 
301(49), 257(29), 256(31), 
241(36) 
  15-OH-14C1-KA (13) M+ 406(7), 391(5), 316(5), 
301(17), 274(12), 257(34), 
241(16), 199(10), 197(11), 
158(100) 
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  ent-14C1]kaurenoic acid (60) M+ 318(65), 303(44), 
273(99), 259(100), 258(60), 
257(48), 243(79), 213(40), 
189(25), 121(83) 
SffdGA ent-7-OH-
14C4]kaurenoic acid 
ent-7-OH 14C4]kaurenoic acid 
(81) 
M+ 412(43), 410(46), 
408(20), 397(15), 395(16), 
322(87), 320(100), 318(45), 
307(35), 305(37), 303(18), 
278(10), 26350), 262(48), 
261(60), 260(52), 259(33), 
258(21), 247(38), 245(38), 
239(25), 227(30), 189(34) 
 
  14C4]GA12 (8) 336(11), 334(7), 328(11), 
308(100), 306(78), 304(7), 
300(52), 293(6), 291(8), 
247(45), 246(42), 231(35) 
 
SffdGA 14C4]GA12-aldehyde 14C4]GA12 (63) 
 
336(26), 334(20), 308(96), 
306(100), 304(29), 300(90), 
293(23), 291(23), 247(88), 
246(67), 244(48), 231(78), 
229(15) 
 
  14C4]GA15 (37) M+ 352(13), 350(8), 
320(24), 312(15), 306(15), 
290(73), 288(27), 245(100), 
243(93), 239(83), 201(72), 
199(44) 
 
SffdGA [14C1]GA12 14C1]GA12 (78) 
 
330(19), 302(100), 300(24), 
287(46), 271(27), 243(57), 
242(56), 227(37), 187(31) 
 
  14C1]GA15 (22) 
 
M+ 346(6), 314(20), 
300(14), 286(44), 241(100), 
195(31) 
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Supplementary Table 5.  Comprehensive examination of enzyme functionality with GA 
pathway intermediates.  +, viable substrate; -, non-viable substrate; P, product formed; n.t., 
not tested. Note that some intermediates are both products and viable substrates. 
 CYP117 CYP114 CYP114-FdGA SDRGA CYP112 
ent-kaurene (1) + - - - - 
ent-kaurenol (2) +/P - - - - 
ent-kaurenal (3) +/P - - - - 
ent-kaurenoic acid (4)‡ -/P + + - - 
ent-7α-OH-kaurenoic acid (5) - -/P -/P - - 
GA12-aldehyde (6) - - +/P + - 
GA12 (7) - - -/P -/P + 
GA15 (8) - - - - +/P 
GA24 (9) - - - - +/P 
GA9 (10) - - - - -/P 
‡methyl ester derivative was also tested with CYP114 +/-FdGA with no turnover detected. 
 
 
Supplementary Table 6. Identity between plant, fungal, and bacterial cytochromes P450 
involved in GA biosynthesis. Representative protein sequences from B. japonicum 
USDA110, Arabidopsis thaliana, and Gibberella fujikuroi were compared using pairwise 
alignments. 
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BjCYP117 -         
BjCYP114 22.9 -        
BjCYP112 19.8 27 -       
AtKO 
(CYP701) 18.2 16.4 16.6 -      
AtKAO1 
(CYP88) 19 21.8 19.5 19.7 -     
AtKAO2 
(CYP88) 16.2 17.5 18.6 19.7 76.2 -    
GfKO 
(CYP503) 16.4 19.5 17.2 18.2 17.4 16.8 -   
GfKAO 
(CYP68A) 15.3 13.1 17.6 17.3 20.7 20.7 28 -  
GfGA20ox 
(CYP68B) 14.3 13.6 17.2 21.4 20.9 19.2 27.7 37.4 - 
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Supplementary Table 7. List of prominent strains, plasmids, and constructs used in 
experiments. 
Strain, plasmid, construct Description Reference or Source 
 
Bacterial Strains 
 
  
One Shot® TOP10 Chemically Competent 
E. coli 
F- mcrA ∆( mrr-hsdRMS-mcrBC) 
Φ80lacZ∆M15 ∆ lacX74 recA1 araD139 
∆(araleu)7697 galU galK rpsL 
(StrR) endA1 nupG; for plasmid propagation 
and cloning 
 
Thermo Fisher Scientific 
OverExpressTM C41(DE3) Chemically 
Competent E. coli 
F- ompT hsdSB (rB- mB-) gal dcm (DE3); for 
pCDF-BjSDR/Fd expression 
Lucigen 
One Shot® BL21 StarTM (DE3) Chemically 
Competent E. coli 
F- ompT hsdSB (rB-, mB-) galdcmrne131 
(DE3); for pET101-BjCYP114 and pCDF-
FdRx/Fd coespression 
Thermo Fisher Scientific 
C41 pCDF-BjSDR/Fd E. coli C41 cells transformed for expression of 
B. japonicum USDA110 SDRGA expression; 
SpR 
This study 
BL21 pET101-BjCYP114 E. coli BL21 cells transformed for expression 
of B. japonicum USDA110 CYP114 
This study 
BL21 pET101-BjCYP114+pCDF-FdRx/Fd E. coli BL21 cells transformed for 
coexpression of B. japonicum USDA110 
CYP114, FdGA, and FdR1-5 
This study 
E. coli MM294A pro-82 thi-1 endA hsdR17 supE44; donor 
strains for triparental mating 
51 
E. coli MT616 MM294A recA56 carrying plasmid pRK600, 
CmR; helper strains for triparental mating 
52 
Sinorhizobium meliloti 1021 (a.k.a. Ensifer 
meliloti 1021, S. meliloti Rm1021) 
Rhizobial symbiont of Medicago spp.; SmR; 
heterologous host for expression of S. fredii 
GA operon genes 
46 
Sm1021 pstb-LAFR5-SfCYP117 S. meliloti 1021 transformed for expression of 
S. fredii NGR234 CYP117; SmR, TcR 
This study 
Sm1021 pstb-LAFR5-SfCYP117-Fd S. meliloti 1021 transformed for coexpression 
of S. fredii NGR234 CYP117 and FdGA; SmR, 
TcR 
This study 
Sm1021 pstb-LAFR5-SfCYP114 S. meliloti 1021 transformed for expression of 
S. fredii NGR234 CYP114; SmR, TcR 
This study 
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Supplementary Table 7 continued 
Sm1021 pstb-LAFR5-SfCYP114-Fd S. meliloti 1021 transformed for coexpression 
of S. fredii NGR234 CYP114 and FdGA; SmR, 
TcR 
This study 
Sm1021 pstb-LAFR5-SfSDR S. meliloti 1021 transformed for expression of 
S. fredii NGR234 SDRGA; SmR, TcR 
This study 
Sm1021 pstb-LAFR5-SfCYP112 S. meliloti 1021 transformed for expression of 
S. fredii NGR234 CYP112; SmR; TcR 
This study 
Sm1021 pstb-LAFR5-SfCYP112-Fd S. meliloti 1021 transformed for coexpression 
of S. fredii NGR234 CYP112 and FdGA; SmR, 
TcR 
This study 
Bradyrhizobium japonicum USDA110 
(a.k.a. B. diazoefficiens USDA110) 
wild-type rhizobial symbiont of Glycine max; 
CmR 
USDA; Beltsville, MD 
Bj∆cyp117 deletion strain of CYP117 derived from B. 
japonicum USDA110 parent strain; CmR 
This study 
Bj∆cyp114 deletion strain of CYP114 derived from B. 
japonicum USDA110 parent strain; CmR 
This study 
Bj∆fdGA deletion strain of FdGA derived from B. 
japonicum USDA110 parent strain; CmR 
This study 
Bj∆sdrGA deletion strain of SDRGA derived from B. 
japonicum USDA110 parent strain; CmR 
This study 
Bj∆cyp112 deletion strain of CYP112 derived from B. 
japonicum USDA110 parent strain; CmR 
This study 
Sinorhizobium fredii NGR234 (a.k.a. 
Ensifer fredii NGR234) 
widely nodulating wild-type rhizobial symbiont 
of Vigna unguiculata, among others; RfR 
47 
Sf∆cyp117 deletion strain of CYP117 derived from S. 
fredii NGR234 parent strain; RfR 
This study 
Sf∆cyp114 deletion strain of CYP114 derived from S. 
fredii NGR234 parent strain; RfR 
This study 
Sf∆fdGA deletion strain of FdGA derived from S. fredii 
NGR234 parent strain; RfR 
This study 
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Supplementary Table 7 continued 
Sf∆sdrGA deletion strain of SDRGA derived from S. fredii 
NGR234 parent strain; RfR 
This study 
Sf∆cyp112 deletion strain of CYP112 derived from S. 
fredii NGR234 parent strain; RfR 
This study 
Plasmids   
pCRTM-Blunt II-TOPO® KmR; for cloning and propagation of constructs Thermo Fisher Scientific 
pCDF-DuetTM-1 SpR; for expression in C41 E. coli cells Novagen (EMD Millipore) 
pstb-LAFR5 pLAFR5 with the SMb21651 promoter 
sequence; Broad-range-host cosmid 
expression vector shown to be functional in S. 
meliloti 1021; mob+; TcR 
50 
pK19mobsacB Suicide vector containing the sacB gene for 
negative selection; mob+; KmR; for double 
cross-over homologous recombination 
deletion of bacterial genes 
23 
 
Expression Constructs 
  
pstb-LAFR5-SfCYP117 For expression of SfCYP117 in S. meliloti 
1021; TcR 
This study 
pstb-LAFR5-SfCYP117-Fd For coexpression of SfCYP117 and SfFdGA in 
S. meliloti 1021; TcR 
This study 
pstb-LAFR5-SfCYP114 For expression of SfCYP114 in S. meliloti 
1021; TcR 
This study 
pstb-LAFR5-SfCYP114-Fd For coexpression of SfCYP114 and SfFdGA in 
S. meliloti 1021; TcR 
This study 
pstb-LAFR5-SfSDR For expression of SfSDRGA in S. meliloti 1021; 
TcR 
This study 
pstb-LAFR5-SfCYP112 For expression of SfCYP112 in S. meliloti 
1021; TcR 
This study 
pstb-LAFR5-SfCYP112-Fd For coexpression of SfCYP112 and SfFdGA in 
S. meliloti 1021; TcR 
This study 
 
 
 
 
 
113 
 
 
Supplementary Table 7 continued 
pET101-BjCYP114 For expression of BjCYP114 in BL21 E. coli 
cells; CbR 
This study 
pCDF-BjSDR/Fd For expression of BjSDRGA in C41 E. coli 
cells; SpR 
This study 
pCDF-BjFdR1/Fd For coexpression of B. japonicum USDA110 
FdGA with FdR1 in BL21 E. coli cells; SpR 
This study 
pCDF-BjFdR2/Fd For coexpression of B. japonicum USDA110 
FdGA with FdR2 in BL21 E. coli cells; SpR 
This study 
pCDF-BjFdR3/Fd For coexpression of B. japonicum USDA110 
FdGA with FdR3 in BL21 E. coli cells; SpR 
This study 
pCDF-BjFdR4/Fd For coexpression of B. japonicum USDA110 
FdGA with FdR4 in BL21 E. coli cells; SpR 
This study 
pCDF-BjFdR5/Fd For coexpression of B. japonicum USDA110 
FdGA with FdR5 in BL21 E. coli cells; SpR 
This study 
Deletion constructs   
pK19mobsacB-BjCYP117-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of BjCYP117 for clean deletion of the gene 
through double homologous recombination 
 
This study 
pK19mobsacB-BjCYP114-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of BjCYP114 for clean deletion of the gene 
through double homologous recombination 
 
This study 
pK19mobsacB-BjSDRGA-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of BjSDRGA for clean deletion of the gene 
through double homologous recombination 
This study 
pK19mobsacB-BjFdGA-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of BjFdGA for clean deletion of the gene 
through double homologous recombination 
 
This study 
pK19mobsacB-BjCYP112-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of BjCYP112 for clean deletion of the gene 
through double homologous recombination 
 
This study 
pK19mobsacB-SfCYP117-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of SfCYP117 for clean deletion of the gene 
through double homologous recombination 
 
This study 
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pK19mobsacB-SfCYP114-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of SfCYP114 for clean deletion of the gene 
through double homologous recombination 
 
This study 
pK19mobsacB-SfSDRGA-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of SfSDRGA for clean deletion of the gene 
through double homologous recombination 
 
This study 
pK19mobsacB-SfFdGA-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of SfFdGA for clean deletion of the gene 
through double homologous recombination 
 
This study 
pK19mobsacB-SfCYP112-AB/CD Construct containing a fused DNA fragment of 
regions upstream (AB) and downstream (CD) 
of SfCYP112 for clean deletion of the gene 
through double homologous recombination 
This study 
 
 
 
Supplementary Table 8. Primers used to create expression constructs and deletion bacteroid 
strains. Bj=Bradyrhizobium japonicum; Sf=Sinorhizobium fredii. Red=restriction site within 
primer for cloning. Bold=overlap region for fusing together DNA fragments. 
Name Sequence (5' to 3') Description 
Expression constructs   
Sf-sCYP117/sCYP112-F CGCGGATCCTAACGTAACGTAA
ATGGAGTCACCTCT 
Forward primer to amplify sCYP117/sCYP112 and 
sCYP117-Fd/sCYP112-Fd; anneals to 5' linker and 
BamHI which are located in both synthetic constructs, 
allowing for use of this single primer 
Sf-FdGA-R CCGGAATTCTCAAACCGTTCCAT
CGTGTCCTCCTGG 
Reverse primer to amplify sCYP117-Fd, CYP114-Fd, 
and sCYP112-Fd; contains EcoRI 
Sf-sCYP117-R CCGGAATTCTCATGAGAATCCG
ATGCGGATTGTCAT 
Reverse primer to amplify sCYP117; contains EcoRI 
Sf-CYP114-ORF-F CACCATGGACATGCAAGAAACC
ACGACA 
Forward primer to amplify the ORF of CYP114 and 
combined CYP114-Fd amplicon from gDNA; contains 
CACC for use in pENTR 
Sf-CYP114-ORF-R CTACGGTTGCGCCCTGCGATCA
GTCG 
 
Reverse primer to amplify the ORF of CYP114 
Sf-CYP114-ORF-linker-F CGCGGATCCTAACGTAACGTAA
ATGGAGTCACCTCTATGGACAT
GCAAGAAACCACGACAGC 
 
Forward primer to add BamHI and the 5' linker 
sequence to the CYP114 construct 
Sf-CYP114-ORF-EcoRI-R CCGGAATTCCTACGGTTGCGCC
CTGCGATCAGTCG 
 
Reverse primer to add EcoRI onto the 3' end of the 
CYP114 construct 
Sf-sCYP112-R CCGGAATTCTCACCAGAGCACC
GGGAACTCCTCGA 
 
Reverse primer to amplify sCYP112; contains EcoRI 
Sf-SDR-ORF-F ATGGAACGGTTTGAAGGCAAGG
TGGCCG  
 
Forward primer to amplify ORF of SDR from gDNA 
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Supplementary Table 8 continued 
Sf-SDR-ORF-R TCAGCAGCGCGCCGTTTCGGCG
GTGTC  
 
Reverse primer to amplify ORF of SDR from gDNA 
Sf-SDR-linker-F1 AATGGAGTCACCTCTATGGAAC
GGTTTGAAGGCAAGGTGG 
Forward primer to add 15 bp of linker sequence to the 
5' end of SDR construct 
Sf-SDR-EcoRI-R CCGGAATTCTCAGCAGCGCGCC
GTTTCGGCG  
 
Reverse primer to add EcoRI onto the 3' end of the 
SDR construct 
Sf-SDR-linker-F2 CGCGGATCCTAACGTAACGTAA
ATGGAGTCACCTCT 
Forward primer used to add the remainder of the linker 
sequence and a 5' BamHI site to the SDR construct 
Knockout constructs   
Bj-CYP117ko-A-F CATGGAATTCAACCGGACGGCG
TGGCCGAAGTGTG 
Forward primer to amplify a ~1kb region upstream of 
CYP117 (AB fragment); contains 5' EcoRI 
Bj-CYP117ko-B-R CACACGGGGCATGCGATGCCA
GCCAGCAGCGCGGCGCCGCGT
CCGCTTC  
 
Reverse primer to amplify ~1kb region upstream of 
CYP117 (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Bj-CYP117ko-C-F GCGGACGCGGCGCCGCGCTGC
TGGCTGGCATCGCATGCCCCGT
GTGGTG 
 
Forward primer to amplify a ~1kb region downstream 
of CYP117 (CD fragment); contains overlap region for 
annealing/fusing to AB fragment 
Bj-CYP117ko-D-R CATGAAGCTTTCATGCGCGTGG
CGCGTGTTTGAAC  
Reverse primer to amplify ~1kb region downstream of 
CYP117 (CD fragment); contains HindIII 
Bj-CYP117ko-check-F ATCGTCAACATGTCGTCGTGCC
AGG  
Forward primer ~400bp upstream to check for 
presence or deletion of CYP117; wild-type 
fragment=2.1 kb, knockout=0.8 kb 
Bj-CYP117ko-check-R TGCGCCGGCAGCCAAACAGAGC
AAG  
Reverse primer ~400 bp downstream to check for 
presence or deletion of CYP117; wild-type 
fragment=2.1 kb, knockout=0.8 kb 
Bj-CYP114ko-A-F GCGAATTCGTCCCTGGTCGACA
AGGCGGTAGAG 
Forward primer to amplify ~500bp region upstream of 
CYP117 (AB fragment); contains 5' EcoRI 
Bj-CYP114ko-B-R ACGCGCATCCCTGGTTACCTGT
TGGCGGGCTG 
Reverse primer to amplify ~500bp region upstream of 
CYP114 (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Bj-CYP114ko-C-F GTAACCAGGGATGCGCGTCATG
GTCGAC 
Forward primer to amplify a ~500bp region 
downstream of CYP114 (CD fragment); contains 
overlap region for annealing/fusing to AB fragment 
Bj-CYP114ko-D-R ACTAAGCTTCTGCGCATCGGCG
ATGTCGAT 
Reverse primer to amplify ~500bp region downstream 
of CYP117 (CD fragment); contains HindIII 
Bj-CYP114ko-check-F ATTCCCGCGGAGAGCAAGGTGC
TGG  
Forward primer ~400bp upstream to check for 
presence or deletion of CYP114; wild-type 
fragment=2.2 kb, knockout=0.8 kb 
Bj-CYP114ko-check-R ATAGCCGCCGAGCCATCAATGT
CGGC  
Reverse primer ~400bp downstream to check for 
presence or deletion of CYP114; wild-type 
fragment=2.2 kb, knockout=0.8 kb 
Bj-FdGAko-A-F ACCGAGAATTCTCATACAGCGC
AAGCGCACCGATCC  
Forward primer to amplify ~600bp region upstream of 
FdGA (AB fragment); contains 5' EcoRI 
Bj-FdGAko-B-R TGCCTTCAAACCGTCCCATCGA
ACGTCCGAAGGAATGCCGAGG  
Reverse primer to amplify ~600bp region upstream of 
FdGA (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Bj-FdGAko-C-F CGGCATTCCTTCGGACGTTCGA
TGGGACGGTTTGAAGGCAAAGT
GG  
Forward primer to amplify a ~800bp region 
downstream of FdGA (CD fragment); contains overlap 
region for annealing/fusing to AB fragment 
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Supplementary Table 8 continued 
Bj-FdGAko-D-R TCGGAGAATTCCTGTTGCCACC
GTCGGCGTATGTCG  
Reverse primer to amplify ~800bp region downstream 
of FdGA (CD fragment); contains EcoRI 
Bj-FdGAko-check-F TCGAAGAAGTCCTGCGCTGCGA
CGC  
Forward primer ~400bp upstream to check for 
presence or deletion of FdGA; wild-type fragment=1.1 
kb, knockout=0.8 kb 
Bj-FdGAko-check-R ATGTTGACGATCGCGCCACCGC
CGC  
Reverse primer ~400bp downstream to check for 
presence or deletion of FdGA; wild-type fragment=1.1 
kb, knockout=0.8 kb 
Bj-SDRGAko-A-F ACCGTGAATTCTATCGCCCAGC
GCGACATCGAACTGG  
Forward primer to amplify ~600bp region upstream of 
SDRGA (AB fragment); contains 5' EcoRI 
Bj-SDRGAko-B-R CAGCGGGTTGAGCAGCATGTC
CACGTGTCATCCTAGATTGTGCT
GGTC 
  
Reverse primer to amplify ~600bp region upstream of 
SDRGA (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Bj-SDRGAko-C-F CCAGCACAATCTAGGATGACAC
GTGGACATGCTGCTCAACCCGC
TGAACC  
Forward primer to amplify a ~700bp region 
downstream of SDRGA (CD fragment); contains overlap 
region for annealing/fusing to AB fragment 
Bj-SDRGAko-D-R GAATTCTCGTCGCTGCGATCGA
AGGCGCTCACC  
Reverse primer to amplify ~700bp region downstream 
of SDRGA (CD fragment); contains BamHI 
Bj-SDRGAko-check-F TCACTTCTGCCTCGGTGCGCAA
CTG  
Forward primer ~400bp upstream to check for 
presence or deletion of SDRGA; wild-type fragment=1.7 
kb, knockout=0.8 kb 
Bj-SDRGAko-check-R TAGATCGCCGGTTTCGCGCAGG
ATG  
Reverse primer ~400bp downstream to check for 
presence or deletion of SDRGA; wild-type fragment=1.7 
kb, knockout=0.8 kb 
Bj-CYP112ko-A-F GCGGATCCGCACATTCAGCGCG
AGAGCAGG 
Forward primer to amplify ~500bp region upstream of 
CYP112 (AB fragment); contains 5' BamHI 
Bj-CYP112ko-B-R CGCGACAGGTGGCACTTCACTC
TCTAAG  
Reverse primer to amplify ~500bp region upstream of 
CYP112 (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Bj-CYP112ko-C-F GAAGTGCCACCTGTCGCGGAC
GCCACG 
Forward primer to amplify a ~500bp region 
downstream of CYP112 (CD fragment); contains 
overlap region for annealing/fusing to AB fragment 
Bj-CYP112ko-D-R ACTAAGCTTTGCCGTCCAGGCG
CGCTG  
Reverse primer to amplify ~500bp region downstream 
of CYP112 (CD fragment); contains HindIII 
Bj-CYP112ko-check-F AGCTATGTAGTGCCTGCTGAGC
CTGC  
Forward primer ~400bp upstream to check for 
presence or deletion of CYP112; wild-type 
fragment=2.0 kb, knockout=0.8 kb 
Bj-CYP112ko-check-R TATGCGTCGGTGGGTCCTTCAT
CGC  
Reverse primer ~400bp downstream to check for 
presence or deletion of CYP112; wild-type 
fragment=2.0 kb, knockout=0.8 kb 
   
Sf-CYP117ko-A-F ATAAGGATCCCAGACCATGGCG
ACCAATCTGCGCG 
Forward primer to amplify a ~1kb region upstream of 
CYP117 (AB fragment); contains 5' BamHI 
Sf-CYP117ko-B-R GCATGCGATGCCAGCCAGCAG
CGCGCCGTTTCGGCGGTGT 
Reverse primer to amplify ~1kb region upstream of 
CYP117 (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Sf-CYP117ko-C-F AAACGGCGCGCTGCTGGCTGG
CATCGCATGCCCCGTGTGG 
Forward primer to amplify a ~1kb region downstream 
of CYP117 (CD fragment); contains overlap region for 
annealing/fusing to AB fragment 
Sf-CYP117ko-D-R TAATAAGCTTAGGTCGTCGTGG
ACCAGGGTACAAG 
Reverse primer to amplify ~1kb region downstream of 
CYP117 (CD fragment); contains HindIII 
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Supplementary Table 8 continued 
Sf-CYP117ko-check-F CGTCAACATGTCGTCGTGCCAG
GG  
Forward primer ~400bp upstream to check for 
presence or deletion of CYP117; wild-type 
fragment=2.1 kb, knockout=0.8 kb 
Sf-CYP117ko-check-R CCAGTGCTCCAGCAGCCAGACA
GAGC  
Reverse primer ~400 bp downstream to check for 
presence or deletion of CYP117; wild-type 
fragment=2.1 kb, knockout=0.8 kb 
Sf-CYP114ko-A-F ATAAGGATCCCCATCCCTGGTG
GACAAGGCGGTGG 
Forward primer to amplify ~400bp region upstream of 
CYP117 (AB fragment); contains 5' BamHI 
Sf-CYP114ko-B-R CCTTTTCATGCGGTTCACCAGA
GCACCGGGAACTCCTCGA 
Reverse primer to amplify ~400bp region upstream of 
CYP114 (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Sf-CYP114ko-C-F TCCCGGTGCTCTGGTGAACCGC
ATGAAAAGGGTACAAGGG 
Forward primer to amplify a ~500bp region 
downstream of CYP114 (CD fragment); contains 
overlap region for annealing/fusing to AB fragment 
Sf-CYP114ko-D-R TAATAAGCTTGCCAGCGCATTG
CCCGCTTCGGCCG 
Reverse primer to amplify ~500bp region downstream 
of CYP117 (CD fragment); contains HindIII 
Sf-CYP114ko-check-F GACGGCATCATGCGCTATCCGA
GG  
Forward primer ~400bp upstream to check for 
presence or deletion of CYP114; wild-type 
fragment=2.2 kb, knockout=0.8 kb 
Sf-CYP114ko-check-R TCAAACCGTTCCATCGTGTCCTC
CTGG  
Reverse primer ~400bp downstream to check for 
presence or deletion of CYP114; wild-type 
fragment=2.2 kb, knockout=0.8 kb 
Sf-FdGAko-A-F CATGGAATTCACCTGCATCGGC
AATTCGCGCTGGC  
Forward primer to amplify ~1kb region upstream of 
FdGA (AB fragment); contains 5' EcoRI 
Sf-FdGAko-B-R ACCTTGCCTTCAAACCGTTCCA
TCTCAGCCCTTGTACCCTTTTCA
TGCGG  
 
Reverse primer to amplify ~1kb region upstream of 
FdGA (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Sf-FdGAko-C-F ATGAAAAGGGTACAAGGGCTG
AGATGGAACGGTTTGAAGGCAA
GGTGGCC  
Forward primer to amplify a ~1kb region downstream 
of FdGA (CD fragment); contains overlap region for 
annealing/fusing to AB fragment 
Sf-FdGAko-D-R CATGAAGCTTAGTGGCTGCCCA
GCGTCCGTTCCGC 
Reverse primer to amplify ~1kb region downstream of 
FdGA (CD fragment); contains HindIII 
Sf-FdGAko-check-F TAGCTTCGGCCACGGCATCCAC
TTCTG  
Forward primer ~300bp upstream to check for 
presence or deletion of FdGA; wild-type fragment=0.9 
kb, knockout=0.6 kb 
Sf-FdGAko-check-R CCGAAGTGCCGCTCCGCCGTCT
CGAA  
Reverse primer ~300bp downstream to check for 
presence or deletion of FdGA; wild-type fragment=0.9 
kb, knockout=0.6 kb 
Sf-SDRGAko-A-F CATGGAATTCCACGCTATCGGA
TGCGGAGTTGATCAGC  
Forward primer to amplify ~1kb region upstream of 
SDRGA (AB fragment); contains 5' EcoRI 
Sf-SDRGAko-B-R TAGGGGGTTGAGCAGCACGTTC
ACGTGTCCTCCTGGAATGCGTT
GGTCTTTC  
 
Reverse primer to amplify ~1kb region upstream of 
SDRGA (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Sf-SDRGAko-C-F CCAACGCATTCCAGGAGGACA
CGTGAACGTGCTGCTCAACCCC
CTAAACCG  
 
Forward primer to amplify a ~1kb region downstream 
of SDRGA (CD fragment); contains overlap region for 
annealing/fusing to AB fragment 
Sf-SDRGAko-D-R CATGAAGCTTACAGATGGGTGC
CCGCCGGAATGCGC  
Reverse primer to amplify ~1kb region downstream of 
SDRGA (CD fragment); contains HindIII 
Sf-SDRGAko-check-F CGTCGTGATTGACCAAGATCTG
TGCGG  
Forward primer ~400bp upstream to check for 
presence or deletion of SDRGA; wild-type fragment=1.6 
kb, knockout=0.75 kb 
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Supplementary Table 8 continued 
Sf-SDRGAko-check-R CGCCGGTTTCGGGCAGGATGGT
TACGT  
Reverse primer ~400bp downstream to check for 
presence or deletion of SDRGA; wild-type fragment=1.6 
kb, knockout=0.75 kb 
Sf-CYP112ko-A-F ATAAGGATCCCCACGCACAATT
CCGCAACGGTCG 
Forward primer to amplify ~500bp region upstream of 
CYP112 (AB fragment); contains 5' BamHI 
Sf-CYP112ko-B-R GGCGGCGTCCGCGCAGGTGGC
ACTCCACTCTCTAAGCGAT 
Reverse primer to amplify ~500bp region upstream of 
CYP112 (AB fragment); contains overlap region for 
annealing/fusing to CD fragment 
Sf-CYP112ko-C-F GTGGAGTGCCACCTGCGCGGA
CGCCGCCGGGAATCGC 
Forward primer to amplify a ~500bp region 
downstream of CYP112 (CD fragment); contains 
overlap region for annealing/fusing to AB fragment 
Sf-CYP112ko-D-R TAATAAGCTTCATGCCGTCCAG
GCGCGCTGCGACG 
Reverse primer to amplify ~500bp region downstream 
of CYP112 (CD fragment); contains HindIII 
Sf-CYP112ko-check-R CCTGTCGTCGGCAAATTTCGTTT
GAGC  
Forward primer ~400bp upstream to check for 
presence or deletion of CYP112; wild-type 
fragment=2.0 kb, knockout=0.8 kb 
Sf-CYP112ko-check-F GCAGACGCGTATGCGTCGGTGG
TTCC  
Reverse primer ~400bp downstream to check for 
presence or deletion of CYP112; wild-type 
fragment=2.0 kb, knockout=0.8 kb 
   
sacB-F GTGCGTAACTAACTTGCCATCTT
C  
Forward primer to amplify a portion of the sacB gene 
for confirmation of pK19mobsacB knockout construct 
integration into the host genome 
sacB-R CCGAAGCCCAACCTTTCATAGA
AG  
Reverse primer to amplify a portion of the sacB gene 
for confirmation of pK19mobsacB knockout construct 
integration into the host genome 
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Supplementary Table 9. List of genes characterized in this study.  Provided are the 
NCBI/GenBank gene symbols, gene description, gene ID's, locus tags, and UniProtKB 
identifiers. 
 gene symbol gene description gene ID locus tag 
UniProtKB 
identifier 
 
Bradyrhizobium japonicum USDA110 
     
CYP112 cyp112 cytochrome P-450 BJ-1 1055403 blr2144 Q59203  
(CPXP_BRADU) 
CYP114 cyp114 cytochrome P-450 BJ-3 1055406 blr2145 Q59204  
(CPXR_BRADU) 
FdGA not annotated P450-system 3Fe-4S 
ferredoxin 
- blr2145.1 Q45218  
(FE45_BRADU) 
SDRGA blr2146 dehydrogenase 1055404 blr2146 Q45219  
(Y2146_BRADU) 
CYP117 cyp117 cytochrome P-450 BJ-4 1055402 blr2147 Q59205 
 (CPXU_BRADU) 
 
Sinorhizobium fredii NGR234 
     
CYP112 cpxP cytochrome P450 protein 
CpxP 
962601 NGR_a02700 P55544  
(CPXP_RHISN) 
CYP114 cpxR cytochrome P450 protein 
CpxR 
962600 NGR_a02710 P55543  
(CPXR_RHISN) 
FdGA NGR_a02720 P450-system 3Fe-4S 
ferredoxin protein 
962355 NGR_a02720 P55542  
(FE45_RHISN) 
SDRGA NGR_a02730 short chain 
dehydrogenase/reductase 
962611 NGR_a02730 P55541  
(Y4LA_RHISN) 
CYP117 cpxU cytochrome P450 962613 NGR_a02740 P55540  
(CPXU_RHISN) 
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CHAPTER 3 
LABELING STUDIES CLARIFY THE COMMITTED STEP IN BACTERIAL 
GIBBERELLIN BIOSYNTHESIS 
 
A manuscript published in Organic Letters.‡ 
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Abstract 
Bacteria have evolved gibberellin phytohormone biosynthesis independently of plants 
and fungi.  Through 13C-labeling and NMR analysis, the mechanistically unusual “B” ring 
contraction catalyzed by a cytochrome P450 (CYP114), which is the committed step in 
gibberellin biosynthesis, was shown to occur via oxidative extrusion of carbon-7 from ent-
kaurenoic acid in bacteria.  This is identical to the convergently evolved chemical 
transformation in plants and fungi, suggesting a common semipinacol rearrangement 
mechanism potentially guided by carbon-4α carboxylate proximity.  
 
 
 
121 
 
 
Gibberellins (GAs) are phytohormones that play important roles in plant growth, 
development, and interactions with microbes.1,2  These diterpenoid-derived compounds are 
characterized by a 6-5-6-5 fused ring structure, termed the ent-gibberellane carbon skeleton.  
However, GAs are produced via ent-kaurane precursors, which have a 6-6-6-5 carbon 
skeleton (see Scheme 1 for numbering and ring nomenclature).  Accordingly, the 
committed step in GA biosynthesis is contraction of the “B” ring from a cyclohexane to 
cyclopentane.  This occurs via oxidation of ent-kaurenoic acid (1; ent-kaur-16-en-19-oic 
acid), first to 7β-hydroxy-ent-kaurenoic acid (2; ent-7α-hydroxykaurenoic acid), and then to 
GA12-aldehyde (3), the latter of which involves oxidative extrusion of an endocyclic “B” ring 
carbon (Scheme 1).  The cytochrome P450 mono-oxygenases (CYPs) catalyzing this 
mechanistically unusual and challenging reaction are termed ent-kaurenoic acid oxidases 
(KAOs).  
In addition to their endogenous production by plants, GAs are also produced by 
certain plant-associated fungi and bacteria, wherein the relevant biosynthetic pathways have 
independently evolved.3,4  Plant and fungal GA biosynthesis has been extensively studied, 
and it has been directly demonstrated that the carbon extruded from the “B” ring is C-7 in 
fungal biosynthesis,5–7 and convincing indirect evidence has been presented that plants also 
extrude C-7 (i.e., retention of the C-6α proton when the aldehyde from 3 is oxidized to the 
acid).8,9  Moreover, 2 has been shown to be a bona fide intermediate in both plant and fungal 
GA biosynthesis.  By contrast, 6β,7β-dihydroxy-ent-kaurenoic acid (4; ent-6α,7α-dihydroxy-
kaurenoic acid), which is also produced in the KAO-catalyzed oxidation of 1 by plants and 
fungi, is not.10–14  Thus, implicating a mechanism in which C-7, but not C-6, is hydroxylated 
prior to ring contraction.5,15 
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The GA biosynthetic pathway in bacteria has only recently been elucidated.4,16  In 
particular, the role of each enzyme from a CYP-rich gene cluster/operon in symbiotic 
rhizobia has now been functionally identified, showing that they act to produce GA9 
(Scheme S2).  While rhizobia only express these enzymes and produce GA after 
differentiation into their nodule-residing bacteroid form,17 it was possible to observe activity 
with the individual enzymes upon recombinant expression.4,16,18,19  Notably, “B” ring 
contraction requires not only a CYP (CYP114), but also the ferredoxin (FdGA) found within 
the operon, which presumably acts as an electron donor.4  This is distinct from plant and 
fungal KAOs, which simply utilize an archetypical cytochrome P450 reductase for their 
activity.12,20,21  When expressed alone, CYP114 only converts 1 to 2, while co-expression of 
CYP114 and FdGA enables full conversion of 1 to 3.  This suggests that endogenous 
ferredoxins from the recombinant host support partial CYP114 activity, and indicates a 
unique role for FdGA in facilitating full activity, presumably through its interaction with 
CYP114.  Although recombinantly co-expressed CYP114 and FdGA are not able to convert 2 
to 3, nodule-extracted rhizobial bacteroids can use 2 as a GA precursor, implicating this as an 
intermediate in bacterial GA biosynthesis as well.4 
Though the intermediacy of 2 might be taken to suggest that C-7 also will be extruded 
during the “B” ring contraction reaction catalyzed by the convergently evolved bacterial 
enzymes, it is still plausible that C-6 might be extruded instead (e.g., via a pinacol ring 
rearrangement mechanism).5  The extrusion of C-7 during fungal GA biosynthesis was 
shown by feeding (2-13C)mevalonolactone (5; the δ-lactone form of mevalonate) to cultures 
of Fusarium fujikuroi (the anamorph of Gibberella fujikuroi), which leads to specific 
labeling of C-7 in 1, followed by NMR analysis of the resulting GA3 final product.5,7  This 
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approach was enabled, at least in part, by the high titers of GA3 produced by fungal cultures.  
By contrast, rhizobia produce only small amounts of GAs.17  Nevertheless, the recombinant 
co-expression of CYP114 and FdGA, which carry out “B” ring contraction with 1, provides a 
means to analyze this reaction in more detail (i.e., via incubation with 13C-labeled 1).   
Although bacteria usually produce isoprenoids/terpenoids via the non-mevalonate 
pathway, Keasling and co-workers have engineered incorporation of the mevalonate-
dependent isoprenoid precursor pathway from yeast into E. coli.22  Of particular relevance 
here, a single plasmid enables production of the universal isoprenoid precursors isopentenyl 
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) from 5.  In turn, a modular 
metabolic engineering system has been developed that is compatible with this plasmid.23  
This enables the production of diterpenoids via incorporation of a (E,E,E)-geranylgeranyl 
diphosphate synthase (producing this general diterpene precursor from IPP and DMAPP), 
subsequently acting diterpene cyclases/synthases, and even further downstream acting CYPs 
in conjunction with their requisite redox partner.24  Thus, it was possible to produce 13C-
labeled 1 by simply feeding (2-13C)-5 to E. coli engineered to produce 1 from 5 (i.e., via co-
expression of the necessary nine enzymes, see Scheme S3, Figs. S1 and S2).  As expected, 
this enabled isolation of 1 with 13C enrichment at four positions, as initially confirmed by gas 
chromatography-mass spectroscopy (GC-MS), with comparison to an authentic standard 
(Fig. S2).  The expected incorporation of 13C at carbons 1, 7, 12, and 18 (Scheme 2)5,7 was 
verified by 13C-NMR analysis with comparison to unlabeled 1 (Fig. S3 and Tables S1 and 
S2).   
To investigate the origin of the extruded carbon, 13C-enriched 1 was fed to bacterial 
cultures recombinantly co-expressing CYP114 and FdGA.  This allowed isolation of 3 
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enriched at four positions, as confirmed by GC-MS comparison to an authentic standard (Fig. 
S4).  Following purification, 13C-NMR analysis showed three enriched carbons with 
chemical shifts between 30-50 ppm, indicative of alkyls, while the fourth had a chemical 
shift of over 200 ppm, representing a carbonyl carbon (Fig. 1 and Tables S3 & S4).  These 
shifts were further verified by comparison to those measured for unlabeled 3.  Thus, it was 
demonstrated that C-7 of 1 was extruded and oxidized to the aldehyde of 3.  
As with plant and fungal GA biosynthesis, 2 is observed and seems to serve as an 
intermediate in bacteria as well,4 implying C-7β hydroxylation prior to ring contraction.  It is 
known for plants and fungi that the 6β hydrogen of 1 is removed prior to rearrangement/ring 
contraction, although 4 does not serve as an intermediate,8,9,25 and seems to be a side product 
of the corresponding CYPs in both kingdoms.  Interestingly, closer analysis of incubations of 
1 in cells co-expressing CYP114 and FdGA showed that a trace amount of 4 is produced (Fig. 
S5).  However, feeding 4 to bacterial cultures recombinantly co-expressing CYP114 and 
FdGA does not result in further conversion (Fig. S5), suggesting that 4 is a side product of 
bacterial KAO activity.  Thus, not only do the KAOs from all three biological kingdoms 
extrude C-7 in “B” ring contraction, but also exhibit a conserved order of chemical 
transformations, with conversion of 1 to 3 via 2, but apparently not 4.   
Although it is possible that the conversion of 1 to 3 could proceed via transient 
formation of a C-19,6-γ-lactone ring, which is used to achieve “B” ring contraction in 
chemical synthesis of GAs,26 this corresponds to the known kaurenolide side-products of GA 
biosynthesis in both plants and fungi.27  Notably, these compounds were not observed here, 
nor have these previously been reported in other investigations of bacterial GA 
biosynthesis.4,16  To further evaluate the possibility of the “B” ring contraction reaction 
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proceeding through this type of intermediate, kaurenolide and 7β-hydroxykaurenolide (see 
Fig. S6 for chemical structures) were fed to bacterial cultures recombinantly co-expressing 
CYP114 and FdGA.  However, these were not converted in this system (Fig. S6), and likely 
are not intermediates in bacterial GA biosynthesis, similar to what has been reported for 
plants and fungi.27  
All three biological kingdoms have convergently evolved KAOs that carry out this 
committed step in GA biosynthesis.4  In each case the KAO is a member of the CYP super-
family, but falls within phylogenetically distinct families specific to each biological 
kingdom, as bacterial KAOs come from the CYP114 family, the fungal KAOs from the 
CYP68 family, and those from plants from the CYP88 family.14,28   However, the results 
reported here show that these convergently evolved KAOs all catalyze extrusion of the same 
carbon, using a conserved order of central chemical transformations (i.e., from 1 to 3 via 2) 
in each case.4  This suggests a physical/chemical restraint for the “B” ring contraction 
reaction.  
Intriguingly, there appears to always be a free C-4α carboxylate (C-19) present.  
While CYPs typically catalyze radical based reactions, it has been previously suggested that 
this “B” ring contraction reaction might proceed via a carbocation based mechanism instead, 
with transfer of the unpaired electron from the initially formed C-6 radical of 2 to the heme-
iron.29,30  Notably, the C-4α carboxylate is ideally positioned to offer anchimeric assistance to 
form this putative C-6 carbocation, potentially guiding the observed oxidative extrusion of C-
7 via a semipinacol rearrangement mechanism (Scheme 3).31  Alternatively, hydroxylation of 
2 to form 4 as a transient intermediate would enable rearrangement via a classical pinacol 
mechanism.  If protonated in the CYP114 active site (pKa ~4.6), the C-4α moiety might then 
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provide anchimeric assistance by acting as an acid to protonate the 6β-hydroxyl group, 
leading to specific extrusion of C-7 (Scheme 3).  While the lack of enzymatic conversion of 
4 may argue against the classic pinacol mechanism, it is possible that suboptimal expression 
of CYP114 and/or FdGA prevented turnover here. 
Consistent with a role for anchimeric assistance by the free C-4α carboxylate, neither 
the methyl ester of 1 nor ent-kaurenal (which in the predominant diol form sterically 
resembles 1) are further transformed by recombinantly expressed CYP114 (either with or 
without co-expression of FdGA).4  Additional support for the proposed mechanism stems from 
the use of pinacol-like intermediates to achieve “B” ring contraction in chemical synthesis of 
GA.26  Thus, it seems likely that the independently evolved CYPs catalyzing the 
characteristic “B” ring contraction in gibberellin biosynthesis in all three biological 
kingdoms may have converged on a common (semi)pinacol rearrangement mechanism to 
selectively carry out this unusual and challenging reaction.  
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Scheme 1. Reaction catalyzed by CYP114 + FdGA in bacterial GA biosynthesis.  1 (ent-
kaurenoic acid) is representative of the ent-kaurane backbone, and 3 (GA12-aldehyde) 
represents the ent-gibberellane backbone. 
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Scheme 2.  The 13C label from (2-13C)-5 is specifically incorporated into 1 via metabolically 
engineered bacteria.  13C-labeled 1 can then be incubated with bacteria recombinantly co-
expressing CYP114 and FdGA to produce 13C-labeled 3. 
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Figure 1. Comparison of the 13C-labeled 3 13C-NMR spectrum to that of the unlabeled 
standard (800 MHz, CDCl3 for each) reveals that C-7 is extruded during the ring contraction 
from ent-kaurenoic acid 1 to GA12-aldehyde 3.  The 13C-enriched carbons in the labeled 
substrate are indicated with asterisks (*). 
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Scheme 3.  Proposed reaction mechanisms for “B” ring contraction during GA biosynthesis 
that proceed either through a semipinacol (path A) or classic pinacol (path B) intermediate. 
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Supplementary Information 
 
Materials and Methods 
General 
 All chemicals were purchased from Sigma-Aldrich and Fisher Scientific, with 
molecular biology tools purchased from Thermo Fisher Scientific. Unless noted otherwise, 
antibiotics were used at the following concentrations: tetracycline (Tc) 2 μg/mL, 
chloramphenicol (Cm) 20 μg/mL, carbenicillin (Cb) 25 μg/mL, spectinomycin (Sp) 25 
μg/mL.  Gas chromatography-mass spectrometry (GC-MS) was performed with a 3900 
Saturn GC with Saturn 2100T ion trap MS (Varian) equipped with an HP-5MS column 
(Agilent).  Relative quantification of purified compounds was determined using GC-FID 
(flame ionization detection) on an Agilent 6890N Network GC System equipped with an HP-
1MS column (Agilent).  High-performance liquid chromatography (HPLC) purification of 
compounds was carried out with an Agilent 1200 series HPLC equipped with a reverse-phase 
C-8 column (Kromasil® C8, 50 x 4.6 mm), autosampler, diode array UV detector, and 
fraction collector.  
Synthesis of (2-13C)mevalonolactone (5) 
(2-13C)Mevalonolactone (5) was synthesized as previously described.1–4  Briefly, 4-
(benzyloxy)butan-2-one was used in an aldol addition with the ester enolate of ethyl (2-
13C)acetate obtained by LDA deprotonation. The product ethyl 5-(benzyloxy)-3-hydroxy-3-
methyl-(2-13C)pentanoate was deprotected by catalytic hydrogenation, followed by 
lactonisation under acidic conditions (p-toluenesulfonic acid) to afford (2-13C)-5 in 63% 
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overall yield. Details of the procedures and spectroscopic data of the products are given in 
reference 4. 
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Scheme S1. Synthesis of (2-13C)mevalonolactone (5). 
 
Preparation of 13C-labeled ent-kaurenoic acid (1) substrate 
 Previous work has shown that C-2 of 5 is incorporated as C-1, C-7, C-12, and C-18 of 
the ent-kaurane backbone,4 and thus the 13C-label from (2-13C)-5 would be located at those 
positions.  13C-labeled ent-kaurenoic acid 1 was produced by metabolic engineering in two 
ways, either via sequential production of ent-kaurene 6 from 5 and then oxidation to 1, or 
direct production of 1 from 5.  For the first method, (2-13C)-5 was fed into a previously 
described metabolic engineering system containing the enzymes necessary for biosynthesis 
of 6.5  Briefly, pMBI6 (TcR; contains mevalonate pathway enzymes for increasing isoprenoid 
precursors), pGGeC (CmR; contains (E,E,E)-geranylgeranyl diphosphate synthase from Abies 
grandis and an ent-copalyl diphosphate synthase from Zea maize, for ent-copalyl diphosphate 
production) and pET-AtKS (CbR; contains ent-kaurene synthase from Arabidopsis thaliana, 
for  production of 6) were co-expressed in C41 OverExpress E. coli cells (Lucigen) with Tc, 
Cm and Cb selection.  Cultures were grown at 37 ˚C with 225 RPM shaking to mid-log phase 
(OD600 = 0.5-0.9), at which point IPTG (1 mM) riboflavin (1 mM), 5-aminolevulinic acid, 
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FeCl3 (0.25 mM), and (2-13C)-5 (2.5 mM) were added and the cultures were moved to 16 ˚C 
with shaking at 225 RPM for 3 days.  After this incubation, cultures were extracted five times 
with an equal volume of hexanes.  These organic fractions were pooled in a round bottom 
flask and dried in a rotary evaporator.  The round bottom flask was extracted five times with 
5 mL of hexanes, and these fractions were pooled and dried under a gentle stream of N2.  
This resulted in production of ~150 μg of 13C-labeled 6, with the labeling confirmed via GC-
MS and comparison to an unlabeled authentic standard produced via the same metabolic 
engineering system described here, but with unlabeled 5 fed into the system to produce 
unlabeled 6 (Figure S1).  Mass spectra of 13C-labeled substrates and products contained mass 
ions with a characteristic “pine-tree” effect – i.e. unlabeled samples have distinct m/z peaks 
with very minor sequential +1 peaks due to natural isotope abundance, while the labeled 
substrate exhibited 13C isotope enrichment at four carbons, leading to higher abundances of 
the corresponding isotopic peaks.  The 13C-labeled 6 was concentrated to 1 mg/mL in a 1:1 
solution of MeOH and DMSO and then fed to cultures of E. coli transformed with pCDF-
AtKO/CPR1 (SpR; contains the ent-kaurenoic acid oxidase and a cytochrome P450 reductase, 
CPR1, from Arabidopsis thaliana for production of 1)7 with Sp selection.  These cultures 
were grown as described above.  For extraction of 1, cultures were acidified with HCl to pH 
3 to neutralize the C-4α (C-19) carboxylate, and extracted five times with an equal volume of 
ethyl acetate.  These organic fractions were pooled in a round bottom flask and dried in a 
rotary evaporator.  The round bottom flask was washed five times with 5 mL of ethyl acetate, 
and these resuspensions were pooled and dried under a gentle stream of N2. When dry, this 
extract was dissolved in 1 mL hexanes and loaded onto a 1 mL packed silica column pre-
eluted with hexanes for chromatographic purification.  The column was washed sequentially 
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with 1 mL volumes of hexane-ethyl acetate solutions starting with 100% hexanes and 
increasing the ethyl acetate proportion by 5% in each subsequent wash solution.  Aliquots 
from the resulting fractions were methylated with diazomethane and checked for the presence 
of 13C-labeled 1 via GC-MS, which showed elution of 1 in the 20-50% ethyl acetate 
fractions.  The retention time and mass spectrum of 13C-labeled 1 was verified by comparison 
to an unlabeled, methylated standard produced via the same metabolic engineering system 
described here, but with unlabeled 5 fed to produce unlabeled 1 (Figure S2).  Fractions 
containing 13C-labeled 1 were combined, dried under N2, dissolved in MeOH, and filtered 
through a 0.2 μm regenerated cellulose filter (WhatmanTM).  1 was then further purified for 
NMR analysis through HPLC.  For HPLC purification, the sample was injected in 100 μL 
aliquots at a flow rate of 0.5 mL/min (25 ˚C) with an initial mobile phase of 50% acetonitrile 
in water which was held for 2 minutes.  For the next 5 minutes, the mobile phase was 
increased to 100% acetonitrile.   This was held for 16 minutes, at which point the mobile 
phase was switched back to 50% acetonitrile in water over a time of 1 minute, and this was 
held for 3 minutes.  With this method, a single peak of 1 eluted at 17.1 minutes, and a 
fraction was collected from 16.6 to 17.5 minutes to recover purified 1.  This method resulted 
in ~100 μg of purified 13C-labeled 1. 
The second method for production of 13C-labeled 1 involved co-expressing pMBI, 
pGGeC, pET-AtKS, and pCDF-AtKO/CPR1 in C41 OverExpress E. coli cells with Tc, Cm, 
Cb and Sp selection (Scheme S3).  This allowed for the direct production of 1 from 5.  These 
cultures were grown, induced and supplemented, with subsequent extraction and purification 
of 1, as described above, with a yield of ~100 μg 1.  Ultimately, such direct production 
appears to be more efficient, particularly in terms of effort.  Between the two methods, a total 
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of ~200 μg purified 13C-labeled 1 was obtained, with 13C-enrichment at carbons 1, 7, 12 and 
18, as confirmed by 13C-NMR analysis (Figure S3).  
Production of 13C-labeled GA12-aldehyde (3) 
 13C-labeled GA12-aldehyde (3) was produced by feeding 13C-labeled 1 to cultures 
heterologously expressing CYP114 and FdGA from Sinorhizobium fredii NGR234, which 
have been shown to convert 1 into 7β-hydroxy-ent-kaurenoic acid (2) and 3.8  Specifically, 
this was done using Sinorhizobium meliloti 1021 (which does not contain the GA 
biosynthetic operon) transformed with pstb-LAFR5-CYP114-FdGA (TcR).8  This recombinant 
strain was grown in LB-MC (Luria-Bertani media with 2.5 mM MgSO4·7H2O and 2.5 mM 
CaCl2·2H2O) media supplemented with Tc (15 μg/mL) and streptomycin (Sm; 500 μg/mL) 
at 30 ˚C with shaking at 225 rpm to mid-log phase, at which point they were supplemented 
with riboflavin (1 mM), 5-aminolevulinic acid, FeCl3 (0.25 mM), and 13C-labeled 1 (10 μM).  
The cultures were allowed to continue growing at 30 ˚C with 225 rpm shaking for 3 days, at 
which point they were acidified to pH 3 with HCl, and extracted five times with an equal 
volume of ethyl acetate.  Labeled 3 was purified in the same fashion as 1.  For silica 
purification, 3 eluted in 20-80% ethyl acetate in hexanes.  HPLC was the same as described 
above, with the exception that 0.1% formic acid was added to the water and acetonitrile 
mobile phases to ensure that the carboxylic acid of 3 remains protonated, and thus elutes in 
one distinct peak/fraction.  This resulted in elution of 3 at 14.3 minutes, and a fraction was 
collected from 13.5 to 14.75 minutes.   Purified 13C-labeled 3 was verified by GC-MS with 
comparison to an authentic standard (purchased from OlChemIm Ltd.) (Figure S4).  A total 
of 50 μg of 13C-labeled 3 was produced with this process. 
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13C-NMR 
 Labeled (~100 μg) and unlabeled (~5 mg) 1, and labeled (~50 μg) and unlabeled (~2 
mg) 3, were each dissolved in 500 μL of CDCl3.  13C-NMR spectra were obtained at 25 ˚C on 
a Bruker AVIII-800 spectrometer equipped with a 5-mm HCN cryogenic probe with analysis 
on TopSpin 3.2 and MestReNova 10.0.2 software.  For all spectra, baseline corrections were 
performed in MestReNova 10.0.2 using the provided Whittaker Smoother.   The chemical 
shifts were calculated from reference to one of the peaks for the CDCl3 solvent (77.23 ppm). 
The obtained 13C-NMR spectra were verified by comparison to previously published 
chemical shifts for 19–11 and 3.12  The four 13C enriched positions in the labeled compounds 
were verified by comparison to carbon shifts of the unlabeled authentic standards.   
Incubation of 6β,7β-dihydroxy-ent-kaurenoic acid (4) and kaurenolides in cultures 
expressing CYP114-FdGA 
 To determine whether or not 6β,7β-dihydroxy-ent-kaurenoic acid (4) is a possible 
intermediate in the ring contraction reaction, we first analyzed samples in which S. meliloti 
1021 cultures co-expressing CYP114 and FdGA were incubated with unlabeled 1, much as 
previously described for the incubations in the “Production of 13C-labeled GA12-aldehyde 
(3)” section.  After extraction, purification, and methylation, these samples were silylated 
using BSA+TMCS+TMSI (3:2:3; Sigma-Aldrich) with incubation at 90 ºC for 30 min, then 
dried down, resuspended in n-hexane, and analyzed with GC-MS.  Close analysis revealed 
the presence of a small amount of 4, as determined by comparison to an authentic standard.   
In an attempt to determine if 4 serves as an intermediate or as a by-product, cultures co-
expressing CYP114 and FdGA were incubated with 4, much as described above.  However, no 
detectable turnover to 3 or any downstream GAs was detected within this system.  
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Incubations with kaurenolide and 7β-hydroxykaurenolide were performed in the same 
fashion, and also had no detectable turnover.  Purified 6β,7β-dihydroxy-ent-kaurenoic acid 
(4), kaurenolide, and 7β-hydroxykaurenolide were kindly provided by Peter Hedden 
(Rothamsted Research, U.K.). 
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Scheme S2. GA biosynthesis in bacteria.  IPP, isopentenyl diphosphate; DMAPP, 
dimethylallyl diphosphate; GGPS, geranylgeranyl diphosphate synthase; CPS, ent-copalyl 
diphosphate synthase; KS, ent-kaurene synthase. 
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Scheme S3. Production of 13C-labeled ent-kaurenoic acid (1) in an E. coli metabolic 
engineering system.  Co-expression of several plasmids (containing the corresponding genes 
within each bracket) allows for a full biosynthetic pathway to 1 from mevalonolactone (5) in 
E. coli.  Feeding labeled 5 to such recombinant cultures allows for the specified incorporation 
of 13C.  MVK, mevalonate kinase; PMVK, phosphomevalonate kinase; MVD, mevalonate 
diphosphate decarboxylase; IDI, isopentenyl diphosphate δ-isomerase; IPP, isopentenyl 
diphosphate; DMAPP, dimethylallyl diphosphate; GGPS, geranylgeranyl diphosphate 
synthase (from Abies grandis); CPS, ent-copalyl diphosphate synthase (from Zea mays); KS, 
ent-kaurene synthase (from Arabidopsis thaliana); KO, ent-kaurene oxidase (from A. 
thaliana); CPR1, cytochrome P450 reductase (from A. thaliana). 
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Figure S1.  Verification of 13C-labeled ent-kaurene (6) via GC-MS.  a) Gas 
chromatography shows that purified 13C-labeled 6 has the same retention time as an authentic 
standard of 6 (selected ion mass m/z = 257).  The mass spectrum of b) the authentic standard 
is similar to that of c) 13C-labeled 6, with the notable exception of isotope-enriched peaks in 
13C-labeled 6.  This is evident at the molecular ion (M+) peak of 6 (m/z = 272). 
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Figure S2. Verification of 13C-labeled ent-kaurenoic acid (1) via GC-MS.  a) Gas 
chromatography of methyl ester derivatives shows that purified 13C-labeled 1 has the same 
retention time as an authentic standard of 1 (selected ion mass = m/z 241 for unlabeled 1 and 
m/z 244 for labeled 1).  The mass spectrum of b) the authentic standard is similar to that of c) 
13C-labeled 1, with the notable exception of isotope-enriched peaks in 13C-labeled 1.  This is 
evident at the molecular ion (M+) peak of 1 (m/z = 316).   
 
 
 
145 
 
 
* * * *
200 150 100 50 0
 (ppm)
ent-kaurenoic acid 1
13C-labeled ent-kaurenoic acid 1 
O
OH
ent-kaurenoic acid
1
H
O
OH
13C-labeled ent-kaurenoic acid
1
H
*
*
*
*
45 40 35 30 25
* * * *
 (ppm) 
45 40 35 30 25
 (ppm) 
C-18
C-12
C-1C-7
CDCl3
 
Figure S3.  13C-NMR of labeled ent-kaurenoic acid (1) substrate.  13C-labeled 1 was 
confirmed to have labels incorporated as carbons C-1, C-7, C-12, and C-18 through 13C-
NMR comparison to an authentic standard (800 MHz, CDCl3 for both).  13C-labeled carbons 
are indicated with an asterisk (*).  Chemical shifts for both unlabeled (standard) and 13C-
labeled 1 are presented in Tables S1 and S2, respectively. 
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Table S1. 13C-NMR chemical shifts for unlabeled ent-kaurenoic acid (1). Chemical shifts 
are referenced to CDCl3 (77.23 ppm). 
carbon number δ (ppm) 
19 183.8 
16 156.1 
17 103.2 
5 57.2 
9 55.3 
15 49.2 
8 44.4 
13 44.1 
4 43.9 
7 41.5 
1 40.9 
10 39.9 
14 39.9 
3 38.1 
12 33.3 
18 29.2 
6 22.0 
2 19.3 
11 18.6 
20 15.8 
 
 
 
Table S2. Enriched/Observed 13C-NMR chemical shifts for 13C-labeled ent-kaurenoic 
acid (1). Chemical shifts are referenced to CDCl3 (77.23 ppm). 
carbon number δ (ppm) 
7 41.5 
1 40.9 
12 33.3 
18 29.1 
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Figure S4. Verification of 13C-labeled GA12-aldehyde (3) via GC-MS.  a) Gas 
chromatography of the methyl ester derivatives shows that purified 13C-labeled 3 has the 
same retention time as an authentic standard of 3 (selected ion mass = m/z 241 for unlabeled 
3 and m/z 242 for labeled 3).  The mass spectrum of b) the authentic standard is similar to 
that of c) 13C-labeled 3, with the notable exception of isotope-enriched peaks in 13C-labeled 
3.  This is evident at the molecular ion (M+) peak of 3 (m/z = 330).  Chemical shifts for both 
unlabeled (standard) and 13C-labeled 3 are presented in Tables S3 and S4, respectively. 
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Table S3. 13C-NMR chemical shifts for unlabeled GA12-aldehyde (3). Chemical shifts are 
referenced to CDCl3 (77.23 ppm).  *Note that the identity of C-6 and C-7 are presented here 
based upon the results of this study.  
carbon number δ (ppm) 
7* 205.9 
19 181.3 
16 157.2 
17 106.7 
5 58.2 
6* 57.9 
9 57.2 
8 50.3 
4 45.2 
10 44.2 
15 43.6 
1 40.3 
13 38.3 
3 37.7 
14 37.2 
12 32.1 
18 30.3 
2 19.9 
11 17.4 
20 15.6 
 
 
  
Table S4. Enriched/Observed 13C-NMR chemical shifts for 13C-labeled GA12-aldehyde 
(3).  Chemical shifts are referenced to CDCl3 (77.23 ppm). 
 
 
 
 
 
 
 
 
 
 
carbon number δ (ppm) 
7 205.9 
1 40.3 
12 32.1 
18 30.3 
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Figure S5. 6β,7β-dihydroxy-ent-kaurenoic acid (4) is produced in incubations of ent-
kaurenoic acid (1) with cells co-expressing CYP114 and FdGA. a) Chemical structure of 4. 
b) When incubated with cells co-expressing CYP114 and FdGA, 1 is converted into a small 
amount of 4, along with the major products 2 and 3, as shown here in gas chromatograms 
with comparison to authentic standards of 2, 3, and 4.  c) The mass spectrum of the putative 4 
peak corresponds with that of d) an authentic standard. e) However, incubation of 4 in cells 
expressing either CYP114 or CYP14 + FdGA does not result in any measured turnover to 3 or 
any downstream GAs.  In this experiment, samples were derivatized to form methyl esters 
and trimethylsilyl-ethers for GC-MS analysis, and thus the chromatograms and mass spectra 
shown in this figure are representative of such derivatives.  
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Figure S6. Incubation of kaurenolide and 7β-hydroxykaurenolide in cells co-expressing 
CYP114 and FdGA. a) Chemical structure of kaurenolide and 7β-hydroxykaurenolide.  
Neither incubations with b) kaurenolide or c) 7β-hydroxykaurenolide result in conversion to 
GA intermediates, as demonstrated here with gas chromatograms of the extracts, which were 
derivatized to form methyl esters and/or trimethylsilyl-ethers (e.g., 7β-hydroxykaurenolide is 
analyzed as the trimethylsilyl-ether derivative).  
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CHAPTER 4 
CHARACTERIZATION OF CYP115 AS A GIBBERELLIN 3-OXIDASE INDICATES 
THAT CERTAIN RHIZOBIA CAN PRODUCE BIOACTIVE GIBBERELLIN A4 
 
A manuscript published as a letter in ACS Chemical Biology.‡ 
 
Ryan S. Nett1, Tiffany Contreras1, and Reuben J. Peters1* 
 
Abstract 
 The gibberellin (GA) phytohormones are produced not only by plants, but also fungi 
and bacteria.  Previous characterization of a cytochrome P450 (CYP) rich GA biosynthetic 
operon found in many symbiotic, nitrogen-fixing rhizobia led to the elucidation of bacterial 
GA biosynthesis, and implicated GA9 as the final product.  However, GA9 does not exhibit 
hormonal/biological activity, and presumably requires further transformation to elicit an 
effect in the legume host plant.  Some rhizobia that contain the GA operon also possess an 
additional CYP (CYP115), and here we show that this acts as a GA 3-oxidase to produce 
bioactive GA4 from GA9.  This is the first GA 3-oxidase identified for rhizobia, and provides 
a more complete scheme for biosynthesis of bioactive GAs in bacteria.  Furthermore, 
phylogenetic analyses suggest that rhizobia acquired CYP115 independently of the core GA 
operon, adding additional complexity to the horizontal gene transfer of GA biosynthetic 
enzymes among bacteria.  
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The gibberellin (GA) phytohormones are critical endogenous regulators of plant 
growth and development,1 but are also produced by some plant-associated fungi and 
bacteria.2  The plant and fungal GA biosynthetic pathways have been extensively studied,1 
but only more recently has GA biosynthesis in bacteria been fully elucidated.3,4  Bacterial 
GA biosynthetic genes are found in an operon (GA operon) that exhibits a scattered 
distribution, although it seems to be exclusively found in plant-associated species (personal 
communication, Dr. Asaf Levy, US-DOE Joint Genome Institute).  The core GA operon 
(Figure 1a), encompassing the genes found in essentially all instances, encodes three 
cytochrome P450 monooxygenases (CYPs; CYP112, CYP114, and CYP117), a ferredoxin 
(FdGA), a short-chain dehydrogenase/reductase (SDRGA), an (E,E,E)-geranylgeranyl 
diphosphate synthase (GGPS), an ent-copalyl diphosphate synthase (CPS) and an ent-
kaurene synthase (KS).  Previous work with the operons from the rhizobia Bradyrhizobium 
japonicum USDA110, Sinorhizobium fredii NGR234, and Mesorhizobium loti MAFF303099 
has led to the characterization of each of these genes in GA biosynthesis (Figure 1b), which 
collectively act to produce GA9 (1).3–7  The functional characterization of this pathway 
further established that bacteria evolved GA biosynthesis independently of plants and fungi, 
at least for the downstream oxidative steps.4  
While these studies elucidated the core bacterial GA pathway, it was surprising that 
biosynthesis ceased at 1, as this GA (of which there are >130) does not seem to function as a 
phytohormone1 – e.g., 1 does not elicit characteristic plant growth phenotypes,8 nor does it 
bind effectively to the appropriate plant receptor (GID1).9,10  Conversion of 1 to a bioactive 
GA only requires hydroxylation at the C-3 position, which would produce bioactive GA4 
(2).  This 3-hydroxyl group is crucial for bioactivity in plants, as 2 binds GID1 roughly 3 
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orders of magnitude more effectively than 1.9,10  It has been hypothesized that the legume 
host plants, which necessarily contain GA biosynthetic enzymes, can convert 1 secreted by 
the symbiotic rhizobial bacteroids to bioactive GAs through the action of endogenous GA 3-
oxidases (GA3ox).3  Indeed, incubation of 1 in root nodule extracts from Lotus japonicus 
plants nodulated with M. loti MAFF303099 led to its conversion into bioactive GAs.3  Given 
the absence of any additional uncharacterized genes within the operon, this transformation 
was assumed to be a result of plant enzymatic activity.  
 For rhizobia with fully assembled genomes, the GA operon seems to be invariably 
located within the symbiotic island or plasmid11–15, which establishes the symbiotic, 
nitrogen-fixing lifestyle of rhizobia.16  It has previously been determined that these symbiotic 
modules can be transferred between species of rhizobia,16 and it further seems that the GA 
operon undergoes independent horizontal gene transfer (HGT) between the symbiotic 
island/plasmid of various rhizobia.6   This operon also is found in several plant pathogens, 
particularly Xanthomonas species.17  Interestingly, the operons present in the phytopathogens 
all contain an additional CYP (CYP115) tightly appended to the 5’ end of the core operon 
(Figure 1a), which suggests a potential role for this gene in bacterial GA metabolism.   
Initially, it appeared that rhizobia either did not contain CYP115, or contained only a 
presumably non-functional fragment of this gene.18  To re-explore the possibility that 
rhizobia might carry out further metabolism of GA beyond the recently demonstrated 
production of 1, BLAST searches were carried out with CYP115 from the GA operon found 
in Xanthomonas oryzae pv. oryzicola BLS256.  This revealed the presence of nominally full-
length CYP115 family members (~410 amino acids) in 20 unique strains of rhizobia 
(Supporting Information Table S1), including M. loti MAFF303099 and Sinorhizobium 
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meliloti WSM4191 (a.k.a. Ensifer medicae WSM4191), with each of these strains also 
containing the core GA operon.  Surprisingly, the CYP115 genes were often not found in 
close proximity to the GA operon, and almost all differ in exact arrangement from the tight 
5’ integration found in the phytopathogens (Supporting Information Table S2).  For 
example, while CYP115 in S. meliloti WSM4191 is found close to the core GA operon, this 
is located proximal to the 3’ rather than 5’ end.  However, in M. loti MAFF303099, which 
has already been shown to produce at least 1,3 CYP115 is found >200 kb away from the GA 
operon, although it is still located within the symbiotic island.12   
To determine if rhizobial CYP115 genes are involved in GA metabolism, those from 
S. meliloti WSM4191 (SmCYP115) and M. loti MAFF303099 (MlCYP115) were 
heterologously expressed in S. meliloti 1021 (which does not contain GA biosynthetic 
enzymes), much as previously described,4 and the resulting recombinant strains were 
incubated with 1.  SmCYP115 was also co-expressed with FdGA from S. fredii NGR234, as 
this has been shown to be necessary for full activity of CYP114,4 and might be needed to 
supply electrons to CYP115 as well. 
Recombinant S. meliloti 1021 cells expressing SmCYP115 efficiently convert 1 to 2 
(Figure 2), and thus, CYP115 acts as a GA3ox.  This activity was independent of FdGA, as 
statistically similar turnover of 1 to 2 was observed either with or without co-expression of 
FdGA (88±2% and 87±2% respectively).  Accordingly, FdGA seems to only be necessary for 
CYP114 activity.   
CYP115 seems to act specifically as a GA3ox, as cells expressing SmCYP115 do not 
react with other bacterial GA biosynthetic intermediates (Figure 1b) to any significant 
extent.  Interestingly, SmCYP115-expressing cells carried out 3-hydroxylation with GA20 
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(which differs from 1 in containing a C-13 hydroxyl group distal to the targeted C-3 
position) to form bioactive GA1, but this transformation did not appear to be as efficient as 
that of 1 to 2 (Supporting Information Figure S1).  This is similar to the activity of plant 
GA3ox, as these also typically react with both 1 and GA20 within the parallel non-13-
hydroxylation and 13-hydroxylation GA biosynthetic pathways found in plants1 (although 
not in bacteria4,7).  This specificity further supports the role of CYP115 as a GA3ox.  
GA3ox activity (conversion of 1 to 2) was also observed with cells expressing 
MlCYP115, though this enzyme was less active (Supporting Information Figure S2).  It is 
possible that this Mesorhizobium-adapted CYP115 family member is not expressed as well in 
S. meliloti 1021, and/or this does not pair as well with the endogenous redox partners (e.g. 
ferredoxins).  Regardless, the GA3ox activity of CYP115 appears to be conserved across 
rhizobia, indicating that that CYP115-containing species are at least capable of producing 
bioactive 2, rather than just the penultimate phytohormone precursor 1.  This is the first 
example of a GA3ox in rhizobia and provides evidence that bacteria are capable of 
synthesizing bioactive GAs without the aid of plant metabolism.  As such, this result affords 
a more complete understanding of GA biosynthesis in bacteria.   Also, much like the 
previously characterized bacterial GA biosynthetic enzymes,4 it seems clear that GA3ox 
activity in bacteria has evolved independently of that in plants or fungi.  Specifically, plants 
make use of 2-oxogluturate dependent dioxygenases for GA3ox activity instead of CYPs,1 
and while fungi use a CYP for this reaction, this belongs to the distinct CYP68A subfamily.19  
The 20 unique strains of rhizobia with CYP115 represent ~16% of the total number of 
strains found to contain the core GA operon (>120 strains of rhizobia total).  Of the four 
major rhizobia genera, Mesorhizobium, Sinorhizobium/Ensifer, and Rhizobium are each 
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represented with at least two strains containing CYP115, while a full-length copy of this gene 
is notably absent within Bradyrhizobium species.  Thus, CYP115 seems to exhibit somewhat 
restricted distribution within the broader Rhizobiales order.  More specifically, CYP115 
appears to be particularly enriched within Mesorhizobium species, as over half (13/20) of the 
strains containing CYP115 are in this genus, which also represents over one-third (13/34) of 
Mesorhizobium strains with the core GA operon.  
While CYP115 is tightly coupled to the GA operon in plant pathogens (within 100 bp 
of the 5’ end of CYP112), only one rhizobium species (Mesorhizobium sp. AA22) exhibits a 
similar arrangement.  Even when nominally located proximal to the 5’ end of the core GA 
operon, such as it is in S. fredii CCBAU83666 and S. arboris LMG 14919, CYP115 is 
located at least 700 bp away.  In two other strains, S. meliloti WSM4191 and S. medicae 
WSM1369, CYP115 is located proximal to the 3’ end of the GA operon.  This presumably 
reflects re-incorporation of CYP115 into the operon, which in theory could occur on either 
end of the pre-existing gene cluster.  However, in most of the strains (15/20), CYP115 is 
located elsewhere within the symbiotic island or plasmid, ranging from ~3 kb away in 
Mesorhizobium sp. WSM3626 to the >200 kb distance in M. loti MAFF303099.  This distal 
location relative to the core GA operon presumably underlies the omission of CYP115 in the 
initial characterization of GA biosynthesis in M. loti MAFF303099.3  Overall, the varying 
location of CYP115 relative to the core GA operon suggests that this gene is in the process of 
either being gained or lost from the operon.   
Closer examination of the region surrounding the distal, full-length copy of CYP115 
in M. loti MAFF303099 revealed that this is followed by a fragment of CYP112, similar to 
the arrangement of CYP115 (i.e., 5’ to CYP112) in the phytopathogen operon.  This suggests 
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that a full-length CYP115, along with at least a portion of the CYP112 gene, was excised 
from an operon structured like that found in the phytopathogens prior to its incorporation 
into, or mobilization within, the M. loti MAFF303099 genome.  Notably, similar CYP112 
fragments follow the full-length CYP115 in most other strain identified here (Supporting 
Information Table S2).  Indeed, even in S. fredii CCBAU83666 and S. arboris LMG 14919, 
where the full-length CYP115 is located near the 5’ of the operon, there is still an intervening 
fragment of CYP112 between CYP115 and the full-length CYP112 that marks the 5’ border 
of the core GA operon.  Thus, it appears that CYP115 is undergoing separate mobilization 
relative to the core GA operon within these two strains, as well as most other rhizobia where 
this is found.  Consistent with this hypothesis, many of the CYP115 genes outside of the 
operon are flanked by transposases and other insertion sequence (IS) elements (Supporting 
Information Table S3).  Phylogenetic analysis hints at differences between the relationships 
of rhizobial full-length CYP115 relative to the core GA operon from the same species, but 
the low bootstrap values of the relevant trees prevent any strong conclusion (Supporting 
Information Figures S3 & S4).  This is presumably due to the low number of available 
sequences, in addition to their high level of overall identity to one another (>91% at the 
nucleotide level).  However, it is notable that CYP115 from Mesorhizobium sp. AA22, which 
is tightly integrated 5’ to the GA biosynthetic operon (i.e., resembling that in the more distant 
phytopathogens), appears to be that most closely related to the ancestral rhizobial CYP115 
(Figure 3 and Supporting Information Figures S3 & S4).    
To further evaluate the scattered distribution of CYP115 among rhizobia, the 
phylogeny of the core GA operon was examined via alignments of individual operon genes 
(e.g., CPS and CYP114) from all (123 total) of the currently identified GA operon-containing 
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rhizobia (Figure 4 & Supporting Information Figure S5).  This revealed that the full-
length CYP115-containing rhizobia fall into several distinct clades that also include strains 
without a full-length CYP115, suggesting that these lineages gained CYP115 independently 
of each another.  In addition, all of these strains were evaluated for the presence of a CYP115 
pseudo-gene or gene fragment, as described for the originally reported copy of the operon 
from B. japonicum USDA110.18  This analysis revealed that nearly every strain of rhizobia in 
which the core GA operon is found also contains a CYP115 fragment tightly appended 5’ to 
CYP112 (Figure 4 & Supporting Information Figure S5).  Strikingly, this also is true for 
most rhizobia that contain a full-length CYP115, with one notable exception being 
Mesorhizobium sp. AA22, where the full-length CYP115 is tightly appended to the core 
operon.  
Collectively, our results suggest that most rhizobia with the extant, full-length 
CYP115 acquired this gene in HGT events independent from their acquisition of the core GA 
operon.  Such separate acquisition of CYP115 would represent an additional layer of HGT 
underlying GA biosynthesis in rhizobia.  It is known that symbiotic plasmids and genomic 
islands are exchanged via HGT among species within the Rhizobiales order.16  Furthermore, 
the GA operon itself seems to undergo separate HGT within these symbiotic 
plasmids/islands, as indicated by both their distinct GC content and phylogenetic 
relationships.6  Therefore, additional HGT of CYP115 within rhizobia that also contain the 
core GA operon adds a third layer of HGT within the Rhizobiales order, and provides a 
means by which rhizobia can acquire the final biosynthetic step to convert 1, the penultimate, 
non-bioactive product of the core GA operon, into 2, a bioactive GA.  
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Consistent with a role in production of GA, CYP115 appears to be co-expressed with 
the core GA operon in rhizobia, regardless of relative genomic location.  In particular, 
numerous studies have shown selective expression of the core operon during rhizobial 
symbiosis.3,12,20–26  Additionally, tt least in M. loti MAFF303099, CYP115 transcripts and 
proteins have also been demonstrated to be upregulated during symbiosis.12,25  Thus, rhizobia 
containing CYP115 may directly produce bioactive 2 rather than just 1.  Notably, this 
includes M. loti MAFF303099, where the core GA operon was shown to lead to production 
of 1.3  While this was suggested to be further transformed by GA3ox from the host plant,3 
CYP115 is clearly expressed during symbiosis,25 and based upon our characterization of this 
enzyme as a GA3ox, this strain is capable of direct production of 2.  
The presence of a CYP115 fragment at the 5’ end of the GA core operon in almost all 
rhizobia suggests that this gene was lost soon after rhizobial acquisition of the operon.  Given 
the apparent ability to re-acquire a functional full-length CYP115 via independent HGT, the 
limited distribution of CYP115 suggests that GA3ox activity by rhizobia may be deleterious 
in most rhizobial-legume symbiotic relationships.  It has recently been reported that GA 
production by M. loti MAFF303099 affects nodulation, presumably to limit nodule numbers 
and, thus, competition within individual host plants.3  Additionally, it has been shown that X. 
oryzae pv. oryzicola, which contains CYP115, can produce 2,27 and that this production 
contributes to the virulence of this rice pathogen via reduction of the jasmonic acid-mediated 
defense response.17  Given that bioactive GA production is advantageous to phytopathogens, 
it may be that production of 2 by rhizobia is deleterious to host legume defense.  To 
ameliorate this effect, it is possible that rhizobia are under selective pressure to lose CYP115 
and leave control of the final step in bioactive GA production to the host plant.  The 
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continued presence of CYP115 in some rhizobia may then reflect a lack of such GA3ox 
expression in nodules by their host legume species.  Although CYP115 seems to be enriched 
in Mesorhizobium species, there is no obvious correlation between the rhizobial strains that 
contain a full-length CYP115 and their host plants, leaving this hypothesis on a speculative 
basis.  
 
Methods 
 Heterologous expression of CYP115 was performed much as previously described for 
the other CYPs from the GA operon.4  Phylogenetic analyses were carried out using 
MEGA7.28  Detailed materials and methods are available in the Supporting Information. 
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Figure 1. GA biosynthesis in bacteria.  a) GA biosynthetic operon.  The core operon 
(CYP112  KS) is mostly conserved, while other genes such as CYP115 and IDI 
(isopentenyl diphosphate δ-isomerase) are only present in certain strains.  Additionally, the 
core GA operon found in most rhizobia contains a 5’ CYP115 fragment, and most full-length 
CYP115 in rhizobia, when present, are followed by a 3’ CYP112 fragment. b) GA 
biosynthesis in core operon containing rhizobia ends at GA9 (1) with C-3β hydroxylation of 
GA9 by a GA3ox required to produce the bioactive GA4 (2). 
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Figure 2.  CYP115 is a GA 3-oxidase.   a) Incubating GA9 (1) in cultures expressing 
SmCYP115 results in efficient transformation to a compound corresponding to GA4, as 
shown here in gas chromatograms.  b) Mass spectrum of GA4 product. c) Mass spectrum of 
GA4 authentic standard. d) GA 3-oxidase reaction catalyzed by CYP115.  Chromatograms 
and mass spectra correspond to compounds derivatized as methyl esters and/or trimethylsilyl 
ethers. 
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Figure 3.  Phylogeny of CYP115 in rhizobia.  Maximum likelihood tree analysis (1000 
bootstraps) of rhizobial full-length CYP115 nucleotide sequences from a codon-based 
alignment (MUSCLE).  The generation of this phylogenetic tree is described in Supporting 
Methods.  See Supporting Information Figure S4 for trees generated with different 
algorithms.  
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Figure 4.  Scattered distribution of CYP115 full-length genes and gene fragments within GA 
operon-containing rhizobia.  Shown is a representative cladogram (Maximum Likelihood 
algorithm, 1000 bootstraps) from codon-based alignment (MUSCLE) of CPS from the GA 
operon with the CPS from the phytopathogen X. oryzae pv. oryzicola BLS236 included as an 
outgroup.  (see Supporting Information Figure S6 for a comprehensive phylogenetic tree 
depicting all GA operon-containing rhizobia with non-fixed branch lengths).  The presence 
of multiple open boxes indicates multiple distinct CYP115 fragments within a strain’s 
genome.   
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Supporting Methods 
Culture and growth conditions 
Unless noted otherwise, chemicals and reagents were purchased from Thermo Fisher 
Scientific and Sigma-Aldrich®.  Where indicated and unless stated otherwise, antibiotics 
were used at the following concentrations: kanamycin (Km) 50 μg mL-1, chloramphenicol 
(Cm) 25 μg mL-1, streptomycin (Sm) 500 μg mL-1, and tetracycline (Tc) 20 μg mL-1.  E. coli 
strains were grown at 37˚ C in NZY media (5 g L-1 yeast extract, 10 g L-1 casein hydrolysate, 
5 g L-1 NaCl, and 1 g L-1 MgSO4·7H2O).  S. meliloti 10211 was grown at 30 ˚C in LB-MC 
media (Luria-Bertani media supplemented with 2.5 mM MgSO4·7H2O and 2.5 mM 
CaCl2·2H2O) using Sm as the selecting antibiotic.  See Table S4 for all strains used in this 
study. 
Identification and genomic analysis of CYP115 and core GA operon in rhizobia 
 In plant pathogens containing the GA biosynthetic operon, CYP115 is always found 
tightly appended to the 5’ end of the operon, and could thus be hypothesized to act in GA 
biosynthesis in these organisms.  The presence of CYP115 in 20 rhizobial strains (Table S1) 
was found through protein BLAST searches on NCBI 
(https://blast.ncbi.nlm.nih.gov/blast/Blast.cgi) and the Joint Genome Institute (JGI; 
https://img.jgi.doe.gov/cgi-bin/mer/main.cgi?section=FindGenesBlast&page=gene 
SearchBlast) using the amino acid sequence of CYP115 from Xanthomonas oryzae pv. 
oryzicola BLS256, which contains the GA operon.  The legumes from which these strains 
were isolated are listed as found at JGI and/or within the BioSample webpage for each strain 
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on NCBI (Table S1).  CYP115 and CYP112 pseudo-genes and fragments were further 
identified by using DNA BLAST searches with the NCBI/GenBank and JGI databases.  
CYP115 fragments were characterized as being ≥17 base-pairs (bp) in length with nearly 
100% identity, in addition to being located within 50 bp of the start codon for CYP112 of the 
core GA biosynthetic operon.  The average length of these fragments (with standard 
deviation) from 116 rhizobia is 158 ± 130 bp. 
The total number of rhizobia with core GA biosynthetic operons (123) was estimated 
by comparing strains confirmed by BLAST searches to have CPS, KS, CYP117, CYP114 
and CYP112 within the JGI database.  This number is likely an underrepresentation as it 
excludes sequences from NCBI/GenBank (and other databases) that may not be available in 
JGI.  Additionally, the confirmation of a full operon relies upon genomic scaffolds in which 
not only the presence, but also clustering, of operon genes can be observed.  As many strains 
containing GA operon genes do not have well-assembled genomes, this results in many 
strains being omitted from this analysis. 
The location of CYP115 in relation to the core GA operon (Table S2) was 
determined manually by using the graphic genome browser on NCBI.  Briefly, CYP115 and 
the core operon were located via BLAST searches on NCBI, and DNA coordinates were used 
to calculate the distance between CYP115 genes and the closest gene of the GA operon.  For 
many rhizobial strains with CYP115, this was not possible, as fully assembled genomes were 
not available, and CYP115 and the GA operon were sometimes located on separate contigs.  
Insertion sequence (IS) elements near CYP115 genes (Table S3) were located and analyzed 
manually with the graphic genome browser on NCBI by searching the genomic content in 
direct proximity to CYP115.  Each identified IS element was further categorized and 
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annotated based upon the conserved domains found by using the Conserved Domains tool on 
NCBI (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi). 
CYP115 expression constructs 
 CYP115 expression constructs were created similarly to those used in previous study 
of the GA biosynthetic operon from S. fredii NGR234.2  For expression of CYP115 from S. 
meliloti WSM4191 (SmCYP115), a clone was synthesized using GeneArtTM Gene Synthesis 
(Thermo Fisher Scientific).  Included on the 3’ of this clone was the intergenic region 
following CYP114 from S. fredii NGR234, along with the S. fredii NGR234 FdGA, which 
follows this intergenic region.  FdGA has been shown to be necessary for full CYP114 
functionality in GA biosynthesis,2 and was included as it could be a potential redox partner 
for CYP115.  The synthetic clone also contained a 5’ leader sequence that contained a 
ribosome binding site, in addition to several upstream stop codons, as previously described.2  
This clone was amplified from the synthetic gene-containing plasmid (pMK-SmCYP115-
FdGA) using primers specific to the 5’ leader sequence and the 3’end of this dual gene 
fragment (see Table S5 for a list of all primers used).  Additionally, a construct without FdGA 
was amplified, using a reverse primer that anneals to the 3’ end of SmCYP115.  These 
primers contained restriction sites (BamHI for the forward primer, EcoRI for the reverse 
primer) allowing for subsequent digestion and ligation into the expression plasmid, pstb-
LAFR5 (TcR), which has been previously shown to be useful for heterologous expression in 
S. meliloti 10213, and particularly for the genes found in the GA biosynthetic operon.2  
Notably, S. meliloti 1021 contains neither the GA biosynthetic operon, nor a homolog of 
CYP115.4  This construct and the pstb-LAFR5 plasmid were digested using BamHI and 
EcoRI restriction enzymes (New England Biolabs® Inc.).  The digested SmCYP115 and 
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SmCYP115-FdGA clones were run on a 1% agarose gel and purified using the GenEluteTM 
Gel Extraction Kit (Sigma-Aldrich®), then ligated into digested pstb-LAFR5 with T4 DNA 
ligase (New England Biolabs® Inc.). 
 CYP115 from Mesorhizobium loti MAFF303099 (MlCYP115) was cloned directly 
from genomic DNA, which was previously purified using Wizard® SV Genomic DNA 
Purification Kit (Promega).  Analysis of CYP115 revealed several potential open reading 
frames (ORF) of similar length (~1200-1300 bp) and in the same reading frame.  The longest 
predicted ORF of MlCYP115 (1278 bp; MlCYP115) was PCR amplified using forward and 
reverse primers specific to the 5’ and 3’ ends of this ORF (Table S5), and this construct was 
ligated into pCRTM-Blunt II-TOPO® (Thermo Fisher Scientific).  In a subsequent PCR 
reaction, the 5’ leader sequence, along with a BamHI restriction site for cloning into pstb-
LAFR5, was added to the 5’ end via the forward primer and a 3’ EcoRI restriction site was 
added via the reverse primer.  This MlCYP115 construct was digested and ligated into pstb-
LAFR5 in the same fashion as described for SmCYP115.  Though functional activity was 
found with this clone, sequence alignment with other predicted CYP115 proteins (Figure S6) 
and the presence of a canonical Shine-Dalgarno sequence suggests that the native ORF is 
1233 bp (410 amino acids).  This shorter coding sequence was subsequently cloned and 
expressed, but exhibited indistinguishable activity from the longer clone. 
Triparental mating to transfer constructs into S. meliloti 1021 
 The pstb-LAFR5-CYP115 constructs and an empty pstb-LAFR5 vector were 
transformed into chemically competent E. coli MM294A “donor” cells5 and selected on LB 
agar plates containing Tc (20 μg mL-1).  Individual colonies were picked for growth in 5 mL 
NZY media cultures supplemented with Tc.  Additionally, 5 mL cultures of E. coli MT616 
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“helper” cells6 (CmR) were grown in NZY media, and 5 mL cultures of S. meliloti 1021 
“recipient” cells (SmR) were grown in LB-MC media.  All cultures were grown to late log 
phase, at which point 1 mL of each cultures was centrifuged at 5000 x g for 5 minutes to 
pellet the cells.  The pellets were then washed with 1 mL of sterile 0.85% (w/v) NaCl in 
water, and centrifuged again.  Pellets of the donor, helper, and recipient cells were 
resuspended in 50 μL of 0.85% NaCl, mixed in equal proportion, and 10-30 μL of this 
mixture was plated on non-selective LB-MC agar plates.  Matings were incubated for 1-2 
days, after which the spots were picked and resuspended in 1 mL of 0.85% NaCl.  Serial 
dilutions of this resuspension were then plated on LB-MC agar containing Sm (for selection 
of the S. meliloti 1021 recipient) and Tc (for selection of pstb-LAFR5 constructs).  Colonies 
were screened by PCR using primers specific to the construct of interest, or in the case of the 
empty vector, primers specific to the region upstream of the multiple cloning site. 
CYP115 heterologous expression in S. meliloti 1021 
 Incubations with wild-type (untransformed) strains of S. meliloti 1021 and 
heterologous strains expressing either an empty vector or pstb-LAFR5-CYP115 constructs 
were performed in a similar fashion to previous characterization of the GA biosynthetic 
operon.2  Briefly, individual colonies were used to inoculate 5 mL LB-MC cultures 
containing appropriate antibiotics (Sm for S. meliloti 1021 wild-type and Sm + Tc for 
heterologous strains), and these cultures were shaken at 225 RPM at 30 ˚C until reaching late 
log phase (1-2 days).  For initial experiments, 500 μL of each culture was used to inoculate 
50 mL LB-MC cultures containing 5 mL phosphate buffer (pH 7) and the appropriate 
antibiotic(s).  Cultures were grown at 30 ˚C with 225 RPM shaking until they reached early 
log phase (OD600 0.4-0.7), at which point substrate (5 μM), riboflavin (1 mM; for enhanced 
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redox metabolism), δ-aminolevulinic acid (1 mM; to enhance heme synthesis for 
incorporation into the recombinant CYP), and FeCl3 (0.1 mM; also for incorporation into 
heme of the expressed CYP) were added.  GAs were purchased commercially from 
OlChemIm Ltd. (GA9, GA20, GA4, and GA1), or generously provided by Professor Peter 
Hedden (Rothamsted Research, Harpenden, U.K.; GA9).  Cultures were incubated at 30 ˚C 
with 225 RPM shaking for 3-5 days.  Once the GA3ox functionality of CYP115 was 
observed, subsequent experiments were run with 10 mL cultures with the added supplements 
adjusted proportionally.  To quantify relative levels of turnover of GA9 to GA4, incubations 
were run as described above in triplicate for heterologous cells expressing pstb-LAFR5 
empty vector, pstb-LAFR5-SmCYP115, pstb-LAFR5-SmCYP115-FdGA, or pstb-LAFR5-
MlCYP115. 
Metabolite extraction, purification, and GC-MS analysis 
 After incubations, cultures were acidified to pH 3 with 5 M HCl to neutralize the free 
carboxylic acids found in many of the GA metabolites of interest here.  Cultures were then 
extracted 3 times with an equivalent volume of ethyl acetate.  These extracts were combined 
in a round bottom flask and dried with a rotary evaporator.  The dried flask was extracted 
three times with 3 mL of ethyl acetate which was combined in glass tubes and dried under a 
gentle stream of N2.  The dried metabolites in each tube were resuspended in 1 mL hexanes 
for purification over a silica gel column (~1 mL).  The 1 mL aliquots were loaded to the 
silica column and eluted with solutions of hexanes:ethyl acetate (v/v), starting with 100% 
hexanes and increasing polarity incrementally (by 10-15%) to 100% ethyl acetate with 
separate fractions collected for each elution solution.  Purified fractions were dried under N2 
and resuspended in 500 μL ethyl acetate, after which diazomethane was added to produce the 
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methyl esters of any free carboxylic acids, and this solution was incubated at room 
temperature for several hours.  The methylated fractions were then dried under a gentle 
stream of N2 and resuspended in BSTFA+TMCS [N,O-Bis(trimethylsilyl)trifluoroacetamide 
+ Trimethylchlorosilane; 99:1 v/v] or MSTFA [N-Methyl-N-(trimethylsilyl)- 
trifluoroacetamide] for 30 min at 80 ˚C to produce the trimethylsilyl ethers of any free 
hydroxyl groups.  Samples were then dried down under a gentle stream of N2 and 
resuspended in n-hexane for analysis with gas chromatography-mass spectrometry (GC-MS) 
using a 3900 Saturn GC with Saturn 2100T ion trap MS (Varian) equipped with an HP-5MS 
column (Agilent). For this analysis, 1 μL of each sample was injected in splitless mode with 
a column flow of 1.2 mL min-1 at an initial injector temperature of 250 ˚C and a column 
temperature of 50 ˚C, which was held for 3 minutes.  The column temperature was increased 
to 300 ˚C at a rate of 15 ˚C min-1, and this temperature (300 ˚C) was held for 3 minutes.  
Mass spectra acquisition using electron ionization with a collection range of 90 m/z to 650 
m/z began at 13 minutes and continued until the end of the run.  For optimal peak resolution, 
publication quality GC-MS runs were performed with a column temperature increase of 10˚ 
C min-1 and a mass range of 90-550 m/z.  GA4 (2) and GA1 products were identified via 
comparison to an authentic standard and to published mass spectral data.7 
 For relative quantification of samples run in triplicate, chromatograms were extracted 
with the 270 and 284 mass-to-charge ions (m/z 270 to distinguish GA9 and m/z 284 to 
distinguish GA4), with GA9 and GA4 peak areas being integrated manually within the Varian 
GC-MS software.  Relative turnover was calculated by dividing the area of the GA4 peak by 
the combined areas of the GA9 and GA4 peaks and multiplying this by 100 to give percent 
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turnover.  Student’s t-test (two sample, assuming equal variance) was performed in Microsoft 
Excel to determine any statistically significant differences between the tested samples. 
CYP115 and GA operon sequence analysis 
 The identity between CYP115 nucleotide and protein sequences were calculated 
using the tools available on the European Molecular Biology Laboratory-European 
Bioinformatics Institute (EMBL-EBI) website.  For nucleotide sequences, the MUSCLE 
program (default parameters) was used, while for proteins the Needle EMBOSS pairwise 
alignment tool (default parameters) was utilized with the M. loti MAFF303099 CYP115 
compared to each rhizobial CYP115 (Table S1). 
Phylogenetic trees were created in MEGA7.8  Nucleotide alignments were performed 
using the MUSCLE algorithm with the GA operon orthologs from X. oryzae pv. oryzicola 
BLS256 as the outgroup sequences for CYP115 and core GA biosynthetic operon 
alignments, while the Azotobacter vinelandii DJ nifK sequence was used as the outgroup in 
the nifK alignment.  The trees shown in Figs. 3, 4 & Fig. S3 were created via the Maximum-
Likelihood statistical method using the highest ranked substitution model (as determined 
within MEGA7 for each alignment) with complete deletion and 1000 bootstrap analyses.  To 
verify the observed phylogeny of CYP115 from Mesorhizobium sp. AA22 as closest to the 
ancestral node among the rhizobia, trees were also calculated using the Neighbor-Joining and 
Minimum evolution methods (Figure S4).  The resulting trees are essentially congruent with 
that shown for the Maximum-Likelihood tree in Figure 3, including the placement of 
CYP115 from Mesorhizobium. sp. AA22. 
 For the phylogenetic trees generated from alignments with CPS and CYP114 from the 
GA operon, initial trees that included all strains of rhizobia with the core GA biosynthetic 
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operon were created via the Maximum-Likelihood statistical method using the highest ranked 
substitutional model with complete deletion and 1000 bootstrap analyses (Figure S5).  
Inspection of these trees showed redundancy and very high similarity among certain clusters 
of sequences (i.e. no observable branch length).  Accordingly, these clusters were condensed 
to individual sequences and the analysis repeated with this reduced set of sequences to 
present the representative tree shown in Figure 4. 
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Supporting Figures and Tables 
 
Table S1. Rhizobial strains containing a presumed full-length CYP115. (a.a. = amino acids) 
Rhizobia strain  Legume host (original isolation) 
protein 
length (a.a.) 
% identity to 
MlCYP115 
GenBank Accession 
Version 
Mesorhizobium loti MAFF303099  Lotus pedunculatus  410  ‐  WP_044549111.1 
Mesorhizobium loti R7A  Lotus corniculatus  410  97.8  WP_027033340.1 
Mesorhizobium loti CJ3sym  Lotus corniculatus  410  97.8  WP_027033340.1 
Mesorhizobium loti R88b  Lotus corniculatus  410  97.8  WP_027033340.1 
Mesorhizobium loti (Mesorhizobium erdmanii) 
USDA3471 
Lotus corniculatus  410  97.6  WP_027056407.1 
Mesorhizobium loti NZP2042  Lotus sp.  410  96.6  WP_064987301.1 
Mesorhizobium loti NZP2014  Lotus sp.  410  96.6  WP_064987301.1 
Mesorhizobium loti TONO  Lotus japonicus  410  96.6  BAV50319.1 
Mesorhizobium sp. AA22  Biserrula pelecinus L.  410  91.5  WP_065010997.1 
Mesorhizobium sp. SEMIA 3007  Pisum sativum  410  97.8  WP_069091147.1 
Mesorhizobium sp. (Mesorhizobium metallidurans) 
STM4661 
Anthyllis vulneraria  398  95.1  WP_036240890.1 
Mesorhizobium sp. WSM2561  Lessertia diffusa  410  90.0  WP_027155432.1 
Mesorhizobium sp. WSM3626  Lessertia diffusa  409  88.8  WP_027145827.1 
Rhizobium mongolense USDA1844  Medicago ruthenica  410  91.0  WP_022718896.1 
Rhizobium favelukesii OR191 (LPU83)  Medicago sativa  410  90.2  WP_024317976.1 
Sinorhizobium arboris (Ensifer arboris) LMG 14919  Prosopis chilensis  410  91.2  WP_028002554.1 
Sinorhizobium fredii CCBAU83666 AJQR  Glycine max  410  92.2  WP_037436960.1 
Sinorhizobium medicae (Ensifer medicae) WSM1369  Medicago 
sphaerocarpa 
425  87.1  WP_018009729.1 
Sinorhizobium meliloti (Ensifer medicae) WSM4191  Melilotus 
messanensis/Melilotus 
siculus 
425  86.8  WP_028055591.1 
Sinorhizobium terangae (Ensifer sp.) WSM1721  Indigofera sp.  410  91.2  WP_026621921.1 
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Table S2.  Analysis of CYP115 genomic location and synteny. (kb = kilobase, bp = base 
pairs) 
Rhizobia strain Location Distance from GA operon 
3’ CYP112 fragment 
(present/absent); 
length 
Mesorhizobium loti MAFF303099 Not in operon ~200 kb Present; 203 bp 
Mesorhizobium loti R7A Not in operon ~105 kb Present; 222 bp 
Mesorhizobium loti CJ3sym Not in operon ~105 kb Present; 221 bp 
Mesorhizobium loti R88b Not in operon ~105 kb Present; 221 bp 
Mesorhizobium loti USDA3471 Not in operon ~98 kb Present; 206 bp 
Mesorhizobium loti NZP2042 Not in operon ~85 kb Present; 20 bp 
Mesorhizobium loti NZP2014 Not in operon N.A.a Present; 20 bp 
Mesorhizobium loti TONO Not in operon ~134 kb Present; 223 bp 
Mesorhizobium sp. AA22 5’ end of operon Precedes CYP112 by 17 bp b 
Mesorhizobium sp. SEMIA 3007 Not in operon ~126 kb Present; 213 bp 
Mesorhizobium sp. STM4661 Not in operon ~153 kb Present; 145 bp 
Mesorhizobium sp. WSM2561 Not in operon ~10 kb upstream of operon; opposite 
orientation 
Present; 84 bp 
Mesorhizobium sp. WSM3626 Not in operon ~3 kb upstream of operon; opposite 
orientation 
Absent 
Rhizobium mongolense USDA1844 Not in operon N.A.a Present; 252 bp 
Rhizobium favelukesii OR191 (LPU83) Not in operon N.A.a Present; 241 bp 
Sinorhizobium arboris LMG 14919 5’ end of operon Precedes CYP112 by 739 bp Present; 225 bp 
Sinorhizobium fredii CCBAU83666 
AJQR 
5’ end of operon Precedes CYP112 by 736 bp Present; 225 bp 
Sinorhizobium medicae WSM1369 3’ end of operon Follows IDI by 78 bp Absent 
Sinorhizobium meliloti WSM4191 3’ end of operon Follows IDI by 138 bp Absent 
Sinorhizobium terangae WSM1721 Not in operon N.A.a Present; 176 bp 
aN.A. = not available; this is due to CYP115 and the GA operon being found in different genomic scaffolds, and therefore 
relative location cannot be determined. 
bCYP115 is adjacent to CYP112, and thus no 3’ CYP112 is possible. 
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Figure S1.  CYP115 converts GA20 into bioactive GA1.  a) When incubated in cells 
expressing SmCYP115, GA20 is converted into a compound corresponding to GA1 as shown 
here through GC-MS chromatograms. b) Zoom-in on putative GA1, as indicated by the 
dotted box from the first panel.  c) Mass spectrum of the putative GA1 product. d) Mass 
spectrum of an authentic GA1 standard. e) Reaction catalyzed by SmCYP115, which 
corresponds to a C-3β hydroxylation of GA20 to form GA1, a bioactive GA.  Chromatograms 
and mass spectra are representative of compounds derivatized to methyl esters and/or 
trimethylsilyl ethers. 
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Figure S2.  CYP115 function is conserved in Mesorhizobium loti MAFF303099.  a) 
Although turnover is low (<1%), when GA9 (1) is incubated with cells expressing CYP115 
from M. loti MAFF303099, transformation to GA4 (2) is observed, as shown here through 
GC-MS chromatograms.  b) Mass spectrum of putative 2 (indicated by * in corresponding 
chromatogram). c) Mass spectrum of an authentic 2 standard. Chromatograms and mass 
spectra correspond to compounds derivatized as methyl esters and/or trimethylsilyl ethers. 
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Table S3. Insertion sequence (IS) elements flanking CYP115 genes. 
Rhizobia strain 
Annotated 
IS element 
present? 
(yes/no) 
Location 
relative to 
CYP115 
Type of element GenBank accession version 
Mesorhizobium loti MAFF303099 yes 5’ IS4/IS5 transposase WP_010913789.1 
Mesorhizobium loti R7A no - - - 
Mesorhizobium loti CJ3sym no - - - 
Mesorhizobium loti R88b no - - - 
Mesorhizobium loti USDA3471 no - - - 
Mesorhizobium loti NZP2042 yes 5’ IS4/IS5 transposase WP_032921559.1 
Mesorhizobium loti NZP2014 no - - - 
Mesorhizobium loti TONO no - - - 
Mesorhizobium sp. AA22 no - - - 
Mesorhizobium sp. SEMIA 3007 yes 5’ IS4/IS5 transposase WP_069091149.1 
Mesorhizobium sp. STM4661 no - - - 
Mesorhizobium sp. WSM2561 yes 5’ DDE transposase WP_027155434.1 
Mesorhizobium sp. WSM3626 yes 3’ integrase (partial) M653_RS0125265a 
Rhizobium mongolense USDA1844 yes (x2) both 5’ 1. DNA replication protein 
DnaC 
2. transposase (COG3316) 
1. A3C3_RS42030b 
 
2. A3C3_RS42035b 
Rhizobium favelukesii OR191 
(LPU83) 
yes (x2) both 5’ 1. transposase (DUF772 
superfamily) 
2. DDE transposase 
1. WP_051166744.1 
 
2. A3A1_RS40375a   
Sinorhizobium arboris LMG 14919 no - - - 
Sinorhizobium fredii CCBAU83666 
AJQR 
yes 5’ integrase (rve superfamily) WP_037436957.1 
Sinorhizobium medicae WSM1369 yes (x2) both 3’ 1. transposase (pfam14319) 
2. transposase (Y2_Tnp 
super family) 
1. WP_018009730.1 
2. WP_026160775.1 
Sinorhizobium meliloti WSM4191 yes 3’ transposase (pfam00872) SINMEL_RS0135775b 
Sinorhizobium terangae WSM1721 yes 5’ transposase (COG3464) WP_026621920.1 
aGene cut off at end of contig and no protein accession was provided.  Shown instead is the gene name. 
bGene is annotated as a pseudo or partial gene, and no protein accession is provided.  Shown instead is the gene name. 
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Figure S3.  Phylogenetic analysis of CYP115.  Shown are phylogenetic trees (Tamura 3-
parameter model, gamma distribution, complete deletion of gaps, 1000 bootstraps) for a) 
CYP115, b) core GA operon, and c) nifK nucleotide sequences for rhizobia strains 
containing a full length CYP115.  d) Zoom-in of rhizobia nifK subtree (excludes Azotobacter 
vinlandii DJ outgroup).  All sequences were aligned with MUSCLE. 
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Figure S4. Confirmation of CYP115 phylogeny in rhizobia.  Phylogenetic trees (Tamura 
3-parameter model, gamma distribution, complete deletion of gaps, 1000 bootstraps) 
representing CYP115 DNA alignments (MUSCLE) are consistent when using the a) 
Maximum Likelihood, b) Neighbor Joining, and c) Maximum Parsimony methods for tree 
construction.  
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= full-length CYP115
= CYP115 fragment or pseudogene
‡ = CYP112 fragment following CYP115
5’ = CYP115 located 5’ to operon
3’ = CYP115 located 3’ to operon
O = CYP115 located outside of operon
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Figure S5a continued 
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= full-length CYP115
= CYP115 fragment or pseudogene
‡ = CYP112 fragment following CYP115
5’ = CYP115 located 5’ to operon
3’ = CYP115 located 3’ to operon
O = CYP115 located outside of operon
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Figure S5b continued 
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Figure S5. Representative phylogenetic analysis of the core GA operon in rhizobia. 
Shown are the phylogenetic analyses (Tamura 3-parameter model, gamma distribution with 
invariant sites, complete deletion of gaps, 1000 bootstraps) for nucleotide alignments with 
the a) CPS and b) CYP114 from the GA operon (both aligned with MUSCLE).  Only 
rhizobia confirmed to have each gene of the core GA operon are represented here. 
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Table S4. List of bacterial strains used in this study. 
Strain Description Reference or source 
 
One Shot® TOP10 Chemically 
Competent E. coli 
 
F- mcrA ∆( mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 
∆ lacX74 recA1 araD139 
∆(araleu)7697 galU galK rpsL 
(StrR) endA1 nupG; for plasmid propagation and 
cloning 
 
 
Thermo Fisher Scientific 
OverExpressTM C41(DE3) Chemically 
Competent E. coli 
F- ompT hsdSB (rB- mB-) gal dcm (DE3); for 
pCDF-BjSDR/Fd expression 
Lucigen 
   
E. coli MM294A pro-82 thi-1 endA hsdR17 supE44; donor strains 
for triparental mating 
5 
   
E. coli MT616 MM294A recA56 carrying plasmid pRK600, CmR; 
helper strains for triparental mating 
6 
   
Sinorhizobium meliloti 1021 (a.k.a. 
Ensifer meliloti 1021, S. meliloti 
Rm1021) 
 
Rhizobial symbiont of Medicago spp.; SmR; 
heterologous host for expression of S. fredii GA 
operon genes 
1 
Mesorhizobium loti MAFF303099 Rhizobial symbiont of Lotus japonicus; genomic 
DNA was isolated from this strain for cloning 
Genetic Resource Center, 
National Institute of 
Agrobiological Resources, 
Ministry of Agriculture, Forestry 
and Fisheries, Japan 
   
Sm1021 pstb-LAFR5-SfCYP115 S. meliloti 1021 transformed for expression of S. 
meliloti WSM4191 CYP115; SmR, TcR 
 
This study 
Sm1021 pstb-LAFR5-SfCYP115-Fd S. meliloti 1021 transformed for coexpression of 
S. meliloti WSM4191 CYP115 and S. fredii 
NGR234 FdGA; SmR, TcR 
This study 
   
Sm1021 pstb-LAFR5-MlCYP115 S. meliloti 1021 transformed for expression of M. 
loti MAFF303099 CYP115; SmR, TcR 
This study 
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Table S5. List of primers used to create CYP115 expression constructs.  Underlined type 
indicates restriction sites. 
Name Sequence (5’ to 3’) Description 
SmCYP115-F CGCGGATCCTAACGTAACGT
AAATGGAGTCACCTCT 
Forward primer used to amplify synthetic 
SmCYP115 construct.  Contains BamHI 
restriction site. 
 
SmCYP115-R CCGGAATTCCTATGCCGCAC
CGCGGGTACGACCTAATG 
Reverse primer used to amplify synthetic 
SmCYP115 construct without FdGA 
coexpression.  Contains EcoRI restriction site. 
   
SmCYP115-FdGA-R CCGGAATTCTCAAACCGTTC
CATCGTGTCCTCCTGG 
Reverse primer used to amplify synthetic 
SmCYP115 construct with FdGA coexpression.  
Contains EcoRI restriction site. 
 
MlCYP115-F ATGCCGAGAAGTGGACCCG
CGATGG 
Forward primer used to amplify the longer 
MlCYP115 coding sequence (1278 
nucleotides) from genomic DNA.  While the 
genomic sequence contains a GTG start 
codon, this was changed to ATG for optimal 
expression. 
 
MlCYP115-F’ ATGCGCGTAGAAAACGAT 
CATTGCG 
Forward primer used to amplify the shorter 
predicted MlCYP115 coding sequence (1233 
nucleotides) from the previously cloned longer 
sequence. 
 
MlCYP115-R CTAAGCGACGGAAGGGCGG
AAGCTG 
Reverse primer used to amplify MlCYP115 
coding sequence from genomic DNA.   
 
MlCYP115-F2 CGCGGATCCTAACGTAACGT
AAATGGAGTCACCTCT 
ATGCCGAGAAGTGGACCCG
CGATGG 
 
Forward primer used to add the 5’ leader 
sequence and BamHI restriction site to the 
long MlCYP115 coding sequence. 
 
 
MlCYP115-F2’ CGCGGATCCTAACGTAACGT
AAATGGAGTCACCTCTATGC
GCGTAGAAAACGATCATTGC
G 
Forward primer used to add the 5’ leader 
sequence and BamHI restriction site to the 
short MlCYP115 coding sequence. 
 
 
MlCYP115-R2 CCGGAATTCCTAAGCGACGG
AAGGGCGGAAGC 
Reverse primer used to add EcoRI to the 3’ 
end of the MlCYP115 coding sequence. 
 
 
191 
 
 
1       10        20        30        40        50        60        70        80
SmCYP115 M      CD I    A  QLD  S  IL   G ARV LPG VVTWAA  H TL   L DQRF  DWR WRA QDGEIPE  RV NDH  A VSV PS   L A  Q G M            G  Q  R M     NR             DG G N S Q S D G R S Q F
MlCYP115 M      CD I    A  QLD  S  IL   G ARV LPG VVTWAA  H TL   L DQRF  DWR WRA QDGEIPE  RVENDH  V V A PT   L A  G M            R Q  R M     NK      L       DG P R S RQ S D A Q S Q
XocCYP115 M      CD I    A  QLD  S  IL   G ARV LPG VVTWAA  H TL   L DQRF  DWR WRA QDGEIPE  ESDH  V ISI PT   L A  Q P M            GH S  L     NR      L       WP D R L R A N GR A H N
XttCYP115 M      CD I    A  QLD  S  IL   G ARV LPG VVTWAA  H TL   L DQRF  DWR WRA QDGEIPE  RLESER  V MSI S   A   Q  V            GR Q  K I     SR      L       DD Q N FS WD A N C A H
        90       100       110       120       130       140       150       160
SmCYP115 HPLIG C  DNM TAHGADH RLRGLL  SFAP RIALLAP  E   D LL     R GSA LM EFA PLP  VIA LF     M KV   V       R      R           RI CA   AEMA     D     V   TN   E  S A Q R Q G C
MlCYP115 HPLIG C  DNM TAHGADH RLRGLL  SFAP RIALLAP  E   D LL     R GSA LM EFA PLP  VIA LF     I KV          R          S       RV CV   AEMA     D     A   TN   E  T SS Q R Q G S
XocCYP115 HPLIG C  DNM TAHGADH RLRGLL  SFAP RIALLAP  E   D LL     R GSA LM EFA PLP  VIA LF     M KL   V       R      R    S       RI CV   EML     E     I   TS   D  A R A T R . G
XttCYP115 HPLIG C  DNM TAHGADH RLRGLL  SFAP RIALLAP  E   D LL     R GSA LM EFA PLP  VIA LF     M RL   V             R    S       I V   A IA     D     V   S   E  Q A D RR Q G A . Q A
       170       180       190       200       210       220       230       240
SmCYP115 GLP   R EI  LT SLA TSA   EV QTRQR P  F  LIA KR   GDDLASALI  RD G LVSDTELIDMLFMVL   DEQ E  VA     N   TA   R     L E  RR              VA  N E               Y A C F GQL
MlCYP115 GLP   R EI  LT SLA TSA   EV QTRQR P  F  LIA KR   GDDLASALI  RD G LVSDTELIDMLFMVL   DEQ E  VA     S   TA   R     I EF RR              VA   E               Y E L GQL K
XocCYP115 GLP   R EI  LT SLA TSA   EV QTRQR P  F  LIA KR   GDDLASALI  RD G LVSDTELIDMLFMVL   DDQ E  VL     N   S   R     I EF HR              A   N                N EE R REP G Q
XttCYP115 GLP   R EI  LT SLA TSA   EV QTRQR P  F  LIA KR   GDDLASALI  RD G LVSDTELIDMLFMVL   EEN   IL     S   SA        I DF R               AA  S E               A N A Q W L RLP
       250       260       270       280       290       300       310       320
SmCYP115 SAGFVTT GVIGNGVLALLT PQQL LV SGQVPW QAIEEILRWG S  NLPFRYAT    I G    RG A LMAFHA       T            H    H        S          S VA        DVE D CTV   D V      R E P
MlCYP115 SAGFVTT GVIGNGVLALLT PQQL LV SGQVPW QAIEEILRWG S  NLPFRYAT    I G    RG A LMAFHA                   H    H        S          T AA        QDVE D C VR  D V      A R L
XocCYP115 SAGFVTT GVIGNGVLALLT PQQL LV SGQVPW QAIEEILRWG S  NLPFRYAT    I G    RG A LMAFHA       S                H        S          S V         Q M   SLR  D V      Q L T G Q A V
XttCYP115 SAGFVTT GVIGNGVLALLT PQQL LV SGQVPW QAIEEILRWG S  NLPFRYAT    I G    RG A LMAFHA       T            H    R                  S VA        QDVE D CTIR  E I      L A
       330       340       350       360       370       380       390       400
SmCYP115 ANRDE AFGPGA   DVTR  NPHLSFG GPH CLGAALARLEL CAF  LF RL  LAL  A ED  Y PSYVIRCPQR     K          RH                     R   A    ED   AI A  VV M          DRF K V T G
MlCYP115 ANRDE AFGPGA   DVTR  NPHLSFG GPH CLGAALARLEL CAF  LF RL  LAL  A ED  Y PSYVIRCPQR     K          RH                     R   P     ED   I A  VV M          NRF E S P G T
XocCYP115 ANRDE AFGPGA   DVTR  NPHLSFG GPH CLGAALARLEL CAF  LF RL  LAL  A ED  Y PSYVIRCPQR               RH                     R   PA    ED   AI A  VA M          E AAL Q F T
XttCYP115 ANRDE AFGPGA   DVTR  NPHLSFG GPH CLGAALARLEL CAF  LF RL  LAL  A ED  Y PSYVIRCPQR     R                                  PA    E   AV L  IA           QAL QP Q F L A H Q
       410       420                                                            
SmCYP115 LP  FRPS                                                                          VT    IVPPIETKALGRTRGAA
MlCYP115 LP  FRPS                                                                          VS    VA...............
XocCYP115 LP  FRPS                                                                          IT    AV...............
XttCYP115 LP  FRPS                                                                          VT    IARE.............
  
Figure S6.  Sequence alignment of CYP115 proteins.  The predicted CYP115 proteins of 
the two functionally characterized genes from S. meliloti WSM4191 (SmCYP115) and M. 
loti MAFF303099 (MlCYP115) are shown aligned with analogous proteins from two plant 
pathogens, X. oryzae pv. oryzicola BLS256 (XocCYP115) and X. translucens pv. translucens 
DSM 18974 (XttCYP115), showing that CYP115 length and sequence is highly similar 
between these distant lineages.  Red highlights with white text indicates strict identity, red 
characters indicate similarity in a group, and a blue outline represents similarity across 
groups.  The visualization of this alignment was created using ESPript 3.0.9 
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CHAPTER 5 
 
GIBBERELLIN PRODUCTION BY RHIZOBIA ENACTS A SELECTIVE ADVANTAGE 
BY INCREASING LEGUME NODULE SIZE 
 
A manuscript in preparation. 
 
Ryan S. Nett1, Kelly Bender2, Reuben J. Peters1,* 
 
Abstract 
 Plant-associated microbes have evolved the ability to produce gibberellin (GA) 
phytohormones independently of plants as a means to manipulate their host.  In 
phytopathogenic fungi and bacteria, GA acts as a virulence factor to enhance infection.  The 
nitrogen-fixing bacteria known as rhizobia, which inhabit the root nodules of legumes, also 
produce GA, and it has been previously postulated that this acts to suppress nodulation by the 
host plant.  It is demonstrated here that GA produced by the rhizobium Bradyrhizobium 
japonicum effects an increase in average nodule size of its soybean host.  This increase in 
nodule size allows for larger populations of rhizobia within a nodule and presumably a 
greater number of bacterial progeny released back into the soil, thereby providing a selective 
advantage to rhizobia that can produce GA.  Additionally, while many GA-producing 
rhizobia, including B. japonicum, cease biosynthesis at non-bioactive GA9, it appears that at 
least soybean plants express functional GA 3-oxidase genes within the nodule, which can 
perform the critical biochemical transformation to convert GA9 into bioactive GAs.  
Therefore, it would appear that rhizobial GA biosynthesis has coevolved with endogenous 
plant metabolism to arrive at a bioactive GA phytohormone that acts to influence growth of 
the nodule. 
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Introduction 
 Bacterial fixation of atmospheric nitrogen (N2) is a major natural means by which 
nitrogen can be assimilated into the biological environment.  Perhaps the most relevant to 
agriculture is the reduction of N2 by rhizobia, which form symbiotic relationships with 
legumes, including important crops like soybean, cowpea, and common bean.1  In this 
symbiosis, rhizobia reside in novel organs attached to the plant root called nodules, within 
which they are provided with a carbon source and a relatively competition-free niche in 
exchange for reduced nitrogen.  When inside the nodule, the rhizobia cells are referred to as 
bacteroids, and are located within plant nodule cells in membrane-bound structures called 
symbiosomes.2  Although the relationship between rhizobia and legumes is often considered 
as a mutualistic symbiosis in which both partners benefit, there are examples in which either 
plant or bacterium try to gain an advantage at the other organisms’ expense.  This includes 
rhizobia trying to “cheat” and not optimally fix nitrogen inside the nodule, which is 
countered by host plant sanctions on these cheaters that affect rhizobial proliferation in the 
nodule.3  Additionally, certain legumes will force differentiation of bacteroids into elongated 
cells, which decreases the ability of rhizobia to revert to a free-living form in the soil.4   This 
forced differentiation occurs mainly in legumes that form indeterminate type nodules,5 which 
are characterized by having a persistent meristem and an elongated shape.6  Conversely, 
many legumes instead form determinate nodules, which do not have a persistent meristem 
and instead grow by cell expansion, resulting in a more spherical shaped structure.  
Typically, the bacteroids found within determinate nodules are not differentiated, as they 
essentially resemble free living rhizobia cells, and it is thought that the majority of these cells 
are viable upon release into the soil.3 
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 Many rhizobia have been implicated to produce the plant hormone gibberellin (GA), 
and this has been confirmed through characterization of the GA biosynthetic pathway in 
these organisms.7,8  The ability to produce GA is imparted by a biosynthetic gene cluster 
referred to as the GA operon (Figure 1), and this operon seems to be widely distributed in 
rhizobia, including in Bradyrhizobium japonicum, Sinorhizobium fredii, Rhizobium etli, and 
Mesorhizobium loti.9,10  However, it is particularly enriched within rhizobia strains that have 
symbioses with legumes that form determinate nodules, suggesting a specific role for 
rhizobial production of GA.8,10  This includes the aforementioned species, which all typically 
associate with determinate nodule-forming hosts (B. japonicum with soybean, S. fredii with 
cowpea, R. etli with common bean, and M. loti with Lotus japonicus).  Transcriptomic and 
proteomic studies from several rhizobia species have confirmed that the GA operon is 
expressed specifically during symbiosis and not when the bacteria are free-living in the 
soil,11–19 suggesting a role for bacterial GA in this symbiosis.  
Surprisingly, initial analysis of the GA operon from B. japonicum in symbiosis with 
soybean (Glycine max), found no differences in soybean height or nodulation phenotypes 
when plants were inoculated with either wild-type or GA operon knockout strains.20  Though 
it was not yet known that this operon was responsible for GA biosynthesis, this negative 
result suggested that the product of this operon did not seem to have a noticeable function in 
planta, at least for soybean.  However, this experiment analyzed soybean phenotypes 
relatively early in the plant’s development (~5 weeks after planting and inoculation with 
rhizobia), and thus also relatively early in the rhizobia-legume symbiosis.  Although many of 
the transcriptomic/proteomic studies confirmed expression of the GA operon as early as 3 
weeks post inoculation, more specific analysis of the expression of the GA operon cps and ks 
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transcripts from B. japonicum in symbiosis with soybean revealed that at least these two 
genes are not expressed highly until around the flowering and early pod stages of soybean 
development.21  Furthermore, this same study found that bacteroid GA oxidase activity was 
also not observed until the flowering stage.  Thus, it could be hypothesized that significant 
amounts of rhizobial GA are not being produced until around the flowering stage of the plant, 
and therefore a phenotype resulting from this GA production may not be evident until after 
this point. 
It was previously found that GA production by M. loti, the symbiont of Lotus 
japonicus, decreases nodule formation, and it was hypothesized that this restriction of 
nodulation provides a selective advantage to these rhizobia by excluding other rhizobia from 
forming symbiosis with the host plant.8  This study also found that rhizobial GA leads to 
significantly larger nodules, though this was not concluded to be the major phenotype 
associated with production of GA by the bacteria.  In this study, we analyzed the effect of 
GA production by B. japonicum in symbiosis with soybean and S. fredii in association with 
cowpea (Vigna unguiculata), and demonstrate that rhizobial GA appears to act by increasing 
the size of nodules, thereby resulting in an increase in total bacteroids per nodule, and 
presumably a larger number of bacteria then released into the soil.  Additionally, our results 
suggest that some rhizobia have coevolved GA biosynthesis with their plant host such that 
the ultimate chemical transformation in production of bioactive GA is performed by the 
plant, potentially as a means to control the effect of bacterial GA. 
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Results 
GA operon expression 
 To assess and clarify the expression of the GA operon in B. japonicum during its 
symbiosis with soybean, quantitative real-time PCR  (qPCR) was used to measure the 
relative expression of the cyp112 and ks genes from the operon over essentially the entire 
course of soybean development (12 weeks of measurement, covering vegetative to full pod 
stages).  This analysis confirmed that while the operon is indeed expressed as early as 3 
weeks post inoculation, there is a notable increase in transcript abundance at the flowering 
and early pod stages of plant development (Figure 2).  Thus, it seemed likely that a 
phenotype may not be evident until at or after these developmental stages. 
Rhizobia GA knockout phenotypes 
 To evaluate the phenotypic role that rhizobial GA may be playing in symbiosis, a GA 
operon knockout strain was created for B. japonicum USDA110 (GA+) by inserting an 
antibiotic resistance cassette into cyp112, resulting in the strain B. japonicum KB2011 (GA-).  
Plants nodulated with the GA- strain were not significantly altered in height or fresh plant 
mass in comparison to GA+ nodulated plants (Figure 3a, b), which corresponds to previous 
reports showing that the GA operon does not appear to affect the gross phenotype of the 
plant.8,20  Additionally, much like previous analysis of GA knockout B. japonicum strains,20 
no significant alterations in nodulation were observed early in soybean development 
(vegetative stage).  However, after the flowering stage there are noticeable differences in 
nodulation phenotypes.  In particular, while the GA- -nodulated plants have a significantly 
higher number of nodules per plant (Figure 3c), the nodules inhabited by GA- B. japonicum 
are significantly smaller than those of the GA+ strain (Figure 3d).  These effects are 
199 
 
 
particularly striking at the full pod stage, as nodules inhabited by GA+ B. japonicum are 
roughly twice as large as those of the knockout, and the total number of nodules per plant for 
the GA- strain are essentially twice as high as the number for plant nodulated with the GA+ 
strain.  Ultimately, this disparity in size and number results in the a statistically similar total 
nodule mass per plant for the two conditions by the early pod and full pod stages (Figure 3e).  
The similarity in total nodule mass, along with no significant difference in total plant mass, 
would suggest that knockout of the GA operon does not restrict nitrogen assimilation by the 
plant. 
 The nodulation phenotypes associated with loss of GA production could be reversed 
with the application of exogenous GA.  Specifically, application of GA3, a bioactive GA, to 
the roots of the plants nodulated by the GA- strain resulted in a decrease in nodule number 
and an increase in average nodule size that restored the wild-type control phenotype (Figure 
4 and Supplementary Figure 1).  However, this was only evident for GA3 concentrations 
greater than or equal to 10 nM.  While previous studies have shown that GA3 concentrations 
of 1 µM are inhibitory to nodule formation,  they have also observed that at concentrations 
greater than or equal to 10 nM,  aberrant plant growth phenotypes such as increased height 
and decreased root formation are associated with this application.22  The increased height 
observed in this experiment from 10 nM GA3 was subtle, yet significant, but application with 
concentrations of 1 µM or even 100 nM resulted in an extreme increase in height as early as 
one week post treatment (Supplementary Figures 1 and 2).  Additionally, a significant 
reduction in root mass was observed at the higher concentrations (10 nM, 100 nM, and 1 
µM), consistent with an inhibitory effect of GA3 on root growth.   Thus, concentrations 
higher than 10 nM are unrealistic in terms of a biologically relevant concentration of GA to 
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complement the GA- phenotype.  Though 1 nM GA3 was able to slightly increase the average 
nodule size and decrease the nodule number of the knockout nodulated plants without 
affecting plant height or mass (Figure 4), this did not fully rescue the wild-type phenotype, 
which 10 nM GA3 was able to do.  Overall, an applied concentration in the range of 1 to 10 
nM (which equates to roughly 300 ng of GA3 per gram of nodule tissue) seems to be the most 
realistic in being able to restore the GA+ nodulation phenotype with minimal effects on plant 
height and development.  The amount of bacterial GA9 calculated to be present within 
soybean nodules is considerably less than this (14 ng per gram of nodule mass),21 but it is 
likely that not all of the GA applied to the plant roots is able to enter plant tissue to exert an 
effect. 
Bacteroid content of nodules 
 Because rhizobial GA results in an increase in the average nodule size per plant, it 
can be hypothesized that GA production confers a selective advantage as larger nodules will 
have more bacteroids inhabiting them to be released into the soil upon nodule senescence.  
To analyze the relationship between nodule size and bacteroid numbers, bacteroids were 
isolated from mature nodules of varying sizes and counted with both flow cytometry and by 
plating for colony-forming units (CFUs).  Both of these analyses confirmed the trend that 
larger nodules do indeed harbor greater numbers of isolated bacteroid cells (Figure 5).  
Though not a surprising result, it is supportive of and consistent with a selective advantage 
for larger nodules resulting from rhizobial GA production. 
GA 3-oxidase activity 
 Although GA production by B. japonicum seems to clearly be affecting nodulation 
phenotypes of its soybean host, it is noteworthy that the final product of endogenous GA 
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biosynthesis in this organism is GA9,7,21 which is not considered to be a bioactive GA as it 
does not elicit a response in growth assays,23 nor does it bind effectively to the appropriate 
GA receptor.24,25  Although certain rhizobia contain an additional enzyme (CYP115) that acts 
as a gibberellin 3-oxidase (GA3ox) to produce bioactive GA4 from GA9, this is only found in 
a small subset of rhizobia that does not include B. japonicum.26  However, it has been shown 
that GA9 fed into nodule extracts from the Mesorhizobium loti–Lotus japonicus symbiosis is 
converted to bioactive GAs.8  While M. loti contains CYP115 and is thus capable of 
performing the conversion of GA9 to GA4 endogenously, it could be hypothesized that plant 
GA3ox are also expressed in the nodule tissue and can act on GA9 to produce bioactive GAs, 
particularly when the rhizobium in the symbiosis does not possess CYP115. 
 To determine if any soybean GA3ox are expressed in the nodule, an initial PCR 
screen with cDNA generated from RNA isolated from root nodules was performed to probe 
the six GA3ox isoforms encoded within the soybean genome.27  This revealed that two 
isoforms, GmGA3ox4 and GmGA3ox6, were noticeably expressed in the nodule around the 
flowering stage (Supplementary Figure 3).  Analysis with qPCR was then used to assess the 
expression of these two isoforms in both the nodule and in the root tissue over the course of 
symbiosis between B. japonicum and soybean.  This analysis demonstrated that transcripts 
for both GmGA3ox4 and GmGA3ox6 are expressed at a significantly higher level in nodule 
than in root tissue (Figure 6), suggesting that the expression of these GA3ox isoforms is 
specific to the nodule, which is in agreement with a potential role for converting rhizobial 
GA9 into bioactive GAs.  Additionally, both GmGA3ox4 and GmGA3ox6 expression peaked 
at around 12 weeks post inoculation, which is also the time point at which the GA operon is 
most highly expressed (Figure 2).  This would suggest that the expression of these GA3ox 
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isoforms may be regulated to coincide with that of the operon genes to allow for efficient 
conversion of rhizobial GA9. 
To confirm the function of these genes as GA3ox, E. coli codon-optimized clones 
were synthesized and expressed in E. coli.  Incubation of GA9 with cells expressing 
GmGA3ox6 resulted in 3β-hydroxylation to form GA4 (Supplementary Figure 4a), 
confirming that this predicted GA3ox does indeed have the activity to convert GA9 into a 
bioactive form.  This enzyme was further verified as specifically having GA3ox activity as 
GA20 (i.e. 13-hydroxy GA9) incubated in cells expressing GmGA3ox6 was hydroxylated at 
the C-3β position to form GA1 (Supplementary Figure 4b).  From these studies, it can be 
concluded that functional soybean GA3ox enzymes are expressed in the right place and at the 
appropriate time for them to act on GA9 that is presumably secreted by bacteroids within the 
nodule. 
 
Ongoing and Future Experiments 
Chemical complementation 
 Currently, an experiment is being performed that is essentially identical to the 
aforementioned GA3 chemical complementation, with the exception that GA9 is being used 
instead.  Although GA3 was able to restore the GA+ phenotype to plants nodulated by the 
GA- strain, the final product of GA biosynthesis in B. japonicum is GA9, a non-bioactive 
GA.7,21  We hypothesize that this GA is further metabolized by the plant into bioactive forms, 
so if this compound is produced by the bacteroids and secreted to the plant cells to exert its 
effect, then it could be predicted that exogenous GA9 applied to the plant soil would also be 
taken up and metabolized within root nodules into bioactive GA, thereby rescuing the 
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knockout nodulation phenotype.  As with the GA3 chemical complementation, GA9 will be 
applied at a range of different concentrations (1 nM, 10 nM, and 100 nM) such that a 
minimum amount can be found at which the nodule phenotypes are restored without 
affecting plant height and mass. 
Genetic complementation 
 In order to be fully confident in the phenotypes associated with plants nodulated by 
GA+ vs. GA- rhizobia, genetic complement strains were created and will be used to determine 
if this complementation can restore the wild-type, GA-producing phenotype.  In previous 
analysis of the GA operon, scar-less gene deletions of cyp117 and cyp114 were created for 
both B. japonicum and S. fredii (BjΔcyp117, BjΔcyp114, SfΔcyp117, and SfΔcyp114), and 
these strains were confirmed to be compromised in the function of the knocked-out gene, 
with the rest of  GA biosynthesis remaining unperturbed.7  These deletions strains have been 
transformed with plasmids (pBBR1MCS2 for B. japonicum and pstb-LAFR5 for both B. 
japonicum and S. fredii) containing the appropriate native gene (CYP117 for Δcyp117 and 
CYP114 in coexpression with FdGA for Δcyp114, as this Fd has been shown to be essential 
for full CYP114 function7), which were placed under the control of constitutive promoters.  
Incubations of the appropriate substrates (ent-kaurenol with CYP117 and ent-kaurenoic acid 
with CYP114-FdGA) in transformed cells expressing these genes in aerobic culture has 
confirmed that the heterologous genes for S. fredii are functional in this system 
(Supplementary Figure 5).  The B. japonicum heterologous complementation strains have 
recently been created, and the functionality of the genes via substrate incubation still needs to 
be confirmed. 
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 The experimental set-up for these strains will be straightforward.  Soybean or cowpea 
will be inoculated with GA+ strains of the appropriate rhizobial symbiont (B. japonicum with 
soybean and S. fredii with cowpea), with gene deletion strains, with deletion strains 
transformed with empty expression plasmids, or with deletion strains complemented with 
plasmids containing the appropriate gene to complement the knockout.  These plants will be 
grown until after the flowering stage, at which point nodulation and growth phenotypes will 
be observed to determine if the complementation strains are able to restore the wild-type 
phenotype.  This genetic complementation, if effective in restoring GA+ phenotypes, will 
confirm that the nodulation phenotypes associated with GA- strains are indeed due to the 
absence of rhizobial GA production.  Additionally, we hypothesize that the same effects will 
be seen in cowpea plants nodulated with GA- S. fredii.  If this is true, then we will have 
demonstrated that the phenotypes associated with rhizobial GA are more broadly applicable 
to all rhizobia with the GA operon. 
Nitrogen complementation 
 Our hypothesis is that rhizobial GA is acting as a selective advantage by increasing 
the size of the nodule in which they reside, thereby allowing for a greater population of 
rhizobia to inhabit the nodule.  However, consistent with a previous report,8 we observe that 
soybean nodulated with GA- rhizobia form significantly more nodules than soybean 
nodulated by the GA+ strain.  Thus, it could be speculated that rhizobial GA is not only 
acting to increase nodule size, but also to negatively regulate the formation of new nodules 
by the host legume, which was previously speculated to be the true selective advantage of 
rhizobial GA production, as this would prevent other rhizobia in the soil from forming 
subsequent nodules.  It was reasoned that by limiting the formation of new nodules, the 
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rhizobia already in symbiosis with the plant would receive a greater partitioning of resources 
from the plant, thereby increasing their fitness. 
 An increase in nodule size provides a more straightforward selective advantage, as it 
would directly benefit the bacteroids that produce GA within that specific nodule.  The larger 
nodules evaluated here, which we show to harbor larger numbers of bacteroids, presumably 
have more nitrogen fixing capability, as a positive correlation between nodule mass and 
nitrogen fixation and/or plant mass (as a proxy for nitrogen fixation) has been previously 
documented.28,29  It can be speculated then that the greater number of nodules formed in a 
legume’s symbiosis with the GA- strain is due to the smaller average nodule size.  The 
smaller nodules would have less bacteroids, and thus fix less nitrogen, so it is possible that 
the plant the allows for more nodules to be formed in order to meet its nitrogen fixing needs.  
This is supported by the statistically similar amount of total nodule mass between soybean 
nodulated by GA+ and GA- strains of B. japonicum (Figures 3e & 4c). 
 To test if this concept is true, soybean will be nodulated with GA+ or GA- B. 
japonicum in the same fashion as previous experiments.  At three weeks post inoculation, at 
which point the operon has been confirmed to be expressed,11,12 plants will be treated with 
either nutrient solution that lacks nitrogen (which is normally given to the soybean plants in 
our experiments), or with nutrient solution containing nitrogen in the form of nitrate.  If the 
phenotype associated with rhizobial GA production is indeed an increase in nodule size and 
not a decrease in nodule number, we would predict that soybean nodulated with GA- B. 
japonicum should not have as extreme a statistically significant increase in nodule number 
(or any increase at all), as the plants’ nitrogen needs will be met by the exogenous nitrogen 
applied in the nutrient solution. 
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Biochemical characterization of GmGA3ox4 
 Although GmGA3ox6 has been confirmed to possess GA3ox activity, the other 
isoform expressed in the nodule, GmGA3ox4, still needs to be characterized.  This will be 
done in essentially the same fashion as the experiments outlined for GmGA3ox6.  The amino 
acid identity of GmGA3ox4 and GmGA3ox6 is ~90%, suggesting that GmGA3ox4 will have 
a similar function to that of GmGA3ox6.  This function is likely to be 3β-hydroxylation 
activity to produce GA4 from GA9 or GA1 from GA20, but GA3ox enzymes have also been 
shown to catalyze the formation of a 2,3 double bond.30  This desaturation activity coupled 
with 3β-hydroxylation would ultimately result in the formation of the 1,2 double bond-
containing GA7 or GA3 (depending on whether the substrate has a 13-hydroxyl group), both 
of which are also bioactive GAs and have been found within the nodules of Lotus japonicus 
nodulated with M. loti.8 
Incubating GA9 in nodule extracts 
 A major anomaly regarding the production of GA by symbiotic rhizobia is that most 
species only contain the genes necessary to produce GA9, a non-bioactive GA.26  It has 
previously been found that GA9 is converted into bioactive GAs within Lotus japonicus 
nodules inhabited by M. loti.  While, this is consistent with GA9 being converted into 
bioactive forms in the nodule, it is confounded by the fact that M. loti contains CYP115, 
which has been shown to be a GA3ox.26  Thus, it is unclear whether the transformation of 
GA9 is due to the plant or to the bacterial symbiont.  We plan to perform this same 
experiment with soybean nodules inhabited by B. japonicum, which does not contain 
CYP115, and thus is incapable of producing bioactive GA4 endogenously.  We predict that 
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incubating GA9 in soybean nodule extracts will result in the production of bioactive GAs, 
consistent with the expression and activity of GA3ox from the soybean host. 
 To perform this experiment, soybean nodules will be homogenized in buffer 
containing the appropriate cofactors for GA3ox activity (these enzymes are 2-oxoglutarate 
dependent dioxygenases [2ODDs] and thus require 2-oxoglutarate, along with ascorbate and 
iron for their activity).  GA9 will be incubated in these extracts at 25 ˚C overnight.  Reactions 
will then be acidified to neutralize the free acids on GA metabolites, then extracted with ethyl 
acetate to obtain any GAs.  Fractions will be further purified, derivatized, and analyzed with 
GC-MS to determine if any bioactive GAs are produced.  These incubations will be 
compared to homogenized extracts in which no GA9 has been added.  If GA9 is indeed turned 
over, we would expect for there to be significantly more bioactive GAs in the GA9-fed 
samples than in the controls.  This same experiment will also be performed with root 
extracts, as it is possible that GA9 secreted by the bacteroid is transported to the root tissue 
before it is metabolized into bioactive forms, as GA has previously been shown to be capable 
of movement throughout the plant.31,32  If GA9 is transformed into bioactive GA by nodule 
extracts, we can be more confident in the scenario in which bacteroids secrete GA9 to the 
plant cells of the nodule, wherein host GA3ox enzymes then convert GA9 into bioactive 
forms that then carry out GA signaling to enact the nodulation phenotype observed with 
rhizobial production of GA. 
 
Discussion 
 There are currently over 120 strains of rhizobia confirmed to have the GA operon,26 
and among these, roughly 80% inhabit determinate nodules or were initially isolated from 
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determinate nodules (JGI database).  It would appear then that the ability to produce GA is 
likely to be beneficial in the symbiotic interactions of these particular rhizobia with 
determinate nodule-forming legumes, and here we show that this effect is likely enacted via 
an increase in nodule size.  Determinate nodules grow through cell expansion/enlargement,33 
and this type of cell growth can be stimulated by GA phytohormones in other plant tissues.34  
Therefore, we hypothesize that the rhizobial GA produced by bacteroids increases the size of 
the cells in which they reside, which ultimately results in an increase in total nodule organ 
size, thereby allowing for more bacteroids to collectively inhabit that nodule (Figure 7).  
Ultimately, this increase in size and bacteroids per nodule would result in more bacteroids 
being released into the soil upon nodule senescence, and thus the ability to produce GA 
would act as a fitness advantage for rhizobia.  However, we would predict that this advantage 
would only be observed in determinate nodules, which grow by cell expansion, as opposed to 
indeterminate nodules, which grow continuously by cell division.33 
 The presence of the GA operon in rhizobia that form symbioses with indeterminate 
nodule-forming legumes, though a minority overall, presents a potential problem with this 
hypothesis.  It is possible that many of the rhizobia that are characterized as forming a 
symbiotic interaction with indeterminate nodule-forming legumes are also capable of 
nodulating other legumes in their environment other than their canonical host.  Indeed, it has 
been found that at least some strains of rhizobia have broad host ranges and can nodulate 
both determinate and indeterminate nodule-forming legumes.35 
 It is interesting to note that along with a decrease in size, an increase in nodule 
number was also observed with GA- strains of rhizobia, which has been previously noted and 
hypothesized to be the main selective advantage for rhizobial GA production.8  It is possible 
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that rhizobial GA is indeed having a negative effect on the formation of nodules, consistent 
with the inhibitory effect of GA previously established in many legumes,36 and that the 
observed phenotypes (size and number) could both be enacted by rhizobial GA.  This could 
then provide a role for rhizobial GA in affecting indeterminate nodule-forming legumes, as 
GA has been shown to be inhibitory to nodulate formation in these types of legumes.37,38  
However, it is also possible that because nodules formed by GA- rhizobia are smaller (and 
thereby inhabited by fewer rhizobia), they have less overall nitrogen fixing capacity, and thus 
the host plant needs to allow for more nodules to form in order to meet its nitrogen needs.  
Indeed, it has been shown that these is a positive correlation between nodule mass and 
nitrogen fixation and/or plant mass (as a proxy for nitrogen fixation),28,29 and this is 
supported by the fact that the total nodule mass is statistically similar between soybean 
nodulated by GA+ and GA- B. japonicum (Figures 3e & 4c). 
The vast majority of rhizobia with the GA operon only contain the core set of genes 
(CYP112 thru KS) and lack CYP115, as only 20 strains of rhizobia are known to possess a 
full-length copy of this gene.7  Unless a separate GA3ox gene is found within the genomes of 
these organisms, then it can likely be assumed that they cease GA biosynthesis at the non-
bioactive precursor GA9.  However, as was previously shown, nodule lysates from the M. 
loti–Lotus japonicus symbiosis are capable of converting GA9 into multiple bioactive GAs 
including GA1, GA3, GA4, and GA7.8  Though this is confounded by a functional CYP115 
being present in the genome of the M. loti strain used in this study (M. loti MAFF303099), 
the absence of CYP115 in most rhizobia suggests a scenario in which GA9 is secreted from 
the bacteroid and into the host plant cell where plant GA3ox enzymes are able to convert this 
into bioactive GAs.  Our results confirm that two GA3ox isoforms are expressed within the 
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nodule, with particular enrichment when compared to regular root tissue, and that at least one 
of these isoforms does indeed possess GA3ox activity.  Assuming that GA9 is secreted from 
bacteroids within the nodule, it is possible that the host plant GA3ox enzyme(s) are 
responsible for the ultimate transformation(s) to produce bioactive GA.  The relatively high 
expression of these GA3ox isoforms at the same time as the GA operon agrees with this 
hypothesis, and suggests that the expression of these genes is regulated such that they are 
present at the same time that rhizobial GA9 is being synthesized, thus allowing for their 
subsequent activity to convert GA9 into bioactive forms (Figure 7). 
While it is plausible that GA9 may have novel activity not previously noted, it is 
perhaps more likely that rhizobial GA production relies on this last biosynthetic step being 
performed by the plant.  Intriguingly, it appears that most rhizobia contain a fragment or 
pseudogene of CYP115 appended to the 5’ end of the operon where a full-length copy of 
CYP115 is often found in other bacteria with the operon.26  This would then suggest that 
CYP115, and thus GA3ox activity, may have been selectively lost from most rhizobial 
genomes.  Though this gene is noticeably absent in most rhizobia, it is invariably found 
within plant pathogenic bacteria that also contain analogous copies of this operon.39  The 
presence of CYP115 allows plant pathogens to produce GA4 instead of GA9,40 and it has 
been previously shown that this bioactive GA acts as a virulence factor in the infection of 
rice by Xanthomonas oryzae pv. oryzicola through suppression of the jasmonate-induced 
defense response.41  Therefore, it is possible that the production of a bioactive GA such as 
GA4 by rhizobia may be deleterious to the host legume in their symbiotic interaction, and 
rhizobia may be under selective pressure to lose CYP115 activity, and thus the ability to 
produce bioactive GA endogenously.   
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Turnover of rhizobial GA9 into bioactive forms by the plant would perhaps present a 
problem with this scenario, but it may be that by assuming control of the ultimate step in 
biosynthesis, the legume host is better able to tune the effect that this bioactive GA will have.  
Additionally, the increase in individual nodule size is presumably not detrimental to the host 
legume, and indeed may be more energy efficient for the plant than forming additional, 
smaller nodules, as larger nodules have been shown to have a higher ratio of nitrogen-fixing 
tissue to overall nodule volume than smaller nodules.42–44  Thus, the plant may not be under 
selection to prevent GA production by their rhizobial symbionts, and may instead gain a 
selective advantage through this increase in average nodule size, both due to the rhizobial 
production of GA (saving the plant carbon and energy input into biosynthesis) along with the 
relative gain in nitrogen fixation in comparison to smaller nodules.  This may suggest that the 
expression of plant host GA3ox enzymes in the nodule, while acting to enact a selective 
advantage to the rhizobial symbionts, may also have been evolved to deliver an advantage to 
the plant as well.   
Overall, it would seem that bacteria with varying effects on plants, both symbiotic 
and pathogenic, have found a way to utilize an analogous GA biosynthetic operon to impart a 
selective advantage upon their own specific lifestyle.  Our results further suggest an intricate 
level of coevolution between GA-producing rhizobia and determinate nodule-forming 
legumes in which microbial GA is presumably acting as a selective advantage both for the 
rhizobial symbiont and the host plant.  While rhizobia may have initially obtained the GA 
biosynthetic operon, and therefore GA production, in order to manipulate their host, this 
coevolution suggests that the legume has co-opted this GA production to their own advantage 
in this symbiosis. 
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Methods 
Bacterial growth 
 See Supplementary Table 1 for all bacterial strains used in this study.  E. coli strains 
were grown in NZY (10 g L-1 casein hydrolysate, 5 g L-1 yeast extract, 5 g L-1 NaCl, 1 g L-1 
MgSO4·7H2O) media at 37 ˚C, with 225 RPM shaking for liquid cultures.  For general 
antibiotic use with all bacterial strains, the following concentrations were used unless stated 
otherwise: chloramphenicol (Cm) 25 µg mL-1, tetracycline (Tc) 10 µg mL-1, kanamycin (Km) 
50 µg mL-1, carbenicillin (Cb) 50 µg mL-1, trimethoprim (Tm) 50 µg mL-1. 
 Bradyrhizobium japonicum strains were grown using arabinose-gluconate (AG) 
media (1 g L-1 arabinose, 1 g L-1 sodium gluconate, and 1 g L-1 yeast extract, pH 7) with Cm 
at 34 μg mL-1 or Tm for triparental matings.  The appropriate antibiotics to select for 
knockouts and/or complementing plasmids were applied as needed.  For liquid cultures of B. 
japonicum, 10 mL of the following sterilized supplements were added per 930 mL of AG 
media (making 1 L total) following autoclaving of media: HEPES-MES buffer (13 g L-1 
HEPES, 11 g L-1 MES, pH 6.6-6.9), 0.67 g L-1 FeCl3, 18.0 g L-1 MgSO4·7H20, 1.3 g L-1 
CaCl2·2H20, 25.0 g L-1 NaSO4, 32.0 g L-1 NH4Cl, and 12.5 g L-1 Na2HPO4. 
 Sinorhizobium fredii strains were grown in tryptone-yeast (TY) media (5 g L-1 casein, 
5 g L-1 yeast extract, 0.5 g L-1 CaCl2·2H20, pH 7) with rifampicin (Rf) at 25 µg mL-1.  
Appropriate antibiotics to select for knockouts and/or complementing plasmid were applied 
as necessary.  Liquid cultures of S. fredii were supplied with the same supplements as listed 
above for B. japonicum. 
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Rhizobia knockout strains and generation of genetic complementation constructs 
 B. japonicum KB2011 was graciously provided by Professor Kelly Bender 
(University of Southen Illinois), and this strain was created by inserting a streptomycin 
resistance cassette followed by transcription terminator sequences into the open reading 
frame of cyp112, much in the same way as previously described.45  Deletion strains for the 
individual CYPs within the GA operon for both B. japonicum (BjΔcyp117, BjΔcyp114)  and 
S. fredii (SfΔcyp117, SfΔcyp114) were previously developed for characterization of GA 
biosynthesis in rhizobia7.   
 Genetic complements for B. japonicum were created by first having synthetic gene 
constructs synthesized using GeneArtTM  gene synthesis.  The native open reading frames 
(ORFs) for BjCYP117, and BjCYP114-FdGA (which contains the intergenic region following 
CYP114 in addition to the subsequent FdGA gene) were synthesized with the aphII promoter 
appended to the 5’ end, as this has been shown to be effective for overexpression in B. 
japonicum,46 and a native transcriptional terminator from B. japonicum47 was appended to the 
3’ end of the ORF.  Also included was a 5’ HindIII restriction site and a 3’ SpeI restriction 
site for downstream cloning.  pBBR1MCS2 (KmR) was selected as an expression plasmid as 
this has been shown to be effective for genetic complementation in rhizobia,48 including 
nodulation studies with soybean and B. japonicum.49  See Supplementary Table 2 for all 
plasmids and constructs used in this study.  CYP117 and CYP114-FdGA constructs, along 
with the pBBR1MCS2 plasmid, were digested with HindIII and SpeI restriction enzymes 
(New England Biolabs), run on a 1% agarose gel, and purified using a Gel Purification Kit 
(Sigma).  Digested constructs and plasmid were ligated with T4 DNA ligase (New England 
Biolabs) and transformed into Top10 cells for positive clone selection and screening.  
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Positive clones were sequenced and transformed into B. japonicum strains using triparental 
mating (see Triparental mating).  The pBBR1MCS2 empty vector was transformed into B. 
japonicum USDA110, BjΔcyp117, and BjΔcyp114.  pBBR1MCS2-BjCYP117 was 
transformed into BjΔcyp117 and pBBR1MCS2-BjCYP114-FdGA was transformed into 
BjΔcyp114. 
Genetic complement constructs for S. fredii were created using the pstb-LAFR5 
constructs utilized in the characterization of the GA operon.7  The promoter of this construct 
was shown to have high, constitutive expression in S. meliloti 1021,50 and was particularly 
useful for expression of S. fredii GA operon genes in S. meliloti 1021, so it was reasoned that 
this same promoter would work within the relatively closely related S. fredii.  The pstb-
LAFR5 empty vector was transformed into S. fredii NGR234, SfΔcyp117, and SfΔcyp114, 
pstb-LAFR5-CYP117 was transformed into SfΔcyp117, and pstb-LAFR5-CYP114-FdGA was 
transformed into SfΔcyp114.   
Triparental Mating 
All transformations of plasmids into rhizobia were accomplished using a previously 
described triparental mating method.7  Briefly, expression plasmids for B. japonicum or S. 
fredii were first transformed into chemically competent E. coli MM294A cells51 and selected 
for with the appropriate antibiotic (Tc for pstb-LAFR5 constructs and Km for pBBR1MCS2 
constructs).  Liquid cultures of these transformed “donor” cells, along with E. coli MT616 
“helper” cells,52 and B. japonicum or S. fredii “recipient” cells were grown, with appropriate 
antibiotics, to late log phase, at which point 1 mL of each (5 mL for B. japonicum) was 
centrifuged at 5000 x g for 10 min to pellet the cells.  Cell pellets were resuspended in 1 mL 
of sterile 0.85% (w/v) NaCl solution to wash away media and antibiotics, and were then 
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centrifuged at 5000 x g for 10 min to re-pellet the cells.  Pellets for donor, helper, and 
recipient cells were resuspended in 50 µL of sterile saline, and mixed in equal proportion.  20 
µL aliquots of these mixtures were plated on non-selective agar plates (AG for B. japonicum 
matings, TY for S. fredii matings) and allowed to incubate for either 1-2 days (S. fredii 
matings) or 5 days (B. japonicum matings).  After incubation, the plated mixtures were 
resuspended in 1 mL of sterile saline, serial dilutions were created, and 100 µL of these 
dilutions were plated on agar plates containing appropriate antibiotics to select for both the 
recipient strain and the transformed plasmid.  For B. japonicum matings, Tm at 50 µg mL-1 
was used for selecting the B. japonicum host to allow for use of the Cm-resistant E. coli 
MT616 helper strain.  Genetic complements of each strain were confirmed with a second 
round of selection on plates containing the relevant antibiotics and also via colony PCR using 
primers corresponding to the gene of interest, or for the plasmid itself to confirm successful 
transformation of the empty vector (see Supplementary Table 3 for a list of primers used in 
this study).  These complements were further tested for the corresponding GA biosynthetic 
activity imparted by the heterologous gene.  This was done essentially in same way as 
previous studies within a S. meliloti 1021 host,7 specifically by incubating the relevant 
substrates in aerobic cultures of these strains.  This analysis revealed specific turnover only 
by the strains expressing the gene of interest, with no turnover detected for non-transformed 
knockout strain or with the empty vector controls (Supplementary Figure 5). 
Plant growth, measurements, and nodule harvest 
 Soybean (Glycine max cv. Williams ’82) seeds were surface sterilized for 10 minutes 
with 20% Clorox (6% [w/v] sodium hypochlorite) followed by five washes with sterile water.  
Seeds were then immersed in 0.01 M HCl for 10 minutes followed by an additional five 
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washes with sterile water, and then germinated on sterile, moist paper towels in the dark for 3 
days.  Cowpea (Vigna unguiculata cv. Blackeye) seeds were sterilized with 70% (v/v) 
ethanol in water for 1 minute, then washed three times with sterile water.  Seeds were then 
further sterilized with 20% Clorox for 20 minutes followed by five washes with sterile water, 
and then were germinated on moist paper towels in the dark for 3 days.  After germination, 
seeds were planted into a 3:1 mixture (v/v) of sterile vermiculite and perlite within 4” 
diameter x 3.5” tall pots and were grown in a growth chamber with a 16 hours of light at 27 
˚C and 8 hours of darks at 18 ˚C.  Plants were watered every other day with sterile, deionized 
water, unless otherwise noted.  Once per week, the plants were supplemented with Murashige 
and Skoog (MS) nutrient solution without nitrogen (bioWORLD).   
 Upon harvest, vermiculate and perlite attached to the root system was removed with 
light shaking and gentle washing with water, followed by root drying with a paper towel.  
Root and green mass measurements were taken immediately following harvest.  For height, 
plants were measured from the cotyledon scar up to the base of the apical meristem.  Nodules 
were removed from the roots by hand, counted, and the collective total mass of the nodules 
was measured.  Mass per nodule was calculated by dividing the total nodule mass per plant 
by the number of nodules. 
Plant inoculation 
 Plants were inoculated with rhizobia one week after planting.  For both B. japonicum 
and S. fredii, rhizobial liquid cultures were grown until late log phase, at which point cultures 
were centrifuged at 5000 x g for 10 min to pellet cells.  Pellets were resuspended in an 
original culture volume of sterile water to wash away media and antibiotics, then centrifuged 
again at 5000 x g.  Pellets were then resuspended in sterile water to a final OD600 of 0.1 ± 
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0.03.  For each plant, 10 mL of the appropriate rhizobial suspension was pipetted into the 
vermiculite/perlite soil substrate. 
Chemical complementation 
 For chemical complementation experiments, soybean plants were germinated, 
planted, and inoculated in the same manner as described above (see Plant growth, 
measurements, and harvest).  After three weeks post planting, at which point the GA 
operon has been implicated to be expressed,11,14 plants were watered twice per week with 50 
mL of either a GA solution or sterile water.  The GA3 solutions were made by first dissolving 
GA3 (Sigma) in ethanol at a stock concentration of 0.1 M.  An appropriate amount of this 
stock (or a serial dilution of the stock) was added to sterile water to make the 1 µM, 100 nM, 
10 nM, and 1 nM solutions.  The GA9 solutions were made in the same method, but with GA9 
(provided by Dr. Peter Hedden, Rothamsted Research, Harpenden, U.K.) initially dissolved 
in methanol. 
Bacteroid isolation and counting 
 B. japonicum bacteroids were extracted from root nodules via grinding in ascorbate 
buffer (100 mM KH2PO4, 200 mM sodium ascorbate, 2% [w/v] polyvinylpyrrolidone, and 34 
µg mL-1 Cm, pH 7.5).  Plant material was removed with centrifugation at 100 x g for 10 min.  
The supernatant was removed, and this phase was then centrifuged at 5000 x g for 10 min. to 
pellet the bacteroids.  Bacteroid pellets were then resuspended in 1 mL of sterile 0.85% (w/v) 
NaCl solution. 
 To determine the number of viable bacteroids, serial dilutions were created for three 
samples from each time point and/or condition, and 10 µL of these dilutions were plated on 
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AG plates in triplicate.  After 6-7 days of incubation at 30 ˚C, colony forming units (CFUs) 
were counted, and total number of viable bacteria per nodule mass were calculated. 
 Total numbers of bacteroids extracted from nodules was measured with flow 
cytometry.  Aliquots of isolated bacteroids from three samples per time point and/or 
condition were stained using the LIVE/DEAD BacLightTM Bacterial Viability kit (Thermo 
Fisher Scientific), which contains SYTO9 dye for staining live cells and propidium iodine 
(PI) for staining dead cells, and this was done as per the manufacturer instructions.  
Additionally, counting beads provided in this kit (with a known concentration) were added to 
each sample in order to facilitate quantification of the total number of cells in the sample.   
Samples were run and counted using a BD FACSAriaTM III flow cytometer (BD 
Biosciences). 
Soybean GA 3-oxidase cloning and heterologous expression 
 Soybean contains six GA 3-oxidase isoforms (GmGA3ox1-6) that are all annotated as 
belonging to the 2-oxoglutarate dependent dioxygenase (2ODD) family,27 which was 
expected based upon previous characterization of GA 3-oxidases.  Preliminary PCR with 
cDNA synthesized from nodule RNA revealed that GmGA3ox4 (locus tag: Glyma14g16060) 
and GmGA3ox6 (locus tag: Glyma17g30800) were the only isoform genes noticeably 
expressed in the nodule at 8 weeks post inoculation with B. japonicum.  Based on this 
information, E. coli codon-optimized synthetic gene clones of the coding sequences of these 
genes (sGmGA3ox4 and sGmGA3ox6) were synthesized via GeneArtTM Strings synthesis 
(Thermo Fisher Scientific).  Clones were amplified with primers specific to the 5’ and 3’ of 
the ORFs, with an additionally CACC added onto the 5’ primer (Supplementary Table 3) to 
allow for directional cloning into the pET101/D-TOPO® (Champion™ pET101 Directional 
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TOPO® Expression Kit; Thermo Fisher Scientific) expression vector.  The stop codon was 
included on the reverse primer to prevent the C-terminal His-tag option of pET101.  
Following PCR amplification with Accuprime Pfx (Thermo Fisher Scientific) and gel 
purification, synthetic clones were ligated into pET101/D-TOPO as per the product manual, 
transformed into chemically competent Top10 cells, and selected on agar plates containing 
carbenicillin (Cb).  Positive clones were screened with colony PCR and confirmed with 
Sanger sequencing.  This resulted in the construction of pET101-sGmGA3ox4 and pET101-
sGmGA3ox6 expression plasmids. 
 These plasmids were then transformed into chemically competent E. coli BL21-star 
for heterologous expression.  Positive colonies were used to inoculate 5 mL terrific broth 
(TB) media (10 g L-1 casein, 24 g L-1 yeast, 0.4% [v/v] glycerol, pH 7) cultures, which were 
allowed to grow overnight.  500 µL of these cultures was then used to inoculate 50 mL TB 
cultures, 5 mL of phosphate buffer (pH 7.5) and appropriate antibiotics were added, and 
these cultures were allowed to grow at 37 ˚C and 225 RPM shaking until reaching an OD600 
of 0.6-0.8, at which point they were incubated for an hour at 16 ˚C with 225 RPM shaking.  
Following this incubation, isopropyl β-D-1-thiogalactopyranoside (IPTG) was added at 1 
mM to induce expression.  At this time, the 2ODD cofactors 2-oxoglutarate (a.k.a α-
ketoglutarate; final concentration of 4 mM), ascorbate (final concentration of 4 mM) , and 
FeSO4 (final concentration of 0.5 mM) were added, along with GA substrate (final 
concentration of 5 µM).  Cultures were then allowed to incubate at 16 ˚C with 225 RPM 
shaking for 3-4 days, at which point they were extracted (see Metabolite extraction and 
purification). 
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 Additionally, GmGA3ox function was characterized with crude cell lysates.  
Expression conditions were identical to those described earlier with the exception that 100 
mL cultures of NZY media were used (with supplements scaled up accordingly) and were 
only allowed to incubate for 24 hours following IPTG induction.  After this incubation, cells 
were centrifuged at 5000 x g for 10 min to pellet cells, and these pellets were then 
resuspended in 10 mL Tris buffer (100 mM Tris-HCL, 4 mM dithiothreitol, pH 7.1).  
Resuspended cells were homogenized with an EmulsiFlex C-5 (Avestin, Canada).  Cell 
lysates were then incubated with GA substrate and 2ODD supplements at the aforementioned 
concentrations at 30 ˚C for 12 hours, after which they were extracted as described below. 
Metabolite extraction and purification 
 GA incubation assays were first acidified to pH 3 with 5 M HCl in order to neutralize 
free carboxylates.  Each incubation was then extracted three times with an equivalent volume 
of ethyl acetate, and these extracts were pooled in a round bottom flask and dried using a 
rotary evaporator.  Dried extracts were washed 3 times with 3 mL fractions of ethyl acetate, 
which were pooled in glass tubes and dried under a gentle stream of N2.  Each extract was 
then purified over a silica column.  This was done by first resuspending the sample in 1 mL 
of hexane and adding the sample to a silica column pre-washed with hexane.  The column 
was then washed with successive 1 mL solutions of ethyl acetate in hexane, starting with 
100% hexane, and increasing the ethyl acetate proportion by 10% with each wash.  Collected 
fractions were derivatized with diazomethane at room temperature for 1 hour in order to 
methylate free carboxylic acids.  These were dried under a gentle stream of N2, then 
resuspended in either BSTFA+TMCS [N,O-Bis(trimethylsilyl)trifluoroacetamide + 
Trimethylchlorosilane; 99:1 v/v] or MSTFA [N-Methyl-N-(trimethylsilyl)trifluoroacetamide] 
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and incubated at 80 ˚C for 30 min in order to silylate free alcohols to the trimethylsilyl 
(TMS) ether.  Derivatized samples were then dried under a gentle stream of N2, and 
resuspended in n-hexane for gas chromatography-mass spectrometry (GC-MS) analysis. 
Gas chromatography-mass spectrometry (GC-MS) analysis 
 Samples were run on a Varian 3900 GC equipped with an HP-5MS column (Agilent) 
paired with a Saturn® 2100T MS detector (Varian).  For each sample, 1 µL was injected 
under splitless mode with an initial injector temperature of 250 ˚C, column flow rate of 1.2 
mL min-1, and an initial column oven temperature of 50 ˚C, which was held for 3 min.  The 
column oven temperature was then increased at a rate of 15 ˚C min-1 until a final temperature 
of 300 ˚C, at which point this temperature was held for 3 min.  Electron ionization was used 
to ionize and fragment compounds, and mass spectra data with a range of 90-650 m/z was 
collected starting at 13 min and continued until the end of the run.  Potential products were 
compared to previously published mass spectra,53 and were further confirmed via comparison 
to authentic standards. 
RNA isolation, cDNA synthesis, and qPCR 
 Plant tissue (root nodules and roots, each in triplicate) collected from plants harvested 
at 3 to 15 weeks post rhizobial inoculation were ground in liquid nitrogen with a mortar and 
pestle, and RNA was purified from this homogenized tissue using the RNeasy® Plant Mini 
Kit (Qiagen) as per the manufacturer’s instructions.  Contaminating DNA was digested and 
removed using the Turbo DNA-freeTM kit (Life Technologies), and cDNA was synthesized 
using the iScriptTM cDNA Synthesis kit (Bio-Rad) according to the manufacturer’s 
instructions.  PCR amplification using primers specific to the genes of interest was performed 
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using RNA, DNase-treated RNA, and cDNA as templates to confirm that downstream PCR 
analysis was only detecting cDNA. 
 Relative quantitative PCR (qPCR) was performed to test expression of the cyp112 
(NCBI gene ID: 1055403; locus tag: blr2144) and ks (NCBI gene ID: 1055399; locus tag: 
blr2150) genes from the GA operon in B. japonicum USDA110, along with two GA 3-
oxidase homologs (GmGA3ox4 and GmGA3ox6) from soybean.  For B. japonicum genes, 
hisS (histidyl-tRNA synthetase; NCBI gene ID: 1054697; locus tag: bll7457) was used as the 
internal reference gene as previously described.12,54  For soybean genes, cons7 (NCBI gene 
ID: 100804856; locus tag: Glyma_03g137100), which has been identified to be expressed 
stably under a number of conditions, including nodule development,55 was used as the 
reference gene.  See Supplementary Table 4 for the sequences of qPCR primers used.  
qPCR samples were prepared with PowerUpTM SYBR® Green Master Mix (Life 
Technologies) according to the recommended manufacturer conditions and reactions were 
measured on a StepOnePlusTM thermocycler (Applied Biosystems).  The following program 
was used for each primer set: 50 ˚C for 2 minutes followed by 95 ˚C for 2 minutes, then 45 
cycles of 95 ˚C for 15 seconds and 60 ˚C for 1 minutes.  After these cycles, a melt curve 
stage was performed to confirm specificity of the qPCR reaction as per the instructions of the 
aforementioned qPCR kit.  Primer efficiencies were determined for each primer set by using 
serial dilutions of PCR amplified cDNA fragments generated from soybean cDNA (or 
fragments generated from genomic DNA for B. japonicum) as template, and this analysis 
confirmed the reported primer sets to have between 90 and 110% efficiency (Supplementary 
Figure 6). 
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Figure 1. GA biosynthetic operon in B. japonicum and S. fredii.  Both of these rhizobia 
species contain the core GA operon (CYP112 thru KS), and thus produce non-bioactive GA9 
as a final product.  Hydroxylation in the C-3β position can be performed by GA 3-oxidases to 
produce bioactive GA4. 
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Figure 2. GA operon gene expression during symbiosis. Bacteroid expression of a) cyp112 
and b) ks over the course of B. japonicum symbiosis with soybean normalized to the 
expression of hisS as a reference gene. n = 3 biological replicates for each time point. 
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Figure 3. Knockout of GA in rhizobia affects nodulation phenotypes but not height or 
mass.  Soybean plants nodulated with either wild-type, GA-producing B. japonicum 
USDA110 (GA+) or the GA operon-knockout B. japonicum KB2011 (GA-) do not show 
consistent significant differences at four developmental time points in a) average plant 
heights or b) plant fresh mass.  (Though statistical significance is indicated for height at the 
flowering stage, this result has not been replicated.)  However, significant differences are 
found at or after the flowering stage in c) the average number of nodules and d) the average 
mass per nodule for each plant.  e) Collectively, the average total nodule mass is statistically 
similar by the early pod and full pod stages. n = 6 per treatment at each time point; Statistical 
significance was performed using Student’s t-test; n.s. = not significant; * = p < 0.05; ** = 
p< 0.01. 
 
233 
 
 
0
1
2
3
4
5
6
water 1 nM 10 nM 100 nM
m
as
s 
pe
r n
od
ul
e 
(m
g)
GA+ GA-
GA3 treatment
n.s.n.s.
n.s. n.s.
n.s.
** **
0
20
40
60
80
100
120
140
water 1 nM 10 nM 100 nM
no
du
le
 n
um
be
r
GA+ GA-
GA3 treatment
**
*
n.s. n.s. n.s.
n.s.
n.s.
0
0.1
0.2
0.3
0.4
water 1 nM 10 nM 100 nMto
ta
l n
od
ul
e 
m
as
s 
pe
r p
la
nt
 (
g) GA+ GA-
GA3 treatment
** **
n.s. n.s. n.s. n.s. n.s.
a) b)
c)
 
Figure 4. Chemical complementation with GA3 restores nodulation phenotypes to GA 
knockout.  Consistent treatment of soybean that have been nodulated by a GA-deficient 
strain (GA-) with 10-100 nM GA3 restores wild-type nodulation phenotypes.  This includes a) 
the average mass per nodule and b) the number of nodules per plant.  c) The total nodule 
mass is unaffected except with 100 nM GA3 treatment. n = 7 for each treatment; Statistical 
significance was determined using Student’s t-test; each annotation of significance is in 
comparison to water control-treated plants nodulated with GA+ B. japonicum; n.s. = not 
significant, * = p < 0.05, ** = p < 0.01. 
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Figure 5. Larger nodules are inhabited by greater numbers of bacteroid cells.  Cell 
counting through either a) flow cytometry or b) colony-forming units (CFUs) demonstrates a 
trend whereby a greater number of bacteroid cells are isolated from larger nodules. 
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Figure 6. GmGA3ox4 and GmGA3ox6 are expressed more highly in the nodule than in 
the root. qPCR analysis of a) GmGA3ox4 and b) GmGA3ox6 demonstrates that for the most 
part, both isoforms are expressed significantly higher in nodule tissue than in root tissue. The 
soybean gene cons7, which has been previously demonstrated to be stably expressed in many 
soybean tissues including nodules,56 was used as a reference gene. n = 3 biological replicates 
for each tissue and time point. Statistical significance was determined using Student’s t-test; 
n.s. = not significant, ‡ = p < 0.01, * = p < 0.05, ** = p < 0.01. 
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Figure 7. Proposed model for the function of rhizobial GA in symbiosis.  Rhizobia 
express the GA operon within symbiosis, which leads to biosynthesis of either non-bioactive 
GA9 or bioactive GA4, depending on whether or not the rhizobial species in question has 
CYP115.  If GA9 is the final product, we propose that host plant GA 3-oxidases convert GA9 
into bioactive GAs such as GA4.  Bioactive GA signaling then enacts an increase in nodule 
size, which leads to more bacteroids within that nodule, and ultimately more rhizobial cells 
released into the soil upon nodule senescence.  If rhizobia cannot produce GA, then the host 
legume allows for the formation of more nodules to make up for nitrogen fixation, but these 
nodules are relatively smaller and harbor fewer bacteroids, which results in less rhizobia 
being released back into the soil. 
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Supplementary Figure 1. Chemical complementation with 1 µM GA3.  Treating plants 
nodulated by GA- B. japonicum with 1 µM GA3 results in a) a decrease in nodule number 
and b) an increase in the average size per nodule.  However, this application also results in an 
extreme increase in c) height, and also results in significant reductions in d) green mass, e) 
root mass, and f) total plant fresh mass. n = 5 for each treatment; Statistical significance was 
determined using Student’s t-test; each annotation of significance is in comparison to water 
control-treated plants nodulated with GA+ B. japonicum; n.s. = not significant, * = p < 0.05, 
** = p < 0.01. 
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Supplementary Figure 2. Effects of a range of GA3 concentrations on plant height and 
mass.  a) 1 nM GA3 treatment has little effect on overall plant height over time for soybean 
plants nodulated with either GA+ or GA- B. japonicum. b) 10 nM GA3 has a small, but 
significant effect on growth, while c) 100 nM has a more extreme effect on growth.  d) Only 
100 nM GA3 has a significant effect on fresh green mass, while treatment with 
concentrations of 10 and 100 nM have a significant effect on e) root mass and f) total fresh 
plant mass. n = 7 for each treatment; Statistical significance was determined using Student’s 
t-test; each annotation of significance is in comparison to water control-treated plants 
nodulated with GA+ B. japonicum; n.s. = not significant, * = p < 0.05, ** = p < 0.01. 
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Supplementary Figure 3.  Expression of six soybean GA 3-oxidase isoforms in nodule 
tissue.  PCR with cDNA isolated from mature nodules (during flowering stage) demonstrates 
that two isoforms are noticeably expressed in this tissue via agarose gel analysis.  Primers for 
this PCR were design to produce amplicons of roughly 800-1000 base pairs.  Arrows indicate 
detected amplicon bands. 1: GmGA3ox1, 2: GmGA3ox2, 3: GmGA3ox3, 4: GmGA3ox4, 5: 
GmGA3ox5, 6: GmGA3ox6, L: DNA ladder. kb = kilobase. 
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Supplementary Figure 4. Confirmation of GA 3-oxidase activity by GmGA3ox6.  a) 
Incubating GA9 in cells expressing sGmGA3ox6 results in 3β-hydroxylation and thus 
conversion to GA4, as shown here through gas chromatograms. b) GA20 is also 3β-
hydroxylated to form GA1.  The peaks shown are representative of the methyl esters and/or 
trimethylsilyl ethers of the corresponding compounds. 
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Supplementary Figure 5.  Confirmation of enzyme activity in genetic complementation 
strains of Sinorhizobium fredii.  Knockout strains of S. fredii complemented with the 
corresponding gene turn over the appropriate substrate incubated in aerobic culture, as shown 
here with gas chromatograms. a) SfΔcyp117 strains complemented with CYP117 in the 
plasmid vector pstb-LAFR5 convert ent-kaurenol into ent-kaurenoic acid, but this activity is 
not seen with the non-transformed knockout strain, nor with the knockout strain 
complemented with a pstb-LAFR5 empty vector. b) Likewise, SfΔcyp114 strains 
complemented with CYP114 coexpressed with FdGA in the plasmid vector pstb-LAFR5 
convert ent-kaurenoic acid into GA12-aldehyde, while the non-transformed knockout strain 
and empty vector-transformed strains are not.  The chromatographic peaks shown here are 
representative of the methyl esters of the corresponding compounds. 
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Supplementary Figure 6. qPCR primer efficiencies.  Shown are the calculated cycle 
threshold (Ct) values plotted against the corresponding DNA template concentration (log 
scale) for the qPCR primer sets used to quantify expression for a) cyp112, b) ks, and c) hisS 
(reference gene) from B. japonicum USDA110, along with d) GA3ox4, e) GA3ox6, and f) 
cons7 (reference gene) from G. max cv. Williams ’82. 
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Supplementary Table 1.  Bacterial strains used in this study. 
Strain Description Source 
One Shot® TOP10 Chemically 
Competent E. coli 
F- mcrA Δ( mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 Δ lacX74 recA1 araD139 
Δ(araleu)7697 galU galK rpsL 
(StrR) endA1 nupG; for plasmid propagation 
and cloning 
 
Thermo Fisher 
Scientific 
One Shot® BL21 StarTM (DE3) 
Chemically Competent E. coli 
F- ompT hsdSB (rB-, mB-) galdcmrne131 
(DE3); for pET101 expression of soybean GA 
3-oxidases 
 
Thermo Fisher 
Scientific 
E. coli MM294A pro-82 thi-1 endA hsdR17 supE44; donor 
strains for triparental mating 
 
1 
E. coli MT616 MM294A recA56 carrying plasmid pRK600, 
CmR; helper strains for triparental mating 
 
2 
Bradyrhizobium japonicum USDA110 
(a.k.a. B. diazoefficiens USDA110) 
wild-type rhizobial symbiont of Glycine max; 
CmR, TmR 
 
USDA; 
Beltsville, MD 
BjΔcyp117 cyp117 deletion strain derived from B. 
japonicum USDA110 parent strain; CmR 
 
3 
BjΔcyp117::pBBR1MCS2 BjΔcyp117 deletion strain harboring the empty 
pBBR1MCS2 plasmid; CmR, KmR 
 
This study 
BjΔcyp117::pBBR1-aphII-CYP117 BjΔcyp117 deletion strain harboring the 
CYP117 expression plasmid; CmR, KmR 
 
This study 
BjΔcyp114 cyp114 deletion strain derived from B. 
japonicum USDA110 parent strain; CmR 
 
3 
BjΔcyp114::pBBR1MCS2 BjΔcyp114 deletion strain harboring the empty 
pBBR1MCS2 plasmid; CmR, KmR 
 
This study 
BjΔcyp114::pBBR1-aphII-CYP114-
FdGA 
BjΔcyp114 deletion strain harboring the 
CYP114-FdGA expression plasmid; CmR, KmR 
 
This study 
Sinorhizobium fredii NGR234 (a.k.a. 
Ensifer fredii NGR234) 
widely nodulating wild-type rhizobial symbiont 
of Vigna unguiculata, among others; RfR 
 
4 
SfΔcyp117 deletion strain of CYP117 derived from S. 
fredii NGR234 parent strain; RfR 
 
3 
SfΔcyp117::pstb-LAFR5 SfΔcyp117 deletion strain harboring the empty 
pstb-LAFR5 plasmid; RfR, TcR 
 
This study 
SfΔcyp117::pstb-LAFR5-CYP117 SfΔcyp117 deletion strain harboring the 
CYP117 expression plasmid; RfR, TcR 
 
This study 
SfΔcyp114 deletion strain of CYP114 derived from S. 
fredii NGR234 parent strain; RfR 
 
SfΔcyp114::pstb-LAFR5 SfΔcyp114 deletion strain harboring the empty 
pstb-LAFR5 plasmid; RfR, TcR 
This study 
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Supplementary Table 1 continued 
SfΔcyp114::pstb-LAFR5-CYP114-FdGA SfΔcyp114 deletion strain harboring the 
CYP114-FdGA expression plasmid, TcR 
 
This study 
 
 
 
 
Supplementary Table 2.  Plasmids and expression constructs used in this study. 
Plasmid/construct Description Source 
 
Plasmids 
 
  
pCRTM-Blunt II-TOPO® For cloning and propagation of blunt-end 
PCR constructs; KmR 
 
Thermo Fisher 
Scientific 
pET101/D-TOPO® For directional cloning and expression; 
contains C-terminal His-tag; CbR 
 
Thermo Fisher 
Scientific 
pstb-LAFR5 pLAFR5 with the SMb21651 promoter 
sequence; Broad-range-host cosmid 
expression vector shown to be functional in S. 
meliloti 1021; mob+; TcR 
 
5 
pBBR1MCS2 Broad host-range plasmid shown to be 
propagated in rhizobia; for gene 
complementation in B. japonicum mob+; 
KmR 
 
6 
Expression constructs 
 
  
pET101-sGmGA3ox4 For expression of synthetic soybean GA3ox4 
in E. coli; CbR 
 
This study 
pET101-sGmGA3ox6 For expression of synthetic soybean GA3ox6 
in E. coli; CbR 
 
This study 
pBBR1-aphII-CYP117 For genetic complementation of BjΔcyp117; 
Contains CYP117 under control of the aphII 
promoter 
 
This study 
pBBR1-aphII-CYP114-FdGA For genetic complementation of BjΔcyp114: 
Contains BjCYP114 and BjFdGA in 
coexpression under control of the aphII 
promoter 
 
This study 
pstb-LAFR5-CYP117 For genetic complementation of SfΔcyp117; 
contains SfCYP117 
 
3 
pstb-LAFR5-CYP114-FdGA For genetic complementation of SfΔcyp114; 
Contains SfCYP114 and SfFdGA 
3 
 
 
245 
 
 
Supplementary Table 3.  Primers used in this study. Restriction sites are indicated with 
underlined nucleotide sequence. bp = base pairs, kb = kilobase. 
Primer Sequence (5’ to 3’) Description 
 
Construction of genetic 
complementation plasmids 
 
  
aphII-comp F AATGCAAAGCTTCAC
GC 
TGCCGCAAGCACTCA
G 
Forward primer for amplifying 
synthetic BjCYP constructs along 
with the included promoter and 
terminator regions; contains a 
HindIII restriction site with 6 bp 
upstream of enhance restriction 
digest 
 
aphII-comp R AACAGCACTAGTCTC
GA 
GGATTTCGATCCCGC 
Reverse primer for amplifying 
synthetic BjCYP constructs along 
with the included promoter and 
terminator regions; contains a 
SpeI restriction site with 6 bp 
upstream of enhance restriction 
digest 
 
For colony PCR screening of 
strains transformed with 
genetic complementation 
constructs 
 
  
M13 F TGTAAAACGACGGCC
AGT 
Forward primer 5’ to the MCS of 
pBBR1MCS2 used to determine 
the presence of either an empty 
vector (~100 bp) or the presence 
of an inserted construct (~2 kb) 
 
M13 R CAGGAAACAGCTATG
ACC 
Reverse primer 5’ to the MCS of 
pBBR1MCS2 used to determine 
the presence of either an empty 
vector (~100 bp) or the presence 
of an inserted construct (~2 kb) 
 
LAFR5 F GGCACGCGTCTGAAT
GTCCATTGT 
Forward primer for confirming 
presence of pstb-LAFR5 
construct (either empty or with 
gene construct); amplicon = 400 
bp 
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Supplementary Table 3 comtinued 
LAFR5 R CTGCAGGTCGATGTC
CGTGCCGCAACT 
Reverse primer for confirming 
presence of pstb-LAFR5 
construct (either empty or with 
gene construct); amplicon = 400 
bp 
SfCYP F CGCGGATCCTAACGT
AACGTAAATGGAGTC
ACCTCT 
Forward primer that anneals to 
the linker region 5’ to the genes 
present in pstb-LAFR5 
constructs; because this linker is 
present in all constructs, this can 
be used to confirm each gene  
 
SfCYP117 R CCGGAATTCTCATGA
GAATCCGATGCGGAT
TGTCAT 
Reverse primer that is used with 
SfCYP F to confirm presence of 
pstb-LAFR5-CYP117 in 
transformed S. fredii strains; 
amplicon = ~1.4 kb 
 
SfCYP114-Fd R CCGGAATTCTCAAAC
CGTTCCAT 
CGTGTCCTCCTGG 
Reverse primer that is used with 
SfCYP F to confirm presence of 
pstb-LAFR5-CYP114-FdGA in 
transformed S. fredii strains; 
amplicon = ~1.6 kb 
 
For cloning synthetic 
soybean GA 3-oxidases 
 
  
GmGA3ox4 F CACCATGGTTACCAC
AC 
TGAGCGAAG 
Forward primer for amplifying 
synthetic GmGA3ox4.  Contains 
a 5’ CACC for cloning into 
pET101/D-TOPO. 
 
GmGA3ox4 R TTAGTTATTATTCAGC
AT 
GCTAAT CAGGC 
Reverse primer for amplifying 
synthetic GmGA3ox4.  Contains 
the native stop codon to prevent 
the addition of a His tag in 
pET101/D-TOPO. 
 
GmGA3ox6 F CACCATGGCAACCAC 
ACTGAGCGAAG 
Forward primer for amplifying 
synthetic GmGA3ox6.  Contains 
a 5’ CACC for cloning into 
pET101/D-TOPO. 
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Supplementary Table 3 continued 
GmGA3ox6 R TTAGTTTTTCAGCAT 
GCTAATCAGGCTC 
Reverse primer for amplifying 
synthetic GmGA3ox6.  Contains 
the native stop codon to prevent 
the addition of a His tag in 
pET101/D-TOPO. 
 
For confirming insertion 
within cyp112 in B. 
japonicum KB2011 
 
  
BjCYP112-kb F TGGTGGGTGACAGGC
TATGACGAGG 
Forward primer 5’ to the ~2 kb 
cassette insertion site in cyp112.  
Wild-type amplicon = 762 bp; 
insertion mutant = 2.8 kb 
 
Bj CYP112-kb R TCACGTCGGTCCTCG
GATAGCGCATG 
Reverse primer 3’ to the ~2 kb 
cassette insertion site in cyp112.  
Wild-type amplicon = 762 bp; 
insertion mutant = 2.8 kb 
 
For confirming clean 
deletion strains of B. 
japonicum USDA110 
 
  
Bj-CYP117ko-check F ATCGTCAACATGTCG
TCGTGCCAGG 
Forward primer ~400 bp 
upstream of cyp117 to check for 
presence or deletion of this gene; 
wild-type fragment =  2.1 kb, 
knockout = 0.8 kb 
 
Bj-CYP117ko-check R TGCGCCGGCAGCCAA
ACAGAGC AAG 
Reverse primer ~400 bp 
downstream of cyp117 to check 
for presence or deletion of this 
gene; wild-type fragment = 2.1 
kb, knockout = 0.8 kb 
 
Bj-CYP114ko-check F  ATTCCCGCGGAGAGC
AAGGTGC 
Forward primer ~400 bp 
upstream of cyp114 to check for 
presence or deletion of this gene; 
wild-type fragment = 2.2 kb, 
knockout = 0.8 kb 
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Supplementary Table 3 continued 
Bj-CYP114ko-check R ATAGCCGCCGAGCCA
TCAATGT CGGC 
Reverse primer ~400 bp 
downstream of cyp114 to check 
for presence or deletion of this 
gene; wild-type fragment = 2.2 
kb, knockout = 0.8 kb 
 
 
For confirming clean 
deletion strains of S. fredii 
NGR234 
 
  
Sf-CYP117ko-check F CGTCAACATGTCGTC
GTGCCAGGG  
Forward primer ~400 bp 
upstream of cyp117 to check for 
presence or deletion of this gene; 
wild-type fragment = 2.1 kb, 
knockout = 0.8 kb 
 
Sf-CYP117ko-check R CCAGTGCTCCAGCAG
CCAGACAGAGC  
Reverse primer ~400 bp 
downstream of cyp117 to check 
for presence or deletion of this 
gene; wild-type fragment = 2.1 
kb, knockout =  0.8 kb 
 
Sf-CYP114ko-check F GACGGCATCATGCGC
TATCCGAGG  
Forward primer ~400 bp 
upstream of cyp114 to check for 
presence or deletion of this gene; 
wild-type fragment=2.2 kb, 
knockout=0.8 kb 
 
Sf-CYP114ko-check R TCAAACCGTTCCATC
GTGTCCTCCTGG  
Reverse primer ~400 bp 
downstream of cyp114 to check 
for presence or deletion of this 
gene; wild-type fragment=2.2 kb, 
knockout=0.8 kb 
 
To amplify fragments for use 
as templates in determining 
qPCR primer efficiency 
 
  
BjCYP112 frag-F TGGTGGGTGACAGGC
TATGACGAGG 
Forward primer; amplicon = ~800 
bp 
 
BjCYP112 frag-R TCACGTCGGTCCTCG
GATAGCGCATG 
Reverse primer; amplicon = ~800 
bp 
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Supplementary Table 3 continued 
BjKS frag-F ATGATCCAGACTGAA
CGCGCGGTG 
 
Forward primer; amplicon = 831 
bp 
BjKS frag-R TGGTCGAGGTCCGGT
AGTACTGC 
 
Reverse primer; amplicon = 831 
bp 
BjhisS frag-F ACCCCAGAAACTGAA
GGCGCGCCTG 
 
Forward primer; amplicon = 1.5 
kb 
BjhisS frag-R CTAGCCCCAGCTCAC
GTCATGGC 
 
Reverse primer; amplicon = 1.5 
kb 
GmGA3ox4 frag-F ATGCATGGCCTCAAT
CTGAAGATGG 
 
Forward primer; amplicon = 863 
bp 
GmGA3ox4 frag-R TCAAGGAACGAAACC
GAGGCAAGG 
 
Reverse primer; amplicon = 863 
bp 
GmGA3ox6 frag-F TTCACTTAGGACCTTA
CCTGATTCG 
 
Forward primer; amplicon = 877 
bp 
GmGA3ox6 frag-R AATCAAGAACCAAAG
GAGAAACCAC 
 
Reverse primer; amplicon = 877 
bp 
cons7 frag-F AGTCTCCTGGTAACA
TTGAGCAAAG 
 
Forward primer; amplicon = 540 
bp 
cons7 frag-R ATGAGAGTGCCCAAT
ATTACAGGTG 
 
 
Reverse primer; amplicon = 540 
bp 
 
To check for expression of 
the 6 GA3ox isoforms in 
soybean 
 
  
GmGA3ox1 check-F ACTGTCAACCCAATG
ATGATGCATC 
Forward primer; amplicon = 796 
bp after splicing of an intron from 
the gene 
 
GmGA3ox1 check-R CATCGGTGGAGAATA
GAAATAAGCC 
Reverse primer; amplicon = 796 
bp after splicing of an intron from 
the gene 
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Supplementary Table 3 continued 
GmGA3ox2 check-F ATGGTCTCACTCTCAA
CCCAACGATG 
Forward primer; amplicon = 851 
bp after splicing of an intron from 
the gene 
 
GmGA3ox2 check-R ACAGAGTCAACTAAA
GGAGAAACC 
Reverse primer; amplicon = 851 
bp after splicing of an intron from 
the gene 
 
 
 
GmGA3ox3 check-F 
 
 
ACACAAGCACCCTGA
CTTAAACTCC 
 
 
Forward primer; amplicon = 952 
bp after splicing of an intron from 
the gene 
 
GmGA3ox3 check-R TGCCAAGGTACTCAT
TCCAAGTCAC 
Reverse primer; amplicon = 952 
bp after splicing of an intron from 
the gene 
 
GmGA3ox4 check-F ATGCATGGCCTCAAT
CTGAAGATGG 
Forward primer; amplicon = 863 
bp after splicing of an intron from 
the gene 
 
GmGA3ox4 check-R TCAAGGAACGAAACC
GAGGCAAGG 
Reverse primer; amplicon = 863 
bp after splicing of an intron from 
the gene 
 
GmGA3ox5 check-F AGTCTTACACTTGGA
CACACCATGG 
Forward primer; amplicon = 909 
bp after splicing of an intron from 
the gene 
 
GmGA3ox5 check-R AGGTACTCATTCCAA
GTCACTGCC 
Reverse primer; amplicon = 909 
bp after splicing of an intron from 
the gene 
 
GmGA3ox6 check-F TTCACTTAGGACCTTA
CCTGATTCG 
Forward primer; amplicon = 877 
bp after splicing of an intron from 
the gene 
 
GmGA3ox6 check-R AATCAAGAACCAAAG
GAGAAACCAC 
Reverse primer; amplicon = 877 
bp after splicing of an intron from 
the gene 
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Supplementary Table 4.  Primers used for qPCR for selected Bradyrhizobium japonicum 
USDA110 and soybean (Glycine max cv. Williams ’82) gene transcripts. 
target forward primer (5’-3’) reverse primer (5’-3’) amplicon size 
(bp) 
 
B. japonicum 
genes 
 
   
cyp112 ATCGAATTCGGCCTG
CTA 
AGGATTTCCTCTAC
CGCCTT 
 
97 
ks CTACGCGAACGTGTT
CTGTT 
CAAGGTCGCCATAT
CCAGC 
 
64 
hisS GATGGAATACACCGA
CGCGCT 
AACGCAAGCTAATC
CACTGCTCG 
106 
 
G. max genes 
 
   
GmGA3ox4 ATCTGGCATAATGAC
TGTGC 
GTTGGTTGAACCAA
TCCACC 
 
150 
GmGA3ox6 TCCATGTGATGATGC
CAAAAAG 
TTTTGCTCCTCAGAA
ATGCCC 
 
150 
cons7 ATGAATGACGGTTCC
CATGTA 
AGCATTAAGGCAGC
TCACTCT 
114 
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CHAPTER 6 
CONLUSIONS, ONGOING EFFORTS, AND FUTURE DIRECTIONS 
 
Conclusions of Disseration Work 
The goal of this doctoral dissertation was to evaluate gibberellin (GA) biosynthesis in 
bacteria and the physiological role that the production of this plant hormone may have within 
the Rhizobia-legume symbiosis.  Information on the GA biosynthetic pathway in bacteria 
was previously limited, and though there was speculation for a role of rhizobial GA in 
symbiosis, this too lacked direct investigation.  Through the efforts detailed in this 
dissertation, GA biosynthesis in bacteria has been fully elucidated via the functional 
characterization of a cytochrome P450 rich operon (GA biosynthetic operon).1,2  This 
represents the first example of an established GA biosynthetic pathway in bacteria, and 
demonstrated that bacteria have convergently evolved GA production independently of plants 
or fungi.  Furthermore, detailed analysis with CYP114, which performs the committed ring 
contraction reaction, revealed mechanistic insights underlying the biosynthesis of GAs that 
are shared between each biosynthetic pathway.3  Finally, investigations into the effect of 
rhizobial GA in symbiosis revealed that this acts as a selective advantage by increasing 
legume nodule size, and thus the number of rhizobia inhabiting the nodule that can be 
released back into the soil.  Overall, our investigations have provided novel insight into GA 
production by bacteria, thereby fulfilling a previous gap in knowledge regarding GA 
biosynthesis and function, which had previously only been established for plants and fungi.  
However, although significant progress has been made, a number of major questions 
regarding GA biosynthesis and function in rhizobia still remain.  These include both ongoing 
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efforts and potential future experiments that will help us to better understand some of the 
fundamental aspects of GA biosynthesis evolution in bacteria, along with how GA 
production by symbiotic rhizobia may have shaped their interactions with host legumes. 
 
Ongoing and Future Experiments 
GA operon evolution 
One aspect that we are currently trying to evaluate is the global evolution of the GA 
operon.  Depending on the species in question, certain genes of the operon may or may not 
be present, which would suggest selected acquisition or deletion of genes from the operon.  
For example, the CYP115 and IDI genes are invariably found within plant pathogens, but 
their presence is inconsistent and scattered within the rhizobia.4  Also, fragments of these 
genes can be found in their normal relative location (5’ end of the operon for CYP115 and 3’ 
of the operon for IDI),2,5,6 indicating that the genes were initially present in the operon, but 
have subsequently been lost.  We have suggested that the pathogen operon is likely 
representative of the “ancestral” version of the operon that rhizobia have acquired before 
losing functionality of these genes.2   
Furthermore, in a select number of Rhizobium species (for example, R. etli CFN 42), 
the operon GGPS contains a premature stop codon, and a second GGPS homolog (termed 
GGPS2) has been appended to the 3’ end of the operon in the reverse orientation from the 
rest of the gene cluster.7  This would potentially indicate that due to a loss of function in the 
original GGPS, a second isofunctional gene has been “recruited” to the operon to restore 
function.  In all, the differences in operon content could provide insight into how this gene 
255 
 
 
cluster may have been constructed and how selective gene loss may have occurred, and may 
give hints as to biological relevance of the presence/absence of certain genes.   
To begin investigating this phenomenon of gene loss and gain within the GA operon, 
we are collaborating with Professor Iddo Friedberg (Department of Veterinary Microbiology 
and Preventive Medicine, Iowa State University), whose lab focuses on the evolution of gene 
blocks in bacteria.  In particular, their group has developed a bioinformatic pipeline to re-
construct the evolution of bacterial gene clusters that we hope can help us to better 
understand the nature of our operon.8  Overall, this analysis will at the very least allow us to 
create a more sophisticated representation of the relationship of this operon between the large 
number of bacteria currently found to possess it within their genomes. 
Analyzing the biological function of CYP115 
 A second major question that remains is why certain rhizobia still possess a 
functional CYP115 gene.  It seems that these species have regained CYP115 after selective 
loss of this gene, which has occurred in most rhizobia with the GA operon.2  This would 
suggest that there is a selective advantage for production of bioactive GA4 only in certain 
specific symbiotic interactions.  We have hypothesized that this is perhaps to circumvent the 
possibility that a host legume may not express a GA 3-oxidase (GA3ox) in the nodule tissue, 
which is likely necessary for conversion of GA9, the product of the core GA operon, into 
bioactive forms.  In a real biological system, a rhizobial species could in theory come into 
contact with one of many different legume hosts, and it is known that at least some rhizobia 
can nodulate many different species.9  Thus, maintaining a CYP115 gene would allow a 
rhizobial species to increase its fitness even in legume species that do not express a GA3ox in 
the nodule.   
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To test the effect of CYP115 in symbiosis, we have constructed heterologous strains 
of B. japonicum and S. fredii (neither of which natively contain a full-length CYP115 gene) 
that contain plasmids with CYP115 genes under constitutive expression.  For a proof of 
concept, the heterologous CYP115 (from S. meliloti WSM4191) transformed into S. fredii 
has been confirmed to be functional, as GA9 incubated in aerobic cultures of this strain is 
efficiently converted into GA4, and incubated GA20 is converted into GA1 (Figure 1), thus 
verifying the GA 3-oxidase associated with CYP115.2  Though this doesn’t assure expression 
and functionality within symbiosis, it at least seems promising for use in future experiments.   
We will then use these strains to nodulate their host plant (B. japonicum with soybean and S. 
fredii with cowpea) with wild-type, empty vector-transformed, or CYP115-transformed 
strains and compare gross plant phenotypes and nodulation phenotypes, much as previously 
outlined in this dissertation.  Additionally, we will nodulate both a determinate nodule 
forming (i.e. cowpea) and indeterminate nodule forming host (Dalea spp.) with the same S. 
fredii strains to evaluate if CYP115 may be involved in interactions with disparate types of 
legumes. 
 Also, to investigate the function of CYP115 more thoroughly, we will evaluate a 
rhizobial strain that contains a native, full-length CYP115 gene.  In particular, GA 
biosynthesis has been demonstrated for M. loti MAFF303099, which contains the core GA 
operon in addition to a distally-located CYP115, and thus is capable of producing GA4 
instead of GA9 as a final product2,10.  The CYP115 gene has been shown to be coexpressed 
with the operon during symbiosis,11,12 so it is likely that M. loti MAFF303099 is producing 
bioactive GA4, and that this is having a specific effect in symbiosis.  Much like our results 
with B. japonicum and soybean, it has been demonstrated that knockout of GA biosynthesis 
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in M. loti MAFF303099 leads to a decrease in nodule size and an increase in nodule number 
for its host plant, Lotus japonicus, and it has been shown that rhizobial GA in this system is 
acting to increase fitness of this rhizobial species, either through increasing nodule size or by 
decreasing nodulation by other rhizobia.10  However, this study looked specifically at 
knockout of the core operon, and thus a specific role for CYP115 in this organism remains 
unknown. 
 To investigate the role that CYP115, and thus bioactive GA4, may be playing in the  
symbiosis of M. loti, I will create knockouts of the CYP115 genes (mll6125) through double 
homologous recombination, much as I have previously done with GA operon genes in B. 
japonicum and S. fredii.1  Additionally, a transposon-insertion mutagenesis study with M. loti 
MAFF303099 created an insertional knockout of CYP115, in addition to several of the core 
operon genes,13 all of which are available for purchase and will be obtained.  Wild-type, 
knockout, or CYP115-knockout strains complemented with CYP115 (through use of the 
pstb-LAFR5-MlCYP115 construct previously used to characterize function of CYP115 from 
M. loti) will be used to nodulate Lotus japonicus, and any changes in plant phenotypes, 
particularly in nodulation, will be assessed.  If our hypothesis is correct in that the rhizobia 
containing a functional CYP115 reacquired this to make up for a lack of GA3ox expression 
by their host plant, then it can be predicted that knockout of CYP115 in these strains will 
result in the same nodulation phenotypes associated with knockouts of the core operon.10  In 
particular, though the CYP115 deletion strains will still be capable of producing GA9, this 
may not be converted to GA4 or other bioactive GAs at a high enough level to enact a 
physiological effect. 
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A role for rhizobial GA in plant defense 
 A final major avenue that will be worth investigating in the future is the potential 
influence that rhizobial GA may have on legume host disease resistance.  It has previously 
been shown that GA signaling has a negative impact on jasmonic acid (JA)-mediated defense 
responses,14 resulting in susceptibility to necrotrophic pathogens, which usually trigger JA 
defense signaling.  In agreement with this concept, the nectrotrophic fungal rice pathogen 
Gibberella fujikuroi produces GA3 as a virulence factor to enhance its infection,15 and it has 
more recently been shown that knockout of the GA operon in Xanthomonas oryzae pv. 
oryzicola results in reduced virulence, and it appears that this bacterial GA is enacting its 
effect through suppression of the JA response.16  Because production of GA has a clear role 
for plant pathogens, it could be reasoned that rhizobial production of GA may also be 
detrimental to the defense responses of their legume host, at least against certain pathogens. 
 To assess whether this was a possibility, we collaborated with Professor Leonor 
Leandro (Department of Plant Pathology and Microbiology, Iowa State University), whose 
lab studies Fusarium virguliforme, the necrotrophic fungal pathogen that causes soybean 
sudden death syndrome (SDS), a major soybean disease in the United States.17  We 
hypothesized that soybean nodulated with rhizobia that produce GA would be more 
susceptible to SDS than those nodulated with rhizobia in which the GA operon has been 
knocked out, as rhizobial GA may be lowering the plant’s JA response against F. 
virguliforme.  
 To evaluate this possibility, soybean plants were nodulated with either the GA-
producing strain B. japonicum USDA110 (GA+) or the GA-deficient knockout strain B. 
japonicum KB2011 (GA-).  Plants were grown for three weeks before being transplanted into 
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a mix of sand and F. virguliforme infested sorghum (20:1 v/v), as the GA operon has been 
shown to be expressed by this time in symbiosis.18,19  Leaves of these infected plants were 
then monitored for a “mottling” phenotype indicative of SDS infection, which could be 
visually assessed and relatively quantified/scored by members of the Leandro lab. 
 An initial experiment suggested that our hypothesis was correct, as soybean nodulated 
with GA+ B. japonicum appeared to be more susceptible to SDS infection (Figure 2).  
However, in subsequent experiments, we have not been able to replicate this result.  
Specifically, there have been numerous experiments in which no disease symptoms were 
observed, and at least one experiment in which the plants nodulated by GA- B. japonicum 
appeared to be more susceptible.  
 One of the major roadblocks with the experimental setup is that we need our rhizobia 
to be able to nodulate and begin producing GA either before or during infection.  However, 
most disease assays for SDS are run at the seedling stage where soybean are more susceptible 
to infection, which is likely prior to nodulation.  Additionally, the nodulation phenotype 
associated with rhizobial GA is not observed until after the flowering stage, which indicates 
that rhizobial GA isn’t significantly exerting an effect until much later in symbiosis, and this 
time also seems to be beyond when most studies on SDS are performed.  Furthermore, my 
results suggest that there is variability in both the inoculum used and in separate experiments 
run, which has been noted within the SDS community.20  Thus, there are several technical 
hurdles to overcome before this phenomenon can be assayed using F. virguliforme as the 
pathogen in question.   
An alternative approach to investigate a potential role for rhizobial GA in modulating 
legume defense responses would be to use different pathogens that have more well-
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established disease assays in addition to being compatible for the time-line necessary to 
evaluate the potential effects of rhizobial GA (i.e. after the flowering stage).  Additionally, 
qPCR could be used to compare JA-related transcripts in nodules inhabited by either GA+ or 
GA- rhizobia to determine if there is any effect on the expression of genes related to defense.  
In all, I believe that the potential for rhizobial GA to be affecting legume disease resistance 
should continue to be assessed, as even a small change could have a large agricultural impact 
due to soybean being one of the most valuable crops in the United States, and indeed the 
world.21 
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Figure 1.  Heterologous CYP115 is functional within S. fredii NGR234.  a) GA9 incubated 
in S. fredii NGR234 cultures expressing CYP115 from S. meliloti WSM4191 is efficiently 
transformed into GA4, while wild-type and empty vector-transformed strains do not have this 
activity, as shown here through gas chromatograms.  b) Likewise, GA20 incubated in S. fredii 
NGR234 transformed with CYP115 is turned over to GA1, which is further indicative of the 
GA 3-oxidase activity of CYP115, while the strain with the empty vector control is unable to 
do so.  Chromatographic peaks are indicative of the methyl esters and/or trimethylsilyl 
ethers. 
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B. japonicum USDA110 (GA+) - nodulated
B. japonicum KB2011 (GA-) - nodulated
3rd trifoliate
3rd trifoliate
4th trifoliate
4th trifoliate
 
Figure 2. SDS symptoms in soybean nodulated by GA+ or GA- B. japonicum.  Shown are 
the leaf mottling symptoms on the 3rd and 4th trifoliates for soybean infected by Fusarium 
virguliforme.  The pictures shown here were taken during the early pod to full pod stage of 
the plant.  n = 3 plants for each rhizobial treatment.  Only two images are shown for the 4th 
trifoliate of GA+ nodulated plants because this trifoliate was lost from one of the plants, 
presumably due to the disease. 
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Summary 
•  Phytopathogens have developed elaborate mechanisms to attenuate the defense response of 
their host plants, including convergent evolution of complex pathways for production of the 
gibberellin (GA) phytohormones, which were actually first isolated from the rice fungal 
pathogen Gibberella fujikuroi.  The rice bacterial pathogen Xanthomonas oryzae pv. 
oryzicola (Xoc) has been demonstrated to contain a biosynthetic operon with cyclases 
capable of producing the universal GA precursor ent-kaurene.   Genetic (knock-out) studies 
indicate that the derived diterpenoid serves as a virulence factor for this rice leaf streak 
pathogen, serving to reduce the jasmonic acid (JA) mediated defense response.   
•  Here the function of the remaining genes in the Xoc operon are elucidated and the 
distribution of the operon in X. oryzae investigated in over 100 isolates.  
•  The Xoc operon leads to production of the bioactive GA4, an additional step beyond 
production of the penultimate precursor GA9 mediated by the homologous operons recently 
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characterized from rhizobia.  Moreover, this GA biosynthetic operon was found to be 
widespread in Xoc (>90%), but absent in the other major oryzae pathovar.  
•  These results indicate selective pressure for production of GA4 in the distinct lifestyle of 
Xoc, and the importance of GA to both fungal and bacterial pathogens of rice.  
 
Introduction 
Pathogenic microbes are under intense selection to manipulate their hosts, particularly 
to attenuate the host defense response.  An example of the complexity that can arise from this 
selective pressure appears to be the independent evolution of biosynthetic pathways leading 
to the production of plant hormones by phytopathogens.  Indeed, the gibberellins (GAs), 
production of which requires over ten transformations from the general diterpenoid precursor 
(E,E,E)-geranylgeranyl diphosphate (GGPP), were first isolated from the rice fungal 
pathogen Gibberella fujikuroi (anamorph Fusarium fujikuroi).1  The production of GAs by 
G. fujikuroi leads to the characteristic excessive growth phenotype of the resulting bakanae 
or foolish seedling disease, and has recently been demonstrated to act as virulence factor for 
this phytopathogen.2 
It has long been recognized that certain bacteria also produce GAs.3  Such 
biosynthetic capacity has been speculatively ascribed to a cytochrome P450 (CYP) rich 
operon widely distributed in rhizobia (Figure 1),4,5 which has been demonstrated by 
characterization of the encoded enzymes.  The three associated synthases/cyclases lead to 
production of ent-kaurene, one is a GGPP synthase (GGPS), the next is an ent-copalyl 
diphosphate synthase (CPS), while the last is an ent-kaurene synthase (KS).6,7  The three 
CYPs (CYP112, CYP114, and CYP117), along with the ferredoxin (FdGA) and short-chain 
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alcohol dehydrogenase (SDRGA), have recently been shown to transform ent-kaurene to GA9 
(although this is not thought to exhibit hormonal activity – i.e., be bioactive) in several of the 
rhizobia in which the operon is found.8,9   
In addition to appearing in a sub-set of symbiotic rhizobia from the Rhizobiales order 
in the Alphaproteobacteria class,7 a similar operon also can be found in a few 
phytopathogens from the separate Gammaproteobacteria class, indicating that this has been 
more widely distributed by horizontal gene transfer.  It has been suggested that the rice 
bacterial leaf streak pathogen Xanthomonas oryzae pv. oryzicola (Xoc), which contains a 
copy of this operon, might produce GA(s) as a virulence factor. However, only the capacity 
to produce ent-kaurene from GGPP, by functional characterization of the associated CPS and 
KS, has been reported to-date.  Intriguingly, knocking out the CPS, KS, or CYP112 was 
sufficient to attenuate the virulence of Xoc, allowing rice to mount a more robust jasmonic 
acid (JA) mediated defense response.10  Nevertheless, the fact that this operon was only 
found in the single oryzicola pathovar that had been sequenced at that time, and not in any of 
the several genome sequences available for other X. oryzae pathovars, left the broader 
importance of this operon and resulting ent-kaurene derived diterpenoid in these rice 
bacterial pathogens, and even Xoc more specifically, in question.  
Here biochemical characterization is reported demonstrating that the enzymes 
encoded by this operon in Xoc can function to produce the bioactive GA4.  This represents 
further transformation of the GA9 produced by the previously characterized rhizobial operon, 
with the relevant activity of 3-hydroxylation carried out by the additional CYP (CYP115) 
found in the Xoc operon (Figure 1).  Moreover, although seemingly restricted to the 
oryzicola pathovar in X. oryzae, investigation of the biogeographical distribution of the GA 
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biosynthetic operon with over 100 isolates of Xoc found widespread conservation that would 
be consistent with an important role for production of GA4 specifically in this rice bacterial 
leaf streak pathogen.   
 
Materials and Methods 
Unless otherwise specified, chemicals were purchased from Sigma and Fisher 
Scientific.  GA12-aldehyde, GA12, GA9 and GA4 were purchased from OlChemIm Ltd., while 
ent-7α-hydroxykaurenoic acid, GA15 and GA24 were kindly provided by Dr. Peter Hedden 
(Rothamsted Research). 
Genes were cloned by amplification from genomic DNA of Xoc strain BLS256 using 
Q5 Hot Start High-Fidelity DNA polymerase (NEB) according to the product manual, and 
using 5 µl of the high GC-content enhancer and gene specific primers (Supplemental Table 
S1).  The forward primer included a CACC sequence before the start codon to allow cloning 
via directional TOPO isomerization into pET100 (Invitrogen) according to the instructions 
supplied by the manufacturer.  Clones were sequenced to verify the correct DNA sequence.  
CYP114 was cloned either alone or in tandem with the neighboring ferredoxin, using the 
forward primer for CYP114 and the reverse primer for FdGA.  
For recombinant in vivo feeding studies the pET100 based expression constructs for 
CYP117, CYP112, CYP114, CYP114+FdGA, CYP115 and SDRGA were transformed into 
Escherichia coli expression strain BL21-Star (Invitrogen).  Three individual colonies were 
inoculated into 10 ml TB broth (12 g/L casein, 24 g/L yeast extract, 0.4% glycerol), 
including 50 µg/ml carbenicillin, and grown at 18 °C for 2 days with constant shaking at 200 
RPM.  From these starter cultures, 2 ml were transferred into 25 ml fresh TB broth, including 
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50 µg/ml carbenicillin.  Cultures expressing CYPs were induced at an OD of 0.8, while that 
for SDRGA was induced at an OD 0.6, with 1 mM IPTG.  Upon induction, 5 ml 1 M 
phosphate buffer pH 7.5, 1 mM aminolevulenic acid, 1 mM riboflavin, 0.1 mM FeCl3 and 10 
µM of specific substrates dissolved in a 1:1 mixture of DMSO and methanol (v:v) were 
added. Cultures were then grown at 18 °C with constant shaking at 200 RPM for 3 days. 
To analyze recombinant enzymatic activity, the fed cultures were acidified to pH 3.0 
with 5 N HCl to neutralize the expected carboxylated products, then extracted three times 
with 50 ml hexanes (CYP117) or 50 ml ethyl acetate (CYP112, CYP114, CYP114+FdGA, 
CYP115 and SDRGA).  The organic phases were combined in a 250 ml round bottom flask 
and evaporated in a rotary evaporator to dryness.  The flask contents were washed three times 
with 2 ml hexanes or ethyl acetate, with the exception of CYP117, reduced to about 0.5 ml 
volume and purified using 1 ml silica gel in a glass Pasteur pipette, with elution via a 
stepwise gradient starting at 100% hexane and ending at 100% ethyl acetate, with 25% 
increments between solvent combinations. Fractions were methylated using diazomethane, 
and for reactions with CYP115, silylated with BSTFA+TMCS (99:1).  Derivatized samples 
were dried under a stream of nitrogen, dissolved in n-hexane and analyzed by GC-MS, 
carried out with a 3900 Saturn GC (Varian), equipped with an HP-5MS column and coupled 
to a Saturn 2100T ion trap mass spectrometer detector (Varian). The injector of the GC was 
kept at a temperature of 250°C, the temperature gradient of the column started at 50°C, held 
for 3 min, which was then raised by 15°C/min to 300°C, again held for 3 min.  
Bioinformatic searches for copies of the GA biosynthetic operon in X. oryzae were 
carried by BLAST searches of this species at NCBI and JGI using the characteristic cps, ks 
and cyp112 genes as query sequences.  Insertion sequences elements in the GA operon 
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vicinity were first found using ISfinder,11 and then more completely elucidated by manual 
curation.  
For screening, previously described West African12 and Asian13 X. oryzae strains 
were obtained from a collection maintained at Colorado State University (Fort Collins, 
USA).  The presence of the GA biosynthetic operon was directly investigated by PCR 
amplification using four overlapping fragments that together cover the entire operon 
(Supplemental Figure S1).  Primers were designed to anneal within the genes.  Fragments 
were amplified using Phusion High-Fidelity DNA polymerase (Thermo Scientific), according 
to the manufactures’ instructions, in reactions optimized for GC-rich templates by the 
addition of 3% DMSO.  Amplified fragments were detected via gel electrophoresis, using 
0.8% TAE gels and GelRed stain (Biotium Inc.).  In most cases all four fragments could be 
detected, although for six isolates only three fragments (and in one case only one), were 
observed.  Given the extensive overlap and difficulty in amplification (presumably due to the 
high GC content), it was assumed that detection of any fragment indicated the presence of the 
operon.  Nucleotide polymorphisms in the primer target sequences also may result in failure 
of amplification. 
 
Results 
The CPS and KS from the Xoc operon together produce ent-kaurene from GGPP.10  
Here we report functional characterization of the remaining oxidative enzymes from the 
operon (i.e., CYP112, CYP114, CYP115, CYP117, SDRGA and FdGA; see Figure 1).  For 
this purpose, each of the CYPs and the SDRGA were individually expressed in E. coli.  
CYP114 was also co-expressed with FdGA, which has been shown to be required for full 
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activity of this CYP, while the other CYPs presumably are efficiently reduced by endogenous 
Fd.8  The resulting recombinant strains were fed each biosynthetic intermediate/precursor, in 
parallel cultures that were then extracted for analysis by gas-chromatography mass-
spectrometry (GC-MS) to determine what (if any) enzymatic transformations had been 
catalyzed.   
The results of these studies demonstrated that the enzymes in common between the 
Xoc operon and those from rhizobia (Figure 1) catalyze the same reactions, such that the 
pathway from ent-kaurene to GA9 elucidated by these studies is analogous to that recently 
reported for the rhizobial species Bradyrhizobium japonicum and Sinorhizobium fredii.8  
Briefly, CYP117 catalyzed the three oxidative transformations required to transform ent-
kaurene to ent-kaurenoic acid (Figure 2).  This was further converted to GA12-aldehyde by 
CYP114, which includes ring contraction from the 6-6-6-5 kaurane backbone to the 6-5-6-5 
ring structure characteristic of the gibberellanes (Figure 2 and Supplemental Figure S2).  
We predict that this transformation proceeds via initial conversion of ent-kaurenoic acid to 
ent-7α-hydroxykaurenoic acid, with the subsequent oxidative ring contraction reaction 
dependent on co-expression of FdGA, because cultures expressing CYP114 alone only 
produced ent-7α-hydroxykaurenoic acid (Supplemental Figure S3).  SDRGA efficiently 
catalyzes the further oxidation of GA12-aldehyde to GA12 (Figure 2 and Supplemental 
Figure S2).  CYP112 then catalyzes the conversion of GA12 to GA9, which also requires 
three reactions, first hydroxylation to the C-20 alcohol derivative GA15, then oxidation to the 
aldehyde GA24, before catalysis of the coupled loss of C-20 with formation of a -lactone 
ring (Figure 2 and Supplemental Figure S2).  
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Notably, the operon in Xoc contains an additional CYP, CYP115, which is not 
generally present in rhizobia.10  CYP115 proved to catalyze 3-hydroxylation of GA9 to form 
GA4 (Figure 2 and Supplemental Figure S2).  Thus, beyond the penultimate precursor GA9 
observed with rhizobia,14 the operon in Xoc can not only be confidently assigned to GA 
biosynthesis, but also to further lead to production of the bioactive GA4.  
Bioinformatic searches of the sequence information currently available for X. oryzae 
indicated that the GA biosynthetic operon is present in Xoc, but not those for the closely 
related and other major pathovar X. oryzae pv. oryzae (Xoo), whose genomes have been fully 
sequenced.15–19  In Xoc, examination of the available genome sequences20,21 revealed that the 
GA biosynthetic operon is flanked by multiple insertion sequence (IS) elements.  Although 
there is some difference in the exact composition of these, all Xoc isolates have at least one 
IS element on each side of the operon (Supplemental Figure S4).  
The presence of mobile elements flanking the GA biosynthetic operon denotes 
potential mobility, and raises questions about the ephemerality of GA4 production in Xoc.  
Thus, it seemed worth investigating how widespread the GA biosynthetic operon is within 
Xoc.  For this purpose, 116 isolates from different regions where the resulting bacterial leaf 
streak disease is of agronomic concern, both West Africa and Asia, were screened by PCR 
for the presence of the GA biosynthetic operon.  Included among these are ten isolates whose 
complete genome sequences are currently available.21 The isolates from West Africa were 
collected from rice and wild grasses showing disease symptoms between 2003 and 2011 in 
Mali and Burkina Faso (35 and 32 isolates, respectively), while those from Asia were 
collected from rice only, with 41 isolates from the Philippines, collected between 1978 and 
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1990, along with three from Malaysia, four from China and one from India (Table 1 and 
Supplemental Table S2).   
Interestingly, the GA biosynthetic operon is highly prevalent in Xoc, as it is present in 
106 of 116 isolates screened (91.3%), being absent in only 10 isolates (Supplemental Table 
S2).  On a regional level, the operon is absent only in a single isolate from the Philippines, 
and is absent somewhat more frequently in isolates from West Africa (9 of 67; 13.4%) 
(Figure 3).  While the isolates that do not contain the GA biosynthetic operon were all found 
on Oryza sativa rather than other species from the Oryza genus, this may not be significant, 
as only a limited number of isolates from these wild grasses were tested.  To further test the 
generality of the observation that the GA biosynthetic operon is not present in the thirteen 
complete genomes available for Xoo, five Xoo isolates from Asia and an isolate of X. oryzae 
(no pathovar designation) from the United States were tested, and found to not contain the 
operon (Supplemental Table S2).  
 
Discussion 
The biochemical results reported here demonstrate that the GA biosynthetic operon in 
Xoc leads to the production of bioactive GA4 (Figure 2).  This is consistent with the previous 
demonstration that the operon acts to produce a virulence factor that reduces the JA-mediated 
defense response,10 as an antagonistic relationship between GA and JA has already been 
established.22–24  The importance of such production of GA4 for Xoc is indicated by the very 
high prevalence of the GA biosynthetic operon in this pathovar over both a broad 
geographical range and different periods of time also shown here (Figure 3 and 
Supplemental Table S2).  
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While the GA biosynthetic operon is somewhat less prevalent in the West African 
isolates tested here, it is still widely found in this region (>85%).  Interestingly, the virulence 
factor AvrRxo1, which (along with its chaperone Arc1) is similarly flanked by several IS 
elements,25,26 also is more prevalent in Asian than African isolates of X. oryzae.27  
Nevertheless, particularly given the lack of a clear pattern in more specific location or date of 
collection of these isolates, any underlying rationale for the slightly decreased prevalence of 
the GA biosynthetic operon in this region remains uncertain.  
More critically, it also is unclear why the GA biosynthetic operon seems to be tightly 
restricted to Xoc and is not found in Xoo.  This is especially puzzling given that exogenous 
application of bioactive GA3 has been reported to increase the susceptibility of rice to Xoo.28  
Nevertheless, the selective distribution of the operon in X. oryzae presumably reflects a 
differential ability of GA4 to act as a virulence factor in the distinct lifestyles of these 
pathovars.  Notably, Xoc nominally enters rice leaves through stomata and propagates 
throughout the mesophyll parenchyma causing leaf streak disease, while Xoo enters through 
hydathodes and propagates in the xylem causing leaf blight.29  While both Xoc and Xoo also 
can enter through wounds, given the association of the JA response with wounding, it can be 
hypothesized that such damaged tissue may provide a more important route for the entry of 
Xoc than Xoo.  
Beyond Xoc and rhizobia, the GA biosynthetic operon has only been reported to be 
present in various pathovars of Xanthomonas translucens (Supplemental Figure S5), where 
it includes CYP115.10  These phytopathogens infect either forage grasses or small grain 
cereal crops such as wheat, barley and rye, and cause leaf streak disease.  Thus, their tissue 
specificity and mode of infection resemble that of Xoc.30–32  Assuming that production of 
276 
 
 
GA4 also serves to increase virulence for these phytopathogens, it can be similarly 
hypothesized that damaged tissue may be an important route of entry for X. translucens as 
well.   
Intriguingly, while not otherwise particularly closely related,33 Xoc and X. 
translucens both infect plants from a sub-family of the Poaceae/grass family, specifically the 
BEP clade.34  Accordingly, it can be further speculated that the selective presence of the GA 
biosynthetic operon in these phytopathogens is a function of the high water-repellency of 
their host plant leaves,35 due to their vertical/upright nature and hydrophobic surface,36 which 
limits bacterial colonization and access to stomata.37  Consistent with an important role for 
wounding in the entry of these pathogens, outbreaks of bacterial leaf streak disease have been 
correlated with the aftereffects of typhoons in rice,29 and with mowing in forage grass 
pastures.32  
Lastly, it is notable that the final 3-hydroxylation reaction catalyzed by the 
additional CYP115 found in the Xoc GA biosynthetic operon differentiates this from 
previously characterized operons (Figure 1), which are all from rhizobia that seem to 
produce only the penultimate precursor GA9.8,9,14  The presence of a short fragment of 
CYP115 in rhizobia,4,38 suggests that this gene was lost due to some negative effect on the 
symbiotic interaction of these rhizobia with their host plants.  Indeed, the GA biosynthetic 
operon is not found in all rhizobia,7 and knock-out mutants are still able to nodulate their 
respective host plants.8,9,39  The presence of CYP115 and, therefore, the ability to produce 
bioactive GA4, may reflect the difference between the relationships of these bacteria with 
their host plants.  As bioactive GA suppresses the JA defense response,22 rhizobia 
presumably benefit from maintaining the health of their host legume and it can be 
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hypothesized that these symbionts may leave the final step in production of bioactive GA to 
the plant in order to not compromise the ability of the host to respond to infection by 
pathogenic microbes.  Regardless of such speculation, the results reported here highlight the 
use of bioactive GAs as virulence factors by both fungal and bacterial pathogens of rice,2,10 
which indicates the importance of the balance between GA and JA in the defense response of 
this important cereal crop plant to these disparate microbial disease agents, and is consistent 
with previous evidence that these hormonal interactions differ between rice and other plants 
such as Arabidopsis thaliana.40  
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Figures 
 
CYP115 CYP112 CYP114 FdGA SDRGA CYP117 IDS CPS KS IDI
CYP112 CYP114 FdGA SDRGA CYP117 IDS CPS KS IDI(         )
Xoc
rhizobia
 
Figure 1: Schematic representation of the GA biosynthetic operon. Abbreviations for the 
genes in the arrows are CYP, cytochrome P450; Fd, ferredoxin; SDR, short-chain alcohol 
dehydrogenase/reductase; IDS, isoprenyl diphosphate synthase; CPS, ent-copalyl 
diphosphate synthase; KS, ent-kaurene synthase; and isopentenyl diphosphate isomerase 
(IDI), which is not found in all copies of the operon in rhizobia; the arrow indicates the 
direction of transcription. 
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Figure 2: GC-MS of XocCYP117, CYP114+FdGA, SDRGA, CYP112 and CYP115 from 
E. coli extracts. (Left Panel) GC-MS chromatograms of hexane extracts from E. coli 
cultures expressing the indicated enzymes and chromatograms of standard compounds as a 
reference. (Right panel) Reactions catalyzed by the respective enzymes. 
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Figure 3: Origin of Xanthomonas oryzae pv. oryzicola isolates screened for the presence 
of the GA biosynthetic operon. A) Countries where Xanthomonas oryzae pv. oryzicola 
were isolated.  Blue areas indicate Mali and Burkina Faso (West Africa) as well as India, 
Malaysia, China and the Philippines (Asia). Details on the collection area of West African 
(B) and Philippines (C) isolates. Red areas indicate provinces or towns (when available); 
yellow triangles indicate regions where isolates which do not have the GA biosynthetic 
operon were found. 
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Tables 
 
Table 1. Total number of X. oryzae pv. oryzicola isolates screened for the presence of the 
GA biosynthetic operon, by country. 
 
Country  
Number of isolates 
total 
GA 
+   
GA -  
Mali 35 31 4 
Burkina 
Faso 
32 27 5 
Philippines 41 40 1 
Malaysia 3 3 0 
China 4 4 0 
India 1 1 0 
Total  116 106 10 
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Supporting Information 
 
 
Supporting Figure S1:  Strategy used for PCR screening of Xoc isolates.  Genes 
comprising the GA biosynthetic operon are indicated in black blocks.  Grey bars represent 
overlapping amplification products. Primers are indicated as dashed arrows (primer sequence 
can be found in Table S1). 
 
 
 
 
 
 
Supporting Table S1: Primers used in this study 
Primer Primer sequence (5´ to 3´) Product 
ID Forward Reverse 
size 
(bp) 
 
Cloning Xoc genes for heterologous expression 
 
Xoc CYP117 CACCATGGACGTGCTGCGCAACCC TCATGCGAAGCCGATATGGA
CGG 
Xoc CYP114 CACCATGGCCGTACAAGCAGCACA
CAG 
TCAGCCATCGTGCACCGCC 
Xoc FdGA  TCACATCGTCCCATCGTGGCC 
Xoc SDRGA CACCATGGGACGATGTGAAGGCAA
AGTGG 
TCAGCGATCCACCCCGACG 
Xoc CYP112 CACCATGTCAGACGATCCGTTGCC
GATGC 
TCACCAGCGAACCGGGAACG 
Xoc CYP115 CACCATGTGGCCTGAAAGCGATCA
TTGTG 
CTAGACGGCAGAAGGGCGAA
AGGTGATC 
 
GA biosynthetic operon 
screening 
 
 
Fragment 1 TCCGCGAGGTAATACCTAATCCAG
TG 
CCGCTGCTGCATTTCTC 4929 
Fragment 2 CTGGCTCGAACACATTGATA ACCGTACTGGGAGGATTGA 5045 
Fragment 3 GCGGGGCCGAAGTCC CGCCGCTGCCTTAGATGT 4146 
Fragment 4 GCGTCGGCGGCTCCTT GGTCGGGGCTAATCAGGTTC
T 
3001 
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Supporting Figure S2:  Mass spectra of peaks from GC-chromatograms.  Mass spectra 
of peaks shown in Figure 2 and Supplemental Figure 2 were compared to the mass spectra of 
the corresponding authentic standards to confirm their identity.  
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Supporting Figure S3: Activity of recombinant XocCYP117, CYP114±FdGA and 
CYP112.  GC-MS chromatograms of hexane extracts from E. coli cultures expressing the 
indicated enzymes and chromatograms of standard compounds as a reference.  Just as with B. 
japonicum and S. fredii,1 ent-7-hydroxykaurenoic acid is not further transformed by 
cultures co-expressing CYP114 and FdGA.    
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Supporting Figure S4:  Insertional sequence (IS) elements flanking the GA biosynthetic 
operon in Xoc the indicated isolates. 
 
 
  
 
Supporting Table S2. Isolates of X. oryzae pv. oryzicola screened for GA biosynthetic 
operon.  
Xanthomonas  
Year Country Town Province Host  
XODB fragments 
Isolate 1 2 3 4 
oryzae pv. oryzicola 
MAI_03 2003 Mali O. du Niger Niono O. sativa         
MAI_04 - Mali  - - -         
MAI_05 Mali         
MAI_06 - Mali - - -         
MAI_07 2003 Mali O. du Niger Niono O. sativa Jamajigi         
MAI_10a 2003 Mali O. du Niger Niono O.sativa         
MAI_11 2003 Mali O. du Niger Niono O.sativa         
MAI_16 2009 Mali O. du Niger Molodo O.sativa         
MAI_18 2009 Mali O. du Niger Kogoni O.longistaminata         
MAI_19 2009 Mali O. du Niger Kogoni O.longistaminata         
MAI_20 2009 Mali O. du Niger Kogoni O.longistaminata         
MAI_21 2009 Mali O. du Niger Kogoni O.longistaminata         
MAI_22 2009 Mali O. du Niger Kogoni O.barthii         
MAI_23 2009 Mali O. du Niger Kogoni O.barthii         
MAI_24 2009 Mali O. du Niger Kogoni O.barthii         
MAI_25 2009 Mali O. du Niger Kogoni O.longistaminata         
MAI_26 2009 Mali O. du Niger Macina O.sativa         
MAI_28 2009 Mali O. du Niger Macina O.sativa         
MAI_29 2009 Mali O. du Niger Macina O.sativa         
MAI_30 2009 Mali O. du Niger Macina O.sativa         
MAI_31 2009 Mali O. du Niger Macina O.sativa         
MAI_32 2009 Mali O. du Niger Macina O.sativa         
MAI_33 2009 Mali O. du Niger Macina O.sativa         
MAI_34 2009 Mali O. du Niger Macina O.sativa         
MAI_35 2009 Mali O. du Niger Macina O.sativa         
MAI_36 2009 Mali O. du Niger Ndebougou O.barthii         
MAI_37 2009 Mali O. du Niger Niono O.sativa         
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Supporting Table 2 continued 
MAI_38 2009 Mali Koulikoro  Dialakoroba O.sativa         
MAI_39 2009 Mali Sikasso  Sélingué O.sativa         
MAI_40 2009 Mali Sikasso  Sélingué O.sativa         
MAI_41 2009 Mali Sikasso  Sélingué O.sativa         
MAI_42 2009 Mali Sikasso  Sélingué O.sativa         
MAI_43 2009 Mali Sikasso  Sélingué O.sativa         
MAI_44 2009 Mali Sikasso  Sélingué O.sativa         
MAI_46 2009 Mali Koulikoro  Baguineda O.sativa         
 BAI_05
a 2009 B. Faso HautsBassins Vallée O.sativa         
 BAI_06 2009 B. Faso 
HautsBassi
ns Vallée O.sativa         
BAI_07 2009 B. Faso EastCenter Itenga O.longistaminata         
BAI_08 2009 B. Faso EastCenter Itenga O.longistaminata         
BAI_09 2009 B. Faso EastCenter Itenga O.longistaminata         
BAI_10 2009 B. Faso EastCenter Itenga O.longistaminata         
BAI_11a 2009 B. Faso EastCenter Itenga Wild rice         
BAI_12 2009 B. Faso EastCenter Bagré O.sativa         
BAI_13 2009 B. Faso EastCenter Bagré Weeds         
BAI_14 2009 B. Faso EastCenter Bagré O.sativa         
BAI_15 2009 B. Faso EastCenter Bagré O.sativa         
BAI_16 2009 B. Faso EastCenter Bagré O.sativa         
BAI_17 2009 B. Faso EastCenter Bagré Pennisetum sp.         
BAI_18 2009 B. Faso EastCenter Koulwooko O.sativa         
BAI_19 2009 B. Faso Cascades Karfiguela O.sativa         
BAI_20 2009 B. Faso Cascades Karfiguela Weeds         
BAI_21 2009 B. Faso Cascades Karfiguela O.sativa         
BAI_22 2009 B. Faso Cascades Karfiguela O.longistaminata         
BAI_34 2009 B. Faso Cascades Karfiguela O.sativa         
BAI_35 2010 B. Faso Center Nabadougou O.longistaminata         
 BAI_36 2010 B. Faso 
B.Mouhou
n Niassan O.sativa         
BAI_37 2010 B. Faso EastCenter Bagré O.sativa         
BAI_38 2009 B. Faso Cascades Karfiguela O.sativa         
BAI_39 2009 B. Faso Cascades Karfiguela O.sativa         
BAI_40 2010 B. Faso EastCenter Bagré O.sativa         
BAI_41 2010 B. Faso Center Nabadougou O.longistaminata         
BAI_42 2010 B. Faso EastCenter Bagré O.sativa         
 BAI_43 2010 B. Faso 
HautsBassi
ns Nienadonkele O.sativa         
 BAI_44 2010 B. Faso 
HautsBassi
ns Nienadonkele O.sativa         
BAI_49 2011 B. Faso B. Mouhon Niassan O. longistaminata         
BAI_60 2011 B. Faso B. Mouhon Niassan O. sativa         
BAI_82 2011 B. Faso Cascades Karfiguela O. sativa         
BLS_001 1978 Philippines Laguna  College -         
BLS_030 1978 Philippines Laguna  College -         
 BLS_046 1980 Philippines 
Nueva 
Ecija MRRTC Peta         
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Supporting Table 2 continued 
 BLS_098 1982 Philippines 
Nueva 
Ecija Talavera IR52         
BLS_099 1982 Philippines Bacolod  Sum-Ag -         
BLS_102 1982 Philippines Benguet  Baguio -         
BLS_103 1982 Philippines Benguet  Baguio -         
BLS_105 1982 Philippines Laguna  College -         
 BLS_106 1982 Philippines 
Camarines 
Sur  -         
BLS_123 1983 Philippines Laguna  College -         
BLS_125 1983 Philippines Laguna  College -         
BLS_150 1983 Philippines Laguna  College -         
BLS_159 1983 Philippines Laguna  College -         
 BLS_175 1983 Philippines 
North 
Cotabato  -         
 BLS_176 1983 Philippines 
North 
Cotabato  -         
BLS_222 1983 Philippines Laguna  College -         
BLS_256a 1984 Philippines IRRI-IRTP Los Baños IR29692-99-3-2-1         
BLS_276 1984 Philippines Laguna  College -         
BLS_279a 1984 Philippines Laguna  College         
BLS_280 1984 Philippines Laguna  College -         
BLS_281 1984 Philippines IRRI Los Baños -         
BLS_285 1984 Philippines Laguna  College -         
 BLS_289 1984 Philippines 
Camarines 
Nortec -         
BLS_290 1984 Philippines Leytec -         
BLS_291 1985 Philippines Iloiloc -         
 BLS_294 1984 Philippines 
Nueva 
Ecijac -         
 BLS_295 1984 Philippines 
North 
Cotabatoc -         
BLS_303 1985 Philippines Iloilo San Dionisio C732-14(upland)         
BLS_305 1985 Philippines Iloilo San Dionisio C894-21         
BLS_348 1988 Philippines Cagayan  Alilino -         
BLS_354b 1983 Philippines Isabela Cabatuan -         
BLS_356 1988 Philippines Isabela San Fabian IR68         
BLS_357 1988 Philippines Isabela San Manuel -         
BLS_365 1988 Philippines Isabela Burgos         
 BLS_372 1989 Philippines 
Nueva 
Ecija CLSU, Muñoz C4         
 BLS_377 1989 Philippines 
Nueva 
Ecija Guimba -         
 BLS_391 1989 Philippines 
Nueva 
Ecija Bagsak, Calinan          
BLS_413 1990 Philippines Tarlac  La Paz O. sativa IR72         
BLS_415 1990 Philippines Tarlac  La Paz O. sativa IR72         
BLS_417 1990 Philippines Tarlac  La Paz O. sativa IR72         
BLS_420 1990 Philippines Tarlac  La Paz O. sativa IR72         
RS105a 1992 China         
B8-12a 2007 China         
L8a < 1995 China         
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Supporting Table 2 continued 
Xoc China 1990 China - - -         
CFBP2286a 1964 Malaysia na na O. sativa         
CFBP2287 - Malaysia - - -         
UPB497 Malaysia - - -         
BXOR1a 1996 India         
 oryzae pv. oryzae 
BAI3 2003 Burkina East center Bagre         
MAFF311018 na Japan         
37012 2003 Mali Niono         
PXO113 - Philipines         
Thai Xoo12 - Thailand         
KACC10331a Korea         
PXO99Aa 1980 Philipines         
PXO86a 1977 Philipines         
PXO282a 1990 Philipines         
PXO83a 1976 Philipines 
Nueva 
Ecija         
AXO1947a 2015 Cameroon         
PXO602a 2006 Philipines         
PXO71a 1974 Philipines         
PXO236a 1989 Philipines         
PXO145a 1982 Philipines         
PXO211a 1989 Philipines         
PXO524a 1994 Philipines         
PXO563a 1998 Philipines         
campestris pv. leersiae 
BAI23 2009 Burkina Cascades Karfiguela Weeds         
oryzae 
US-X8-1A USA Lousiana Rice         
                      
a Genome published  
b Genome sequenced (personal communication, Prof. Adam Bogdanove, Cornell Univ.) 
c Town of collection 
unknown 
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Supporting Figure S5: Phylogeny of the GA biosynthetic operon. Unrooted Maximum 
likelihood phylogenetic tree of the concatenated amino acid sequence spanning CYP112 to 
KS, which includes the proteins found in all examples of the GA biosynthetic operon (the 
scale bar represents substitutions per site).  These sequences were aligned in MEGA7 using 
the Muscle algorithm, the phylogenetic tree was constructed and tested with the bootstrap 
method (1,000 replicate runs) in the same program using the Maximum likelihood algorithm 
with the JTT model and gamma distribution including all sites.2  
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Abstract 
Gibberellin (GA) phytohormones have crucial roles in plant growth and development, 
and also modulate defense responses.  Beyond their endogenous production by vascular plants, 
GAs are also produced by plant-associated fungi and bacteria, which presumably evolved GA 
biosynthesis in order to manipulate their plant host.  The recent elucidation of bacterial GA 
production makes it clear that plants, fungi, and bacteria have independently evolved GA 
biosynthesis.  Additionally, further studies have revealed intriguing distribution and genetic 
architecture of the bacterial GA biosynthetic operon in sub-sets of both plant pathogens and 
symbiotic rhizobia over a wide phylogenetic range, which offers some insight into the function 
for GA production in these organisms.  While it seems that bacterial phytopathogens produce 
bioactive GA4 as a virulence factor, the limited distribution of the GA biosynthetic operon 
suggests that this production is only beneficial to pathogens with certain lifestyles and 
mechanisms of infection.  In rhizobia, it has been proposed that GA is produced to influence 
nodulation of the host plant.  However, the GA biosynthetic operon is found only in certain 
species, which is further complicated by the fact that most, but not all, rhizobia only produce 
GA9, the penultimate non-bioactive intermediate.  This review discusses the current state of the 
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literature regarding bacterial GA biosynthesis to provide a basis for future investigations into the 
biological role of bacterial GA production. 
 
Introduction 
 Within plant-microbe interactions, there are numerous examples in which bacterial and 
fungal species are able to produce a plant hormone, or a small molecule mimic of that hormone 
[1].  One of the earliest studied examples of this phenomenon was the discovery of gibberellin 
(GA) production by the fungus Gibberella fujikuroi, which causes “bakanae” or “foolish 
seedling” disease in rice.  The production of GA by this phytopathogen during infection leads to 
extreme elongation of the host plant, and crucially, increases the pathogen’s virulence [2].  The 
ability of GA to restore growth defects in plant dwarf mutants led to the discovery that GAs were 
endogenously-produced plant hormones as well [3].  Additionally, subsequent analyses 
suggested that even certain plant-associated bacteria were capable of producing GA [4].  
Although the roles of GA in plant biology are continuing to emerge, some of the major 
physiological processes known to be regulated by GAs include cell expansion, stem elongation, 
seed germination, and flowering [5].  Recently, a comprehensive review by Hedden and Sponsel 
covered the history of GA research in plants and fungi, which now spans over 100 years [6].  
While these aspects of GA research have been extensively studied, little had been determined 
regarding GA in bacteria, which were shown to be capable of GA production in the late 1980’s 
[4].  However, more recently the underlying biosynthetic pathway for GA production in multiple 
bacterial species has been elucidated, and additionally, biological roles for bacterial GA 
production are being identified.  This review catalogs the recent developments for bacterial GA, 
298 
 
 
which are put within the context of the previously well-established understanding of plant and 
fungal GA. 
 Chemically, GAs are diterpenoid-derived compounds containing a fused, tetracyclic 6-5-
6-5 ring structure, referred to as the ent-gibberellane backbone [7].  As diterpenoids, they are 
derived from the 20-carbon general precursor (E,E,E)-geranylgeranyl diphosphate (GGPP) [8].  
The biosynthesis of these compounds from GGPP is complex and requires over 10 distinct 
enzymatically mediated transformations in order for biologically active GAs (GA1, GA3, GA4, 
and GA7) to be produced (Figure 1).  Additionally, the metabolic network encompassing GA 
anabolism and catabolism, particularly in plants, is vast, as over 130 unique GA structures have 
been identified [6].  This review will be focused almost exclusively on bacterial GA biosynthesis 
and the effects that this production has in plant-microbe interactions.  For a comprehensive 
overview of GA in plants and fungi, the aforementioned review by Hedden and Sponsel is 
recommended [6]. 
 
GA Biosynthesis in Plants and Fungi 
 GA biosynthesis is initiated by cyclization of GGPP to first form ent-copalyl diphosphate 
(CPP), then a subsequent cyclization to form the olefin GA precursor ent-kaurene [6].  In plants, 
this is performed by two distinct enzymes, an ent-copalyl diphosphate synthase (CPS) and an 
ent-kaurene synthase (KS), while this is performed by a single, fused CPS/KS protein in fungi.  
A series of oxidation/oxygenation reactions are then catalyzed by either cytochrome P450 
monooxygenase (CYP) or 2-oxoglutarate dependent dioxygenase (2ODD) enzymes.  In both 
plants and fungi, ent-kaurene is oxidized to ent-kaurenoic acid, which is carried out by a ent-
kaurene oxidase (KO), and ent-kaurenoic acid is then oxidized to GA12-aldehyde, which is 
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carried out by a ent-kaurenoic acid oxidase (KAO).  These two reactions are performed by 
distinct CYPs in both plants and fungi, but the KO and KAO from plants belong to different 
CYP families than those of fungi and share less than 20% identity, suggesting that the 
biosynthetic activity has been independently evolved [9].   
Following the production of GA12-aldehyde, the biosynthetic pathways in plants and 
fungi have distinct intermediates as well.  While the plant KAO oxidizes GA12-aldehyde to GA12, 
the KAO in fungi adds a 3β-hydroxyl group to GA12-aldehyde to form GA14-aldehyde before 
further oxidation to produce GA14.  In plants, 13-hydroxylation catalyzed by a CYP can occur to 
produce GA53, but 13-hydroxylation and non-13-hydroxylation pathways both exist in plants.  In 
each pathway, a GA 20-oxidase (GA20ox) enzyme then catalyzes oxidation of C-20, and 
ultimately loss of this carbon, to form a lactone ring.  For plant biosynthesis, this results in the 
formation of either GA20 (13-hydroxylation pathway) or GA9 (non-13-hydroxylation pathway).  
In fungi this same GA20ox activity occurs on GA14, resulting in formation of bioactive GA4.  
However, while this chemical transformation is performed by a CYP in fungi, plants make use of 
a 2ODD for this reaction.  Plant biosynthesis then further utilizes a GA 3-oxidase (GA3ox), 
which is a 2ODD enzyme, to produce either GA1 from GA20 (13-hydroxylation pathway), or 
GA4 from GA9 (non-13-hydroxylation pathway), both of which are bioactive GAs, and are the 
major bioactive forms found in plants.  Fungal biosynthesis generally further proceeds first 
through desaturation of GA4, catalyzed by a 2ODD-type desaturase, to produce GA7, and 
ultimately GA3ox activity, catalyzed by a CYP, to produce GA3 as a final product. 
 Collectively, the plant and fungal GA biosynthetic pathways differ in both enzymes 
utilized and biosynthetic intermediates.  However, because both pathways end on bioactive GAs, 
this represents an extreme example of biosynthetic convergent evolution [9].  While the early 
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cyclization steps are suggested to share an evolutionary origin [10,11], it is widely held that the 
downstream oxidative steps have been independently evolved in plants and fungi.   
A prominent disparity between plant and fungal biosynthesis is the production of the 
more highly elaborated GA3 by fungi (particularly by G. fujikuroi), which contains a C-13 
hydroxyl group and a 1,2 double bond [12], while plants typically end biosynthesis at either GA1 
or GA4, which do not contain this double bond [13].  The presence of the double bond makes 
GA3 resistant to 2β-hydroxylation, a common means by which bioactive GAs are inactivated 
[14].  Because fungi are producing GA3 as a virulence factor, the addition of this double bond 
may have been evolved to help ensure prolonged biological activity of this compound during 
fungal infection of rice [12].  
 
Bacterial GA Biosynthesis 
 Several decades ago, it was found that Bradyrhizobium japonicum, the nitrogen-fixing, 
rhizobial symbiont of soybean, possesses a CYP-rich gene cluster/operon (Figure 2) encoding 
three full length CYPs (CYP112, CYP114, and CYP117), a CYP pseudogene (pCYP115), a 
ferredoxin (FdGA), a short chain dehydrogenase/reductase (SDRGA; SDR274C family, as per the 
SDR nomenclature system [15]), an isopentenyl diphosphate synthase (IDS) presumed to be an 
(E,E,E)-geranylgeranyl diphosphate synthase (GGPS), and two putative diterpene cyclases (CPS 
and KS) [16,17].  The presence of putative diterpene cyclases along with oxidative enzymes led 
to speculation that this operon may be involved in bacterial GA biosynthesis [17], and this 
operon was found to be distributed within many different rhizobial genera, including 
Bradyrhizobium, Mesorhizobium, Rhizobium, and Sinorhizobium [18].  Because the 
aforementioned, full-length genes appear to be universally located within the operon when it is 
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present, they can be considered to be the “core operon”.  Analogous operons are also found in 
several plant pathogenic bacteria, particularly within Xanthomonas species (Figure 2b), and 
these gene clusters additionally contain a full-length CYP115 gene, along with a putative 
isopententyl diphosphate δ-isomerase (IDI), which would presumably be involved in balancing 
the concentration of the 5-carbon isoprenoid precursors isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP).  Some rhizobia also contain full length CYP115 and IDI 
genes, but these do not seem to be invariably conserved throughout rhizobia with operon (Figure 
2a). 
 Like plants and fungi, bacterial GA biosynthesis is initiated by the cyclization of GGPP 
(Figure 1).  The first enzymes of the operon studied were the two separate diterpene cyclase 
enzymes from B. japonicum, which were confirmed to act as a CPS and KS, producing ent-
kaurene from GGPP [11].  Subsequently, the CPS and KS orthologs from Rhizobium etli, 
Sinorhizobium fredii, Mesorhizobium loti, and Xanthomonas oryzae pv. oryzicola were 
confirmed to have this same activity, suggesting that the functions of genes in this operon are 
likely conserved within divergent species [19,20].  The presence of the putative GGPS from the 
operon was shown to be necessary for production of the GGPP precursor in rhizobia, consistent 
with the general absence of diterpenoid production in most bacteria [19].  Detailed incubation 
studies of labeled GA substrates with B. japonicum extracted from soybean root nodules 
subsequently revealed various GA oxidase activities, indicating that rhizobial GA biosynthesis 
likely proceeds via a pathway similar to the non-13-hydroxylation pathway in plants, with the 
final product likely being GA9 [21].  This biosynthetic route was then confirmed and 
characterized through study of the remaining genes of the operon from B. japonicum, S. fredii, 
and M. loti (Figure 1). 
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Following ent-kaurene production, CYP117 acts as a KO, oxidizing ent-kaurene to form 
ent-kaurenoic acid [22,23].  Next, ent-kaurenoic acid is oxidized by CYP114 first to ent-7α-
hydroxykaurenoic, and then to GA12-aldehyde as the major end product, but only with 
coexpression of FdGA [22,23].  Interestingly, CYP114 is the only CYP within bacterial GA 
biosynthesis that requires the dedicated activity of FdGA as an electron donor.  Without FdGA as a 
redox partner, CYP114 is still able to oxidize ent-kaurenoic acid to ent-7α-hydroxykaurenoic 
acid, but cannot perform the oxidative ring contraction to form GA12-aldehyde [22].   
Further oxidation is then carried out by SDRGA, a GA 7-oxidase (GA7ox) that oxidizes 
C-7 of GA12-aldehyde to form GA12  [22].  Following this oxidation, CYP112 acts as a GA20ox, 
oxidizing GA12 to produce GA9 as a final product.  Characterization of these enzymes from the 
core operon further agreed with the previous finding that GA9 is the final product in rhizobia 
with the core operon [21].  Characterization of CYP115, which is present in some rhizobia and 
all plant pathogens with the operon, revealed that this enzyme acts as a GA3ox, hydroxylating 
GA9 to produce bioactive GA4 [24,25].  Thus, depending on the species in question, bacterial GA 
biosynthesis ends at either GA9, or bioactive GA4 (Figure 1).  For plant pathogens, this would 
appear to invariably be GA4, as all plant pathogens found with the operon contain CYP115.  
While a subset (~17%) of rhizobia with the GA operon do possess CYP115, and thus are capable 
of GA4 production, the absence of this gene from most species would indicate that most rhizobia 
cease biosynthesis at GA9. 
The initial characterization of the full operon was demonstrated within rhizobia [22,23], 
but complete biosynthesis also has now been demonstrated for the plant pathogens X. oryzae pv. 
oryzicola [24], X. translucens pv. translucens, and Erwinia tracheiphila [26].  The operon gene 
functions are congruent between these distinct lineages, suggesting that the function of the GA 
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operon is conserved more generally, and thus biosynthetic function for GA production can be 
tentatively assumed based upon the genomic presence of the corresponding biosynthetic genes. 
 
Triply Convergent Evolution of GA Biosynthesis 
Analysis of the genes involved in bacterial GA biosynthesis suggests that bacteria have 
likely evolved their biosynthetic enzymes independently of either plants or fungi.  A notable 
exception to this are the diterpene synthases, CPS and KS, which have been speculated to share 
an ancient evolutionary origin with the analogous plant and fungal enzymes [11,27].  However, 
downstream of the formation of ent-kaurene, bacterial GA biosynthesis appears to be quite 
distinct.  The CYPs that act as KO and KAO enzymes in bacteria belong to CYP families distinct 
from the functionally analogous enzymes utilized in plants and fungi (and share less than 22% 
identity), suggesting different evolutionary origins.  Indeed, the CYPs in the GA operon are 
clearly of bacterial origin [28] and are in general more similar to one another than to the 
analogous plant and fungal enzymes [22].  The C-7 oxidation catalyzed by SDRGA is similarly 
distinct, as such GA7ox activity in plants, when present, is carried out by a 2ODD enzyme [29].  
Notably, this is the only example of an SDR dedicated to GA biosynthesis.  The GA20ox 
reaction carried out by CYP112 is similar to that catalyzed within the plant non-13-
hydroxylation pathway, but the bacterial use of a CYP for this reaction is distinct from plants, 
which make use of a 2ODD for GA20ox activity.  Also, while fungi do utilize a CYP for 
GA20ox activity, it falls within a distinct CYP family, and again, this indicates that the bacterial 
enzyme likely has distinct evolutionary origins.  Finally, while bacteria utilize a CYP for GA3ox 
activity (CYP115), plants make use of a 2ODD for this transformation, while fungi differ quite 
significantly in that the CYP that acts as a GA3ox also functions as the KAO.  Collectively, the 
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differences in enzymes utilized within bacterial GA biosynthesis shows that bacteria have 
independently evolved a third distinct pathway to GA production.  
 The full elucidation of bacterial GA biosynthesis also further suggested that there are 
central chemical transformations, and an underlying “biosynthetic logic”, shared by all three 
pathways.  For example, it has been speculated that the early formation of the C-19 carboxylate 
in ent-kaurenoic acid, which is necessarily formed in each characterized pathway, may be 
essential for the subsequent ring contraction to form the ent-gibberellane backbone, as ring 
contraction does not occur without this moiety being present [22,30].  Further evidence has been 
presented indicating that the ring contraction mechanism is likely to be similar within all three 
pathways, as C-7 is extruded from the B-ring in each system despite the convergent evolution of 
the KAO enzymes that catalyze this reaction [30].  This suggests that there are 
biophysical/biochemical restraint on this unique ring contraction reaction, and that the presence 
of a C-19 carboxylate and the extrusion of C-7 underlie the most amenable route for this to 
occur.  
 An alternative hypothesis to explain the conserved transformations observed in GA 
biosynthesis is an arms race scenario [31], whereby ancient plant-associated microbes gained the 
ability to produce a hormone-like GA precursor, and plants responded to this manipulation by 
further transformation of the chemical structure of this compound (along with the corresponding 
receptor).  The microbes would then need to gain an additional biosynthetic step to copy the 
plant hormone.  This back-and-forth could then have been played out to result in the extant GAs 
that currently act as phytohormones.  As all three biological kingdoms have independently 
evolved GA biosynthetic pathways, and indeed analogous individual biosynthetic enzymes, an 
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arms race scenario could possibly explain how such a complicated biosynthetic scheme could be 
copied – almost to perfection – in three distinct biological kingdoms. 
 
Distribution of GA Biosynthesis in Bacteria 
 Although there have been many reports of GAs being isolated from cultures of various 
bacterial strains [4,32], direct demonstration of GA biosynthesis has only been shown for 
bacteria containing the GA biosynthetic operon.  In particular, while many strains have been 
reported to produce a wide array of GAs, many of these do not appear to have orthologous genes 
from the GA operon present in their genomes.  The presence of an additional convergent 
pathway in bacteria is possible, but at this time, it seems that only the bacteria possessing the GA 
operon can be confidently predicted to be capable of GA biosynthesis.  
Rhizobia – α- and β- proteobacteria 
 The GA operon is widely distributed throughout the order Rhizobiales, specifically within 
the four major genera Bradyrhizobium, Mesorhizobium, Sinorhizobium (now called Ensifer), and 
Rhizobium [18], all of which fall within the α-proteobacteria class.  Currently, BLAST searches 
within available databases (specifically NCBI/GenBank and JGI) using GA operon genes shows 
that over 130 strains of rhizobia, all of which are implicated to be nitrogen-fixing symbionts of 
legumes, possess a full GA biosynthetic operon [25], which now also includes species from the 
Azorhizobium and Microvirga genera (Table 1).  Additionally, this operon is not restricted to 
only the α-proteobacterial rhizobia, but is also found in several species from the β-proteobacteria 
rhizobia, specifically in a few Burkholderia species that typically form symbioses with legumes 
from the plant genus Mimosa [26]. 
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 For rhizobia species with well annotated and analyzed genomes, it is clear that the GA 
biosynthetic operon is located within the symbiotic plasmid or genomic island [33–37].  These 
genomic regions are associated with the symbiotic lifestyle of rhizobia [38], and the location of 
the GA operon would thus suggest a potential role in symbiosis.  Furthermore, most rhizobia 
with the operon do not possess a full length CYP115 gene, as this has only been found in 22 
strains of α-rhizobia thus far (Table 1).  However, within the subset of α-rhizobia that do contain 
this gene, it appears to be functional [25].  Although there are a few instances in which CYP115 
is located directly within the GA operon in rhizobia, in most cases the full length CYP115 gene 
is instead located quite distantly from the operon (Figure 2a), though it is still found within the 
symbiotic module. 
Plant pathogens – γ-proteobacteria 
 Analysis of GA biosynthetic operon distribution beyond rhizobia revealed that an 
analogous gene cluster is found in the rice (Oryza sativa) leaf-streak pathogen Xanthomonas 
oryzae pv. oryzicola (Xoc) [20].  It has subsequently been determined that this operon is widely 
distributed within Xoc, but not other X. oryzae pathovars [24], although it also can be found in 
other plant pathogens more generally [26], with all of these pathogens falling within the γ-
proteobacteria class (Table 2).  This includes other Xanthomonas lineages, including wide 
distribution within X. translucens (e.g., both pathovars translucens, Xtt, and graminis, Xtg) and 
X. bromi, which infect small-grain cereals such as wheat (Triticum aesvitum) and barley 
(Hordeum vulgare), in addition to forage grasses, all of which fall within the BEP clade of the 
Poaceae family [39].  Additionally, the operon is found in Erwinia tracheiphila, a pathogen of 
the Cucurbitaceae (Cucurbit) family (i.e. pumpkin, squash, cucumber), and based upon gene 
homology, this appears to be the most phylogenetically distant copy of the GA biosynthetic 
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operon.  The only γ-proteobacteria species with the operon that is not a confirmed pathogen is a 
strain of Pseudomonas psychrotolerans that was isolated from rice seeds [40], though it should 
be noted that some Pseudomonas species are known to be plant pathogens [41]. 
Horizontal gene transfer 
Phylogenetic and genomic analysis of the GA operon strongly suggests that this gene 
cluster is mobilized among bacteria through horizontal gene transfer (HGT).  This was noted 
initially for S. fredii, as this operon contains a significantly higher GC content (over 10% higher) 
than the rest of the symbiotic plasmid [42], and such anomalous GC content has been further 
noted for the operon in B. japonicum, M. loti and R. etli [36,37].  Within the α-rhizobia more 
generally, there are noticeable phylogenetic incongruences between nitrogen fixation genes, 
which are representative of the symbiotic island or plasmid associated with symbiosis, and the 
genes of the GA operon [19].  This indicates that the operon has been transferred independently 
of the symbiotic module, which is also known to be mobilized via HGT among rhizobia [38].  In 
accordance with this, the GA operons are usually flanked by various insertional sequence (IS) 
elements such as transposases [24,25,36], which is further indicative of the operon being a 
mobile sequence element.  Additional support for an HGT scenario is evident due to the 
phylogeny of the β-rhizobia GA biosynthetic operon, which shares higher amino acid identity to 
the operon in plant pathogens than that from the α-rhizobia [26], suggesting that the β-
proteobacteria gained the operon in events distinct from the α-proteobacteria. 
 Also, it seems that within rhizobia, full length CYP115 genes have been reacquired 
independently of the core GA operon [25].  When present in α- proteobacterial rhizobia, CYP115 
can be found either 5’ or 3’ to the operon, or elsewhere in the symbiotic module entirely.  
Additionally, when present outside of the operon, a CYP112 gene fragment usually follows 
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CYP115 (Figure 2a), suggesting that this genetic region has been excised from a pre-existing 
operon with CYP115, and indeed, these CYP115 genes are often flanked by IS elements.  
Overall, this seems to represent an additional layer of HGT associated with the GA biosynthetic 
genes.   
 In plant pathogens, the general scattered distribution of the GA biosynthetic operon also 
suggests acquisition via HGT.  For example, the operon is widely distributed in Xoc and the 
phylogenetically distinct X. translucens, yet is absent in Xanthomonas oryzae pv. oryzae (Xoo) 
[24], suggesting horizontal instead of vertical inheritance.  Additionally, the presence of the 
operon in only a few examples of Erwinia and Pseudomonas species indicates that only certain 
pathogens with a particular lifestyle have gained this gene cluster, which they presumably 
obtained via HGT.  
 
Biological Function of Bacterial GA 
It appears that all bacteria possessing the GA biosynthetic operon are plant-associated 
(personal communication, Dr. Asaf Levy, US-DOE Joint Genome Institute), so it can be 
hypothesized that GA is produced by bacteria in order to manipulate their plant host.  Previous 
reports of GA production by bacteria were limited to plant growth-promoting rhizobacteria, 
which were implicated to increase growth and yield of plants, at least in part, through production 
of GAs [32].  However, the organisms now known to produce GA have highly diverse lifestyles, 
as both symbiotic and pathogenic bacteria produce GA, and it has now been shown that GA 
exerts different effects depending on the specific lifestyle of the bacterial species in question.   
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Plant pathogens 
The rice fungal pathogen Gibberella fujikuroi produces GA as a virulence factor [2], and 
thus it would be logical that GA produced by bacterial plant pathogens would also act to help aid 
in infection.  Indeed, it was found that knocking out the GA operon in Xoc, the causal agent of 
bacterial leaf streak in rice, results in decreased virulence of this pathogen in rice infection [20].  
Interestingly, this virulence seems to be enacted through suppression of the jasmonate (JA)-
induced defense responses, which is in agreement with the observed down-regulation of JA 
signaling that is mediated by GA in rice [43].   
More generally, it could be hypothesized that all plant pathogens with the operon produce 
GA in order to lower the defense of their host plant.  However, the distribution of the GA 
biosynthetic operon suggests that production of GA would not benefit all plant pathogens 
equally.  In particular, while Xoc species do contain the GA operon in general, it is noticeably 
absent within X. oryzae pv. oryzae (Xoo) species that cause bacterial blight in rice [20,24].  
Thus, it is possible that the differences in the lifestyles between these pathovars may underlie the 
presence or absence of the GA operon.  Intriguingly, these pathovars differ in their mode of entry 
and infected tissue during pathogenesis, whereby Xoc nominally enters through the stomata and 
infects the mesophyll parenchyma, while Xoo enters through the hydathodes and infects the 
xylem [44].  Additionally, X. translucens and X. bromi, which also contain the GA biosynthetic 
operon, have a similar mode of entry and lifestyle as Xoc, suggesting a conserved biological role 
for GA in this type of infection [24].  It has been hypothesized that perhaps the upright structure 
and water repellency of the grasses these pathogens infect, specifically those within the BEP 
clade [39], are particularly resistant to stomatal entry, and that plant wounding is a more 
effective means for these pathogens to infect.  Consistent with this hypothesis, JA-mediated 
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defenses are usually activated following wounding [45], and, thus, pathogen-produced GA 
presumably plays a role in suppressing this defense response.  Intriguingly, many outbreaks of 
these pathogens occur following damaging storms or mowing of forage grasses [44,46], 
suggesting wounding as a major, and effective, means of entry for these organisms.   
Additionally, JA signaling has been shown to be involved in stomatal closure [47], so it is 
also possible that the Xanthomonas pathogens produce GA prior to entry in order to ensure that 
stomata remain open, thus facilitating their entry into the plant.  GA has also been shown to 
antagonize abscisic acid (ABA) mediated closure of stomata, at least within certain plant species 
[48,49].  This further supports a possibility for pathogenic GA in promoting increased stomatal 
opening for bacterial infiltration, although this does not explain the more limited distribution of 
the GA operon. 
At first glance, GA production by Erwinia species would seem somewhat less clear, as 
these pathogens infect Cucurbit species as opposed to grasses, and are unique in that they are 
transmitted via feeding of an insect vector [50].  However, insect feeding damages the plant, and 
this herbivory is well documented to be counteracted by induction of JA-mediated defenses [43].  
Therefore, GA production by Erwinia tracheiphila could be utilized to suppress this response, 
thereby allowing this pathogen to more efficiently infect its host plant after being deposited by 
the insect vector. 
Although a role in JA-mediated defense suppression has been shown for Xoc [20], more 
detailed plant pathology studies could shed light on the exact mechanism by which production of 
GA by phytopathogens increases bacterial virulence.  For example, a major open question is why 
Xoo species have not have acquired this operon, as GA application to rice leaves increases their 
virulence [51].  Additionally, investigations into the potential role of GA as a virulence factor in 
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Erwinia would be quite interesting, given the distinct lifestyle of this pathogen, and may provide 
insight into this tritrophic interaction (i.e. plant host, herbivore insect, and bacterial pathogen). 
It is interesting to note that the bacterial plant pathogens cease GA biosynthesis at GA4, 
as opposed to more highly transformed GA3 produced by phytopathogenic fungi such as G. 
fujikuroi.  The formation of the 1,2 double bond in GA3 makes this bioactive GA more resistant 
to the inactivating 2β-hydroxylation carried out by plant GA 2-oxidases, and it has been 
speculated that G. fujikuroi produces GA3 to take advantage of this and enact a longer lasting 
effect of the GA it supplies to its host plant during infection [12].  It could then be predicted that 
other GA-producing plant pathogens would produce GA3 (or GA7, which also contains a 1,2 
double bond) as well, but 1,2 desaturation products have not been detected for any of the 
characterized bacterial pathogens with the GA operon.  However, GA4 binds to the GA receptor 
more strongly than GA3 (~20-fold more in rice) [52], so perhaps this stronger affinity 
compensates for any catabolism of bacteria-produced GAs by the plant host.  This disparity in 
the final bioactive GA remains an open question, and investigation into this difference may 
provide insight into the mechanisms underlying virulence in GA-producing bacterial and fungal 
phytopathogens.  
Rhizobia 
Initially, a role for the GA operon in rhizobia was elusive, as knockouts of the operon in 
B. japonicum did not result in any significant changes in plant growth, nor in general nodulation 
phenotypes [16].  While transcriptomic and proteomic studies have since determined that the B. 
japonicum operon is expressed as early as three weeks following nodulation of soybean [53,54], 
more recently it has been shown that at least the CPS and KS genes are not appreciably 
expressed until around the flowering and early pod stages of the plant, which are around 8-10 
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weeks after nodulation [21].  As these enzymes are essential for the early steps of GA 
biosynthesis, this would suggest that at least within the B. japonicum–soybean symbiosis, GA 
may not be exerting an effect until much later in plant development. 
 More generally, multiple studies have confirmed that transcripts and proteins from genes 
of the GA biosynthetic operon in rhizobia are selectively expressed during symbiosis [34,53–59].  
Indeed, it appears that at least some of these operons are under control of a NifA-type promoter, 
which is also implicated in the expression of nitrogen fixing-related genes [19].  Together with 
the location of the GA operon in the symbiotic island or plasmid, these results would strongly 
indicate that GA production by rhizobia is likely involved within symbiosis with their plant host. 
 Recently, studies of the symbiosis between M. loti MAFF303099 and Lotus japonicus 
have found that knockout of the GA operon in M. loti leads to an increase in the total number of 
nodules per plants [23].  The authors of this study hypothesized that this rhizobium is making 
GA within the nodule to control the total number of nodules, as GAs have been shown to be 
negative regulators of nodule number in Lotus japonicus [60,61].  This could then in turn 
potentially act as a selective advantage, as early nodulating rhizobia, if producing GA, would 
essentially block other rhizobia from forming symbiosis with the plant, thereby ensuring greater 
allocation of plant resources to previously formed nodules.  Interestingly, the aforementioned 
study also found that nodules inhabited by GA operon knockout stains were significantly smaller 
than those inhabited by wild-type, GA-producing M. loti [23].  This further suggests that 
rhizobial GA may be involved in increasing the individual nodule size in which they reside.  An 
increase in nodule size would likely correspond to a larger population of bacteroids within the 
nodule, and this would then be a selective advantage as more bacteria would ultimately be 
released back into the soil upon nodule senescence.  It was shown that in co-inoculation 
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nodulation assays, GA-producing rhizobia were able to out-compete GA operon knockouts [23], 
so regardless of the exact biological function of rhizobia GA (nodule number vs. size), it seems 
clear that the GA operon is imparting a selective advantage for bacteria within symbiosis. 
 This study further implicated that rhizobia with the GA operon exclusively with legumes 
that have determinate nodules, which are characterized as having a non-persistent meristem [23].  
While this had been previously suggested when the number of species possessing the operon was 
quite low [19], current analysis of the over 130 rhizobia with the GA operon makes this 
somewhat less certain, as some rhizobia that inhabit or were isolated from indeterminate nodules, 
which have a persistent meristem, also possess the GA operon.  However, the operon is indeed 
noticeably enriched in rhizobia that form symbioses with determinate nodule-forming legumes, 
as ~80% of rhizobia with the GA operon were isolated from this type of host (Table 1).  This 
includes the symbioses of Bradyrhizobium with soybean (Glycine max), Rhizobium with 
common bean (Phaseolus vulgaris), and Mesorhizobium with Lotus species.  It is possible that 
the enrichment in these species is skewed due to the economic importance (and thus greater 
study) of the Bradyrhizobium–soybean and Rhizobium–common bean symbioses, along with the 
basic scientific importance of the model Mesorhizobium–Lotus symbiosis.  However, the 
enrichment of the GA operon within rhizobia of this type is noteworthy and may provide insight 
into the basic nature of this phenomenon.   
Regardless, it is difficult to reconcile the enrichment of the GA biosynthetic operon, and 
thus GA production, in rhizobia that inhabit determinate nodules, if the true selective advantage 
is inhibition of nodulation.  In particular, it has been shown for both determinate and 
indeterminate nodule-forming legumes that GA is inhibitory to nodulation [60–65].  If the 
selective advantage is indeed inhibition of nodulation to exclude other rhizobia from forming 
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nodules, then it would be expected for GA production to be equally advantageous in both the 
determinate and indeterminate nodule scenarios.  The fact that the operon is found mainly in 
rhizobia that associate with determinate nodule-forming legumes would suggest that another 
physiological effect of the rhizobial GA is resulting in the phenotype that enacts a selective 
advantage.  Therefore, it would seem that significant work still needs to be accomplished in 
order to determine the rationale for the observed enrichment of the GA operon in determinate-
nodule inhabiting rhizobia, along with any potential effects that rhizobial production of GA may 
have on indeterminate nodules.  
 Another interesting anomaly associated with the rhizobia possessing the GA operon is the 
general absence of CYP115.  The implication of this is that most rhizobia are only capable of 
synthesizing non-bioactive GA9.  While a subset of α-rhizobia do possess a full-length, 
functional CYP115 [25], including M. loti MAFF303099, the majority of rhizobia have lost 
CYP115 and  instead only possess a CYP115 gene fragment/pseudogene.  This fragment is 
almost always located 5’ to CYP112 in the operon, which is the usual location for full length 
CYP115 when present in the operon, suggesting that rhizobia have selectively lost this gene 
(Figure 2a).  Indeed, even within the β-proteobacterial Burkholderia species, in which the GA 
operon is more closely related phylogenetically to that of the plant pathogens [26], CYP115 also 
appears to have been lost.  This suggests that the presence of CYP115 in symbiotic bacteria is 
either detrimental to their interaction with the legume host, or that selection upon this gene has 
been lost. 
It has been hypothesized that the final step of bioactive GA biosynthesis (i.e. 3β-
hydroxylation of GA9 to GA4) can be performed by the legume host, which contains the native 
GA3ox enzymes for endogenous GA production, as it was shown that GA9 incubated in nodule 
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lysates from the M. loti–L. japonicus symbiosis is converted into bioactive GAs [23].  However, 
this is confounded by the fact that the M. loti strain utilized in this study (M. loti MAFF303099) 
contains a functional CYP115 that can carry out the conversion of GA9 to bioactive GA4 [25].  
Therefore, it is unclear whether the conversion of GA9 to bioactive GA by nodule lysates is due 
to plant or bacterial enzymes.   
However, in most rhizobia with the GA operon, the full length CYP115 has been lost.  
Thus, in these cases, it may be that plant GA3ox enzymes perform the ultimate biosynthetic step.  
If this is true, then it is possible that host expression of GA3ox enzymes has resulted in loss of 
the selection for bacteria to retain CYP115, thereby causing the observed CYP115 pseudogenes 
present in most rhizobia.  It can further be hypothesized that direct production of bioactive GA4 
by rhizobia is deleterious to the host legume, as all of the plant pathogens with the GA operon 
invariably contain CYP115, and thus make GA4, which acts as a virulence factor in their 
pathogenic lifestyle [20].  If rhizobial production of GA compromised host plant defense 
responses in a similar fashion, then there would likely have been selective pressure for rhizobia 
to lose the production of this compound.  Perhaps by assuming control of the ultimate 
biosynthetic step, the host legumes are better able to regulate and temper the effect of bacterial 
GA, thereby minimizing any potential deleterious effects.   
This concept would make it puzzling why certain rhizobia persist in the maintenance of 
CYP115 within their genomes.  It is noteworthy that rhizobia containing CYP115 seem to have 
reacquired this gene independently of the core GA operon [25], which would suggest a potential 
advantage in regaining the ability to produce bioactive GA.  While there does not appear to be a 
clear correlation among rhizobial species that contain CYP115, nor with their corresponding host 
legumes, it is noticeably enriched within Mesorhizobium species, and absent within 
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Bradyrhizobium species.  We suggest that rhizobia may have reacquired CYP115 in order to 
improve their ability to influence nodulation on species that they have not necessarily coevolved 
with – i.e. those that have not evolved to express a GA3ox in their nodules when in association 
with the rhizobial species in question.  This would then allow a rhizobium strain to influence 
many types of plants in which it can form symbiotic interactions, regardless of the host’s 
facilitation of bioactive GA biosynthesis. 
 
Conclusions 
Although GA biosynthesis has now been elucidated, there still remains a good deal of 
research in order to understand the evolution of bacterial GA production and the role that GA 
plays in the lifestyle of the diverse plant-associated bacteria that have obtained the GA 
biosynthetic operon. The work done to date has provided a basis for GA function in pathogenic 
and symbiotic bacteria, but it is still unclear why only certain species/strains possess the GA 
operon, and what this indicates regarding their lifestyle and interaction with their plant hosts.  In 
a similar theme, it is still an open question as to why most rhizobia have lost CYP115, and in 
many cases IDI, from the core operon.  Overall, this area invites further studies of the 
distribution and function of GA production in plant-associated bacteria that may in turn provide 
insights that are not only pertinent to basic science, but that may also have agricultural relevance.  
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Figure 1. GA biosynthesis in plants, fungi, and bacteria.  Plant enzymes are shown in green, 
fungi in brown, and bacteria in blue.  GA4 is distinguished by a dotted box to signify 
convergence of all three kingdoms. 
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Figure 2. Structure of GA biosynthetic operon. a) In rhizobia, only the core operon genes 
(CYP112 thru KS) are invariably conserved, while CYP115 and IDI are only present in some 
strains.  Additionally, CYP115 is often located outside of the operon, but still within the 
symbiotic module. b) The operon in pathogens seems to always contain both CYP115 and IDI 
along with the core operon. 
 
 
Tables 
 
Table 1. List of α- and β-proteobacterial rhizobia that contain a GA biosynthetic operon and 
their corresponding legume host plant.  Legumes are categorized as having either determinate 
(D) or indeterminate (I) nodules.  Underlined strains contain a full-length, presumably functional 
CYP115 gene. *Neither determinate nor indeterminate. 
Species/strain Legume host Nodule type (D/I) 
 
α-proteobacteria 
 
  
Azorhizobium doebereinerae UFLA1-100 Sesbania virgata * 
Bradyrhizobium arachidis LMG 26795 Arachis hypogaea D 
Bradyrhizobium daqingense CGMCC 1.10947 Glycine max D 
Bradyrhizobium elkanii USDA 3254 Phaseolus acutifolius D 
Bradyrhizobium elkanii USDA 3259 Phaseolus lunatus D 
Bradyrhizobium elkanii WSM1741 Rhynchosia minima D 
Bradyrhizobium genosp. SA-4 CB756 Macrotyloma africanum D 
Bradyrhizobium huanghuaihaiense CGMCC 1.10948 Glycine max D 
Bradyrhizobium japonicum CCBAU 83623 Glycine max D 
Bradyrhizobium japonicum E109 Glycine max D 
Bradyrhizobium japonicum FN1 soil isolate N.A. 
Bradyrhizobium japonicum Is-1 Glycine max D 
Bradyrhizobium japonicum Is-34 Glycine max D 
Bradyrhizobium japonicum NK6 Glycine max D 
Bradyrhizobium japonicum SEMIA 5079 Glycine max D 
Bradyrhizobium japonicum USDA 110 Glycine max D 
Bradyrhizobium japonicum USDA 122 Glycine max D 
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Table 1 continued 
Bradyrhizobium japonicum USDA 123 Glycine max D 
Bradyrhizobium japonicum USDA 124 Glycine max D 
Bradyrhizobium japonicum USDA 135 Glycine max D 
Bradyrhizobium japonicum USDA 38 Glycine max D 
Bradyrhizobium japonicum USDA 4 Glycine max D 
Bradyrhizobium japonicum USDA 6 Glycine max D 
Bradyrhizobium liaoningense CCBAU 05525 Glycine max D 
Bradyrhizobium liaoningense CCBAU 83689 Glycine max D 
Bradyrhizobium pachyrhizi BR3262 Vigna unguiculata D 
Bradyrhizobium pachyrhizi PAC 48 Pachyrhizus erosus D 
Bradyrhizobium sp. CCBAU 15615 Glycine max D 
Bradyrhizobium sp. CCBAU 15635 Glycine max D 
Bradyrhizobium sp. CCBAU 43298 Glycine max D 
Bradyrhizobium sp. Cp5.3 Centrosema pubescens D 
Bradyrhizobium sp. ERR11 Erythrina brucei D 
Bradyrhizobium sp. Gha Vigna unguiculata D 
Bradyrhizobium sp. Ghvi Vigna unguiculata D 
Bradyrhizobium sp. R5 Vigna unguiculata D 
Bradyrhizobium sp. Rc2d Vigna unguiculata D 
Bradyrhizobium sp. Rc3b Vigna unguiculata D 
Bradyrhizobium sp. SEMIA 6148 Neonotonia wightii I 
Bradyrhizobium sp. SEMIA 6208 Desmodium heterocarpon D 
Bradyrhizobium sp. SEMIA 690 Centrosema pubescens D 
Bradyrhizobium sp. Th.b2 Amphicarpaea bracteata D 
Bradyrhizobium sp. USDA 3384 Kennedia coccinea D 
Bradyrhizobium sp. WSM1253 Ornithopus compressus D 
Bradyrhizobium sp. WSM1417 Lupinus sp. I 
Bradyrhizobium sp. WSM2254 Acacia dealbata I 
Bradyrhizobium sp. WSM2793 Rhynchosia totta D 
Bradyrhizobium sp. WSM3983 Kennedia coccinea D 
Bradyrhizobium sp. WSM471 Ornithopus pinnatus D 
Bradyrhizobium yuanmingense BR3267 Kennedia coccinea D 
Bradyrhizobium yuanmingense CCBAU 05623 Glycine max D 
Bradyrhizobium yuanmingense CCBAU 35157 Glycine max D 
Ensifer arboris LMG 14919 Prosopis chilensis I 
Ensifer aridi LMR001 Acacia gummifera I 
Ensifer fredii GR64 Phaseolus vulgaris D 
Ensifer fredii NGR234 Lablab purpureus D 
Ensifer medicae WSM1369 Medicago murex I 
Ensifer medicae WSM4191 Melilotus siculus I 
Ensifer meliloti 4H41 Phaseolus vulgaris D 
Ensifer meliloti GVPV12 Phaseolus vulgaris D 
Ensifer sp. LCM 4579 Prosopis juliflora I 
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Table 1 continued 
Ensifer sp.  WSM1721 Indigofera sp. I 
Ensifer sp. PC2 Prosopis cineraria I 
Ensifer sp. TW10 Tephrosia purpurea I 
Mesorhizobium alhagi CCNWXJ12-2 Alhagi sparsifolia I 
Mesorhizobium amorphae CCNWGS0123 Robinia pseudoacacia I 
Mesorhizobium ciceri bv. biserrulae WSM1284 Biserrula pelecinus I 
Mesorhizobium loti CJ3sym Lotus corniculatus D 
Mesorhizobium loti MAFF303099 Lotus pedunculatus D 
Mesorhizobium loti NZP2042 Lotus sp. D 
Mesorhizobium loti NZP2014 Lotus sp. D 
Mesorhizobium loti NZP2037 Lotus divaricatus D 
Mesorhizobium loti R7A Lotus corniculatus D 
Mesorhizobium loti R88b Lotus corniculatus D 
Mesorhizobium loti TONO Lotus japonicus D 
Mesorhizobium loti USDA 3471 Lotus corniculatus D 
Mesorhizobium sp. AA22 Biserrula pelecinus L. I 
Mesorhizobium sp. L103C105A0 Acmispon wrangelianus D 
Mesorhizobium sp. L2C066B000 Acmispon wrangelianus D 
Mesorhizobium sp. L2C085B000 Acmispon wrangelianus D 
Mesorhizobium sp. L48C026A00 Acmispon wrangelianus D 
Mesorhizobium sp. LNHC232B00 Acmispon wrangelianus D 
Mesorhizobium sp. LNJC372A00 Acmispon wrangelianus D 
Mesorhizobium sp. LSHC412B00 Acmispon wrangelianus D 
Mesorhizobium sp. LSHC414A00 Acmispon wrangelianus D 
Mesorhizobium sp. LSHC420B00 Acmispon wrangelianus D 
Mesorhizobium sp. LSHC422A00 Acmispon wrangelianus D 
Mesorhizobium sp. LSHC440B00 Acmispon wrangelianus D 
Mesorhizobium sp. LSJC265A00 Acmispon wrangelianus D 
Mesorhizobium sp. LSJC268A00 Acmispon wrangelianus D 
Mesorhizobium sp. LSJC269B00 Acmispon wrangelianus D 
Mesorhizobium sp. LSJC277A00 Acmispon wrangelianus D 
Mesorhizobium sp. SEMIA 3007 Pisum sativum I 
Mesorhizobium sp. STM 4661 Anthyllis vulneraria D 
Mesorhizobium sp. WSM1293 Lotus sp. D 
Mesorhizobium sp. WSM2561 Lessertia diffusa I 
Mesorhizobium sp. WSM3224 Otholobium candicans D 
Mesorhizobium sp. WSM3626 Lessertia diffusa I 
Microvirga lupini Lut6 Lupinus texensis I 
Rhizobium boleqi HBR26 Phaseolus vulgaris D 
Rhizobium etli bv. mimosae IE4771 Phaseolus vulgaris D 
Rhizobium etli bv. mimosae Mim1 Mimosa affinis I 
Rhizobium etli bv. phaseoli IE4803 Phaseolus vulgaris D 
Rhizobium etli CFN 42, DSM 11541 Phaseolus vulgaris D 
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Table 1 continued 
Rhizobium etli CIAT 652 Phaseolus vulgaris D 
Rhizobium gallicum bv. gallicum R602 Phaseolus vulgaris D 
Rhizobium leguminosarum bv. phaseoli 4292 Phaseolus vulgaris D 
Rhizobium leguminosarum bv. phaseoli CCGM1 Phaseolus vulgaris D 
Rhizobium leguminosarum bv. phaseoli FA23 Phaseolus vulgaris D 
Rhizobium leguminosarum bv. trifolii CC278f Trifolium nanum I 
Rhizobium leguminosarum bv. trifolii CC283b Trifolium ambiguum I 
Rhizobium leguminosarum bv. viciae VF39 Vicia faba I 
Rhizobium leucaenae USDA 9039 Phaseolus vulgaris D 
Rhizobium lusitanum P1-7 Phaseolus vulgaris D 
Rhizobium mesoamericanum STM3625 Mimosa pudica I 
Rhizobium mesoamericanum STM6155 Mimosa pudica I 
Rhizobium mongolense USDA 1844 Medicago ruthenica I 
Rhizobium phaseoli Ch24-10 Phaseolus vulgaris (maize stem 
isolate) 
D 
Rhizobium sp. CCGE 502 Dalea leporin I 
Rhizobium sp. CCGE 510 Phaseolus albescens D 
Rhizobium sp. CNPSO 671 Phaseolus vulgaris D 
Rhizobium sp. FH23 Phaseolus vulgaris D 
Rhizobium favelukesii OR 191 Medicago sativa I 
Rhizobium sp. Pop5 Phaseolus vulgaris D 
Rhizobium tibeticum CGMCC 1.7071 Trigonella archiducis I 
Rhizobium tropici CIAT899 Phaseolus vulgaris D 
Rhizobium tropici PRF 81 Phaseolus vulgaris D 
Sinorhizobium americanum CCGM7 Phaseolus vulgaris D 
Sinorhizobium fredii CCBAU 83666 AJQR Glycine max D 
 
β-proteobacteria 
 
  
Burkholderia sp. JPY251 Mimosa velloziana I 
Burkholderia sp. UYPR1.413 Parapiptadenia rigida I 
Paraburkholderia mimosarum LMG 23256 Mimosa pigra I 
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Table 2.  List of γ-proteobacteria that contain a GA biosynthetic operon, along with the host or 
source from which they were isolated. N.A. = not available. 
Species/strain Host/Isolation source 
Erwinia tracheiphila BuffGH Cucurbita pepo var. texana 
Erwinia tracheiphila DSM 21139 Cucumis melo 
Pseudomonas psychrotolerans  NS274 Oryza sativa seeds 
Pseudomonas psychrotolerans  RSA46 Oryza sativa seeds 
Xanthomonas axonopodis DSM 3585 Axonopus scoparius 
Xanthomonas axonopodis pv. axonopodis LMG 982 Axonopus scoparius 
Xanthomonas oryzae CIX44 Oryza sativa 
Xanthomonas oryzae pv. oryzicola B8-12 Oryza sativa 
Xanthomonas oryzae pv. oryzicola BLS256 Oryza sativa 
Xanthomonas oryzae pv. oryzicola BLS279 Oryza sativa 
Xanthomonas oryzae pv. oryzicola BXOR1 Oryza sativa 
Xanthomonas oryzae pv. oryzicola CFBP2286 Oryza sativa 
Xanthomonas oryzae pv. oryzicola CFBP7331 Oryza sativa 
Xanthomonas oryzae pv. oryzicola CFBP7341 Oryza sativa 
Xanthomonas oryzae pv. oryzicola CFBP7342 wild rice species 
Xanthomonas oryzae pv. oryzicola L8 Oryza sativa 
Xanthomonas oryzae pv. oryzicola MAI10 Oryza sativa 
Xanthomonas oryzae pv. oryzicola RS105 Oryza sativa 
Xanthomonas oryzae pv. oryzicola YM15 Oryza sativa 
Xanthomonas oryzae X11-5A Oryza sativa 
Xanthomonas translucens B1 Hordeum vulgare 
Xanthomonas translucens CR31 Triticum aesvitum 
Xanthomonas translucens CS2 Triticum aesvitum 
Xanthomonas translucens CS22 Triticum aesvitum 
Xanthomonas translucens CS4 Triticum aesvitum 
Xanthomonas translucens DAR61454 Triticum aesvitum 
Xanthomonas translucens LB10 Triticum aesvitum 
Xanthomonas translucens LB5 Triticum aesvitum 
Xanthomonas translucens LG48 Triticum aesvitum 
Xanthomonas translucens LG54 Triticum aesvitum 
Xanthomonas translucens LW16 Triticum aesvitum 
Xanthomonas translucens P3 Triticum aesvitum 
Xanthomonas translucens pv. arrhenatheri LMG 727 Arrhenatherum elatius 
Xanthomonas translucens pv. cerealis CFBP 2541 Bromus inermis 
Xanthomonas translucens pv. graminis ART-Xtg29 Lolium multiflorum 
Xanthomonas translucens pv. graminis CFBP 2053 Dactylis glomerata 
Xanthomonas translucens pv. phlei LMG 730 Phleum pratense 
Xanthomonas translucens pv. poae LMG 728 Poa trivialis 
Xanthomonas translucens pv. translucens DSM 18974 Hordeum vulgare 
Xanthomonas translucens pv. translucens UPB787 Hordeum vulgare 
Xanthomonas translucens pv. undulosa Xtu4699 Triticum aesvitum 
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Table 2 continued 
Xanthomonas translucens XT-Rocky Triticum aesvitum 
Xanthomonas translucens XT123 Hordeum vulgare 
Xanthomonas translucens XT130 N.A. 
Xanthomonas translucens XT5523 Triticum aesvitum 
Xanthomonas translucens XT5770 N.A. 
Xanthomonas translucens XT5791 Triticum aesvitum 
Xanthomonas translucens XT8 Hordeum vulgare 
 
